Publications – 2023

  • Hong G, Hansen B, Gulati M The delusion of measuring blood pressure. Br J Cardiol. 2023 Aug 9;30(3):23. doi: 10.5837/bjc.2023.023. eCollection 2023.
  • Ybarra LF, Lim MJ, Baron SJ, Cannon LA, Caputo RP, Cigarroa JE, Dangas GD, Grines CL, Kolansky DM, Naidu SS, Rao SV, Seto A, Henry TD, Baumgard CS, Bell B, Bijoux I, Didonato D, Dunham D, Long V, Lonn L, Martin E, Moriarty B, Shadiow S, Sharma V, West NEJ, Zizzo S, SCAI 2022 Think Tank Coronary Consortium Adopting Best Practices in the Management of Coronary Calcification. J Soc Cardiovasc Angiogr Interv. 2022 Sep 29;2(1):100456. doi: 10.1016/j.jscai.2022.100456. eCollection 2023 Jan-Feb.
  • Altin SE, Box LC, Das T, Feldman DN, Jayasuriya S, Klein AJ, Latif F, Li J, Parikh SA, Secemsky EA, Swaminathan RV, Boutin E, Canorea-Vega F, Chakrabarti AK, Hasegawa J, Howie N, Kohler T, Lauridsen HM, Perez O, Rangwala N, Schicchi M, Taber M, Venditto J, Wimberger J, Zinn L, SCAI 2022 Think Tank Peripheral Consortium Value-Based Interventions for Lower Extremity Peripheral Vascular Interventions. J Soc Cardiovasc Angiogr Interv. 2023 Jan 4;2(1):100533. doi: 10.1016/j.jscai.2022.100533. eCollection 2023 Jan-Feb.
  • Klein LW, Nathan S, Maehara A, Messenger J, Mintz GS, Ali ZA, Rymer J, Sandoval Y, Al-Azizi K, Mehran R, Rao SV, Lotfi A SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis. J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):100971. doi: 10.1016/j.jscai.2023.100971. eCollection 2023 Jul-Aug.
  • Fanaroff AC, Dayoub EJ, Yang L, Shultz K, Ramadan OI, Genovese EA, Wang GJ, Damrauer SM, Secemsky EA, Parikh SA, Nathan AS, Jaff MR, Groeneveld PW, Giri J Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia. J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100982. doi: 10.1016/j.jscai.2023.100982. eCollection 2023 Jul-Aug.
  • Raja A, Secemsky EA Late Mortality and Paclitaxel-Coated Devices: Has the Controversy Finally Come to an End? J Soc Cardiovasc Angiogr Interv. 2023 Jul 12;2(4):100981. doi: 10.1016/j.jscai.2023.100981. eCollection 2023 Jul-Aug.
  • Almarzooq ZI, Tamez H, Wang Y, Curtis JP, Kirtane AJ, Secemsky EA, Valsdottir LR, Yeh RW Long-Term Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention Among Medicare Beneficiaries. J Soc Cardiovasc Angiogr Interv. 2023 Jan 26;2(2):100584. doi: 10.1016/j.jscai.2023.100584. eCollection 2023 Mar-Apr.
  • Cremer PC, Lin D, Luis SA, Petersen J, Abbate A, Jellis CL, Kwon D, Brucato A, Fang F, Insalaco A, LeWinter M, Lewis BS, Zou L, Nicholls SJ, Klein AL, Imazio M, Paolini JF, RHAPSODY Investigators Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis. Eur Heart J Imaging Methods Pract. 2023 May 26;1(1):qyad003. doi: 10.1093/ehjimp/qyad003. eCollection 2023 May.
  • Motairek I, Deo SV, Elgudin Y, McAllister DA, Brook RD, Chen Z, Su J, Rao SV, Rajagopalan S, Al-Kindi S Particulate Matter Air Pollution and Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention. JACC Adv. 2023 Feb 24;2(3):100285. doi: 10.1016/j.jacadv.2023.100285. eCollection 2023 May.
  • Salah HM, Butler J, Fudim M Rapid Sequence Initiation of Device Therapy in Heart Failure. JACC Adv. 2023 May 10;2(3):100316. doi: 10.1016/j.jacadv.2023.100316. eCollection 2023 May.
  • Shvilkin A, Vukajlovic D, Bojovic BP, Hadzievski LR, Vajdic B, Atanasoski VA, Miletic MN, Zimetbaum PJ, Gibson CM, Vukcevic V Coronary Artery Occlusion Detection Using 3-Lead ECG System Suitable for Credit Card-Size Personal Device Integration. JACC Adv. 2023 Jul 27;2(6):100454. doi: 10.1016/j.jacadv.2023.100454. eCollection 2023 Aug.
  • Patel KV, Saha A, Ayers CR, Rohatgi A, Berry JD, Almandoz JP, Johannsen NM, deFilippi C, Church TS, de Lemos JA, Pandey A Exercise Training, Cardiac Biomarkers, and Cardiorespiratory Fitness in Type 2 Diabetes: The HART-D Study. JACC Adv. 2023 Jan 27;2(1):100174. doi: 10.1016/j.jacadv.2022.100174. eCollection 2023 Jan.
  • Sevilla-Cazes J, Almarzooq ZI, Kyalwazi AN, Wang Y, Song Y, Batchelor WB, Keller VA, Strom J, Wadhera RK, Yeh RW Residential Racial Segregation in Aortic Stenosis Diagnosis and Transcatheter Aortic Valve Implantation Among Medicare Patients. JACC Adv. 2023 Jul 19;2(5):100415. doi: 10.1016/j.jacadv.2023.100415. eCollection 2023 Jul.
  • Evans K, Wu P, Mamas MA, Irwin C, Kang P, Perlow JH, Foley M, Gulati M Substance Use in Pregnancy and its Association With Cardiovascular Events. JACC Adv. 2023 Sep 14;2(8):100619. doi: 10.1016/j.jacadv.2023.100619. eCollection 2023 Oct.
  • Mehran R, Spirito A, Jin J, Chen C, Seeger J, Mascherbauer J, Vranckx P, Moreno R, Lang IM, Duggal A, Watanabe Y, Capranzano P, Kini AS, Veulemans V, Tessitore E, Hayashida K, Unverdorben M, Van Mieghem NM, Hengstenberg C, Dangas GD Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR. JACC Adv. 2023 Mar 8;2(2):100259. doi: 10.1016/j.jacadv.2023.100259. eCollection 2023 Mar.
  • Kahwash R, Butler J Sodium-Glucose Cotransporter-2 Inhibitors as Enablers of Chronic Glucocorticoid Therapy. JACC Adv. 2023 May 24;2(4):100343. doi: 10.1016/j.jacadv.2023.100343. eCollection 2023 Jun.
  • Nicholls SJ, Chew DP Is it Time to Rethink Screening for Familial Hypercholesterolemia? JACC Adv. 2023 Jun 7;2(4):100336. doi: 10.1016/j.jacadv.2023.100336. eCollection 2023 Jun.
  • Grewal PK, Abboud A, Myserlis EP, Goldschmidt ME, Butler J, Skopicki HA, Kalogeropoulos AP Sacubitril/Valsartan and Cognitive Outcomes in Heart Failure With Reduced Ejection Fraction. JACC Adv. 2023 Jun 7;2(4):100372. doi: 10.1016/j.jacadv.2023.100372. eCollection 2023 Jun.
  • Mehta PK, Levit RD, Wood MJ, Aggarwal N, O’Donoghue ML, Lim SS, Lindley K, Gaignard S, Quesada O, Vatsa N, Leon A, Volgman AS, Malas W, Pepine CJ, American College of Cardiology Cardiovascular Disease in Women Committee Chronic rheumatologic disorders and cardiovascular disease risk in women. Am Heart J Plus. 2023 Feb 9;27:100267. doi: 10.1016/j.ahjo.2023.100267. eCollection 2023 Mar.
  • Bakhshi H, Gibson CM MINOCA: Myocardial infarction no obstructive coronary artery disease. Am Heart J Plus. 2023 Jul 29;33:100312. doi: 10.1016/j.ahjo.2023.100312. eCollection 2023 Sep.
  • Wang JY, Wilson M, Andreev A, Tarsia J, Selim M, Lioutas VA The role of hyperglycemia in the outcome of intracerebral hemorrhage: A causative analysis. J Stroke Cerebrovasc Dis. 2023 Dec;32(12):107439. doi: 10.1016/j.jstrokecerebrovasdis.2023.107439. Epub 2023 Oct 31.
  • Patel J, Almeida H, Alhadad SZ, Pinto AC, Foley M, Al-Lamee R Digital app reshaping cardiac rehabilitation: a pilot study. Future Healthc J. 2023 Nov;10(Suppl 3):15-17. doi: 10.7861/fhj.10-3-s15.
  • Kondo T, Gasparyan SB, Jhund PS, Bengtsson O, Claggett BL, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Kober L, Lam CSP, Langkilde AM, Martinez FA, Petersson M, Ponikowski P, Sabatine MS, Shah SJ, Sjostrand M, Wilderang U, Vaduganathan M, Solomon SD, McMurray JJV Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials. NEJM Evid. 2023 Nov;2(11):EVIDoa2300042. doi: 10.1056/EVIDoa2300042. Epub 2023 Oct 24.
  • Koshino A, Schechter M, Chertow GM, Vart P, Jongs N, Toto RD, Rossing P, Correa-Rotter R, McMurray JJV, Gorriz JL, Isidto R, Kashihara N, Langkilde AM, Wheeler DC, Heerspink HJL Dapagliflozin and Anemia in Patients with Chronic Kidney Disease. NEJM Evid. 2023 Jun;2(6):EVIDoa2300049. doi: 10.1056/EVIDoa2300049. Epub 2023 May 19.
  • Chi G, AlKhalfan F, Lee JJ, Montazerin SM, Fitzgerald C, Korjian S, Omar W, Barnathan E, Plotnikov A, Gibson CM Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial. Front Cardiovasc Med. 2024 Jan 8;10:1269011. doi: 10.3389/fcvm.2023.1269011. eCollection 2023.
  • Sparrow RT, Sposato LA, Alkhouli MA, Garcia S, Elgendy IY, Kuchtaruk AA, Jneid H, Alraies MC, Tzemos N, Mamas MA, Bagur R Readmissions After Left Atrial Appendage Closure in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. CJC Open. 2023 Sep 17;5(12):950-964. doi: 10.1016/j.cjco.2023.09.009. eCollection 2023 Dec.
  • Laferriere C, Moazzami C, Belley-Cote E, Bainey KR, Marquis-Gravel G, Fama A, Lordkipanidze M, Potter BJ Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making. CJC Open. 2023 Aug 30;5(12):881-890. doi: 10.1016/j.cjco.2023.08.011. eCollection 2023 Dec.
  • Schuermans A, Pournamdari AB, Lee J, Bhukar R, Ganesh S, Darosa N, Small AM, Yu Z, Hornsby W, Koyama S, Januzzi JL, Honigberg MC, Natarajan P Integrative proteomic analyses across common cardiac diseases yield new mechanistic insights and enhanced prediction. medRxiv [Preprint]. 2023 Dec 19:2023.12.19.23300218. doi: 10.1101/2023.12.19.23300218.
  • Majety P, Daaboul Y, Rencic J Learning Theories Versus Practice: How Do Internal Medicine Residents Study for Licensing Examinations? Cureus. 2023 Dec 6;15(12):e50052. doi: 10.7759/cureus.50052. eCollection 2023 Dec.
  • Decicco E, Peterson ED, Gupta A, Khalaf Gillard K, Sarnes E, Navar AM Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States. Am J Prev Cardiol. 2023 Nov 12;16:100604. doi: 10.1016/j.ajpc.2023.100604. eCollection 2023 Dec.
  • Myadam R, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Jasti S, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J, Cardiac Sarcoidosis Consortium Reply: Association of Adverse Events With the Different Diagnostic Schemes of Cardiac Sarcoidosis. JACC Clin Electrophysiol. 2023 Dec;9(12):2662-2663. doi: 10.1016/j.jacep.2023.07.011.
  • Lawless M, Damluji A, Dirjayanto VJ, Mills G, Pompei G, Rubino F, Kunadian V Differences in treatment and clinical outcomes in patients aged >/=75 years compared with those aged </=74 years following acute coronary syndromes: a prospective multicentre study. Open Heart. 2023 Dec 26;10(2):e002418. doi: 10.1136/openhrt-2023-002418.
  • Bhagat AA, Kalogeropoulos AP, Baer L, Lacey M, Kort S, Skopicki HA, Butler J, Bloom MW Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines. J Pers Med. 2023 Dec 14;13(12):1710. doi: 10.3390/jpm13121710.
  • Hegeman RRMJJ, McManus S, Toth A, Ladeiras-Lopes R, Kitslaar P, Bui V, Dukker K, Harb SC, Swaans MJ, Ben-Yehuda O, Klein P, Puri R Reference Values for Inward Displacement in the Normal Left Ventricle: A Novel Method of Regional Left Ventricular Function Assessment. J Cardiovasc Dev Dis. 2023 Nov 24;10(12):474. doi: 10.3390/jcdd10120474.
  • White HD Changing the Orbit around Percutaneous Coronary Intervention for Stable Angina. N Engl J Med. 2023 Dec 21;389(25):2387-2388. doi: 10.1056/NEJMe2312633.
  • Kalyani RR, Everett BM, Perreault L, Michos ED Heart Disease and Diabetes. N/A
  • Patel SM, Bonaca MP, Morrow DA, Palazzolo MG, Jarolim P, Steg PG, Bhatt DL, Storey RF, Sabatine MS, O’Donoghue ML Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 Trial. JACC Adv. 2023 Nov;2(9):100675. doi: 10.1016/j.jacadv.2023.100675. Epub 2023 Oct 28.
  • Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ Omega-3 fatty acids and cardiovascular prevention: is the jury still out? Intern Med J. 2023 Dec;53(12):2330-2335. doi: 10.1111/imj.16283. Epub 2023 Dec 17.
  • Siegal DM, Verbrugge FH, Martin AC, Virdone S, Camm J, Pieper K, Gersh BJ, Goto S, Turpie AGG, Angchaisuksiri P, Fox KAA Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke. Open Heart. 2023 Dec 14;10(2):e002506. doi: 10.1136/openhrt-2023-002506.
  • Teramoto K, Ouwerkerk W, Tay WT, Tromp J, Katherine Teng TH, Chandramouli C, Fermer ML, Hung CL, Anand I, Solomon SD, Voors AA, McMurray JJV, Lund LH, Shah SJ, Richards AM, Lam CSP, ASIAN-HF Investigators Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF Registry. JACC Asia. 2023 Aug 22;3(5):739-751. doi: 10.1016/j.jacasi.2023.06.007. eCollection 2023 Oct.
  • Azzopardi R, Nicholls SJ, Nerlekar N, Scherer DJ, Chandramouli C, Lam CSP, Muthalaly R, Tan S, Wong CX, Chew DP, Zoungas S, Yeo KK, Nelson AJ Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020. JACC Asia. 2023 Jul 4;3(5):724-735. doi: 10.1016/j.jacasi.2023.05.010. eCollection 2023 Oct.
  • Withaar C, Meems LMG, Nollet EE, Schouten EM, Schroeder MA, Knudsen LB, Niss K, Madsen CT, Hoegl A, Mazzoni G, van der Velden J, Lam CSP, Sillje HHW, de Boer RA The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF. JACC Basic Transl Sci. 2023 Jul 26;8(10):1298-1314. doi: 10.1016/j.jacbts.2023.05.012. eCollection 2023 Oct.
  • Uzendu A, Chertow GM, Spertus J Reply: Retaining Race in Predicting AKI After Coronary Intervention. JACC Cardiovasc Interv. 2023 Dec 11;16(23):2932. doi: 10.1016/j.jcin.2023.10.053.
  • Chung M, Almarzooq ZI, Xu J, Song Y, Baron SJ, Kazi DS, Yeh RW Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Circ Cardiovasc Qual Outcomes. 2023 Dec;16(12):e010034. doi: 10.1161/CIRCOUTCOMES.123.010034. Epub 2023 Dec 12.
  • Perreault L, Kramer ES, Smith PC, Schmidt D, Argyropoulos C A closer look at weight loss interventions in primary care: a systematic review and meta-analysis. Front Med (Lausanne). 2023 Nov 23;10:1204849. doi: 10.3389/fmed.2023.1204849. eCollection 2023.
  • Connors JM, Fein S How to manage ITP with life-threatening bleeding. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):254-258. doi: 10.1182/hematology.2023000478.
  • Nagori A, Segar MW, Keshvani N, Patel L, Patel KV, Chandra A, Willett D, Pandey A Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System. J Diabetes Sci Technol. 2023 Dec 8:19322968231212219. doi: 10.1177/19322968231212219.
  • Wright RS, Koenig W, Landmesser U, Leiter LA, Raal FJ, Schwartz GG, Lesogor A, Maheux P, Stratz C, Zang X, Ray KK Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials. J Am Coll Cardiol. 2023 Dec 12;82(24):2251-2261. doi: 10.1016/j.jacc.2023.10.007.
  • Dang Q, Othman F, Sheahen B, Marschner S, Psaltis P, Al-Lamee RK, Szirt R, Chong J, Zaman S Regional and temporal variations of spontaneous coronary artery dissection care according to consensus recommendations: a systematic review and meta-analysis. Open Heart. 2023 Dec 6;10(2):e002379. doi: 10.1136/openhrt-2023-002379.
  • Kovacevic M, Pompei G, Kunadian V Tailoring antiplatelet therapy in older patients with coronary artery disease. Platelets. 2023 Dec;34(1):2285446. doi: 10.1080/09537104.2023.2285446. Epub 2023 Dec 5.
  • Laudani C, Capodanno D, Angiolillo DJ Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management. Expert Opin Drug Saf. 2023 Jul-Dec;22(12):1193-1212. doi: 10.1080/14740338.2023.2291865. Epub 2023 Dec 18.
  • Miller M, Bhatt DL, Brinton EA, Jacobson TA, Steg PG, Pineda AL, Ketchum SB, Doyle RT Jr, Tardif JC, Ballantyne CM Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn. Eur Heart J Open. 2023 Nov 12;3(6):oead114. doi: 10.1093/ehjopen/oead114. eCollection 2023 Nov.
  • Arias-Mendoza A, Ortega-Hernandez JA, Araiza-Garaygordobil D, Gonzalez-Pacheco H, Martinez-Garcia M, Hernandez-Lemus E, Gopar-Nieto R, Sandoval-Aguilar TT, Sierra-Lara Martinez D, Mendoza-Garcia S, Altamirano-Castillo A, Briseno-de-la-Cruz JL, Ortega-Hernandez MA, Soliz-Uriona LA, Gaspar-Hernandez J Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits. Ther Clin Risk Manag. 2023 Nov 10;19:903-911. doi: 10.2147/TCRM.S432683. eCollection 2023.
  • Pope MK, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry. Int J Cardiol Heart Vasc. 2023 Nov 16;49:101302. doi: 10.1016/j.ijcha.2023.101302. eCollection 2023 Dec.
  • Landmesser U, Koenig W, Leiter LA, Raal FJ, Ray KK, Wright RS, Han J, Conde LG, Schwartz GG Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials. Atherosclerosis. 2023 Dec;386:117354. doi: 10.1016/j.atherosclerosis.2023.117354. Epub 2023 Oct 18.
  • Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Nowbar AN, Simader FA, Davies JR, O’Kane PD, Haworth P, Routledge H, Kotecha T, Gamma R, Clesham G, Williams R, Din J, Nijjer SS, Curzen N, Ruparelia N, Sinha M, Dungu JN, Ganesananthan S, Khamis R, Mughal L, Kinnaird T, Petraco R, Spratt JC, Sen S, Sehmi J, Collier DJ, Sohaib A, Keeble TR, Cole GD, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee RK, ORBITA-2 Investigators A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. N Engl J Med. 2023 Dec 21;389(25):2319-2330. doi: 10.1056/NEJMoa2310610. Epub 2023 Nov 11.
  • Greene SJ, Butler J Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral Diuretics. Circulation. 2023 Nov 28;148(22):1746-1749. doi: 10.1161/CIRCULATIONAHA.123.066915. Epub 2023 Nov 27.
  • Kadakia KT, Kramer DB, Yeh RW Coverage for Emerging Technologies – Bridging Regulatory Approval and Patient Access. N Engl J Med. 2023 Nov 30;389(22):2021-2024. doi: 10.1056/NEJMp2308736. Epub 2023 Nov 25.
  • Atreja N, Severtson SG, Jiang J, Gao C, Hines DM, Cheng D, Hagan M, Breeze JL, Paulus JK, Secemsky EA The Association between Direct Oral Anticoagulants Prescribing Behavior and Non-Valvular Atrial Fibrillation Outcomes: An Instrumental Variable Analysis of Real-World Data. J Clin Med. 2023 Nov 20;12(22):7190. doi: 10.3390/jcm12227190.
  • Labrada L, Romero C, Sadek A, Belardo D, Raza Y, Forfia P Intravenous Diuresis in Severe Precapillary Pulmonary-Hypertension-Related Right Heart Failure: Effects on Renal Function and Blood Pressure. J Clin Med. 2023 Nov 17;12(22):7149. doi: 10.3390/jcm12227149.
  • Riccardi M, Myhre PL, Zelniker TA, Metra M, Januzzi JL, Inciardi RM Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide. J Cardiovasc Dev Dis. 2023 Nov 17;10(11):468. doi: 10.3390/jcdd10110468.
  • Ahmed A, Anker SD, Butler J, Bakris GL, Bhatt DL, Fonarow GC, Packer M Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial. Lancet Diabetes Endocrinol. 2023 Dec;11(12):892-894. doi: 10.1016/S2213-8587(23)00291-7.
  • Butler J, Filippatos G Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes. Future Cardiol. 2023 Dec;19(15):723-733. doi: 10.2217/fca-2023-0080. Epub 2023 Nov 23.
  • Al-Mukhtar O, Stub D, Reid CM, Lo S, Lefkovits J, Walton A, Chew DP, Yong A, Nicholls SJ, Cox N, Peter K, Chan W Variability in Contemporary Heparin Prescription and Activated Clotting Time Monitoring During Percutaneous Coronary Intervention: Call for Up-To-Date Evidence-Based Guidelines. Heart Lung Circ. 2023 Dec;32(12):1475-1481. doi: 10.1016/j.hlc.2023.09.020. Epub 2023 Nov 22.
  • Butler J, Abildstrom SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Nunez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction. J Am Coll Cardiol. 2023 Nov 28;82(22):2087-2096. doi: 10.1016/j.jacc.2023.09.811. Epub 2023 Oct 8.
  • Cossio-Aranda JE, Jain V, Figueiras-Graillet LM, Arias-Mendoza A, Lopez-Cuellar J, Betancourt-Alvara AB, Sosa-Liprandi A, Pinto F, Eisele JL, Pineiro D Toward a better understanding of cardiovascular risk in the transgender and gender-diverse community: a supplement to the Tijuana Declaration. Arch Cardiol Mex. 2023;93(Supl):1-4. doi: 10.24875/ACME.M23000422.
  • Tang GHL, Spencer J, Rogers T, Grubb KJ, Gleason P, Gada H, Mahoney P, Dauerman HL, Forrest JK, Reardon MJ, Blanke P, Leipsic JA, Abdel-Wahab M, Attizzani GF, Puri R, Caskey M, Chung CJ, Chen YH, Dudek D, Allen KB, Chhatriwalla AK, Htun WW, Blackman DJ, Tarantini G, Zhingre Sanchez J, Schwartz G, Popma JJ, Sathananthan J Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study. Circ Cardiovasc Interv. 2023 Nov;16(11):e013238. doi: 10.1161/CIRCINTERVENTIONS.123.013238. Epub 2023 Nov 21.
  • Law AC, Bosch NA, Song Y, Tale A, Yeh RW, Kahn JM, Stevens JP, Walkey AJ Patient Outcomes After Long-Term Acute Care Hospital Closures. JAMA Netw Open. 2023 Nov 1;6(11):e2344377. doi: 10.1001/jamanetworkopen.2023.44377.
  • Liu M, Aggarwal R, Zheng Z, Yeh RW, Kazi DS, Joynt Maddox KE, Wadhera RK Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study. Ann Intern Med. 2023 Dec;176(12):1595-1605. doi: 10.7326/M23-2109. Epub 2023 Nov 21.
  • Goto S, Goto S Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active Cancer in a Nation With an Overall Low Risk of Thrombosis. Circulation. 2023 Nov 21;148(21):1677-1679. doi: 10.1161/CIRCULATIONAHA.123.066956. Epub 2023 Nov 20.
  • Chen AC, Rao AS, Oropallo A, Goldhaber SZ, Fluharty ME, Maheshwari U, Carrier M, Turpie AGG, Pieper K, Kayani G, Kakkar AK, GARFIELD-VTE investigators Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry. Thromb Res. 2023 Dec;232:123-132. doi: 10.1016/j.thromres.2023.11.008. Epub 2023 Nov 9.
  • Gerhardt T, Gerhardt LMS, Ouwerkerk W, Roth GA, Dickstein K, Collins SP, Cleland JGF, Dahlstrom U, Tay WT, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Lam CSP, Tromp J, Angermann CE Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. Lancet Glob Health. 2023 Dec;11(12):e1874-e1884. doi: 10.1016/S2214-109X(23)00408-4.
  • Bairey Merz CN, Gulati M, Wei J MINOCA: Diagnostic work-up, risk stratification and tailored therapies. Vascul Pharmacol. 2023 Dec;153:107243. doi: 10.1016/j.vph.2023.107243. Epub 2023 Nov 14.
  • Peters TG, Fung JJ, Radcliffe-Richards J, Satel S, Roth AE, McCormick F, Gershun M, Matas AJ, Roberts JP, Morrison J, Chertow GM, Lee LD, Held PJ, Ojo A Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation. Prog Transplant. 2023 Dec;33(4):363-371. doi: 10.1177/15269248231212911. Epub 2023 Nov 15.
  • Kusumoto FM, Bittl JA, Creager MA, Dauerman HL, Lala A, McDermott MM, Turco JV, Taqueti VR, Fuster V, Peer Review Task Force of the Scientific Publications Committee Challenges and Controversies in Peer Review: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Nov 21;82(21):2054-2062. doi: 10.1016/j.jacc.2023.08.056.
  • Usman MS, Davies M, Hall ME, Verma S, Anker SD, Rosenstock J, Butler J The cardiovascular effects of novel weight loss therapies. Eur Heart J. 2023 Dec 21;44(48):5036-5048. doi: 10.1093/eurheartj/ehad664.
  • Siegbahn A, Eriksson N, Assarsson E, Lundberg M, Ballagi A, Held C, Stewart RAH, White HD, Aberg M, Wallentin L Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21). PLoS One. 2023 Nov 14;18(11):e0293465. doi: 10.1371/journal.pone.0293465. eCollection 2023.
  • Zahr F, Smith RL, Gillam LD, Chadderdon S, Makkar R, von Bardeleben RS, Ruf TF, Kipperman RM, Rassi AN, Szerlip M, Goldman S, Inglessis-Azuaje I, Yadav P, Lurz P, Davidson CJ, Mumtaz M, Gada H, Kar S, Kodali SK, Laham R, Hiesinger W, Fam NP, Kessler M, O’Neill WW, Whisenant B, Kliger C, Kapadia S, Rudolph V, Choo J, Hermiller J, Morse MA, Schofer N, Gafoor S, Latib A, Mahoney P, Kaneko T, Shah PB, Riddick JA, Muhammad KI, Boekstegers P, Price MJ, Praz F, Koulogiannis K, Marcoff L, Hausleiter J, Lim DS, CLASP IID Pivotal Trial Investigators One-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation. JACC Cardiovasc Interv. 2023 Oct 26:S1936-8798(23)01358-4. doi: 10.1016/j.jcin.2023.10.002.
  • Dowling C, Haeffele C, Yeung AC, Sharma RP Emergency Transcatheter Repair for Anterior Leaflet Tear Following Percutaneous Balloon Mitral Valvuloplasty. JACC Case Rep. 2023 Aug 24;23:101980. doi: 10.1016/j.jaccas.2023.101980. eCollection 2023 Oct 4.
  • Lawler PR, Manvelian G, Coppi A, Damask A, Cantor MN, Ferreira MAR, Paulding C, Banerjee N, Li D, Jorgensen S, Attre R, Carey DJ, Krebs K, Milani L, Hveem K, Damas JK, Solligard E, Stender S, Tybjaerg-Hansen A, Nordestgaard BG, Hernandez-Beeftink T, Rogne T, Flores C, Villar J, Walley KR, Liu VX, Fohner AE, Lotta LA, Kyratsous CA, Sleeman MW, Scemama M, DelGizzi R, Pordy R, Horowitz JE, Baras A, Martin GS, Steg PG, Schwartz GG, Szarek M, Goodman SG Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis. Crit Care Explor. 2023 Nov 8;5(11):e0997. doi: 10.1097/CCE.0000000000000997. eCollection 2023 Nov.
  • Nissen SE, Linnebjerg H, Shen X, Wolski K, Ma X, Lim S, Michael LF, Ruotolo G, Gribble G, Navar AM, Nicholls SJ Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial. JAMA. 2023 Dec 5;330(21):2075-2083. doi: 10.1001/jama.2023.21835.
  • Carson JL, Brooks MM, Hebert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, Cooper HA, Ghafghazi S, Fergusson DA, Kostis WJ, Noveck H, Kim S, Tessalee M, Ducrocq G, de Barros E Silva PGM, Triulzi DJ, Alsweiler C, Menegus MA, Neary JD, Uhl L, Strom JB, Fordyce CB, Ferrari E, Silvain J, Wood FO, Daneault B, Polonsky TS, Senaratne M, Puymirat E, Bouleti C, Lattuca B, White HD, Kelsey SF, Steg PG, Alexander JH, MINT Investigators Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N Engl J Med. 2023 Dec 28;389(26):2446-2456. doi: 10.1056/NEJMoa2307983. Epub 2023 Nov 11.
  • Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, Gustafsson F, Connors JM, Ivak P, Cowger J, Ransom J, Bansal A, Takeda K, Agarwal R, Byku M, Givertz MM, Bitar A, Hall S, Zimpfer D, Vega JD, Kanwar MK, Saeed O, Goldstein DJ, Cogswell R, Sheikh FH, Danter M, Pya Y, Phancao A, Henderson J, Crandall DL, Sundareswaran K, Soltesz E, Estep JD, ARIES-HM3 Investigators Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023 Dec 12;330(22):2171-2181. doi: 10.1001/jama.2023.23204.
  • Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, Palaniappan LP, Sperling LS, Virani SS, Ho JE, Neeland IJ, Tuttle KR, Rajgopal Singh R, Elkind MSV, Lloyd-Jones DM, American Heart Association Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10.
  • Coylewright M, Holmes DR Jr, Kapadia SR, Hsu JC, Gibson DN, Freeman JV, Yeh RW, Piccini JP, Price MJ, Allocco DJ, Nair DG DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. JACC Cardiovasc Interv. 2023 Nov 27;16(22):2708-2718. doi: 10.1016/j.jcin.2023.08.013. Epub 2023 Nov 8.
  • Landi A, Morici N, Vranckx P, Frigoli E, Bonacchini L, Omazzi B, Tresoldi M, Camponovo C, Moccetti T, Valgimigli M Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial. J Cardiovasc Med (Hagerstown). 2023 Dec 1;24(12):920-930. doi: 10.2459/JCM.0000000000001556. Epub 2023 Nov 3.
  • Ouwerkerk W, Belo Pereira JP, Maasland T, Emmens JE, Figarska SM, Tromp J, Koekemoer AL, Nelson CP, Nath M, Romaine SPR, Cleland JGF, Zannad F, van Veldhuisen DJ, Lang CC, Ponikowski P, Filippatos G, Anker S, Metra M, Dickstein K, Ng LL, de Boer RA, van Riel N, Nieuwdorp M, Groen AK, Stroes E, Zwinderman AH, Samani NJ, Lam CSP, Levin E, Voors AA Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. J Am Coll Cardiol. 2023 Nov 14;82(20):1921-1931. doi: 10.1016/j.jacc.2023.08.053.
  • Testani JM, Butler J, Packer M Improved Decongestion With Devices in Decompensated Heart Failure: Does the End Justify the Means? JACC Heart Fail. 2023 Nov;11(11):1576-1578. doi: 10.1016/j.jchf.2023.07.006.
  • Mohebi R, Coresh J, Crews DC, Estrella MM, Levey AS, Liu Y, Matsushita K, Shlipak MG, Januzzi JL Jr Race-Free Creatinine-Based Estimation of GFR and Projection of CKD to 2060 in the United States. Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1476-1478. doi: 10.2215/CJN.0000000000000245. Epub 2023 Jun 29.
  • Reddy RK, Foley M, Giannini F, Al-Lamee RK Keeping it in the family: Use of the grandmother, mother, and child technique to navigate complex anatomy during Coronary sinus Reducer Implantation. Catheter Cardiovasc Interv. 2023 Nov;102(6):1057-1060. doi: 10.1002/ccd.30858. Epub 2023 Nov 8.
  • Boulet J, Mehra MR Crossing the chasm of donor organ recovery in heart transplantation. Eur Heart J. 2023 Nov 21;44(44):4675-4677. doi: 10.1093/eurheartj/ehac707.
  • Khan MS, Usman MS, Van Spall HGC, Greene SJ, Baqal O, Felker GM, Bhatt DL, Januzzi JL, Butler J Endpoint adjudication in cardiovascular clinical trials. Eur Heart J. 2023 Dec 7;44(46):4835-4846. doi: 10.1093/eurheartj/ehad718.
  • Nissen SE, Nicholls SJ, Lincoff AM Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply. JAMA. 2023 Nov 7;330(17):1696-1697. doi: 10.1001/jama.2023.17341.
  • Kodali S, Hahn RT, Makkar R, Makar M, Davidson CJ, Puthumana JJ, Zahr F, Chadderdon S, Fam N, Ong G, Yadav P, Thourani V, Vannan MA, O’Neill WW, Wang DD, Tchetche D, Dumonteil N, Bonfils L, Lepage L, Smith R, Grayburn PA, Sharma RP, Haeffele C, Babaliaros V, Gleason PT, Elmariah S, Inglessis-Azuaje I, Passeri J, Herrmann HC, Silvestry FE, Lim S, Fowler D, Webb JG, Moss R, Modine T, Lafitte S, Latib A, Ho E, Goldberg Y, Shah P, Nyman C, Rodes-Cabau J, Bedard E, Brugger N, Sannino A, Mack MJ, Leon MB, Windecker S, the TRISCEND study investigators Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur Heart J. 2023 Dec 7;44(46):4862-4873. doi: 10.1093/eurheartj/ehad667.
  • Yu C, Bakshi A, Watts GF, Renton AE, Fulton-Howard B, Goate AM, Natarajan P, Chasman DI, Robman L, Woods RL, Guymer R, Wolfe R, Thao LTP, McNeil JJ, Tonkin AM, Nicholls SJ, Lacaze P Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the CETP Gene. J Am Heart Assoc. 2023 Nov 7;12(21):e031459. doi: 10.1161/JAHA.123.031459. Epub 2023 Nov 6.
  • Deets A, Joshi PH, Chandra A, Singh K, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers C, Navar AM, Pandey A, Wilkins JT, Rohatgi A Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 Nov 7;12(21):e031160. doi: 10.1161/JAHA.123.031160. Epub 2023 Nov 6.
  • Gonzalez-Pacheco H, Ortega-Hernandez JA, Meza-Lopez JA, Soliz-Uriona LA, Manzur-Sandoval D, Gopar-Nieto R, Araiza-Garaygordobil D, Sierra-Lara D, Arias-Sanchez E, Sandoval JP, Altamirano-Castillo A, Mendoza-Garcia S, Arzate-Ramirez A, Baranda-Tovar FM, Martinez H, Montanez-Orozco A, Baeza-Herrera LA, Sierra-Gonzalez De Cossio A, Arias-Mendoza A Analysis of immortal-time effect in post-infarction ventricular septal defect. Front Cardiovasc Med. 2023 Oct 19;10:1270608. doi: 10.3389/fcvm.2023.1270608. eCollection 2023.
  • Novelli A, Ingason AB, Jirka C, Callas P, Hirashima F, Lovoulos C, Dauerman HL, Polomsky M Impact of the COVID-19 Pandemic on Infective Endocarditis Management and Outcomes: Analysis of a National Clinical Database. Am J Cardiol. 2023 Dec 15;209:224-231. doi: 10.1016/j.amjcard.2023.08.190. Epub 2023 Nov 1.
  • Galli M, Bernardi M, Ortega-Paz L, Nerla R, D’Amario D, Franchi F, Biondi-Zoccai G, Angiolillo DJ Bivalirudin in acute coronary syndromes. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):901-911. doi: 10.1080/14779072.2023.2273902. Epub 2023 Dec 13.
  • Aggarwal R, Bhatt DL, Szarek M, Cannon CP, McGuire DK, Inzucchi SE, Lopes RD, Davies MJ, Banks P, Pitt B, Steg PG Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c. J Am Coll Cardiol. 2023 Nov 7;82(19):1842-1851. doi: 10.1016/j.jacc.2023.08.050.
  • Smith RL, Lim DS, Gillam LD, Zahr F, Chadderdon S, Rassi AN, Makkar R, Goldman S, Rudolph V, Hermiller J, Kipperman RM, Dhoble A, Smalling R, Latib A, Kodali SK, Lazkani M, Choo J, Lurz P, O’Neill WW, Laham R, Rodes-Cabau J, Kar S, Schofer N, Whisenant B, Inglessis-Azuaje I, Baldus S, Kapadia S, Szerlip M, Kliger C, Boone R, Webb JG, Williams MR, von Bardeleben RS, Ruf TF, Guerrero M, Eleid M, McCabe JM, Davidson C, Hiesinger W, Kaneko T, Shah PB, Yadav P, Koulogiannis K, Marcoff L, Hausleiter J, CLASP IID Pivotal Trial Investigators 1-Year Outcomes of Transcatheter Edge-to-Edge Repair in Anatomically Complex Degenerative Mitral Regurgitation Patients. JACC Cardiovasc Interv. 2023 Dec 11;16(23):2820-2832. doi: 10.1016/j.jcin.2023.10.020. Epub 2023 Oct 24.
  • Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 Nov;16(11):e009751. doi: 10.1161/CIRCOUTCOMES.122.009751. Epub 2023 Oct 31.
  • Ter Maaten JM, Mebazaa A, Davison B, Edwards C, Adamo M, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Leopold V, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Tomasoni D, Metra M, Cotter G, Voors AA Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure. Eur J Heart Fail. 2023 Dec;25(12):2230-2242. doi: 10.1002/ejhf.3074. Epub 2023 Nov 20.
  • Buck BH, Sposato LA, Field TS Looking for Atrial Fibrillation With Insertable Cardiac Monitors-Is 1 Year Long Enough and Does it Matter? JAMA Neurol. 2023 Dec 1;80(12):1266-1268. doi: 10.1001/jamaneurol.2023.3377.
  • Vogel RF, Delewi R, Wilschut JM, Lemmert ME, Diletti R, van Vliet R, van der Waarden NWPL, Nuis RJ, Paradies V, Alexopoulos D, Zijlstra F, Montalescot G, Angiolillo DJ, Krucoff MW, Van Mieghem NM, Smits PC, Vlachojannis GJ Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-Study. J Clin Med. 2023 Oct 20;12(20):6645. doi: 10.3390/jcm12206645.
  • Cotter G, Davison BA, Lam CSP, Metra M, Ponikowski P, Teerlink JR, Mebazaa A Acute Heart Failure Is a Malignant Process: But We Can Induce Remission. J Am Heart Assoc. 2023 Nov 7;12(21):e031745. doi: 10.1161/JAHA.123.031745. Epub 2023 Oct 27.
  • Murtagh G, Januzzi JL, Scherrer-Crosbie M, Neilan TG, Dent S, Ho JE, Appadurai V, McDermott R, Akhter N Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions. J Am Heart Assoc. 2023 Nov 7;12(21):e029574. doi: 10.1161/JAHA.123.029574. Epub 2023 Oct 27.
  • Kondo T, Butt JH, Curtain JP, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Circ Heart Fail. 2023 Dec;16(12):e010898. doi: 10.1161/CIRCHEARTFAILURE.123.010898. Epub 2023 Oct 27.
  • Wechsler LR, Adeoye O, Alemseged F, Bahr-Hosseini M, Deljkich E, Favilla C, Fisher M, Grotta J, Hill MD, Kamel H, Khatri P, Lyden P, Mirza M, Nguyen TN, Samaniego E, Schwamm L, Selim M, Silva G, Yavagal DR, Yenari MA, Zachrison KS, Boltze J, Yaghi S, XIIth Stroke Treatment Academic Industry Roundtable Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII Workshop. Stroke. 2023 Dec;54(12):3202-3213. doi: 10.1161/STROKEAHA.123.044279. Epub 2023 Oct 27.
  • Peacock WF, Januzzi JL, de Theije F, Briseno T, Headden G, Birkhahn R, Allen BR, Mahler SA Methods of the PivotaL triAl of the Atellica VTLi point of care emergencY dePartment high sensitivity troponin evalUationS. Clin Biochem. 2023 Nov;121-122:110679. doi: 10.1016/j.clinbiochem.2023.110679. Epub 2023 Oct 24.
  • Angiolillo DJ, Cao D, Sartori S, Baber U, Dangas G, Zhang Z, Vogel B, Kunadian V, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Ielasi A, Stefanini GG, Pivato CA, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2514-2524. doi: 10.1016/j.jcin.2023.08.019.
  • Yancy CW, O’Gara PT, Bonow RO Regulatory Oversight of Cardiovascular Devices-Why We Care. JAMA Cardiol. 2023 Dec 1;8(12):1182. doi: 10.1001/jamacardio.2023.3903.
  • Nicolajsen CW, Sogaard M, Jensen M, Eldrup N, Larsen TB, Goldhaber SZ, Behrendt CA, Nielsen PB Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease. JAMA Netw Open. 2023 Oct 2;6(10):e2339715. doi: 10.1001/jamanetworkopen.2023.39715.
  • Genereux P, Sharma RP, Cubeddu RJ, Aaron L, Abdelfattah OM, Koulogiannis KP, Marcoff L, Naguib M, Kapadia SR, Makkar RR, Thourani VH, van Boxtel BS, Cohen DJ, Dobbles M, Barnhart GR, Kwon M, Pibarot P, Leon MB, Gillam LD The Mortality Burden of Untreated Aortic Stenosis. J Am Coll Cardiol. 2023 Nov 28;82(22):2101-2109. doi: 10.1016/j.jacc.2023.09.796. Epub 2023 Oct 24.
  • Fletcher RA, Jongs N, Chertow GM, McMurray JJV, Arnott C, Jardine MJ, Mahaffey KW, Perkovic V, Rockenschaub P, Rossing P, Correa-Rotter R, Toto RD, Vaduganathan M, Wheeler DC, Heerspink HJL, Neuen BL Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. J Am Soc Nephrol. 2023 Dec 1;34(12):1965-1975. doi: 10.1681/ASN.0000000000000248. Epub 2023 Oct 25.
  • Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, Yang Y, Wu J, Wang C, He S, Wang Z, Wang Y, Wang Z, Liu H, Wang X, Zhang M, Zhang J, Li J, An T, Guan H, Li L, Shang M, Yao C, Han Y, Zhang B, Gao R, Peterson ED, CTS-AMI Investigators Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial. JAMA. 2023 Oct 24;330(16):1534-1545. doi: 10.1001/jama.2023.19524.
  • Khan MS, Rashid AM, Shafi T, Ferreira JP, Butler J Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease. Semin Nephrol. 2023 May;43(3):151429. doi: 10.1016/j.semnephrol.2023.151429. Epub 2023 Oct 21.
  • Godfrey S, Peng Y, Lorusso N, Sulistio M, Mentz RJ, Pandey A, Warraich H Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2023 Nov;16(11):e010802. doi: 10.1161/CIRCHEARTFAILURE.123.010802. Epub 2023 Oct 23.
  • Mohammadnia N, Los J, Opstal TSJ, Fiolet ATL, Eikelboom JW, Mosterd A, Nidorf SM, Budgeon CA, Tijssen JGP, Thompson PL, Tack CJ, Simsek S, Bax WA, Cornel JH, El Messaoudi S Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial. Front Cardiovasc Med. 2023 Oct 6;10:1244529. doi: 10.3389/fcvm.2023.1244529. eCollection 2023.
  • Sarkies MN, Testa L, Best S, Moullin JC, Sullivan D, Bishop W, Kostner K, Clifton P, Hare D, Brett T, Hutchinson K, Black A, Braithwaite J, Nicholls SJ, Kangaharan N, Pang J, Abhayaratna W, Horton A, Watts GF Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia. Heart Lung Circ. 2023 Nov;32(11):1347-1353. doi: 10.1016/j.hlc.2023.09.012. Epub 2023 Oct 19.
  • Pandey A, Kolkailah AA, Cosentino F, Cannon CP, Frederich RC, Cherney DZI, Dagogo-Jack S, Pratley RE, Cater NB, Gantz I, Mancuso JP, McGuire DK Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial. Eur Heart J. 2023 Dec 21;44(48):5163-5166. doi: 10.1093/eurheartj/ehad639.
  • Raygor V, Hoeting N, Ayers C, Joshi P, Canan A, Abbara S, Assadourian JN, Khera A, Peterson ED, Navar AM Accuracy of incidental visual coronary artery calcium assessment compared with dedicated coronary artery calcium scoring. J Cardiovasc Comput Tomogr. 2023 Nov-Dec;17(6):453-458. doi: 10.1016/j.jcct.2023.10.001. Epub 2023 Oct 19.
  • Neumiller JJ, Alicic RZ, Tuttle KR Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease. Semin Nephrol. 2023 May;43(3):151427. doi: 10.1016/j.semnephrol.2023.151427. Epub 2023 Oct 17.
  • Gaudino M, Di Franco A, Arbustini E, Bacha E, Bates ER, Cameron DE, Cao D, David TE, De Paulis R, El-Hamamsy I, Farooqi KM, Girardi LN, Grani C, Kochav JD, Molossi S, Puskas JD, Rao SV, Sandner S, Tatoulis J, Truong QA, Weinsaft JW, Zimpfer D, Mery CM Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review. Ann Thorac Surg. 2023 Dec;116(6):1124-1141. doi: 10.1016/j.athoracsur.2023.09.025. Epub 2023 Oct 16.
  • Gaudino M, Di Franco A, Arbustini E, Bacha E, Bates ER, Cameron DE, Cao D, David TE, De Paulis R, El-Hamamsy I, Farooqi KM, Girardi LN, Grani C, Kochav JD, Molossi S, Puskas JD, Rao SV, Sandner S, Tatoulis J, Truong QA, Weinsaft JW, Zimpfer D, Mery CM Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review. J Am Coll Cardiol. 2023 Nov 21;82(21):2034-2053. doi: 10.1016/j.jacc.2023.08.012. Epub 2023 Oct 16.
  • Ben-Assa E, Abu Salman A, Cafri C, Roguin A, Hellou E, Koifman E, Feld Y, Lev E, Sheinman G, Harari E, Abu Dogosh A, Beyar R, Garcia-Garcia HM, Davies J, Ben-Yehuda O Performance of a novel artificial intelligence software developed to derive coronary fractional flow reserve values from diagnostic angiograms. Coron Artery Dis. 2023 Dec 1;34(8):533-541. doi: 10.1097/MCA.0000000000001305. Epub 2023 Oct 18.
  • Silva AL, Chertow GM, Hernandez GT, Lynn RI, Tietjen DP, Rosenbaum DP, Yang Y, Edelstein S Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study. Kidney360. 2023 Nov 1;4(11):1580-1589. doi: 10.34067/KID.0000000000000280. Epub 2023 Oct 19.
  • Hausvater A, Spruill TM, Xia Y, Smilowitz NR, Arabadjian M, Shah B, Park K, Giesler C, Marzo K, Thomas D, Wei J, Trost J, Mehta PK, Har B, Bainey KR, Zhong H, Hochman JS, Reynolds HR Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries. J Am Coll Cardiol. 2023 Oct 24;82(17):1649-1658. doi: 10.1016/j.jacc.2023.08.028.
  • Dauerman HL Optical Coherence Tomography – Light and Truth. N Engl J Med. 2023 Oct 19;389(16):1523-1525. doi: 10.1056/NEJMe2309710.
  • Muluk P, Zhu J, Thoma F, Hay E, Marroquin O, Makani A, Aiyer A, Nasir K, Gulati M, Shapiro MD, Mulukutla S, Saeed A Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes. Diabetes Care. 2023 Dec 1;46(12):2273-2277. doi: 10.2337/dc23-0816.
  • Spagnolo M, Angiolillo DJ, Capodanno D Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administration. Expert Opin Drug Metab Toxicol. 2023 Jul-Dec;19(11):769-784. doi: 10.1080/17425255.2023.2272595. Epub 2023 Nov 17.
  • Silver MJ, Gibson CM, Giri J, Khandhar S, Jaber W, Toma C, Mina B, Bowers T, Greenspon L, Kado H, Zlotnick DM, Chakravarthy M, DuCoffe AR, Butros P, Horowitz JM Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. Circ Cardiovasc Interv. 2023 Oct;16(10):e013406. doi: 10.1161/CIRCINTERVENTIONS.123.013406. Epub 2023 Oct 17.
  • Savarese G, Butler J, Ponikowki P, Anker SD Sodium-glucose cotransporter 2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: Any incremental effect? Eur J Heart Fail. 2023 Dec;25(12):2199-2201. doi: 10.1002/ejhf.3064. Epub 2023 Oct 31.
  • Incontri D, Marchina S, Andreev A, Wilson M, Wang JY, Lin D, Heistand EC, Carvalho F, Selim M, Lioutas VA Etiology of Primary Cerebellar Intracerebral Hemorrhage Based on Topographic Localization. Stroke. 2023 Dec;54(12):3074-3080. doi: 10.1161/STROKEAHA.123.044271. Epub 2023 Oct 16.
  • Lee KH, Carvalho F, Lioutas VA, Heistand E, Das AS, Marchina S, Shoamanesh A, Katsanos AH, Shehadah A, Incontri D, Selim M Relationship between prior statin therapy and radiological features and clinical outcomes of intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2023 Dec;32(12):107378. doi: 10.1016/j.jstrokecerebrovasdis.2023.107378. Epub 2023 Oct 12.
  • Ramu B, Cogswell R, Ravichandran AK, Cleveland J Jr, Mehra MR, Goldstein D, Uriel N, Dirckx N, Ahmed S, Yuzefpolskaya M Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men. JACC Heart Fail. 2023 Dec;11(12):1692-1704. doi: 10.1016/j.jchf.2023.08.020. Epub 2023 Oct 11.
  • Pabon M, Cunningham J, Claggett B, Felker GM, McMurray JJV, Metra M, Diaz R, Wang X, Arias-Mendoza A, Bonderman D, Crespo-Leiro M, Fonseca C, Goncalvesova E, Lund M, O’Meara E, Sliwa-Hahnle K, Malik FI, Solomon SD, Teerlink JR, GALACTIC-HF Investigators Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial. JACC Heart Fail. 2023 Dec;11(12):1729-1738. doi: 10.1016/j.jchf.2023.07.029. Epub 2023 Oct 11.
  • Ferro EG, Alkhouli M, Nair DG, Kapadia SR, Hsu JC, Gibson DN, Freeman JV, Price MJ, Roy K, Allocco DJ, Yeh RW, Piccini JP Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.S. JACC Clin Electrophysiol. 2023 Dec;9(12):2587-2599. doi: 10.1016/j.jacep.2023.08.004. Epub 2023 Oct 11.
  • Ostrominski JW, Vaduganathan M, Selvaraj S, Claggett BL, Miao ZM, Desai AS, Jhund PS, Kosiborod MN, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Maria Langkilde A, McMurray JJV, Solomon SD Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial. Circulation. 2023 Dec 12;148(24):1945-1957. doi: 10.1161/CIRCULATIONAHA.123.065254. Epub 2023 Oct 13.
  • Boulet J, Kelleher J, Wanderley MRB Junior, Nohria A, Andersson C, Kim M, Mehra MR Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation. Prog Cardiovasc Dis. 2023 Nov-Dec;81:48-53. doi: 10.1016/j.pcad.2023.10.001. Epub 2023 Oct 10.
  • Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, Hermans MP, Pandey RC, Ray KK, Tokgozoglu L, Zambon A, Berrou JP, Farnier M Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30.
  • Castagna F, Simitsis P, Mehra MR Overcoming vulnerability in heart failure: Transitional tactical toughness. Eur J Heart Fail. 2023 Nov;25(11):2018-2020. doi: 10.1002/ejhf.3054. Epub 2023 Oct 31.
  • Ortega-Paz L, Sabate M, Angiolillo DJ Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master? J Am Coll Cardiol. 2023 Oct 17;82(16):1579-1582. doi: 10.1016/j.jacc.2023.08.035.
  • Ichihara G, Katsumata Y, Sugiura Y, Matsuoka Y, Maeda R, Endo J, Anzai A, Shirakawa K, Moriyama H, Kitakata H, Hiraide T, Goto S, Ko S, Iwasawa Y, Sugai K, Daigo K, Goto S, Sato K, Yamada KI, Suematsu M, Ieda M, Sano M MRP1-Dependent Extracellular Release of Glutathione Induces Cardiomyocyte Ferroptosis After Ischemia-Reperfusion. Circ Res. 2023 Oct 27;133(10):861-876. doi: 10.1161/CIRCRESAHA.123.323517. Epub 2023 Oct 11.
  • Lam CSP, Docherty KF, Ho JE, McMurray JJV, Myhre PL, Omland T Recent successes in heart failure treatment. Nat Med. 2023 Oct;29(10):2424-2437. doi: 10.1038/s41591-023-02567-2. Epub 2023 Oct 9.
  • Sharma RK, Laham RJ, Sorajja P, Shah B, Garcia S, Jain R, Fender EA, Philip F, Eisenberg R, Popma JJ, Chetcuti S Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve Replacement. Am J Cardiol. 2023 Dec 1;208:37-43. doi: 10.1016/j.amjcard.2023.08.140. Epub 2023 Oct 7.
  • Sanz-Sanchez J, Garcia-Garcia HM, Branca M, Frigoli E, Leonardi S, Gagnor A, Calabro P, Garducci S, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabate M, Heg D, Vranckx P, Valgimigli M Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial. Eur Heart J Acute Cardiovasc Care. 2023 Nov 16;12(11):782-791. doi: 10.1093/ehjacc/zuad122.
  • Leiva O, Connors JM, Connell NT, Berger JS Acute myocardial infarction in von Willebrand disease: characteristics and outcomes. Res Pract Thromb Haemost. 2023 Sep 9;7(7):102198. doi: 10.1016/j.rpth.2023.102198. eCollection 2023 Oct.
  • Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, American Heart Association Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
  • Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, Rangaswami J, American Heart Association A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.
  • Goldberg AC, Soffer D, Ballantyne C, Gulati M, Shapiro M NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents. J Clin Lipidol. 2023 Sep-Oct;17(5):559-560. doi: 10.1016/j.jacl.2023.10.001. Epub 2023 Oct 4.
  • Baber U, Spirito A, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Vogel B, Mehta SR, Moliterno D, Sardella G, Shlofmitz RA, Sharma S, Steg PG, Pocock S, Mehran R Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial. Am J Cardiol. 2023 Dec 1;208:16-24. doi: 10.1016/j.amjcard.2023.09.008. Epub 2023 Oct 6.
  • Heerspink HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, Ji L, Mathieu C, Groop PH, Pratley RE, Rosas SE, Rossing P, Skyler JS, Tuttle KR, Lawatscheck R, Scott C, Edfors R, Scheerer MF, Kolkhof P, McGill JB Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial. Diabetes Res Clin Pract. 2023 Oct;204:110908. doi: 10.1016/j.diabres.2023.110908. Epub 2023 Oct 5.
  • Watson NW, Mosarla RC, Secemsky EA Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review. Curr Cardiol Rep. 2023 Nov;25(11):1611-1622. doi: 10.1007/s11886-023-01973-9. Epub 2023 Oct 7.
  • Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodes-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J, TVARC Steering Committee Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. J Am Coll Cardiol. 2023 Oct 24;82(17):1711-1735. doi: 10.1016/j.jacc.2023.08.008. Epub 2023 Oct 4.
  • Valgimigli M, Spirito A, Sartori S, Angiolillo DJ, Vranckx P, de la Torre Hernandez JM, Krucoff MW, Bangalore S, Bhatt DL, Campo G, Cao D, Chehab BM, Choi JW, Feng Y, Ge J, Hermiller J, Kunadian V, Lupo S, Makkar RR, Maksoud A, Neumann FJ, Picon H, Saito S, Sardella G, Thiele H, Toelg R, Varenne O, Vogel B, Zhou Y, Windecker S, Mehran R 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2498-2510. doi: 10.1016/j.jcin.2023.08.014. Epub 2023 Oct 4.
  • Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodes-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J, TVARC Steering Committee Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. Ann Thorac Surg. 2023 Nov;116(5):908-932. doi: 10.1016/j.athoracsur.2023.09.018. Epub 2023 Oct 4.
  • Srinivasan S, Novelli A, Callas P, Gupta T, Straight F, Dauerman HL Cardiac catheterization, coronary intervention, and wait times for transcatheter aortic valve replacement. Coron Artery Dis. 2023 Nov 1;34(7):475-482. doi: 10.1097/MCA.0000000000001275. Epub 2023 Aug 23.
  • Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, Fonarow GC, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Krumholz HM, Khush KK, Lee C, Morris AA, Page RL 2nd, Pandey A, Piano MR, Stehlik J, Stevenson LW, Teerlink JR, Vaduganathan M, Ziaeian B, Writing Committee Members Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 Oct;29(10):1412-1451. doi: 10.1016/j.cardfail.2023.07.006. Epub 2023 Sep 26.
  • Averbuch T, Greene SJ, Van Spall HGC Guideline-Recommended Therapy Following Hospitalization for Heart Failure: Understanding the Gaps, Navigating the Barriers. JACC Heart Fail. 2023 Oct;11(10):1333-1336. doi: 10.1016/j.jchf.2023.07.022.
  • Sabouret P, Ecarnot F, De Rosa S, Ray KK What about glucagon-like peptide-1 receptor agonist for all? Recent data and perspectives. Eur Heart J. 2023 Nov 14;44(43):4499-4502. doi: 10.1093/eurheartj/ehad632.
  • Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodes-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. Eur Heart J. 2023 Nov 14;44(43):4508-4532. doi: 10.1093/eurheartj/ehad653.
  • Godfrey S, Pandey A, Warraich HJ Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction? JAMA Cardiol. 2023 Nov 1;8(11):1005-1006. doi: 10.1001/jamacardio.2023.3360.
  • Clark AJ, Saade MC, Vemireddy V, Vu KQ, Flores BM, Etzrodt V, Ciampa EJ, Huang H, Takakura A, Zandi-Nejad K, Zsengeller ZK, Parikh SM Hepatocyte nuclear factor 4alpha mediated quinolinate phosphoribosylltransferase (QPRT) expression in the kidney facilitates resilience against acute kidney injury. Kidney Int. 2023 Dec;104(6):1150-1163. doi: 10.1016/j.kint.2023.09.013. Epub 2023 Sep 30.
  • Waksman R, Pahuja M, van Diepen S, Proudfoot AG, Morrow D, Spitzer E, Nichol G, Weisfeldt ML, Moscucci M, Lawler PR, Mebazaa A, Fan E, Dickert NW, Samsky M, Kormos R, Pina IL, Zuckerman B, Farb A, Sapirstein JS, Simonton C, West NEJ, Damluji AA, Gilchrist IC, Zeymer U, Thiele H, Cutlip DE, Krucoff M, Abraham WT Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC). Circulation. 2023 Oct 3;148(14):1113-1126. doi: 10.1161/CIRCULATIONAHA.123.064527. Epub 2023 Oct 2.
  • Lavallee PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Labreuche J, Molina C, Rothwell PM, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong LKS, Amarenco P, TIAregistry.org Investigators Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events. JAMA Neurol. 2023 Nov 1;80(11):1199-1208. doi: 10.1001/jamaneurol.2023.3344.
  • Mihatov N, Kirtane AJ, Stoler R, Feldman R, Neumann FJ, Boutis L, Tahirkheli N, Kereiakes DJ, Toelg R, Othman I, Stein B, Allocco D, Windecker S, Yeh RW Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis). Am J Cardiol. 2023 Nov 15;207:370-379. doi: 10.1016/j.amjcard.2023.06.036. Epub 2023 Sep 29.
  • Bairey Merz CN, Gulati M, Wei J Understanding T2MI: Thank Goodness for the Women. J Am Coll Cardiol. 2023 Oct 24;82(17):1688-1690. doi: 10.1016/j.jacc.2023.08.021. Epub 2023 Sep 29.
  • McCarthy CP, Murphy SP, Amponsah DK, Rambarat PK, Lin C, Liu Y, Mohebi R, Levin A, Raghavan A, Miksenas H, Rogers C, Wasfy JH, Blankstein R, Ghoshhajra B, Hedgire S, Januzzi JL Jr Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction. J Am Coll Cardiol. 2023 Oct 24;82(17):1676-1687. doi: 10.1016/j.jacc.2023.08.020. Epub 2023 Sep 29.
  • Kato ET, Lewis BS, Ono K GLP-1 receptor agonists: new game changing drugs in patients with heart failure with preserved ejection fraction and obesity. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):679-680. doi: 10.1093/ehjcvp/pvad072.
  • Ostrominski JW, Wang CJ, Campia U, Connors JM, Varelmann DJ, Mladinov D, Keshk M, Skali H Pulmonary embolism with thrombus-in-transit across a patent foramen ovale. Lancet. 2023 Sep 30;402(10408):1170. doi: 10.1016/S0140-6736(23)01854-8.
  • Patel KV, Budoff MJ, Valero-Elizondo J, Lahan S, Ali SS, Taha MB, Blaha MJ, Blankstein R, Shapiro MD, Pandey A, Arias L, Feldman T, Cury RC, Cainzos-Achirica M, Shah SH, Ziffer JA, Fialkow J, Nasir K Coronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida. Circ Cardiovasc Imaging. 2023 Oct;16(10):e015314. doi: 10.1161/CIRCIMAGING.123.015314. Epub 2023 Sep 29.
  • Bernard L, Wang AR, Menez S, Henderson JM, Dighe A, Roberts GV, Stutzke C, Tuttle KR, Miller RT, Kidney Precision Medicine Project Kidney Biopsy Utility: Patient and Clinician Perspectives from the Kidney Precision Medicine Project. Kidney Med. 2023 Aug 5;5(10):100707. doi: 10.1016/j.xkme.2023.100707. eCollection 2023 Oct.
  • Bhatt AS, Kosiborod MN, Claggett BL, Miao ZM, Vaduganathan M, Lam CSP, Hernandez AF, Martinez FA, Inzucchi SE, Shah SJ, de Boer RA, Jhund PS, Desai AS, Fang JC, Han Y, Comin-Colet J, Drozdz J, Vardeny O, Merkely B, Lindholm D, Peterson M, Langkilde AM, McMurray JJV, Solomon SD Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial. Eur J Heart Fail. 2023 Dec;25(12):2177-2188. doi: 10.1002/ejhf.3043. Epub 2023 Oct 9.
  • Matsumoto S, Kondo T, Yang M, Campbell RT, Docherty KF, de Boer RA, Desai AS, Lam CSP, Packer M, Pitt B, Rouleau JL, Vaduganathan M, Zannad F, Zile MR, Solomon SD, Jhund PS, McMurray JJV Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Eur J Heart Fail. 2023 Dec;25(12):2202-2214. doi: 10.1002/ejhf.3044. Epub 2023 Oct 5.
  • Ghobrial M, Bawamia B, Cartlidge T, Spyridopoulos I, Kunadian V, Zaman A, Egred M, McDiarmid A, Williams M, Farag M, Alkhalil M Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target. J Clin Med. 2023 Sep 13;12(18):5934. doi: 10.3390/jcm12185934.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Arguello-Bolanos J, Arenas-Diaz JO, Perez-Lopez R, Garcia-Arias MR, Gopar-Nieto R, Sierra-Lara-Martinez D, Araiza-Garaygordobil D, Manzur-Sandoval D, Soliz-Uriona LA, Astudillo-Alvarez GM, Hernandez-Montfort J, Arias-Mendoza A Invasive Phenoprofiling of Acute-Myocardial-Infarction-Related Cardiogenic Shock. J Clin Med. 2023 Sep 7;12(18):5818. doi: 10.3390/jcm12185818.
  • Amezcua-Castillo E, Gonzalez-Pacheco H, Saenz-San Martin A, Mendez-Ocampo P, Gutierrez-Moctezuma I, Masso F, Sierra-Lara D, Springall R, Rodriguez E, Arias-Mendoza A, Amezcua-Guerra LM C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease-Advancing toward Precision Medicine. Biomedicines. 2023 Sep 2;11(9):2444. doi: 10.3390/biomedicines11092444.
  • Amezcua-Guerra B, Amezcua-Castillo LM, Guerra-Lopez JA, Diaz-Dominguez KA, Sanchez-Gloria JL, Cruz-Melendez A, Hernandez-Diazcouder A, Juarez-Vicuna Y, Sanchez-Munoz F, Huang F, Tavera-Alonso C, Brianza-Padilla M, Varela-Lopez E, Sierra-Lara D, Arias-Mendoza A, Fonseca-Camarillo G, Marquez-Velasco R, Gonzalez-Pacheco H, Springall R, Amezcua-Guerra LM Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency Department. Biomedicines. 2023 Aug 30;11(9):2422. doi: 10.3390/biomedicines11092422.
  • Okagawa T, Konnai S, Goto S, Sajiki Y, Ganbaatar O, Watari K, Nakamura H, Wang CX, Tachibana T, Kato Y, Kameda Y, Kohara J, Terasaki N, Kubota M, Takeda A, Takahashi H, Suzuki Y, Maekawa N, Murata S, Ohashi K Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system. Vet Res. 2023 Sep 27;54(1):82. doi: 10.1186/s13567-023-01213-6.
  • Guerrero ME, Eleid MF, Wang DD, Pursnani A, Kodali SK, George I, Palacios I, Russell H, Makkar RR, Kar S, Satler LF, Rajagopal V, Dangas G, Tang GHL, McCabe JM, Whisenant BK, Fang K, Balan P, Smalling R, Kaptzan T, Lewis B, Douglas PS, Hahn RT, Thaden J, Oh JK, Leon M, O’Neill W, Rihal C 5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results. JACC Cardiovasc Interv. 2023 Sep 25;16(18):2211-2227. doi: 10.1016/j.jcin.2023.06.041.
  • Earle W, Misra S, Wester A, Herzig M, Abdallah G, Ross CB, Secemsky EA, Carroll BJ Cause of death in patients with acute pulmonary embolism. Vasc Med. 2023 Dec;28(6):586-588. doi: 10.1177/1358863X231199488. Epub 2023 Sep 27.
  • Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, Donato BMK, Parrinello CM, O’Connell T, Collins EB, Woolley JJ, Kosiborod MN, Vaduganathan M Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. JAMA Cardiol. 2023 Nov 1;8(11):1050-1060. doi: 10.1001/jamacardio.2023.3241.
  • Abrahams T, Fujino M, Nelson AJ, Nicholls SJ Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging. Curr Opin Cardiol. 2023 Nov 1;38(6):504-508. doi: 10.1097/HCO.0000000000001080. Epub 2023 Sep 25.
  • Albaghdadi M, Young MN, Al-Bawardy R, Monteleone P, Hawkins B, Armstrong E, Kassab M, Khraishah H, Chowdhury M, Tripathi A, Kennedy KK, Secemsky EA Outcomes of atherectomy in patients undergoing lower extremity revascularisation. EuroIntervention. 2023 Dec 18;19(11):e955-e963. doi: 10.4244/EIJ-D-23-00432.
  • Harwood OE, Matschke LM, Moriarty RV, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Winchester LC, Fletcher CV, Friedrich TC, Keele BF, O’Connor DH, Lang JD, Reynolds MR, O’Connor SL CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. PLoS Pathog. 2023 Sep 25;19(9):e1011676. doi: 10.1371/journal.ppat.1011676. eCollection 2023 Sep.
  • Bikdeli B, Erlinge D, Valgimigli M, Kastrati A, Han Y, Steg PG, Stables RH, Mehran R, James SK, Frigoli E, Goldstein P, Li Y, Shahzad A, Schupke S, Mehdipoor G, Chen S, Redfors B, Crowley A, Zhou Z, Stone GW Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials. Circulation. 2023 Oct 17;148(16):1207-1219. doi: 10.1161/CIRCULATIONAHA.123.063946. Epub 2023 Sep 25.
  • Lawson CA, Benson L, Squire I, Zaccardi F, Ali M, Hand S, Kadam U, Tay WT, Dahlstrom U, Lund LH, Savarese G, Lam CSP, Khunti K, Stromberg A Changing health related quality of life and outcomes in heart failure by age, sex and subtype. EClinicalMedicine. 2023 Sep 14;64:102217. doi: 10.1016/j.eclinm.2023.102217. eCollection 2023 Oct.
  • Wazni O, Moss J, Kuniss M, Andrade J, Chierchia GB, Mealing S, Mburu W, Sale A, Kaplon R, Ismyrloglou E, Bromilow T, Lane E, Lewis D, Reynolds MR An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective. Heart Rhythm O2. 2023 Jul 27;4(9):528-537. doi: 10.1016/j.hroo.2023.07.007. eCollection 2023 Sep.
  • Talha KM, Greene SJ, Butler J, Khan MS Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment. Cardiol Clin. 2023 Nov;41(4):525-536. doi: 10.1016/j.ccl.2023.06.002. Epub 2023 Jul 14.
  • Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, Omura-Ohata Y, Koezuka R, Tochiya M, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Maruki M, Kanai E, Murai K, Iwai T, Sawada K, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Hosoda K, Nicholls SJ, Yasuda S, Noguchi T The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial. J Diabetes Complications. 2023 Oct;37(10):108592. doi: 10.1016/j.jdiacomp.2023.108592. Epub 2023 Aug 23.
  • Thachil J, Connors JM, Mahlangu J, Sholzberg M “Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets”: Reply. J Thromb Haemost. 2023 Oct;21(10):2980-2981. doi: 10.1016/j.jtha.2023.07.029.
  • Goto S, Goto S Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism? J Thromb Haemost. 2023 Oct;21(10):2708-2710. doi: 10.1016/j.jtha.2023.07.001.
  • Poulin MF, Ultimo B, Omar W, Rathakrishnan BG, Haouzi A, Pinto DS, Buxton AE, Laham RJ Routine Electrophysiology Study During Transcatheter Aortic Valve Replacement: A Safety and Feasibility Pilot Study. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2584-2586. doi: 10.1016/j.jcin.2023.07.017. Epub 2023 Sep 20.
  • Fujino M, Butters J, Boyes M, Duncan N, Streets F, Sabatini A, Herschtal A, Nelson AJ, Nicholls SJ Pop-up screening nested within routine community activities unmasks an addressed cardiovascular risk: A pilot study (Gippsland Healthy Heart Study). Aust J Rural Health. 2023 Dec;31(6):1184-1190. doi: 10.1111/ajr.13042. Epub 2023 Sep 21.
  • Krzemien P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GYH, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jozwiak JJ Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies. Arch Med Sci. 2021 Jul 3;19(5):1214-1227. doi: 10.5114/aoms/139313. eCollection 2023.
  • Verbeeck J, De Backer M, Verwerft J, Salvaggio S, Valgimigli M, Vranckx P, Buyse M, Brunner E Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Sep 26;82(13):1360-1372. doi: 10.1016/j.jacc.2023.06.047.
  • Figtree GA, Vernon ST, Harmer JA, Gray MP, Arnott C, Bachour E, Barsha G, Brieger D, Brown A, Celermajer DS, Channon KM, Chew NWS, Chong JJH, Chow CK, Cistulli PA, Ellinor PT, Grieve SM, Guzik TJ, Hagstrom E, Jenkins A, Jennings G, Keech AC, Kott KA, Kritharides L, Mamas MA, Mehran R, Meikle PJ, Natarajan P, Negishi K, O’Sullivan J, Patel S, Psaltis PJ, Redfern J, Steg PG, Sullivan DR, Sundstrom J, Vogel B, Wilson A, Wong D, Bhatt DL, Kovacic JC, Nicholls SJ, CRE for CAD Collaborators Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Sep 26;82(13):1343-1359. doi: 10.1016/j.jacc.2023.06.045.
  • Chioncel O, Davison B, Adamo M, Antohi LE, Arrigo M, Barros M, Biegus J, Cerlinskaite-Bajore K, Celutkiene J, Cohen-Solal A, Damasceno A, Diaz R, Edwards C, Filippatos G, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Radu RI, Saidu H, Sliwa K, Voors AA, Takagi K, Ter Maaten JM, Tomasoni D, Cotter G, Mebazaa A Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trial. Eur J Heart Fail. 2023 Nov;25(11):1994-2006. doi: 10.1002/ejhf.3039. Epub 2023 Oct 4.
  • Ray KK, Pillas D, Hadjiphilippou S, Khunti K, Seshasai SRK, Vallejo-Vaz AJ, Neasham D, Addison J Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population. Am J Prev Cardiol. 2023 Sep 6;15:100580. doi: 10.1016/j.ajpc.2023.100580. eCollection 2023 Sep.
  • Yuvaraj J, Lim E, Vo T, Huynh D, Rocco C, Nerlekar N, Cheng K, Lin A, Dey D, Nicholls SJ, Kangaharan N, Wong DTL Pericoronary adipose tissue attenuation on coronary computed tomography angiography associates with male sex and Indigenous Australian status. Sci Rep. 2023 Sep 19;13(1):15509. doi: 10.1038/s41598-023-41341-9.
  • Oqab Z, Kunadian V, Wood DA, Storey RF, Rao SV, Mehran R, Pinilla-Echeverri N, Mani T, Boone RH, Kassam S, Bossard M, Mansour S, Ball W, Sibbald M, Valettas N, Moreno R, Steg PG, Cairns JA, Mehta SR Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial. Circ Cardiovasc Interv. 2023 Sep;16(9):e012867. doi: 10.1161/CIRCINTERVENTIONS.122.012867. Epub 2023 Sep 19.
  • Krittanawong C, Khawaja M, Tamis-Holland JE, Girotra S, Rao SV Acute Myocardial Infarction: Etiologies and Mimickers in Young Patients. J Am Heart Assoc. 2023 Sep 19;12(18):e029971. doi: 10.1161/JAHA.123.029971. Epub 2023 Sep 19.
  • Perrichot A, Vaittinada Ayar P, Taboulet P, Choquet C, Gay M, Casalino E, Steg PG, Curac S, Vaittinada Ayar P Assessment of real-time electrocardiogram effects on interpretation quality by emergency physicians. BMC Med Educ. 2023 Sep 18;23(1):677. doi: 10.1186/s12909-023-04670-x.
  • Holtzman JN, Kaur G, Hansen B, Bushana N, Gulati M Sex differences in the management of atherosclerotic cardiovascular disease. Atherosclerosis. 2023 Nov;384:117268. doi: 10.1016/j.atherosclerosis.2023.117268. Epub 2023 Sep 1.
  • Seegers LM, Yeh DD, Wood MJ, Yonetsu T, Minami Y, Araki M, Nakajima A, Yuki H, Ako J, Soeda T, Kurihara O, Higuma T, Kimura S, Adriaenssens T, Nef HM, Lee H, McNulty I, Sugiyama T, Kakuta T, Jang IK Cardiovascular Risk Factors and Culprit Plaque Characteristics in Women With Acute Coronary Syndromes. Am J Cardiol. 2023 Nov 15;207:13-20. doi: 10.1016/j.amjcard.2023.08.152. Epub 2023 Sep 16.
  • Bhatnagar A, Parvathareddy V, Winkelmayer WC, Chertow GM, Erickson KF Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 1;61(11):787-795. doi: 10.1097/MLR.0000000000001924. Epub 2023 Sep 18.
  • Al-Lamee RK, Khan SA, Davies J Reconsidering the evidence for CTO PCI: the devil is in the detail. EuroIntervention. 2023 Sep 18;19(7):537-538. doi: 10.4244/EIJ-E-23-00040.
  • Angiolillo DJ, Galli M, Landi A, Valgimigli M DAPT guided by platelet function tests or genotyping after PCI: pros and cons. EuroIntervention. 2023 Sep 18;19(7):546-548. doi: 10.4244/EIJ-E-23-00022.
  • Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Filippatos TD, Ray KK, Agouridis AP Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association? Atheroscler Plus. 2023 Sep 9;54:1-6. doi: 10.1016/j.athplu.2023.09.001. eCollection 2023 Dec.
  • Mesnier J, Suc G, Sayah N, Abtan J, Steg PG Relevance of medical information obtained from ChatGPT: Are large language models friends or foes? Arch Cardiovasc Dis. 2023 Oct;116(10):485-486. doi: 10.1016/j.acvd.2023.07.009. Epub 2023 Sep 9.
  • Puymirat E, Soulat G, Fayol A, Mousseaux E, Montalescot G, Cayla G, Steg PG, Berard L, Rousseau A, Drouet E, Simon T, Danchin N, APERITIF study investigators Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial. Am Heart J. 2023 Dec;266:98-105. doi: 10.1016/j.ahj.2023.09.005. Epub 2023 Sep 14.
  • Bayes-Genis A, Docherty KF, Petrie MC, Januzzi JL, Mueller C, Anderson L, Bozkurt B, Butler J, Chioncel O, Cleland JGF, Christodorescu R, Del Prato S, Gustafsson F, Lam CSP, Moura B, Pop-Busui R, Seferovic P, Volterrani M, Vaduganathan M, Metra M, Rosano G Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. 2023 Nov;25(11):1891-1898. doi: 10.1002/ejhf.3036. Epub 2023 Sep 26.
  • Divakaran S, Krawisz AK, Secemsky EA, Kant S Sex and Racial Disparities in Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2099-2114. doi: 10.1161/ATVBAHA.123.319399. Epub 2023 Sep 14.
  • Goldstein LB, Toth PP, Dearborn-Tomazos JL, Giugliano RP, Hirsh BJ, Pena JM, Selim MH, Woo D, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular, Biology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral, Vascular Disease; and Stroke Council Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2023 Oct;43(10):e404-e442. doi: 10.1161/ATV.0000000000000164. Epub 2023 Sep 14.
  • Gonsalves CF, Gibson CM, Stortecky S, Alvarez RA, Beam DM, Horowitz JM, Silver MJ, Toma C, Rundback JH, Rosenberg SP, Markovitz CD, Tu T, Jaber WA Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study. Am Heart J. 2023 Dec;266:128-137. doi: 10.1016/j.ahj.2023.09.002. Epub 2023 Sep 12.
  • Truong KP, Press MC, Benharash P, Kar S, Lepor NE, Vorobiof G, Yang EH Hemodynamic Manifestations of Concomitant Radiation-Induced Tricuspid Regurgitation and Pericardial Constriction Undergoing Transcatheter Tricuspid Valve Repair. Circ Heart Fail. 2023 Dec;16(12):e010170. doi: 10.1161/CIRCHEARTFAILURE.122.010170. Epub 2023 Sep 13.
  • Burnett AE, Barnes GD, Allen AL, Ansell J, Blumenstein M, Connors JM, Dager WE, Kaatz S, May JE, Nemeth R, O’Connor C, Ragheb B, Rajasekhar A, Sardo L, Siegal DM, Van Beek A, Anticoagulation Forum Board of Directors Comment on: 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023 Dec;71(12):3951-3953. doi: 10.1111/jgs.18579. Epub 2023 Sep 13.
  • Segar MW, Keshvani N, Pandey A From prediction to prevention: The role of heart failure risk models: Heart to Heart: The Promise and Pitfalls of Heart Failure Risk Prediction Models. Eur J Heart Fail. 2023 Oct;25(10):1739-1741. doi: 10.1002/ejhf.3034. Epub 2023 Sep 26.
  • Goodman SG, Steg PG, Poulouin Y, Bhatt DL, Bittner VA, Diaz R, Garon G, Harrington RA, Jukema JW, Manvelian G, Stipek W, Szarek M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial. J Am Heart Assoc. 2023 Sep 19;12(18):e029216. doi: 10.1161/JAHA.122.029216. Epub 2023 Sep 13.
  • Ganesan C, Thomas IC, Montez-Rath ME, Chertow GM, Leppert JT, Pao AC Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease. JBMR Plus. 2023 Jun 27;7(9):e10786. doi: 10.1002/jbm4.10786. eCollection 2023 Sep.
  • Kanbay M, Copur S, Siriopol D, Yildiz AB, Gaipov A, van Raalte DH, Tuttle KR Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023 Dec;25(12):3766-3778. doi: 10.1111/dom.15272. Epub 2023 Sep 12.
  • Sampath-Kumar R, Ben-Yehuda O Inferior vena cava diameter and risk of acute decompensated heart failure rehospitalisations. Open Heart. 2023 Sep;10(2):e002331. doi: 10.1136/openhrt-2023-002331.
  • Broderick JP, Silva GS, Selim M, Kasner SE, Aziz Y, Sutherland J, Jauch EC, Adeoye OM, Hill MD, Mistry EA, Lyden PD, Mocco J, Smith EM, Hernandez-Jimenez M, Deljkich E, Kamel H, STAIR XII Participants Enhancing Enrollment in Acute Stroke Trials: Current State and Consensus Recommendations. Stroke. 2023 Oct;54(10):2698-2707. doi: 10.1161/STROKEAHA.123.044149. Epub 2023 Sep 11.
  • Chew NWS, Chong B, Kuo SM, Jayabaskaran J, Cai M, Zheng H, Goh R, Kong G, Chin YH, Imran SS, Liang M, Lim P, Yong TH, Liew BW, Chia PL, Ho HH, Foo D, Khoo D, Huang Z, Chua T, Tan JWC, Yeo KK, Hausenloy D, Sim HW, Kua J, Chan KH, Loh PH, Lim TW, Low AF, Chai P, Lee CH, Yeo TC, Yip J, Tan HC, Mamas MA, Nicholls SJ, Chan MY Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort. Lancet Reg Health West Pac. 2023 May 31;37:100803. doi: 10.1016/j.lanwpc.2023.100803. eCollection 2023 Aug.
  • Burger PM, Savarese G, Tromp J, Adamson C, Jhund PS, Benson L, Hage C, Tay WT, Solomon SD, Packer M, Rossello X, McEvoy JW, De Bacquer D, Timmis A, Vardas P, Graham IM, Di Angelantonio E, Visseren FLJ, McMurray JJV, Lam CSP, Lund LH, Koudstaal S, Dorresteijn JAN, Mosterd A, European Society of Cardiology’s Cardiovascular Risk Collaboration (ESC CRC) Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF model. Eur J Heart Fail. 2023 Nov;25(11):1962-1975. doi: 10.1002/ejhf.3028. Epub 2023 Sep 18.
  • Bahit MC, Korjian S, Daaboul Y, Baron S, Bhatt DL, Kalayci A, Chi G, Nara P, Shaunik A, Gibson CM Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review. Clin Ther. 2023 Nov;45(11):1119-1126. doi: 10.1016/j.clinthera.2023.08.011. Epub 2023 Sep 9.
  • Ranasinghe S, Merz CNB, Khan N, Wei J, George M, Berry C, Chieffo A, Camici PG, Crea F, Kaski JC, Marzilli M, Gulati M Sex Differences in Quality of Life in Patients with Ischemia with No Obstructive Coronary Artery Disease (INOCA): A Patient Self-Report Retrospective Survey from INOCA International. J Clin Med. 2023 Aug 30;12(17):5646. doi: 10.3390/jcm12175646.
  • Perone F, Bernardi M, Redheuil A, Mafrica D, Conte E, Spadafora L, Ecarnot F, Tokgozoglu L, Santos-Gallego CG, Kaiser SE, Fogacci F, Sabouret A, Bhatt DL, Paneni F, Banach M, Santos R, Biondi Zoccai G, Ray KK, Sabouret P Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions. J Clin Med. 2023 Aug 26;12(17):5563. doi: 10.3390/jcm12175563.
  • Shah NS, Krishnamurthi RS, Yancy CW, Khan SS Racial and Ethnic Differences in Mortality Related to Comorbid Heart Failure and Diabetes in the United States. J Card Fail. 2023 Dec;29(12):1683-1685. doi: 10.1016/j.cardfail.2023.08.019. Epub 2023 Sep 6.
  • Tromp J, Ezekowitz JA, Ouwerkerk W, Chandramouli C, Yiu KH, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Collins SP, Filippatos G, Cleland JGF, Lam CSP Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. JACC Heart Fail. 2023 Sep;11(9):1262-1271. doi: 10.1016/j.jchf.2023.06.028.
  • Hirai T, Grantham JA, Kandzari DE, Ballard W, Brown WM, Allen KB, Kirtane AJ, Argenziano M, Yeh RW, Khabbaz K, Lombardi W, Lasala J, Kachroo P, Karmpaliotis D, Gosch KL, Salisbury AC, OPTIMUM Study Group Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study. Catheter Cardiovasc Interv. 2023 Nov;102(5):814-822. doi: 10.1002/ccd.30834. Epub 2023 Sep 7.
  • Rossello X, Vranckx P MULTi-vessel Immediate vs. STAged RevaScularization in Acute Myocardial Infarction: the MULTISTARS AMI trial. Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):629-630. doi: 10.1093/ehjacc/zuad104.
  • Field TS, Dizonno V, Almekhlafi MA, Bala F, Alhabli I, Wong H, Norena M, Villaluna MK, King-Azote P, Ratnaweera N, Mancini S, Van Gaal SC, Wilson LK, Graham BR, Sposato LA, Blacquiere D, Dewar BM, Boulos MI, Buck BH, Odier C, Perera KS, Pikula A, Tkach A, Medvedev G, Canfield C, Mortenson WB, Nadeau JO, Alshimemeri S, Benavente OR, Demchuk AM, Dowlatshahi D, Lanthier S, Lee AYY, Mandzia J, Suryanarayan D, Weitz JI, Hill MD, SECRET Investigators Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. Stroke. 2023 Nov;54(11):2724-2736. doi: 10.1161/STROKEAHA.123.044113. Epub 2023 Sep 7.
  • Chaganty SS, Abramov D, Van Spall HGC, Bullock-Palmer RP, Vassiliou V, Myint PK, Bang V, Kobo O, Mamas MA Rural and urban disparities in cardiovascular disease-related mortality in the USA over 20 years; have the trends been reversed by COVID-19? Int J Cardiol Cardiovasc Risk Prev. 2023 Aug 30;19:200202. doi: 10.1016/j.ijcrp.2023.200202. eCollection 2023 Dec.
  • Lee V, Zheng Q, Toh DF, Pua CJ, Bryant JA, Lee CH, Cook SA, Butler J, Diez J, Richards AM, Le TT, Chin CWL Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol. Front Cardiovasc Med. 2023 Aug 22;10:1248468. doi: 10.3389/fcvm.2023.1248468. eCollection 2023.
  • Pandey AK, Bhatt DL, Pandey A, Marx N, Cosentino F, Pandey A, Verma S Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. Eur Heart J. 2023 Oct 1;44(37):3640-3651. doi: 10.1093/eurheartj/ehad389.
  • Raisi-Estabragh Z, Kobo O, Mieres JH, Bullock-Palmer RP, Van Spall HGC, Breathett K, Mamas MA Racial Disparities in Obesity-Related Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020. J Am Heart Assoc. 2023 Sep 19;12(18):e028409. doi: 10.1161/JAHA.122.028409. Epub 2023 Sep 6.
  • Gonzalez-Pacheco H, Gopar-Nieto R, Manzur-Sandoval D, Ayala-Navarrete MA, Eid-Lidt G, Briseno-De-la-Cruz JL, Altamirano-Castillo A, Mendoza-Garcia S, Araiza-Garaygordobil D, Sierra-Lara-Martinez D, Arias-Mendoza A [Acute myocardial infarction patients without COVID-19 manifestations in the pandemic may have high thrombus burden]. Arch Cardiol Mex. 2023 Sep 5;93(Supl 6):10-15. doi: 10.24875/ACM.21000327.
  • Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene SJ Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure. Am J Cardiol. 2023 Oct 15;205:524-526. doi: 10.1016/j.amjcard.2023.08.013. Epub 2023 Sep 4.
  • Pandey A, Van Spall HGC SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race. Ann Intern Med. 2023 Sep;176(9):JC100. doi: 10.7326/J23-0071. Epub 2023 Sep 5.
  • Bainey KR, Marquis-Gravel G, MacDonald BJ, Bewick D, Yan A, Turgeon RD Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis. PLoS One. 2023 Sep 1;18(9):e0291061. doi: 10.1371/journal.pone.0291061. eCollection 2023.
  • Yogasundaram H, Zheng Y, Ly E, Ezekowitz J, Ponikowski P, Lam CSP, O’Connor C, Blaustein RO, Roessig L, Temple T, Westerhout CM, Armstrong PW, Sandhu RK, VICTORIA Study Group Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial. Eur J Heart Fail. 2023 Oct;25(10):1822-1830. doi: 10.1002/ejhf.3021. Epub 2023 Sep 10.
  • Daubert MA, Gulati M Heart of the Matter: Expanding the Applicability of CAC to a More Diverse Population. Circ Cardiovasc Imaging. 2023 Sep;16(9):e015849. doi: 10.1161/CIRCIMAGING.123.015849. Epub 2023 Sep 1.
  • Saade MC, Parikh SM Energy Metabolism in CKD: Running Low on Fuel. Kidney360. 2023 Aug 1;4(8):1014-1016. doi: 10.34067/KID.0000000000000231.
  • James S, Erlinge D, Storey RF, McGuire DK, de Belder M, Bjorkgren I, Johansson PA, Langkilde AM, Ridderstrale W, Parvaresh Rizi E, Deanfield J, Oldgren J Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction. Am Heart J. 2023 Dec;266:188-197. doi: 10.1016/j.ahj.2023.08.008. Epub 2023 Aug 28.
  • Gaist D, Garcia Rodriguez LA, Hallas J, Hald SM, Moller S, Hoyer BB, Selim M, Goldstein LB Association of Statin Use With Risk of Stroke Recurrence After Intracerebral Hemorrhage. Neurology. 2023 Oct 31;101(18):e1793-e1806. doi: 10.1212/WNL.0000000000207792. Epub 2023 Aug 30.
  • Henry TD, Baron SJ, Jacobs AK STEMI-Related Mortality: Don’t Stop Believin’. J Am Coll Cardiol. 2023 Sep 5;82(10):1011-1013. doi: 10.1016/j.jacc.2023.07.007.
  • Rau Steuernagel C, Lam CSP, Greenhalgh T Countering sex and gender bias in cardiovascular research requires more than equal recruitment and sex disaggregated analyses. BMJ. 2023 Aug 30;382:e075031. doi: 10.1136/bmj-2023-075031.
  • Navar AM, Khan SS, Yancy CW Adverse Childhood Experiences as Social Determinants of Cardiovascular Health. JAMA Cardiol. 2023 Oct 1;8(10):936. doi: 10.1001/jamacardio.2023.2678.
  • Averbuch T, Esfahani M, Khatib R, Kayima J, Miranda JJ, Wadhera RK, Zannad F, Pandey A, Van Spall HGC Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries. ESC Heart Fail. 2023 Oct;10(5):3152-3163. doi: 10.1002/ehf2.14468. Epub 2023 Aug 30.
  • Pio SM, Medvedofsky D, Stassen J, Delgado V, Namazi F, Weissman NJ, Grayburn P, Kar S, Lim DS, Zhou Z, Alu MC, Redfors B, Kapadia S, Lindenfeld J, Abraham WT, Mack MJ, Asch FM, Stone GW, Bax JJ Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. J Am Heart Assoc. 2023 Sep 5;12(17):e029956. doi: 10.1161/JAHA.122.029956. Epub 2023 Aug 30.
  • Haywood HB, Fonarow GC, Khan MS, Van Spall HGC, Morris AA, Nassif ME, Kittleson MM, Butler J, Greene SJ Hospital at Home as a Treatment Strategy for Worsening Heart Failure. Circ Heart Fail. 2023 Oct;16(10):e010456. doi: 10.1161/CIRCHEARTFAILURE.122.010456. Epub 2023 Aug 30.
  • Verma S, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Dhingra NK, Kosiborod MN A big STEP for treatment of heart failure with preserved ejection fraction. Cell Metab. 2023 Oct 3;35(10):1681-1687. doi: 10.1016/j.cmet.2023.08.003. Epub 2023 Aug 28.
  • Kobo O, Abramov D, Volgman AS, Mieres JH, Wijeysundera HC, Van Spall HGC, Mamas MA Causes of Death Among Health Care Professionals in the United States. Popul Health Manag. 2023 Oct;26(5):294-302. doi: 10.1089/pop.2023.0070. Epub 2023 Aug 29.
  • Shiyovich A, Berman AN, Besser SA, Biery DW, Huck DM, Weber B, Cannon C, Januzzi JL, Booth JN 3rd, Nasir K, Di Carli MF, Lopez JAG, Kent ST, Bhatt DL, Blankstein R Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population. Eur Heart J Open. 2023 Aug 27;3(4):oead077. doi: 10.1093/ehjopen/oead077. eCollection 2023 Jul.
  • Elbadawi A, de Lemos JA, Girotra S, Pandey A, Grodin JL, Bavry A, Kumbhani DJ Temporal Trends in Left Ventricular Mechanical Unloading With Venoarterial Extracorporeal Membrane Oxygenation. Am J Cardiol. 2023 Oct 15;205:521-523. doi: 10.1016/j.amjcard.2023.08.026. Epub 2023 Aug 26.
  • Kentoffio K, Sun T, Xu J, Parikh RV, Hsue PY, Secemsky EA Longitudinal outcomes following peripheral vascular intervention among older persons living with HIV. Vasc Med. 2023 Dec;28(6):564-570. doi: 10.1177/1358863X231191822. Epub 2023 Aug 28.
  • Nicholls SJ, Nissen SE, Fleming C, Urva S, Suico J, Berg PH, Linnebjerg H, Ruotolo G, Turner PK, Michael LF Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial. JAMA. 2023 Sep 19;330(11):1042-1053. doi: 10.1001/jama.2023.16503.
  • Abovich A, Matasic DS, Cardoso R, Ndumele CE, Blumenthal RS, Blankstein R, Gulati M The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention. Am J Prev Cardiol. 2023 Jul 30;15:100527. doi: 10.1016/j.ajpc.2023.100527. eCollection 2023 Sep.
  • Borlaug BA, Kitzman DW, Davies MJ, Rasmussen S, Barros E, Butler J, Einfeldt MN, Hovingh GK, Moller DV, Petrie MC, Shah SJ, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Nunez J, Perna E, Schou M, Senni M, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nat Med. 2023 Sep;29(9):2358-2365. doi: 10.1038/s41591-023-02526-x. Epub 2023 Aug 27.
  • Chatur S, Vaduganathan M, Claggett BL, Mc Causland FR, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Sabatine MS, Kober L, Ponikowski P, Merkely B, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function. J Am Coll Cardiol. 2023 Nov 7;82(19):1854-1863. doi: 10.1016/j.jacc.2023.08.026. Epub 2023 Aug 25.
  • Mehta SR Complete Revascularization in Older Patients with Myocardial Infarction. N Engl J Med. 2023 Sep 7;389(10):951-952. doi: 10.1056/NEJMe2307941. Epub 2023 Aug 26.
  • Butt JH, Lu H, Kondo T, Bachus E, de Boer RA, Inzucchi SE, Jhund PS, Kosiborod MN, Lam CSP, Martinez FA, Vaduganathan M, Solomon SD, McMurray JJV Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER. Eur J Heart Fail. 2023 Nov;25(11):2078-2090. doi: 10.1002/ejhf.3000. Epub 2023 Sep 1.
  • Munafo AR, Montalto C, Franzino M, Pistelli L, Di Bella G, Ferlini M, Leonardi S, D’Ascenzo F, Gragnano F, Oreglia JA, Oliva F, Ortega-Paz L, Calabro P, Angiolillo DJ, Valgimigli M, Micari A, Costa F External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):709-721. doi: 10.1093/ehjcvp/pvad063.
  • Pabon M, Claggett BL, Wang X, Miao ZM, Chatur S, Bhatt AS, Vaduganathan M, Fang JC, Desai AS, Jhund P, Martinez F, de Boer RA, Kosiborod MN, Lam CSP, Shah SJ, Hernandez AF, McMurray JJV, Solomon SD, Vardeny O Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. Eur J Heart Fail. 2023 Sep;25(9):1663-1670. doi: 10.1002/ejhf.3001. Epub 2023 Aug 29.
  • Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O’Meara E, Ponikowski P, Troughton RW, Wong YW, She L, Harrington J, Adamczyk R, Blackman N, Hernandez AF, HEART-FID Investigators Ferric Carboxymaltose in Heart Failure with Iron Deficiency. N Engl J Med. 2023 Sep 14;389(11):975-986. doi: 10.1056/NEJMoa2304968. Epub 2023 Aug 26.
  • Chatur S, Vaduganathan M, Claggett BL, Cunningham JW, Docherty KF, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Circulation. 2023 Nov 28;148(22):1735-1745. doi: 10.1161/CIRCULATIONAHA.123.066506. Epub 2023 Aug 26.
  • Ponikowski P, Mentz RJ, Hernandez AF, Butler J, Khan MS, van Veldhuisen DJ, Roubert B, Blackman N, Friede T, Jankowska EA, Anker SD Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J. 2023 Dec 21;44(48):5077-5091. doi: 10.1093/eurheartj/ehad586.
  • Keshvani N, Shah S, Ayodele I, Chiswell K, Alhanti B, Allen LA, Greene SJ, Yancy CW, Alonso WW, Van Spall HG, Fonarow GC, Heidenreich PA, Pandey A Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail. 2023 Sep;25(9):1544-1554. doi: 10.1002/ejhf.3003. Epub 2023 Sep 1.
  • Mohebi R, Liu Y, Butler J, Felker GM, Ward JH, Prescott MF, Pina IL, Solomon SD, Januzzi JL Jr Importance of the ‘area under the curve’ from serial NT-proBNP measurements during treatment with sacubitril/valsartan. ESC Heart Fail. 2023 Oct;10(5):3133-3140. doi: 10.1002/ehf2.14503. Epub 2023 Aug 26.
  • Komori Y, Taniguchi A, Shibata H, Goto S, Saito H Phase-Separated Structure of NBR/PVC Blends with Different Acrylonitrile Contents Investigated Using STEM-EDS Mapping Analysis. Polymers (Basel). 2023 Aug 9;15(16):3343. doi: 10.3390/polym15163343.
  • Kosiborod MN, Abildstrom SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Moller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Nunez J, Perna E, Schou M, Senni M, Sharma K, Van der Meer P, von Lewinski D, Wolf D, Petrie MC, STEP-HFpEF Trial Committees and Investigators Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
  • Marx N, Federici M, Schutt K, Muller-Wieland D, Ajjan RA, Antunes MJ, Christodorescu RM, Crawford C, Di Angelantonio E, Eliasson B, Espinola-Klein C, Fauchier L, Halle M, Herrington WG, Kautzky-Willer A, Lambrinou E, Lesiak M, Lettino M, McGuire DK, Mullens W, Rocca B, Sattar N, ESC Scientific Document Group 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.
  • Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Juni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, ESC Scientific Document Group 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
  • Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Andersen KR, Sumin M, Zwiener I, Hernandez AF, Butler J Baseline characteristics of patients enrolled in the EMPACT-MI trial. Eur J Heart Fail. 2023 Sep;25(9):1708-1715. doi: 10.1002/ejhf.2990. Epub 2023 Aug 25.
  • Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Singer DE, Secemsky E, Piccini J, Tahir UA, Shen C, Yeh RW Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants. Circulation. 2023 Sep 19;148(12):936-946. doi: 10.1161/CIRCULATIONAHA.123.064556. Epub 2023 Aug 25.
  • Packer M, Butler J, Zeller C, Pocock SJ, Brueckmann M, Ferreira JP, Filippatos G, Usman MS, Zannad F, Anker SD Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure. Circulation. 2023 Sep 26;148(13):1011-1022. doi: 10.1161/CIRCULATIONAHA.123.065748. Epub 2023 Aug 24.
  • Levy JH, Sniecinski RM, Rocca B, Ghadimi K, Douketis J, Frere C, Helms J, Iba T, Koster A, Lech TK, Maier CL, Neal MD, Scarlestscu E, Spyropoulos A, Steiner ME, Tafur AJ, Tanaka KA, Connors JM Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis. J Thromb Haemost. 2023 Dec;21(12):3649-3657. doi: 10.1016/j.jtha.2023.08.013. Epub 2023 Aug 22.
  • Sharma K, Zhang G, Hansen J, Bjornstad P, Lee HJ, Menon R, Hejazi L, Liu JJ, Franzone A, Looker HC, Choi BY, Fernandez R, Venkatachalam MA, Kugathasan L, Sridhar VS, Natarajan L, Zhang J, Sharma VS, Kwan B, Waikar SS, Himmelfarb J, Tuttle KR, Kestenbaum B, Fuhrer T, Feldman HI, de Boer IH, Tucci FC, Sedor J, Heerspink HL, Schaub J, Otto EA, Hodgin JB, Kretzler M, Anderton CR, Alexandrov T, Cherney D, Lim SC, Nelson RG, Gelfond J, Iyengar R, Kidney Precision Medicine Project Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients. J Clin Invest. 2023 Oct 16;133(20):e170341. doi: 10.1172/JCI170341.
  • Hunter WG, Smith AG, Pinto RC, Saldanha S, Gangwar A, Pahlavani M, Deodhar S, Wilkins J, Pandey A, Herrington D, Greenland P, Tzoulaki I, Rohatgi A Metabolomic Profiling of Cholesterol Efflux Capacity in a Multiethnic Population: Insights From MESA. Arterioscler Thromb Vasc Biol. 2023 Oct;43(10):2030-2041. doi: 10.1161/ATVBAHA.122.318222. Epub 2023 Aug 24.
  • Beska B, Ratcovich H, Bagnall A, Burrell A, Edwards R, Egred M, Jordan R, Khan A, Mills GB, Morrison E, Raharjo DE, Singh F, Wilkinson C, Zaman A, Kunadian V Angiographic and Procedural Characteristics in Frail Older Patients with Non-ST Elevation Acute Coronary Syndrome. Interv Cardiol. 2023 Feb 17;18:e04. doi: 10.15420/icr.2022.20. eCollection 2023.
  • Leong DP, Cirne F, Aghel N, Baro Vila RC, Cavalli GD, Ellis PM, Healey JS, Whitlock R, Khalaf D, Mian H, Jolly SS, Mehta SR, Dent S Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2023 Jul 11;5(4):415-430. doi: 10.1016/j.jaccao.2023.05.008. eCollection 2023 Aug.
  • Lawson CA, Tay WT, Bernhardt L, Richards AM, Zaccardi F, Tromp J, Katherine Teng TH, Hung CL, Chandramouli C, Wander GS, Ouwerkerk W, Seidu S, Khunti K, Lam CSP, ASIAN-HF Investigators Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia. JACC Asia. 2023 May 2;3(4):611-621. doi: 10.1016/j.jacasi.2023.03.005. eCollection 2023 Aug.
  • Dauerman HL, Turco JV, Fuster V Artificial Intelligence, Bob Dylan, and Cardiovascular Scholarship. J Am Coll Cardiol. 2023 Aug 29;82(9):961-963. doi: 10.1016/j.jacc.2023.07.006.
  • Nayak A, Hall SA, Uriel N, Goldstein DJ, Cleveland JC Jr, Cowger JA, Salerno CT, Naka Y, Horstmanshof D, Crandall D, Wang A, Mehra MR Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 Aug 29;82(9):771-781. doi: 10.1016/j.jacc.2023.05.066.
  • Roeters van Lennep JE, Tokgozoglu LS, Badimon L, Dumanski SM, Gulati M, Hess CN, Holven KB, Kavousi M, Kayikcioglu M, Lutgens E, Michos ED, Prescott E, Stock JK, Tybjaerg-Hansen A, Wermer MJH, Benn M Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. Eur Heart J. 2023 Oct 14;44(39):4157-4173. doi: 10.1093/eurheartj/ehad472.
  • Udelson JE, Kelsey MD, Nanna MG, Fordyce CB, Yow E, Clare RM, Mark DB, Patel MR, Rogers C, Curzen N, Pontone G, Maurovich-Horvat P, De Bruyne B, Greenwood JP, Marinescu V, Leipsic J, Stone GW, Ben-Yehuda O, Berry C, Hogan SE, Redfors B, Ali ZA, Byrne RA, Kramer CM, Yeh RW, Martinez B, Mullen S, Huey W, Anstrom KJ, Al-Khalidi HR, Chiswell K, Vemulapalli S, Douglas PS, PRECISE Investigators Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial. JAMA Cardiol. 2023 Oct 1;8(10):915-924. doi: 10.1001/jamacardio.2023.2614.
  • Assadourian JN, Peterson ED, McDonald SA, Gupta A, Navar AM Health Claims and Doses of Fish Oil Supplements in the US. JAMA Cardiol. 2023 Oct 1;8(10):984-988. doi: 10.1001/jamacardio.2023.2424.
  • Douglas PS, Nanna MG, Kelsey MD, Yow E, Mark DB, Patel MR, Rogers C, Udelson JE, Fordyce CB, Curzen N, Pontone G, Maurovich-Horvat P, De Bruyne B, Greenwood JP, Marinescu V, Leipsic J, Stone GW, Ben-Yehuda O, Berry C, Hogan SE, Redfors B, Ali ZA, Byrne RA, Kramer CM, Yeh RW, Martinez B, Mullen S, Huey W, Anstrom KJ, Al-Khalidi HR, Vemulapalli S, PRECISE Investigators Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial. JAMA Cardiol. 2023 Oct 1;8(10):904-914. doi: 10.1001/jamacardio.2023.2595.
  • Ciampa EJ, Flahardy P, Srinivasan H, Jacobs C, Tsai L, Karumanchi SA, Parikh SM Hypoxia-inducible factor 1 signaling drives placental aging and can provoke preterm labor. Elife. 2023 Aug 23;12:RP85597. doi: 10.7554/eLife.85597.
  • Butler J, Khan MS, Fonarow GC The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter. J Am Coll Cardiol. 2023 Sep 5;82(10):1027-1029. doi: 10.1016/j.jacc.2023.06.007. Epub 2023 Aug 21.
  • Kondo T, Wang X, Yang M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Langkilde AM, Petersson M, Zaozerska N, Bachus E, Solomon SD, McMurray JJV Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure. J Am Coll Cardiol. 2023 Sep 5;82(10):1014-1026. doi: 10.1016/j.jacc.2023.05.056. Epub 2023 Aug 21.
  • Silvain J, Lattuca B, Puymirat E, Ducrocq G, Dillinger JG, Lhermusier T, Procopi N, Cachanado M, Drouet E, Abergel H, Danchin N, Montalescot G, Simon T, Steg PG Impact of transfusion strategy on platelet aggregation and biomarkers in myocardial infarction patients with anemia. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):647-657. doi: 10.1093/ehjcvp/pvad055.
  • Wahood W, Duval S, Takahashi EA, Secemsky EA, Misra S Racial and Ethnic Disparities in Treatment of Critical Limb Ischemia: A National Perspective. J Am Heart Assoc. 2023 Sep 5;12(17):e029074. doi: 10.1161/JAHA.122.029074. Epub 2023 Aug 23.
  • Franchi F, Rollini F, Ortega-Paz L, Been L, Giordano S, Galli M, Ghanem G, Garabedian H, Al Saleh T, Uzunoglu E, Rivas A, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Mahowald M, Reiter B, Jilma B, Angiolillo DJ Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2528-2539. doi: 10.1016/j.jcin.2023.08.009. Epub 2023 Aug 21.
  • Fatima K, Butler J, Fonarow GC Residual risk in heart failure and the need for simultaneous implementation and innovation. Eur J Heart Fail. 2023 Sep;25(9):1477-1480. doi: 10.1002/ejhf.3005. Epub 2023 Aug 30.
  • Sarosiek S, Lee MH, Doros G, Edwards CV, Quillen K, Brauneis D, Shelton AC, Sanchorawala V, Sloan JM Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study. Transplant Cell Ther. 2023 Nov;29(11):695.e1-695.e7. doi: 10.1016/j.jtct.2023.08.018. Epub 2023 Aug 20.
  • Januzzi JL, Mohebi R, Liu Y, Sattar N, Heerspink HJL, Tefera E, Vaduganathan M, Butler J, Yavin Y, Li J, Pollock CA, Perkovic V, Neal B, Hansen MK Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial. Circulation. 2023 Aug 22;148(8):651-660. doi: 10.1161/CIRCULATIONAHA.123.065251. Epub 2023 Aug 21.
  • Yancy CW, Barabino G, Bright C, Laurencin CT, Montgomery Rice V The Supreme Court and the Importance of Diversity in Medicine. N Engl J Med. 2023 Aug 24;389(8):677-679. doi: 10.1056/NEJMp2306195. Epub 2023 Aug 19.
  • Buckler AJ, Doros G, Kinninger A, Lakshmanan S, Le VT, Libby P, May HT, Muhlestein JB, Nelson JR, Nicolaou A, Roy SK, Shaikh K, Shekar C, Tayek JA, Zheng L, Bhatt DL, Budoff MJ Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE. Front Cardiovasc Med. 2023 Aug 3;10:1204071. doi: 10.3389/fcvm.2023.1204071. eCollection 2023.
  • Tuttle KR, Bosch-Traberg H, Cherney DZI, Hadjadj S, Mosenzon O, Rasmussen S, Bain SC The authors reply. Kidney Int. 2023 Sep;104(3):619. doi: 10.1016/j.kint.2023.06.008.
  • Kuzemczak M, Lipiecki J, Jeyalan V, Farhat H, Kleczynski P, Legutko J, Minten L, Bennett J, Poels E, Dens J, Spyridopoulos I, Kunadian V, Pawlowski T, Gil R, Egred M, Zaman A, Alkhalil M Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry). Int J Cardiol. 2023 Nov 15;391:131274. doi: 10.1016/j.ijcard.2023.131274. Epub 2023 Aug 18.
  • Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O’Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Blackman N, Hernandez AF Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. Am Heart J. 2023 Dec;266:25-31. doi: 10.1016/j.ahj.2023.08.005. Epub 2023 Aug 19.
  • St Germain L, De Paula E, Ay C, Barco S, Cesarman-Maus G, Connors JM, Dumantepe M, Cecilia Guillermo Esposito M, Lee LH, Morishita E, Samama CM, Okoye H, Robertson T, McPherson G, Castellucci LA Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way – in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022. J Thromb Haemost. 2023 Sep;21(9):2311-2312. doi: 10.1016/j.jtha.2023.06.006.
  • Lim TW, Camm AJ, Virdone S, Singer DE, Bassand JP, Fonarow GC, Fox KAA, Ezekowitz M, Gersh BJ, Kayani G, Hylek EM, Kakkar AK, Mahaffey KW, Pieper KS, Peterson ED, Piccini JP, GARFIELD-AF and ORBIT-AF Investigators Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries. Clin Cardiol. 2023 Nov;46(11):1398-1407. doi: 10.1002/clc.24109. Epub 2023 Aug 18.
  • Rosano G, Ponikowski P, Vitale C, Anker SD, Butler J, Fabien V, Filippatos G, Kirwan BA, Macdougall IC, Metra M, Ruschitzka F, Kumpeson V, Goehring UM, van der Meer P, Jankowska EA, AFFIRM-AHF investigators Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial. Cardiovasc Diabetol. 2023 Aug 17;22(1):215. doi: 10.1186/s12933-023-01943-z.
  • Ording AG, Nielsen PB, Skjoth F, Overvad TF, Noble S, Lash TL, Goldhaber SZ, Christensen TD, Larsen TB, Sogaard M Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study. Int J Cardiol. 2023 Nov 1;390:131271. doi: 10.1016/j.ijcard.2023.131271. Epub 2023 Aug 15.
  • Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP, COVID-19 and Cancer Consortium Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 Oct 1;9(10):1390-1400. doi: 10.1001/jamaoncol.2023.2934.
  • Darabont RO, Ene C, Nicula AI, Badiu CC, Vinereanu D Constrictive Pericarditis in the Light of Multimodal Cardiac Imaging. A Case Report. Maedica (Bucur). 2023 Jun;18(2):342-347. doi: 10.26574/maedica.2023.18.2.342.
  • Lee SY, Jeong YH, Yun KH, Cho JY, Gorog DA, Angiolillo DJ, Kim JW, Jang Y P2Y(12) Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study. JACC Cardiovasc Interv. 2023 Aug 14;16(15):1845-1855. doi: 10.1016/j.jcin.2023.05.035.
  • Mendieta G, Mehta S, Baber U, Angiolillo DJ, Briguori C, Cohen D, Collier T, Dangas G, Dudek D, Escaned J, Gil R, Vogel B, Cao D, Spirito A, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Sardella G, Sartori S, Sharma S, Shlofmitz R, Steg PG, Han YL, Pocock S, Gibson CM, Mehran R Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions. J Am Coll Cardiol. 2023 Aug 22;82(8):687-700. doi: 10.1016/j.jacc.2023.05.062.
  • Talha KM, Pandey A, Fudim M, Butler J, Anker SD, Khan MS Frailty and heart failure: State-of-the-art review. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1959-1972. doi: 10.1002/jcsm.13306. Epub 2023 Aug 16.
  • Butler J, Budden J, Pitt B, Anker S Carat, clarity, colour, and cut: grading the DIAMOND trial. Eur Heart J. 2023 Oct 1;44(37):3702-3703. doi: 10.1093/eurheartj/ehad469.
  • von Bardeleben RS, Lurz P, Sorajja P, Ruf T, Hausleiter J, Sitges M, Da Rocha E Silva J, Nabauer M, Weber M, Tang GHL, Heitkemper M, Ying SW, Trochu JN, Kar S, Hahn RT, Nickenig G, TRILUMINATE Trial Investigators Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial. Circ Cardiovasc Interv. 2023 Aug;16(8):e012888. doi: 10.1161/CIRCINTERVENTIONS.122.012888. Epub 2023 Aug 15.
  • Pierce JB, Butler J, Greene SJ Implementation of sodium-glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be. Eur J Heart Fail. 2023 Sep;25(9):1659-1662. doi: 10.1002/ejhf.2999. Epub 2023 Aug 22.
  • Butala NM, Chandra V, Beckman JA, Parikh SA, Lookstein R, Misra S, Secemsky EA Contextualizing the BEST-CLI Trial Results in Clinical Practice. J Soc Cardiovasc Angiogr Interv. 2023 Jul-Aug;2(4):101036. doi: 10.1016/j.jscai.2023.101036. Epub 2023 May 19.
  • Watson NW, Weinberg I, Dicks AB, Fong E, Strom JB, Carroll BJ, Raja A, Schainfeld R, Secemsky EA Clinical Significance of Right Heart Thrombus With and Without an Associated Pulmonary Embolism. Am J Med. 2023 Nov;136(11):1109-1118.e3. doi: 10.1016/j.amjmed.2023.07.014. Epub 2023 Aug 11.
  • Wilson M, Wang JY, Andreev A, Katsanos AH, Selim M, Lioutas VA Diagnostic utility of brain MRI in spontaneous intracerebral hemorrhage: A retrospective cohort study and meta-analysis. Eur Stroke J. 2023 Dec;8(4):1089-1096. doi: 10.1177/23969873231192761. Epub 2023 Aug 11.
  • Sharma A, Caldeira D, Razaghizad A, Pinto FJ, van Veldhuisen DJ, Mehra MR, Lam CSP, Cleland J, Anker SD, Greenberg B, Ferreira JP, Zannad F Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF. BMJ Open. 2023 Aug 11;13(8):e068865. doi: 10.1136/bmjopen-2022-068865.
  • Alogna A, Koepp KE, Sabbah M, Espindola Netto JM, Jensen MD, Kirkland JL, Lam CSP, Obokata M, Petrie MC, Ridker PM, Sorimachi H, Tchkonia T, Voors A, Redfield MM, Borlaug BA Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2023 Nov;11(11):1549-1561. doi: 10.1016/j.jchf.2023.06.031. Epub 2023 Aug 9.
  • Lam CSP, Pina IL, Zheng Y, Bonderman D, Pouleur AC, Saldarriaga C, Pieske B, Blaustein RO, Nkulikiyinka R, Westerhout CM, Armstrong PW, VICTORIA Study Group Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial. JACC Heart Fail. 2023 Sep;11(9):1246-1257. doi: 10.1016/j.jchf.2023.06.020. Epub 2023 Aug 9.
  • Abu-Qaoud MR, Kumar A, Tarun T, Abraham S, Ahmad J, Khadke S, Husami R, Kulbak G, Sahoo S, Januzzi JL Jr, Neilan TG, Baron SJ, Martin D, Nohria A, Reynolds MR, Kosiborod M, Dani SS, Ganatra S Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes. JACC Clin Electrophysiol. 2023 Oct;9(10):2109-2118. doi: 10.1016/j.jacep.2023.06.008. Epub 2023 Aug 9.
  • Curry BJ, Rikken AOFS, Gibson CM, Granger CB, van ‘t Hof AWJ, Ten Berg JM, Jennings LK Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation. J Thromb Thrombolysis. 2023 Nov;56(4):499-510. doi: 10.1007/s11239-023-02867-x. Epub 2023 Aug 10.
  • Khan MS, Arshad MS, Greene SJ, Van Spall HGC, Pandey A, Vemulapalli S, Perakslis E, Butler J Artificial intelligence and heart failure: A state-of-the-art review. Eur J Heart Fail. 2023 Sep;25(9):1507-1525. doi: 10.1002/ejhf.2994. Epub 2023 Sep 8.
  • Bielecka-Dabrowa A, Banach M, Wittczak A, Cicero AFG, Kallel A, Kubilius R, Mikhailidis DP, Sahebkar A, Pantea Stoian A, Vinereanu D, Penson PE, von Haehling S The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper. Arch Med Sci. 2023 Jun 9;19(4):841-864. doi: 10.5114/aoms/167799. eCollection 2023.
  • Nakagawa A, Nakamura N, Torii S, Goto S Acute pulmonary hypertension due to microthrombus formation following COVID-19 vaccination: a case report. Eur Heart J Case Rep. 2023 Jul 26;7(8):ytad353. doi: 10.1093/ehjcr/ytad353. eCollection 2023 Aug.
  • Kaul S, Siddiqi TJ, Anker SD, Butler J Heart Failure Hospitalizations Versus Cardiovascular Mortality in Heart Failure Trials. Am J Cardiol. 2023 Sep 15;203:484-487. doi: 10.1016/j.amjcard.2023.07.074. Epub 2023 Aug 8.
  • Kerr AJ, Choi Y, Williams MJ, Stewart RA, White HD, Devlin G, Selak V, Lee MAW, El-Jack S, Adamson PD, Fairley S, Jackson RT, Poppe K Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome. Heart. 2023 Nov 27;109(24):1827-1836. doi: 10.1136/heartjnl-2023-322830.
  • Pitt B, Bhatt DL, Szarek M, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Ezekowitz JA, Sun F, Davies MJ, Verma S, Kosiborod MN, Steg PG, SOLOIST-WHF Investigators Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF. JACC Heart Fail. 2023 Aug;11(8 Pt 1):879-889. doi: 10.1016/j.jchf.2023.05.026.
  • Oseran AS, Song Y, Xu J, Dahabreh IJ, Wadhera RK, de Lemos JA, Das SR, Sun T, Yeh RW, Kazi DS Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study. BMJ. 2023 Aug 9;382:e076222. doi: 10.1136/bmj-2023-076222.
  • Khan MS, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Chopra VK, Pina IL, Bohm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Peil B, Zannad F, Packer M, Butler J Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial. J Card Fail. 2023 Oct;29(10):1345-1354. doi: 10.1016/j.cardfail.2023.06.024. Epub 2023 Aug 8.
  • Regan JA, Mentz RJ, Nguyen M, Green JB, Truby LK, Ilkayeva O, Newgard CB, Buse JB, Sourij H, Sjostrom CD, Sattar N, McGarrah RW, Zheng Y, McGuire DK, Standl E, Armstrong P, Peterson ED, Hernandez AF, Holman RR, Shah SH Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes. JCI Insight. 2023 Sep 8;8(17):e168563. doi: 10.1172/jci.insight.168563.
  • Neilan TG, Quinaglia T, Onoue T, Mahmood SS, Drobni ZD, Gilman HK, Smith A, Heemelaar JC, Brahmbhatt P, Ho JS, Sama S, Svoboda J, Neuberg DS, Abramson JS, Hochberg EP, Barnes JA, Armand P, Jacobsen ED, Jacobson CA, Kim AI, Soumerai JD, Han Y, Friedman RS, Lacasce AS, Ky B, Landsburg D, Nasta S, Kwong RY, Jerosch-Herold M, Redd RA, Hua L, Januzzi JL, Asnani A, Mousavi N, Scherrer-Crosbie M Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial. JAMA. 2023 Aug 8;330(6):528-536. doi: 10.1001/jama.2023.11887.
  • Chico TJ, Stamatakis E, Ciravegna F, Dunn J, Redwood S, Al-Lamee R, Sofat R, Gill J Device-based measurement of physical activity in cardiovascular healthcare: possibilities and challenges. Br J Sports Med. 2023 Oct;57(19):1225-1226. doi: 10.1136/bjsports-2022-106460. Epub 2023 Aug 7.
  • Anderson JE, Butler J, Alexandrov AV Reducing Ischemic Stroke in Diabetes: The Role of GLP-1 RAs. J Fam Pract. 2023 Jul;72(6 Suppl):S55-S60. doi: 10.12788/jfp.0624.
  • Yeh RW Bringing the Credibility Revolution to Observational Research in Cardiology. Circulation. 2023 Aug 8;148(6):455-458. doi: 10.1161/CIRCULATIONAHA.123.064645. Epub 2023 Aug 7.
  • Lucas F, Lewis J, Grandoni J, Sylvester KW, Bernier TD, Ting C, Sek R, Ballard K, Connors JM, Battinelli EM One-year retrospective analysis of anti-FXa apixaban and rivaroxaban levels demonstrates utility for management decisions in various urgent and nonurgent clinical situations. Am J Clin Pathol. 2023 Dec 1;160(6):571-584. doi: 10.1093/ajcp/aqad085.
  • Teruya J, Connors JM, Zieger B Editorial: Hemostasis in ECMO and VAD, volume II. Front Med (Lausanne). 2023 Jul 21;10:1251079. doi: 10.3389/fmed.2023.1251079. eCollection 2023.
  • Brandts J, Bray S, Villa G, Catapano AL, Poulter NR, Vallejo-Vaz AJ, Ray KK, DA VINCI study group Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study. Lancet Reg Health Eur. 2023 Jun 8;31:100665. doi: 10.1016/j.lanepe.2023.100665. eCollection 2023 Aug.
  • Dowling C, Haeffele C, Pogatchnik BP, Sharma RP Percutaneous Treatment of an Aorto-Right Ventricular Fistula Following Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC Case Rep. 2023 Jun 12;18:101906. doi: 10.1016/j.jaccas.2023.101906. eCollection 2023 Jul 19.
  • Occhipinti G, Greco A, Angiolillo DJ, Capodanno D Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes. Expert Opin Drug Saf. 2023 Jul-Dec;22(8):669-683. doi: 10.1080/14740338.2023.2245331. Epub 2023 Aug 16.
  • Seligman H, Patel SB, Alloula A, Howard JP, Cook CM, Ahmad Y, de Waard GA, Pinto ME, van de Hoef TP, Rahman H, Kelshiker MA, Rajkumar CA, Foley M, Nowbar AN, Mehta S, Toulemonde M, Tang MX, Al-Lamee R, Sen S, Cole G, Nijjer S, Escaned J, Van Royen N, Francis DP, Shun-Shin MJ, Petraco R Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment. Eur Heart J Digit Health. 2023 May 3;4(4):291-301. doi: 10.1093/ehjdh/ztad030. eCollection 2023 Aug.
  • Smilowitz NR, Rao SV Age or Functional Debility to Predict Death After Percutaneous Coronary Intervention: Age Is More Than a Number. Mayo Clin Proc. 2023 Aug;98(8):1110-1112. doi: 10.1016/j.mayocp.2023.06.010.
  • Brown KN, Goel R, Soman S, Khan E, Ya’Qoub L, Calsavara V, Wang DD, Velagapudi P, Mehran R, Gulati M Gender Disparity in Citations and Altmetric Attention Scores in High-Impact Cardiology Journals. J Am Coll Cardiol. 2023 Aug 8;82(6):572-573. doi: 10.1016/j.jacc.2023.05.044.
  • Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Filippatos G, Gustafsson F, Lam CSP, Lund LH, Mentz RJ, Pieske B, Ponikowski P, Senni M, Skopicki N, Voors AA, Zannad F, Zieroth S, Butler J Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3. J Am Coll Cardiol. 2023 Aug 8;82(6):559-571. doi: 10.1016/j.jacc.2023.04.057.
  • Jalloh MB, Averbuch T, Kulkarni P, Granger CB, Januzzi JL, Zannad F, Yeh RW, Yancy CW, Fonarow GC, Breathett K, Gibson CM, Van Spall HGC Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3. J Am Coll Cardiol. 2023 Aug 8;82(6):544-558. doi: 10.1016/j.jacc.2023.05.050.
  • Patolia H, Khan MS, Fonarow GC, Butler J, Greene SJ Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3. J Am Coll Cardiol. 2023 Aug 8;82(6):529-543. doi: 10.1016/j.jacc.2023.03.430.
  • Navar AM, Kolkailah AA, Gupta A, Gillard KK, Israel MK, Wang Y, Peterson ED Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients. Circ Cardiovasc Qual Outcomes. 2023 Aug;16(8):533-543. doi: 10.1161/CIRCOUTCOMES.122.009787. Epub 2023 Aug 2.
  • Hulsizer AL, Davis S, Gibson CM Does Emergency Medical Services Blood Collection Shorten Time to Tissue Plasminogen Activator in Ischemic Stroke? J Pharm Technol. 2023 Aug;39(4):195-198. doi: 10.1177/87551225231182543. Epub 2023 Jun 28.
  • Lawless M, Brown S, Kunadian V Raising awareness about cardiovascular disease in women. Eur Heart J. 2023 Sep 1;44(33):3110-3112. doi: 10.1093/eurheartj/ehad452.
  • Black JH 3rd, Buckley D, Velezis M, Eldrup-Jorgensen J, Serratore ND, Gutierrez JA, Whatley E, Marmor RA, Bertges DJ, Tcheng JE, Royce S, Malone M, Farb A, Secemsky EA, Parikh SA, Smale J, Jaff MR, White R, Wilgus RW, Krucoff MW Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways “LEAN” working group. J Vasc Surg. 2023 Nov;78(5):1313-1321. doi: 10.1016/j.jvs.2023.07.050. Epub 2023 Jul 29.
  • Khan MS, Van Spall HGC In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence). Ann Intern Med. 2023 Aug;176(8):JC88. doi: 10.7326/J23-0051. Epub 2023 Aug 1.
  • Mohamed AA, Ray KK Inclisiran and cardiovascular events: a comprehensive review of efficacy, safety, and future perspectives. Curr Opin Cardiol. 2023 Nov 1;38(6):527-532. doi: 10.1097/HCO.0000000000001074. Epub 2023 Jul 26.
  • Shapiro MD, Taub PR, Louie MJ, Lei L, Ballantyne CM Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials. Atherosclerosis. 2023 Aug;378:117182. doi: 10.1016/j.atherosclerosis.2023.06.973. Epub 2023 Jun 29.
  • Ismayl M, Hussain Y, Aboeata A, Walters RW, Naidu SS, Messenger JC, Basir MB, Rao SV, Goldsweig AM, Altin SE Pulmonary Artery Catheter Use and Outcomes in Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock Treated With Impella (a Nationwide Analysis from the United States). Am J Cardiol. 2023 Sep 15;203:304-314. doi: 10.1016/j.amjcard.2023.06.117. Epub 2023 Jul 28.
  • Jaltotage B, Ihdayhid AR, Lan NSR, Pathan F, Patel S, Arnott C, Figtree G, Kritharides L, Shamsul Islam SM, Chow CK, Rankin JM, Nicholls SJ, Dwivedi G Artificial Intelligence in Cardiology: An Australian Perspective. Heart Lung Circ. 2023 Aug;32(8):894-904. doi: 10.1016/j.hlc.2023.06.703. Epub 2023 Jul 26.
  • Vinereanu D, Wojdyla DM, Alexander JH, Lopes RD, Al-Khatib SM, Gersh BJ, Bahit MC, Hohnloser SH, Flaker GC, Rosenquist M, Hijazi Z, Wallentin L, Granger CB Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial. Am Heart J. 2023 Nov;265:132-136. doi: 10.1016/j.ahj.2023.07.006. Epub 2023 Jul 26.
  • Fielding-Singh V, Vanneman MW, Morris AM, Chertow GM, Lin E Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease. JAMA Netw Open. 2023 Jul 3;6(7):e2326326. doi: 10.1001/jamanetworkopen.2023.26326.
  • Armstrong PW, Zheng Y, Lund LH, Butler J, Troughton RW, Emdin M, Lam CSP, Ponikowski P, Blaustein RO, O’Connor CM, Roessig L, Voors AA, Ezekowitz JA, Westerhout CM, VICTORIA Study Group Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat. Circ Heart Fail. 2023 Oct;16(10):e010661. doi: 10.1161/CIRCHEARTFAILURE.123.010661. Epub 2023 Jul 28.
  • Adusumalli S, Mohebi R, McCarthy CP, Megaret CA, Rhyne RF, Jaffer FA, Januzzi JL Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions. medRxiv [Preprint]. 2023 Jul 23:2023.07.19.23292911. doi: 10.1101/2023.07.19.23292911.
  • Golbus JR, Gosch K, Birmingham MC, Butler J, Lingvay I, Lanfear DE, Abbate A, Kosiborod ML, Damaraju CV, Januzzi JL Jr, Spertus J, Nallamothu BK Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure. JACC Heart Fail. 2023 Nov;11(11):1521-1530. doi: 10.1016/j.jchf.2023.05.033. Epub 2023 Jul 26.
  • Van Edom CJ, Gramegna M, Baldetti L, Beneduce A, Castelein T, Dauwe D, Frederiks P, Giustino G, Jacquemin M, Janssens SP, Panoulas VF, Poss J, Rosenberg A, Schaubroeck HAI, Schrage B, Tavazzi G, Vanassche T, Vercaemst L, Vlasselaers D, Vranckx P, Belohlavek J, Gorog DA, Huber K, Mebazaa A, Meyns B, Pappalardo F, Scandroglio AM, Stone GW, Westermann D, Chieffo A, Price S, Vandenbriele C Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support: A Practical Approach. JACC Cardiovasc Interv. 2023 Jul 24;16(14):1707-1720. doi: 10.1016/j.jcin.2023.05.043.
  • Ben-Yehuda O Combination Therapy With Lower Statin Dose and the Race to LDL-C Goal: A Clear Winner? J Am Coll Cardiol. 2023 Aug 1;82(5):411-413. doi: 10.1016/j.jacc.2023.06.003.
  • Connors JM, Ariens RAS Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Thromb Haemost. 2023 Oct;21(10):2697-2701. doi: 10.1016/j.jtha.2023.07.012. Epub 2023 Jul 24.
  • Baugh CW, Blankstein R, Ganguli I, Januzzi JL, Morrow DA, Joseph JW, Jordan C, Donohoe G, Fofi J, McKinley K, Heydarpour M, Scirica BM, DiCarli MF, Nagurney JT Frequency, compliance, and yield of cardiac testing after high-sensitivity troponin accelerated diagnostic protocol implementation. Am J Emerg Med. 2023 Oct;72:64-71. doi: 10.1016/j.ajem.2023.07.014. Epub 2023 Jul 13.
  • Varkila MRJ, Montez-Rath ME, Salomon JA, Yu X, Block GA, Owens DK, Chertow GM, Parsonnet J, Anand S Use of Wastewater Metrics to Track COVID-19 in the US. JAMA Netw Open. 2023 Jul 3;6(7):e2325591. doi: 10.1001/jamanetworkopen.2023.25591.
  • D’Angelo RN, Korjian S, D’Avila A, Waks JW Entrapment of high-density grid mapping catheter in a percutaneous ventricular assist device pigtail during ventricular tachycardia ablation with percutaneous hemodynamic support. HeartRhythm Case Rep. 2023 May 2;9(7):478-481. doi: 10.1016/j.hrcr.2023.04.014. eCollection 2023 Jul.
  • Park DY, An S, Jolly N, Attanasio S, Yadav N, Gutierrez JA, Nanna MG, Rao SV, Vij A Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression. Catheter Cardiovasc Interv. 2023 Sep;102(3):440-450. doi: 10.1002/ccd.30784. Epub 2023 Jul 22.
  • Matasic DS, Blumenthal RS, Fonarow GC, Gulati M Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention. Am Heart J. 2023 Dec;266:176-178. doi: 10.1016/j.ahj.2023.07.004. Epub 2023 Jul 20.
  • Patel RB, Reddy VY, Komtebedde J, Wegerich SW, Sekaric J, Swarup V, Walton A, Laurent G, Chetcuti S, Rademann M, Bergmann M, McKenzie S, Bugger H, Bruno RR, Herrmann HC, Nair A, Gupta DK, Lim S, Kapadia S, Gordon R, Vanderheyden M, Noel T, Bailey S, Gertz ZM, Trochu JN, Cutlip DE, Leon MB, Solomon SD, van Veldhuisen DJ, Auricchio A, Shah SJ Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2023 Oct;11(10):1351-1362. doi: 10.1016/j.jchf.2023.05.024. Epub 2023 Jul 19.
  • Goodwin NP, Clare RM, Harrington JL, Badjatiya A, Wojdyla DM, Udell JA, Butler J, Januzzi JL Jr, Parikh PB, James S, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Hernandez AF, Jones WS Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials. J Card Fail. 2023 Dec;29(12):1603-1614. doi: 10.1016/j.cardfail.2023.07.004. Epub 2023 Jul 20.
  • Rao SV, Reynolds HR, Hochman JS Chronic Coronary Disease Guidelines. Circulation. 2023 Aug 29;148(9):729-731. doi: 10.1161/CIRCULATIONAHA.123.064623. Epub 2023 Jul 20.
  • Jonas M, Ben-Yehuda O, Banai S, Segev A, Danenberg H, Assali A, Tuvali O, Haberman D, Chernin G Percutaneous coronary intervention with ridaforolimus-eluting stents in long lesions: the BIONICS 38 mm prospective trial. Coron Artery Dis. 2023 Sep 1;34(6):410-414. doi: 10.1097/MCA.0000000000001264. Epub 2023 Jul 4.
  • van Broekhoven A, Eikelboom JW, Nidorf SM, Mosterd A, Cornel JH, LoDoCo2 investigators Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial. Clin Drug Investig. 2023 Jul;43(7):575-577. doi: 10.1007/s40261-023-01287-2. Epub 2023 Jul 20.
  • Lund LH, Lam CSP, Pizzato PE, Gabrielsen A, Michaelsson E, Nelander K, Ericsson H, Holden J, Folkvaljon F, Mattsson A, Collen A, Aurell M, Whatling C, Baldus S, Drelich G, Goudev A, Merkely B, Bergh N, Shah SJ Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction. Eur J Heart Fail. 2023 Sep;25(9):1696-1707. doi: 10.1002/ejhf.2977. Epub 2023 Aug 22.
  • Maron BJ, Estes NAM, Rowin EJ, Maron MS, Reynolds MR Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023 Jul 25;82(4):353-373. doi: 10.1016/j.jacc.2023.04.056.
  • Rodes-Cabau J, Januzzi JL Jr, Mack MJ Tricuspid Transcatheter Repair: Edging Toward Prime Time? J Am Coll Cardiol. 2023 Jul 25;82(4):292-294. doi: 10.1016/j.jacc.2023.05.028.
  • Goto S, Goto S Long-term outcome of chronic thromboembolic pulmonary hypertension in the era where direct oral anticoagulants become available. J Thromb Haemost. 2023 Aug;21(8):2058-2060. doi: 10.1016/j.jtha.2023.04.032.
  • Fazel R, Yeh RW, Cohen DJ, Rao SV, Li S, Song Y, Secemsky EA Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA. Eur Heart J. 2023 Oct 12;44(38):3845-3855. doi: 10.1093/eurheartj/ehad430.
  • Stone GW, Ali ZA, O’Brien SM, Rhodes G, Genereux P, Bangalore S, Mavromatis K, Horst J, Dressler O, Poh KK, Nath RK, Moorthy N, Witkowski A, Dwivedi SK, Bockeria O, Chen J, Smanio PEP, Picard MH, Chaitman BR, Berman DS, Shaw LJ, Boden WE, White HD, Fremes SE, Rosenberg Y, Reynolds HR, Spertus JA, Hochman JS, Maron DJ, ISCHEMIA Research Group Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. 2023 Sep 19;82(12):1175-1188. doi: 10.1016/j.jacc.2023.06.015. Epub 2023 Jul 17.
  • Harrington J, Butler J Heart failure after myocardial infarction: Glass emptier than full. Eur J Heart Fail. 2023 Aug;25(8):1225-1227. doi: 10.1002/ejhf.2961. Epub 2023 Aug 2.
  • Anker SD, Usman MS, Anker MS, Butler J, Bohm M, Abraham WT, Adamo M, Chopra VK, Cicoira M, Cosentino F, Filippatos G, Jankowska EA, Lund LH, Moura B, Mullens W, Pieske B, Ponikowski P, Gonzalez-Juanatey JR, Rakisheva A, Savarese G, Seferovic P, Teerlink JR, Tschope C, Volterrani M, von Haehling S, Zhang J, Zhang Y, Bauersachs J, Landmesser U, Zieroth S, Tsioufis K, Bayes-Genis A, Chioncel O, Andreotti F, Agabiti-Rosei E, Merino JL, Metra M, Coats AJS, Rosano GMC Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail. 2023 Jul;25(7):936-955. doi: 10.1002/ejhf.2894. Epub 2023 Jul 17.
  • Schechter M, Chertow GM, Heerspink HJL Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease. Ann Intern Med. 2023 Jul;176(7):eL230070. doi: 10.7326/L23-0070.
  • Chiarito M, Cao D, Sartori S, Zhang Z, Vogel B, Spirito A, Smith KF, Weintraub W, Strauss C, Toma C, DeFranco A, Effron MB, Stefanini G, Keller S, Kapadia S, Rao SV, Henry TD, Pocock S, Sharma S, Dangas G, Kini A, Baber U, Mehran R Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study. Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):594-603. doi: 10.1093/ehjacc/zuad083.
  • Osho A, Fernandes MF, Poudel R, de Lemos J, Hong H, Zhao J, Li S, Thomas K, Kikuchi DS, Zegre-Hemsey J, Ibrahim N, Shah NS, Hollowell L, Tamis-Holland J, Granger CB, Cohen M, Henry T, Jacobs AK, Jollis JG, Yancy CW, Goyal A Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry. Circulation. 2023 Jul 18;148(3):229-240. doi: 10.1161/CIRCULATIONAHA.123.065512. Epub 2023 Jul 17.
  • Mentias A, Mujahid MS, Sumarsono A, Nelson RK, Madron JM, Powell-Wiley TM, Essien UR, Keshvani N, Girotra S, Morris AA, Sims M, Capers Q 4th, Yancy C, Desai MY, Menon V, Rao S, Pandey A Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries. Circulation. 2023 Jul 18;148(3):210-219. doi: 10.1161/CIRCULATIONAHA.123.064351. Epub 2023 Jul 17.
  • Liu L, Obuobi S, Gulati M Redesigning the Future of Medicine. JAMA Netw Open. 2023 Jul 3;6(7):e2323831. doi: 10.1001/jamanetworkopen.2023.23831.
  • Mohammadi KA, Brackin T, Schwartz GG, Steg PG, Szarek M, Manvelian G, Pordy R, Fazio S, Geba GP Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials. Cancer Med. 2023 Aug;12(16):16859-16868. doi: 10.1002/cam4.6310. Epub 2023 Jul 17.
  • Meijers TA, Aminian A, Valgimigli M, Dens J, Agostoni P, Iglesias JF, Gasparini GL, Seto AH, Saito S, Rao SV, van Royen N, Brilakis ES, van Leeuwen MAH Vascular Access in Percutaneous Coronary Intervention of Chronic Total Occlusions: A State-of-the-Art Review. Circ Cardiovasc Interv. 2023 Aug;16(8):e013009. doi: 10.1161/CIRCINTERVENTIONS.123.013009. Epub 2023 Jul 17.
  • Sambola A, Del Blanco BG, Kunadian V, Vogel B, Chieffo A, Vidal M, Ratcovich H, Botti G, Wilkinson C, Mehran R Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease. Eur Cardiol. 2023 Mar 2;18:e06. doi: 10.15420/ecr.2022.24. eCollection 2023.
  • Bhatnagar A, Niu J, Ho V, Winkelmayer WC, Erickson KF Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market. Kidney Med. 2023 May 25;5(8):100678. doi: 10.1016/j.xkme.2023.100678. eCollection 2023 Aug.
  • Berman AN, Ginder C, Wang XS, Borden L, Hidrue MK, Searl Como JM, Daly D, Sun YP, Curry WT, Del Carmen M, Morrow DA, Scirica B, Choudhry NK, Januzzi JL, Wasfy JH A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH). Am Heart J. 2023 Nov;265:40-49. doi: 10.1016/j.ahj.2023.06.014. Epub 2023 Jul 14.
  • Faridi KF, Strom JB, Kundi H, Butala NM, Curtis JP, Gao Q, Song Y, Zheng L, Tamez H, Shen C, Secemsky EA, Yeh RW Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study. J Am Heart Assoc. 2023 Jul 18;12(14):e029588. doi: 10.1161/JAHA.123.029588. Epub 2023 Jul 14.
  • Metra M, Adamo M, Tomasoni D, Mebazaa A, Bayes-Genis A, Abdelhamid M, Adamopoulos S, Anker SD, Bauersachs J, Belenkov Y, Bohm M, Gal TB, Butler J, Cohen-Solal A, Filippatos G, Gustafsson F, Hill L, Jaarsma T, Jankowska EA, Lainscak M, Lopatin Y, Lund LH, McDonagh T, Milicic D, Moura B, Mullens W, Piepoli M, Polovina M, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Seferovic P, Sharma R, Thum T, Tocchetti CG, Van Linthout S, Vitale C, Von Haehling S, Volterrani M, Coats AJS, Chioncel O, Rosano G Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC. Eur J Heart Fail. 2023 Jul;25(7):1115-1131. doi: 10.1002/ejhf.2888. Epub 2023 Jul 13.
  • Cosentino F, Verma S, Ambery P, Treppendahl MB, van Eickels M, Anker SD, Cecchini M, Fioretto P, Groop PH, Hess D, Khunti K, Lam CSP, Richard-Lordereau I, Lund LH, McGreavy P, Newsome PN, Sattar N, Solomon S, Weidinger F, Zannad F, Zeiher A Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table. Eur Heart J. 2023 Oct 14;44(39):4141-4156. doi: 10.1093/eurheartj/ehad445.
  • Castaldi G, Bharadwaj AS, Bagur R, Van Spall HGC, Kobo O, Mamas MA Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset. Int J Cardiol. 2023 Oct 15;389:131154. doi: 10.1016/j.ijcard.2023.131154. Epub 2023 Jul 11.
  • Van de Werf F, Ristic AD, Averkov OV, Arias-Mendoza A, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Music LB, Vandenberghe K, Bogaerts K, Westerhout CM, Pages A, Danays T, Bainey KR, Sinnaeve P, Goldstein P, Welsh RC, Armstrong PW, STREAM-2 Investigators STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial. Circulation. 2023 Aug 29;148(9):753-764. doi: 10.1161/CIRCULATIONAHA.123.064521. Epub 2023 Jul 13.
  • Mohebi R, Liu Y, Hansen MK, Yavin Y, Sattar N, Pollock CA, Butler J, Jardine M, Masson S, Heerspink HJL, Januzzi JL Jr Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial. Cardiovasc Diabetol. 2023 Jul 12;22(1):176. doi: 10.1186/s12933-023-01916-2.
  • Golomb BA, Sanchez Baez R, Schilling JM, Dhanani M, Fannon MJ, Berg BK, Miller BJ, Taub PR, Patel HH Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity. Sci Rep. 2023 Jul 12;13(1):10739. doi: 10.1038/s41598-023-35896-w.
  • Lam CSP, Myhre PL Left ventricular ejection fraction in women: when normal isn’t normal. Heart. 2023 Oct 12;109(21):1584-1585. doi: 10.1136/heartjnl-2023-322924.
  • Bassand JP, Virdone S, Camm AJ, Fox KAA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Keltai M, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Kakkar AK, GARFIELD-AF Investigators Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry. Diabetes Obes Metab. 2023 Oct;25(10):3040-3053. doi: 10.1111/dom.15202. Epub 2023 Jul 12.
  • Dastmalchi LN, German CA, Taub PR High density lipoprotein: When to rethink too much of a good thing. Am J Prev Cardiol. 2023 Jun 22;15:100511. doi: 10.1016/j.ajpc.2023.100511. eCollection 2023 Sep.
  • Qu W, Ralto KM, Qin T, Cheng Y, Zong W, Luo X, Perez-Pinzon M, Parikh SM, Ayata C NAD(+) precursor nutritional supplements sensitize the brain to future ischemic events. J Cereb Blood Flow Metab. 2023 Nov;43(2_suppl):37-48. doi: 10.1177/0271678X231156500. Epub 2023 Feb 22.
  • Stabellini N, Dmukauskas M, Bittencourt MS, Cullen J, Barda AJ, Moore JX, Dent S, Abdel-Qadir H, Kawatkar AA, Pandey A, Shanahan J, Barnholtz-Sloan JS, Waite KA, Montero AJ, Guha A Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer. J Natl Compr Canc Netw. 2023 Jul;21(7):705-714.e17. doi: 10.6004/jnccn.2023.7023.
  • Keshvani N, Subramanian V, Wrobel CA, Solomon N, Alhanti B, Greene SJ, DeVore AD, Yancy CW, Allen LA, Fonarow GC, Pandey A Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry. Circ Heart Fail. 2023 Aug;16(8):e010144. doi: 10.1161/CIRCHEARTFAILURE.122.010144. Epub 2023 Jul 11.
  • Karacsonyi J, Stanberry L, Simsek B, Kostantinis S, Allana SS, Rempakos A, Okeson B, Alaswad K, Basir MB, Jaffer F, Poommipanit P, Khatri J, Patel M, Mahmud E, Sheikh A, Wollmuth JR, Yeh RW, Chandwaney RH, ElGuindy AM, Abi Rafeh N, Schimmel DR, Benzuly K, Burke MN, Rangan BV, Mastrodemos OC, Sandoval Y, Ungi I, Brilakis ES Development of a Novel Score to Predict Urgent Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 Sep 1;202:111-118. doi: 10.1016/j.amjcard.2023.06.051. Epub 2023 Jul 8.
  • Cherney DZI, Bhatt DL, Szarek M, Sun F, Girard M, Davies MJ, Pitt B, Steg PG, SCORED Investigators Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2023 Nov;25(11):3410-3414. doi: 10.1111/dom.15203. Epub 2023 Jul 10.
  • Winkelmayer WC, Arnold S, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Parfrey PS Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO(2)TECT Randomized Clinical Trial of ESA-Naive Patients. Kidney Med. 2023 May 12;5(7):100666. doi: 10.1016/j.xkme.2023.100666. eCollection 2023 Jul.
  • Parfrey PS, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Winkelmayer WC Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO(2)TECT Randomized Clinical Trial of ESA-Treated Patients. Kidney Med. 2023 May 12;5(7):100667. doi: 10.1016/j.xkme.2023.100667. eCollection 2023 Jul.
  • Ajufo E, Nayak A, Mehra MR Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions. JACC Basic Transl Sci. 2023 Jun 26;8(6):720-727. doi: 10.1016/j.jacbts.2023.05.004. eCollection 2023 Jun.
  • Kong J, Zaroff JG, Ambrosy AP, Fitzpatrick JK, Ku IA, Mishell JM, Kotinkaduwa LN, Redfors B, Beohar N, Ailawadi G, Lindenfeld J, Abraham WT, Mack MJ, Kar S, Lim DS, Whisenant BK, Stone GW Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. J Am Heart Assoc. 2023 Jul 18;12(14):e029504. doi: 10.1161/JAHA.123.029504. Epub 2023 Jul 8.
  • Ezekowitz JA, McMullan CJ, Westerhout CM, Pina IL, Lopez-Sendon J, Anstrom KJ, Hernandez AF, Lam CSP, O’Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Koglin J, Armstrong PW, Butler J, VICTORIA Study Group Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial. Circ Heart Fail. 2023 Sep;16(9):e010599. doi: 10.1161/CIRCHEARTFAILURE.123.010599. Epub 2023 Jul 7.
  • Zhang RS, Alam U, Maqsood MH, Xia Y, Harari R, Keller N, Elbaum L, Rao SV, Alviar CL, Bangalore S Outcomes With Percutaneous Debulking of Tricuspid Valve Endocarditis. Circ Cardiovasc Interv. 2023 Jul;16(7):e012991. doi: 10.1161/CIRCINTERVENTIONS.123.012991. Epub 2023 Jul 7.
  • Malandish A, Gulati M The impacts of exercise interventions on inflammaging markers in overweight/obesity patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. Int J Cardiol Heart Vasc. 2023 Jun 27;47:101234. doi: 10.1016/j.ijcha.2023.101234. eCollection 2023 Aug.
  • Suc G, Schwartz GG, Goodman SG, Jukema JW, Manvelian G, Poulouin Y, Pordy R, Scemama M, Szarek M, Steg PG, ODYSSEY OUTCOMES Investigators Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes. BMC Ophthalmol. 2023 Jul 6;23(1):301. doi: 10.1186/s12886-023-03065-2.
  • Pandey A, Keshvani N, Pina IL Prevalence and Incidence of Pre-HF Among Hispanics/Latinos. JACC Heart Fail. 2023 Aug;11(8 Pt 1):958-960. doi: 10.1016/j.jchf.2023.05.021. Epub 2023 Jul 5.
  • Shah T, Abu-Much A, Batchelor WB, Grines CL, Baron SJ, Zhou Z, Li Y, Maini AS, Redfors B, Hussain Y, Wollmuth JR, Basir MB, O’Neill WW, Lansky AJ Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study. JACC Cardiovasc Interv. 2023 Jul 24;16(14):1721-1729. doi: 10.1016/j.jcin.2023.04.036. Epub 2023 Jul 5.
  • Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Novoa F, Leite-Moreira A, Neves JS Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure. J Clin Endocrinol Metab. 2023 Dec 21;109(1):4-9. doi: 10.1210/clinem/dgad398.
  • Joshi SS, Kadavath S, Mandoli GE, Gimelli A, Gulati M, Thamman R, Lundberg G, Mehran R, Mulvagh SL, Sade LE, Shivalkar B, Shaw LJ, Hristova K, Dweck MR, Almeida AG, Grapsa J Women in cardiovascular imaging: a call for action to address ongoing challenges. Eur Heart J Cardiovasc Imaging. 2023 Oct 27;24(11):1444-1449. doi: 10.1093/ehjci/jead158.
  • Burger PM, Dorresteijn JAN, Fiolet ATL, Koudstaal S, Eikelboom JW, Nidorf SM, Thompson PL, Cornel JH, Budgeon CA, Westendorp ICD, Beelen DPW, Martens FMAC, Steg PG, Asselbergs FW, Cramer MJ, Teraa M, Bhatt DL, Visseren FLJ, Mosterd A, LoDoCo2 Trial Investigators, UCC-SMART Study Group, REACH Registry Investigators Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease. Eur J Prev Cardiol. 2023 Dec 21;30(18):1950-1962. doi: 10.1093/eurjpc/zwad221.
  • Jensen M, Al-Shahi Salman R, Ng GA, van der Worp HB, Loh P, Campbell BCV, Kalman JM, Hill MD, Sposato LA, Andrade JG, Metzner A, Kirchhof P, Thomalla G Current practice and attitudes of stroke physicians towards rhythm-control therapy for stroke prevention: results of an international survey. Neurol Res Pract. 2023 Jul 6;5(1):29. doi: 10.1186/s42466-023-00255-7.
  • Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, Pettersen AR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabro P, Pocock S, Mehran R, Valgimigli M, PANTHER Collaboration P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events. J Am Coll Cardiol. 2023 Jul 11;82(2):89-105. doi: 10.1016/j.jacc.2023.04.051.
  • Packer M, Butler J Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE. Eur J Heart Fail. 2023 Sep;25(9):1537-1543. doi: 10.1002/ejhf.2968. Epub 2023 Jul 17.
  • Myhre PL, Liu Y, Kulac IJ, Claggett BL, Prescott MF, Felker GM, Butler J, Pina IL, Rouleau JL, Zile MR, McMurray JJV, Ward JH, Solomon SD, Januzzi JL Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan. Eur J Heart Fail. 2023 Aug;25(8):1396-1405. doi: 10.1002/ejhf.2957. Epub 2023 Jul 11.
  • Oskouie S, Michael F, Whitelaw S, Bozkurt B, Fonarow GC, Van Spall HGC A scoping review of heart failure transitional care quality indicators and outcomes for use in clinical care and research. Eur J Heart Fail. 2023 Oct;25(10):1842-1848. doi: 10.1002/ejhf.2955. Epub 2023 Aug 30.
  • van der Pol KH, Aljofan M, Blin O, Cornel JH, Rongen GA, Woestelandt AG, Spedding M Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government. Appl Health Econ Health Policy. 2023 Nov;21(6):831-840. doi: 10.1007/s40258-023-00816-6. Epub 2023 Jul 3.
  • Charu V, Liang JW, Chertow GM, Li ZJ, Montez-Rath ME, Geldsetzer P, de Boer IH, Tian L, Tamura MK Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD. medRxiv [Preprint]. 2023 Jun 15:2023.06.14.23291396. doi: 10.1101/2023.06.14.23291396.
  • Malandish A, Karimi A, Naderi M, Ghadamyari N, Gulati M Impacts of Exercise Interventions on Inflammatory Markers and Vascular Adhesion Molecules in Patients With Heart Failure: A Meta-analysis of RCTs. CJC Open. 2023 Mar 8;5(6):429-453. doi: 10.1016/j.cjco.2023.02.009. eCollection 2023 Jun.
  • Khera R, Kondamudi N, Liu M, Ayers C, Spatz ES, Rao S, Essien UR, Powell-Wiley TM, Nasir K, Das SR, Capers Q, Pandey A Lifetime healthcare expenses across demographic and cardiovascular risk groups: The application of a novel modeling strategy in a large multiethnic cohort study. Am J Prev Cardiol. 2023 Mar 23;14:100493. doi: 10.1016/j.ajpc.2023.100493. eCollection 2023 Jun.
  • Qamar A, Bhatia K, Arora S, Hendrickson M, Gupta P, Fatima A, Mp G, Bansal A, Batra V, Ricciardi MJ, Grines CL, Yusuf J, Mukhopadhyay S, Smith SC Jr, Tyagi S, Bhatt DL, Gulati M, Gupta MD Clinical Profiles, Outcomes, and Sex Differences of Patients With STEMI: Findings From the NORIN-STEMI Registry. JACC Asia. 2023 Apr 4;3(3):431-442. doi: 10.1016/j.jacasi.2022.12.011. eCollection 2023 Jun.
  • Alsbrook DL, Di Napoli M, Bhatia K, Biller J, Andalib S, Hinduja A, Rodrigues R, Rodriguez M, Sabbagh SY, Selim M, Farahabadi MH, Jafarli A, Divani AA Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke. Curr Neurol Neurosci Rep. 2023 Aug;23(8):407-431. doi: 10.1007/s11910-023-01282-2. Epub 2023 Jul 3.
  • Nicholas SB, Daratha KB, Alicic RZ, Jones CR, Kornowske LM, Neumiller JJ, Fatoba ST, Kong SX, Singh R, Norris KC, Tuttle KR Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020. Diabetes Obes Metab. 2023 Oct;25(10):2970-2979. doi: 10.1111/dom.15194. Epub 2023 Jul 3.
  • Sista AK, Vedantham S, Kahn SR, Desai KR, Goldhaber SZ Research Consensus Panel Follow-up: 8-Year Update on Submassive Pulmonary Embolism. J Vasc Interv Radiol. 2023 Oct;34(10):1658-1663. doi: 10.1016/j.jvir.2023.06.032. Epub 2023 Jun 30.
  • Becker MAJ, van der Lingen ACJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis. Am J Cardiol. 2023 Aug 15;201:294-301. doi: 10.1016/j.amjcard.2023.06.042. Epub 2023 Jun 30.
  • Gordon J, Michelis KC, Pandey A, Ayers C, Thibodeau JT, Grodin JL, Drazner MH Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 Aug 15;201:273-280. doi: 10.1016/j.amjcard.2023.06.033. Epub 2023 Jun 30.
  • Potpara T, Angiolillo DJ, Bikdeli B, Capodanno D, Cole O, Yataco AC, Dan GA, Harrison S, Iaccarino JM, Moores LK, Ntaios G, Lip GYH Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report. Chest. 2023 Dec;164(6):1531-1550. doi: 10.1016/j.chest.2023.06.032. Epub 2023 Jun 29.
  • Barkas F, Ray KK The global diagnostic network: what can we learn from half a billion lipid measurements between 2018 and 2020? Eur Heart J. 2023 Jul 1;44(25):2319-2321. doi: 10.1093/eurheartj/ehad308.
  • Wang R, Gerstein HC, Van Spall HGC, Lip GYH, Olier I, Ortega-Martorell S, Thabane L, Ye Z, Li G Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply. Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):547. doi: 10.1093/ehjqcco/qcad038.
  • Forman DE, Kuchel GA, Newman JC, Kirkland JL, Volpi E, Taffet GE, Barzilai N, Pandey A, Kitzman DW, Libby P, Ferrucci L Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement. J Am Coll Cardiol. 2023 Aug 15;82(7):631-647. doi: 10.1016/j.jacc.2023.05.038. Epub 2023 Jun 28.
  • Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Schuyler Jones W, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Singleton Times S, Tseng EE, Wang GJ, Woo YJ, Faxon DP, Upchurch GR Jr, Aday AW, Azizzadeh A, Boisen M, Hawkins B, Kramer CM, Luc JGY, MacGillivray TE, Malaisrie SC, Osteen K, Patel HJ, Patel PJ, Popescu WM, Rodriguez E, Sorber R, Tsao PS, Santos Volgman A, Beckman JA, Otto CM, O’Gara PT, Armbruster A, Birtcher KK, de las Fuentes L, Deswal A, Dixon DL, Gorenek B, Haynes N, Hernandez AF, Joglar JA, Jones WS, Mark D, Mukherjee D, Palaniappan L, Piano MR, Rab T, Spatz ES, Tamis-Holland JE, Woo YJ, Writing Committee Members, Peer Review Committee Members, AHA/ACC Joint Committee Members 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2023 Nov;166(5):e182-e331. doi: 10.1016/j.jtcvs.2023.04.023. Epub 2023 Jun 28.
  • Dixon DD, Knapp SM, Ilonze O, Lewsey SC, Mazimba S, Mohammed S, Van Spall HGC, Breathett K Racial and Ethnic Disparities in Ambulatory Heart Failure Ventricular Assist Device Implantation and Survival. JACC Heart Fail. 2023 Oct;11(10):1397-1407. doi: 10.1016/j.jchf.2023.05.017. Epub 2023 Jun 28.
  • Donovan LM, Hoyos CM, Kimoff RJ, Morrell MJ, Bosch NA, Chooljian DM, McEvoy RD, Sawyer AM, Wagner TH, Al-Lamee RR, Bishop D, Carno MA, Epstein M, Hanson M, Ip MSM, Letourneau M, Pamidi S, Patel SR, Pepin JL, Punjabi NM, Redline S, Thornton JD, Patil SP Strategies to Assess the Effect of Continuous Positive Airway Pressure on Long-Term Clinically Important Outcomes among Patients with Symptomatic Obstructive Sleep Apnea: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2023 Jul;20(7):931-943. doi: 10.1513/AnnalsATS.202303-258ST.
  • Pandey A, Khan MS, Patel KV, Bhatt DL, Verma S Predicting and preventing heart failure in type 2 diabetes. Lancet Diabetes Endocrinol. 2023 Aug;11(8):607-624. doi: 10.1016/S2213-8587(23)00128-6. Epub 2023 Jun 26.
  • Etgen T, Cappellari M, Cernik D, Topakian R, Sposato LA, Sardag P, Wiestler H Ultraearly repeated systemic thrombolysis in recurrent ischemic stroke – A multicentre case study. J Neurol Sci. 2023 Aug 15;451:120714. doi: 10.1016/j.jns.2023.120714. Epub 2023 Jun 15.
  • Macdougall IC, Ponikowski P, Stack AG, Wheeler DC, Anker SD, Butler J, Filippatos G, Gohring UM, Kirwan BA, Kumpeson V, Metra M, Rosano G, Ruschitzka F, van der Meer P, Wachter S, Jankowska EA Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1124-1134. doi: 10.2215/CJN.0000000000000223. Epub 2023 Jun 29.
  • Spirito A, Itchhaporia D, Sartori S, Camenzind E, Chieffo A, Dangas GD, Galatius S, Jeger RV, Kandzari DE, Kastrati A, Kim HS, Kimura T, Leon MB, Mehta LS, Mikhail GW, Morice MC, Nicolas J, Pileggi B, Serruys PW, Smits PC, Steg PG, Stone GW, Valgimigli M, Vogel B, von Birgelen C, Weisz G, Wijns W, Windecker S, Mehran R Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI. EuroIntervention. 2023 Aug 21;19(6):493-501. doi: 10.4244/EIJ-D-23-00086.
  • d’Entremont MA, Alazzoni A, Dzavik V, Sharma V, Overgaard CB, Lemaire-Paquette S, Lamelas P, Cairns JA, Mehta SR, Natarajan MK, Sheth TN, Schwalm JD, Rao SV, Stankovic G, Kedev S, Moreno R, Cantor WJ, Lavi S, Bertrand OF, Nguyen M, Couture EL, Jolly SS No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention. 2023 Aug 7;19(5):e394-e401. doi: 10.4244/EIJ-D-23-00112.
  • Kitahara S, Kataoka Y, Miura H, Nishii T, Nishimura K, Murai K, Iwai T, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Fujino Y, Tsujita K, Puri R, Nicholls SJ, Noguchi T Characterization of plaque phenotypes exhibiting an elevated pericoronary adipose tissue attenuation: insights from the REASSURE-NIRS registry. Int J Cardiovasc Imaging. 2023 Oct;39(10):1943-1952. doi: 10.1007/s10554-023-02907-w. Epub 2023 Jun 29.
  • Mahtta D, Manandhar P, Wegermann ZK, Wojdyla D, Megaly M, Kochar A, Virani SS, Rao SV, Elgendy IY Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1517-1528. doi: 10.1016/j.jcin.2023.03.043.
  • Rogers JH, Asch F, Sorajja P, Mahoney P, Price MJ, Maisano F, Denti P, Morse MA, Rinaldi M, Bedogni F, De Marco F, Rollefson W, Chehab B, Williams MR, Leurent G, Morikawa T, Asgar AW, Rodriguez E, von Bardeleben RS, Kar S Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval Study. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1474-1485. doi: 10.1016/j.jcin.2023.05.014.
  • Vincent F, Redfors B, Kotinkaduwa LN, Kar S, Lim DS, Mishell JM, Whisenant BK, Lindenfeld J, Abraham WT, Mack MJ, Stone GW Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1448-1459. doi: 10.1016/j.jcin.2023.03.023.
  • Vemulapalli S, Simonato M, Ben Yehuda O, Wu C, Feldman T, Popma JJ, Sundareswaren K, Krohn C, Hardy KM, Guibone K, Christensen B, Alu MC, Ng VG, Chau KH, Chen S, Shahim B, Vincent F, MacMahon J, James S, Mack M, Leon MB, Thourani VH, Carroll J, Krucoff MW Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR. JACC Cardiovasc Interv. 2023 Jun 26;16(12):1437-1447. doi: 10.1016/j.jcin.2023.03.034.
  • Egbuna O, Chertow GM Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply. N Engl J Med. 2023 Jun 29;388(26):2491. doi: 10.1056/NEJMc2304780.
  • Nissen SE, Nicholls SJ, Lincoff AM Statin Intolerance, Bempedoic Acid, and Cardiovascular Outcomes. Reply. N Engl J Med. 2023 Jun 29;388(26):2489-2490. doi: 10.1056/NEJMc2305917.
  • Hosoda H, Kataoka Y, Nicholls SJ, Puri R, Murai K, Kitahara S, Mitsui K, Sugane H, Sawada K, Iwai T, Matama H, Honda S, Takagi K, Fujino M, Yoneda S, Otsuka F, Takamisawa I, Nishihira K, Asaumi Y, Kawai K, Noguchi T Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD. Int J Cardiovasc Imaging. 2023 Oct;39(10):1927-1941. doi: 10.1007/s10554-023-02905-y. Epub 2023 Jun 28.
  • Ferraro RA, Ogunmoroti O, Zhao D, Ndumele CE, Lima JAC, Varadarajan V, Subramanya V, Pandey A, Larson NB, Bielinski SJ, Michos ED Hepatocyte Growth Factor and 10-Year Change in Left Ventricular Structure: The Multi-Ethnic Study of Atherosclerosis (MESA). CJC Open. 2023 Feb 19;5(5):364-372. doi: 10.1016/j.cjco.2023.02.004. eCollection 2023 May.
  • Addison D, Branch M, Baik AH, Fradley MG, Okwuosa T, Reding KW, Simpson KE, Suero-Abreu GA, Yang EH, Yancy CW, American Heart Association Cardio-Oncology Committee of the Council on Clinical, Cardiology and Council on Genomic and Precision Medicine; Council on, Cardiovascular and Stroke Nursing; Council on Lifelong Congenital Heart Disease, and Heart Health in the Young; and the Council on Cardiovascular Radiology and, Intervention Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association. Circulation. 2023 Jul 18;148(3):297-308. doi: 10.1161/CIR.0000000000001158. Epub 2023 Jun 28.
  • Alvarado-Bolanos A, Ayan D, Khaw AV, Mai LM, Mandzia JL, Bogiatzi C, Mrkobrada M, Bres-Bullrich M, Fleming LA, Lippert C, Fridman S, Sposato LA Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring. Stroke. 2023 Aug;54(8):2022-2030. doi: 10.1161/STROKEAHA.123.043672. Epub 2023 Jun 28.
  • Amarenco P, Lavallee PC, Kim JS, Labreuche J, Charles H, Giroud M, Lee BC, Mahagne MH, Meseguer E, Nighoghossian N, Steg PG, Vicaut E, Bruckert E, Treat Stroke to Target Investigators More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke. Stroke. 2023 Aug;54(8):1993-2001. doi: 10.1161/STROKEAHA.123.042621. Epub 2023 Jun 28.
  • Anker MS, Potthoff SK, Lena A, Porthun J, Hadzibegovic S, Evertz R, Denecke C, Frohlich AK, Sonntag F, Regitz-Zagrosek V, Rosen SD, Lyon AR, Luscher TF, Spertus JA, Anker SD, Karakas M, Bullinger L, Keller U, Landmesser U, Butler J, von Haehling S Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire. Eur J Heart Fail. 2023 Sep;25(9):1635-1647. doi: 10.1002/ejhf.2951. Epub 2023 Aug 22.
  • Docherty KF, Lam CSP, Rakisheva A, Coats AJS, Greenhalgh T, Metra M, Petrie MC, Rosano GMC Heart failure diagnosis in the general community – Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2023 Aug;25(8):1185-1198. doi: 10.1002/ejhf.2946. Epub 2023 Jul 17.
  • Kondo T, Dewan P, Anand IS, Desai AS, Packer M, Zile MR, Pfeffer MA, Solomon SD, Abraham WT, Shah SJ, Lam CSP, Jhund PS, McMurray JJV Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification? Circulation. 2023 Aug 29;148(9):732-749. doi: 10.1161/CIRCULATIONAHA.122.063642. Epub 2023 Jun 27.
  • Assadpour E, Van Spall HGC Pregnant and lactating women should be included in clinical trials for cardiovascular disease. Nat Med. 2023 Aug;29(8):1897-1899. doi: 10.1038/s41591-023-02416-2.
  • Gray MP, Berman Y, Botta G, Grieve SM, Ho A, Hu J, Hyun K, Ingles J, Jennings G, Kilov G, Levesque JF, Meikle P, Redfern J, Usherwood T, Vernon ST, Nicholls SJ, Figtree GA, PPP-CAD Collaborators Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial. Am Heart J. 2023 Oct;264:163-173. doi: 10.1016/j.ahj.2023.06.009. Epub 2023 Jun 25.
  • Heerspink HJ, Cherney DZ, Groop PH, Matthieu C, Rossing P, Tuttle KR, McGill JB People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action. Lancet Diabetes Endocrinol. 2023 Aug;11(8):536-540. doi: 10.1016/S2213-8587(23)00168-7. Epub 2023 Jun 23.
  • Moskowitz A, Berg KM, Grossestreuer AV, Balaji L, Liu X, Cocchi MN, Chase M, Gong MN, Gong J, Parikh SM, Ngo L, Berlin N, Donnino MW Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial. Am J Respir Crit Care Med. 2023 Sep 1;208(5):570-578. doi: 10.1164/rccm.202301-0034OC.
  • Shavadia JS, Stanberry L, Singh J, Thao KR, Ghasemzadeh N, Mercado N, Nayak KR, Alraies MC, Bagur R, Saw J, Bagai A, Bainey KR, Madan M, Amlani S, Garberich R, Grines CL, Garcia S, Henry TD, Dehghani P Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States. J Soc Cardiovasc Angiogr Interv. 2023 Jun 21;2(5):100970. doi: 10.1016/j.jscai.2023.100970.
  • Nissen SE, Menon V, Nicholls SJ, Brennan D, Laffin L, Ridker P, Ray KK, Mason D, Kastelein JJP, Cho L, Libby P, Li N, Foody J, Louie MJ, Lincoff AM Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients. JAMA. 2023 Jul 11;330(2):131-140. doi: 10.1001/jama.2023.9696.
  • Yogeswaran V, Hidano D, Diaz AE, Van Spall HGC, Mamas MA, Roth GA, Cheng RK Regional variations in heart failure: a global perspective. Heart. 2023 Dec 15;110(1):11-18. doi: 10.1136/heartjnl-2022-321295.
  • Horwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, Hess R, Hodder SL, Jacoby VL, Jordan MR, Krishnan JA, Laiyemo AO, Metz TD, Nichols L, Patzer RE, Sekar A, Singer NG, Stiles LE, Taylor BS, Ahmed S, Algren HA, Anglin K, Aponte-Soto L, Ashktorab H, Bassett IV, Bedi B, Bhadelia N, Bime C, Bind MC, Black LJ, Blomkalns AL, Brim H, Castro M, Chan J, Charney AW, Chen BK, Chen LQ, Chen P, Chestek D, Chibnik LB, Chow DC, Chu HY, Clifton RG, Collins S, Costantine MM, Cribbs SK, Deeks SG, Dickinson JD, Donohue SE, Durstenfeld MS, Emery IF, Erlandson KM, Facelli JC, Farah-Abraham R, Finn AV, Fischer MS, Flaherman VJ, Fleurimont J, Fonseca V, Gallagher EJ, Gander JC, Gennaro ML, Gibson KS, Go M, Goodman SN, Granger JP, Greenway FL, Hafner JW, Han JE, Harkins MS, Hauser KSP, Heath JR, Hernandez CR, Ho O, Hoffman MK, Hoover SE, Horowitz CR, Hsu H, Hsue PY, Hughes BL, Jagannathan P, James JA, John J, Jolley S, Judd SE, Juskowich JJ, Kanjilal DG, Karlson EW, Katz SD, Kelly JD, Kelly SW, Kim AY, Kirwan JP, Knox KS, Kumar A, Lamendola-Essel MF, Lanca M, Lee-Lannotti JK, Lefebvre RC, Levy BD, Lin JY, Logarbo BP Jr, Logue JK, Longo MT, Luciano CA, Lutrick K, Malakooti SK, Mallett G, Maranga G, Marathe JG, Marconi VC, Marshall GD, Martin CF, Martin JN, May HT, McComsey GA, McDonald D, Mendez-Figueroa H, Miele L, Mittleman MA, Mohandas S, Mouchati C, Mullington JM, Nadkarni GN, Nahin ER, Neuman RB, Newman LT, Nguyen A, Nikolich JZ, Ofotokun I, Ogbogu PU, Palatnik A, Palomares KTS, Parimon T, Parry S, Parthasarathy S, Patterson TF, Pearman A, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Porterfield JZ, Quigley JG, Quinn DK, Raissy H, Rebello CJ, Reddy UM, Reece R, Reeder HT, Rischard FP, Rosas JM, Rosen CJ, Rouphael NG, Rouse DJ, Ruff AM, Saint Jean C, Sandoval GJ, Santana JL, Schlater SM, Sciurba FC, Selvaggi C, Seshadri S, Sesso HD, Shah DP, Shemesh E, Sherif ZA, Shinnick DJ, Simhan HN, Singh U, Sowles A, Subbian V, Sun J, Suthar MS, Teunis LJ, Thorp JM Jr, Ticotsky A, Tita ATN, Tragus R, Tuttle KR, Urdaneta AE, Utz PJ, VanWagoner TM, Vasey A, Vernon SD, Vidal C, Walker T, Ward HD, Warren DE, Weeks RM, Weiner SJ, Weyer JC, Wheeler JL, Whiteheart SW, Wiley Z, Williams NJ, Wisnivesky JP, Wood JC, Yee LM, Young NM, Zisis SN, Foulkes AS Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023 Jun 23;18(6):e0286297. doi: 10.1371/journal.pone.0286297. eCollection 2023.
  • Kondo T, Jering KS, Jhund PS, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Packer M, Petrie MC, Pfeffer MA, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation. Circ Heart Fail. 2023 Jul;16(7):e010377. doi: 10.1161/CIRCHEARTFAILURE.122.010377. Epub 2023 Jun 23.
  • Watson NW, Dicks AB, Carroll BJ, Schmaier A, Secemsky EA Predictors of Thrombus Resolution Among Patients Who Undergo Anticoagulation for a Right Heart Thrombus. Chest. 2023 Nov;164(5):1298-1301. doi: 10.1016/j.chest.2023.06.017. Epub 2023 Jun 20.
  • Yamga E, Mantena S, Rosen D, Bucholz EM, Yeh RW, Celi LA, Ustun B, Butala NM Optimized Risk Score to Predict Mortality in Patients With Cardiogenic Shock in the Cardiac Intensive Care Unit. J Am Heart Assoc. 2023 Jul 4;12(13):e029232. doi: 10.1161/JAHA.122.029232. Epub 2023 Jun 22.
  • Shah NP, McGuire DK, Cannon CP, Giugliano RP, Lokhnygina Y, Page CB, Tershakovec AM, Braunwald E, Blazing MA Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. J Am Heart Assoc. 2023 Jul 4;12(13):e029593. doi: 10.1161/JAHA.122.029593. Epub 2023 Jun 22.
  • Capodanno D, Angiolillo DJ Personalised antiplatelet therapies for coronary artery disease: what the future holds. Eur Heart J. 2023 Aug 22;44(32):3059-3072. doi: 10.1093/eurheartj/ehad362.
  • Gaudino M, Dangas GD, Angiolillo DJ, Brodt J, Chikwe J, DeAnda A, Hameed I, Rodgers ML, Sandner S, Sun LY, Yong CM, American Heart Association Council on Cardiovascular Surgery and Anesthesia;, Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and, Stroke Council Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2023 Aug;148(5):442-454. doi: 10.1161/CIR.0000000000001154. Epub 2023 Jun 22.
  • Chuzi S, Wilcox JE, Kao A, Spertus JA, Hsich E, Dew MA, Yancy CW, Pham DT, Hartupee J, Petty M, Cotts W, Pamboukian SV, Pagani FD, Lampert B, Johnson M, Murray M, Takeda K, Yuzefpolskaya M, Silvestry S, Kirklin JK, Wu T, Andrei AC, Baldridge A, Grady KL Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study. Circ Heart Fail. 2023 Aug;16(8):e010038. doi: 10.1161/CIRCHEARTFAILURE.122.010038. Epub 2023 Jun 22.
  • Dauerman HL Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past. J Am Coll Cardiol. 2023 Jun 27;81(25):2417-2419. doi: 10.1016/j.jacc.2023.04.030.
  • Usman MS, Siddiqi TJ, Anker SD, Bakris GL, Bhatt DL, Filippatos G, Fonarow GC, Greene SJ, Januzzi JL Jr, Khan MS, Kosiborod MN, McGuire DK, Pina IL, Rosenstock J, Vaduganathan M, Verma S, Zieroth S, Butler J Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations. J Am Coll Cardiol. 2023 Jun 27;81(25):2377-2387. doi: 10.1016/j.jacc.2023.04.034.
  • Gangavelli A, Liu Z, Wang J, Okoh A, Steinberg R, Patel K, Pandey A, Gupta DK, Dickert N, Patel SA, Morris AA Racial differences in low natriuretic peptide levels: Implications for heart failure clinical trials. Am Heart J. 2023 Nov;265:1-10. doi: 10.1016/j.ahj.2023.06.008. Epub 2023 Jun 19.
  • Almarzooq ZI, Song Y, Dahabreh IJ, Kochar A, Ferro EG, Secemsky EA, Major JM, Farb A, Wu C, Zuckerman B, Yeh RW Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock. JAMA Cardiol. 2023 Aug 1;8(8):744-754. doi: 10.1001/jamacardio.2023.1643.
  • Julien HM, Wang Y, Curtis JP, Johnston-Cox H, Eberly LA, Wang GJ, Nathan AS, Fanaroff AC, Khatana SAM, Groeneveld PW, Secemsky EA, Eneanya ND, Vora AN, Kobayashi T, Barbery C Jr, Chery G, Kohi M, Kirksey L, Armstrong EJ, Jaff MR, Giri J Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry. Circ Cardiovasc Interv. 2023 Jun;16(6):e011485. doi: 10.1161/CIRCINTERVENTIONS.121.011485. Epub 2023 Jun 20.
  • Warisawa T, Cook CM, Ahmad Y, Howard JP, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Matsuo H, Akashi YJ, Escaned J, Davies JE Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance. Circ Cardiovasc Interv. 2023 Jun;16(6):e012700. doi: 10.1161/CIRCINTERVENTIONS.122.012700. Epub 2023 Jun 20.
  • Jiang GY, Urwin JW, Wasfy JH Medicaid Expansion Under the Affordable Care Act and Association With Cardiac Care: A Systematic Review. Circ Cardiovasc Qual Outcomes. 2023 Jun;16(6):e009753. doi: 10.1161/CIRCOUTCOMES.122.009753. Epub 2023 Jun 20.
  • Lindman BR, Fonarow GC, Myers G, Alger HM, Rutan C, Troll K, Aringo A, Shahriary M, Jessup M, Arnold SV, Shah PB, Szeto WY, Yancy CW, Otto CM Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis. Circ Cardiovasc Qual Outcomes. 2023 Jun;16(6):e009712. doi: 10.1161/CIRCOUTCOMES.122.009712. Epub 2023 Jun 20.
  • Mac Grory B, Holmes DN, Matsouaka RA, Shah S, Chang CWJ, Rison R, Jindal J, Holmstedt C, Logan WR, Corral C, Mackey JS, Gee JR, Bonovich D, Walker J, Gropen T, Benesch C, Dissin J, Pandey H, Wang D, Unverdorben M, Hernandez AF, Reeves M, Smith EE, Schwamm LH, Bhatt DL, Saver JL, Fonarow GC, Peterson ED, Xian Y Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke. JAMA. 2023 Jun 20;329(23):2038-2049. doi: 10.1001/jama.2023.8073.
  • Capodanno D, Mehran R, Krucoff MW, Baber U, Bhatt DL, Capranzano P, Collet JP, Cuisset T, De Luca G, De Luca L, Farb A, Franchi F, Gibson CM, Hahn JY, Hong MK, James S, Kastrati A, Kimura T, Lemos PA, Lopes RD, Magee A, Matsumura R, Mochizuki S, O’Donoghue ML, Pereira NL, Rao SV, Rollini F, Shirai Y, Sibbing D, Smits PC, Steg PG, Storey RF, Ten Berg J, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Serruys PW, Yeh RW, Morice MC, Angiolillo DJ Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023 Jun 20;147(25):1933-1944. doi: 10.1161/CIRCULATIONAHA.123.064473. Epub 2023 Jun 19.
  • Charman SJ, Blain AP, Trenell MI, Jakovljevic DG, Kunadian V Physical activity, inactivity and sleep in older patients with coronary artery disease following percutaneous coronary intervention: a longitudinal, observational study. Coron Artery Dis. 2023 Sep 1;34(6):441-447. doi: 10.1097/MCA.0000000000001252. Epub 2023 Jun 5.
  • Vargas-Alarcon G, Perez-Mendez O, Posadas-Sanchez R, Gonzalez-Pacheco H, Arias-Mendoza A, Escobedo G, Juarez-Cedillo T, Arellano-Gonzalez M, Fragoso JM ABO gene polymorphisms are associated with acute coronary syndrome and with plasma concentration of HDL-cholesterol and triglycerides. Biomol Biomed. 2023 Nov 3;23(6):1125-1135. doi: 10.17305/bb.2023.9244.
  • Vijay A, Tay WT, Teng TK, Teramoto K, Tromp J, Ouwerkerk W, Lo SY, Shimizu W, Huffman MD, Lam CSP, Chandramouli C, Agarwal A Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis. Glob Heart. 2023 Jun 15;18(1):33. doi: 10.5334/gh.1215. eCollection 2023.
  • Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam CSP, O’Connor CM, Roessig L, Hernandez AF, Armstrong PW, VICTORIA Study Group Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial. J Card Fail. 2023 Aug;29(8):1113-1120. doi: 10.1016/j.cardfail.2023.04.015. Epub 2023 Jun 17.
  • Suc G, Schwartz GG, Goodman SG, Jukema JW, Manvelian G, Poulouin Y, Pordy R, Scemama M, Szarek M, Steg PG, ODYSSEY OUTCOMES Investigators Effect of alirocumab on cataracts in patients with acute coronary syndromes. BMC Ophthalmol. 2023 Jun 16;23(1):279. doi: 10.1186/s12886-023-03012-1.
  • Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):570-582. doi: 10.1093/ehjcvp/pvad044.
  • Lawson CA, Tay WT, Richards M, Zaccardi F, Tromp J, Teng TK, Hung CL, Chandramouli C, Wander GS, Ouwerkerk W, Teramoto K, Ali M, Kadam U, Hand S, Harrison M, Anand I, Naik A, Squire I, Khunti K, Stromberg A, Lam CSP, ASIAN-HF Investigators Patient-Reported Status and Heart Failure Outcomes in Asia by Sex, Ethnicity, and Socioeconomic Status. JACC Asia. 2023 Jun 6;3(3):349-362. doi: 10.1016/j.jacasi.2023.03.015. eCollection 2023 Jun.
  • Nguyen NV, Lindberg F, Benson L, Ferrannini G, Imbalzano E, Mol PGM, Dahlstrom U, Rosano GMC, Ezekowitz J, Butler J, Lund LH, Savarese G Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry. Eur J Heart Fail. 2023 Aug;25(8):1418-1428. doi: 10.1002/ejhf.2939. Epub 2023 Jun 29.
  • Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, Sarkies MN, Al-Rasadi K, Blom DJ, Daccord M, de Ferranti SD, Folco E, Libby P, Mata P, Nawawi HM, Ramaswami U, Ray KK, Stefanutti C, Yamashita S, Pang J, Thompson GR, Santos RD International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023 Dec;20(12):845-869. doi: 10.1038/s41569-023-00892-0. Epub 2023 Jun 15.
  • van Diepen S, Arias-Mendoza A, Sinha SS The North American perspective on short-term mechanical circulatory support for cardiogenic shock: could differences in policy be driving differences in temporary mechanical circulatory support use? Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):486-489. doi: 10.1093/ehjacc/zuad065.
  • Siracuse JJ, Farber A, Menard MT, Conte MS, Kaufman JA, Jaff M, Kiang SC, Ochoa Chaar CI, Osborne N, Singh N, Tan TW, Guzman RJ, Strong MB, Hamza TH, Doros G, Rosenfield K Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial. J Vasc Surg. 2023 Oct;78(4):1012-1020.e2. doi: 10.1016/j.jvs.2023.05.040. Epub 2023 Jun 14.
  • Swat SA, Xu H, Allen LA, Greene SJ, DeVore AD, Matsouaka RA, Goyal P, Peterson PN, Hernandez AF, Krumholz HM, Yancy CW, Fonarow GC, Hess PL, AHA’s GWTG-HF Program Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2023 Aug;11(8 Pt 1):918-929. doi: 10.1016/j.jchf.2023.04.015. Epub 2023 Jun 14.
  • Kraaijenhof JM, Opstal TSJ, Cornel JH, Gill D, Hovingh GK, Catapano AL, Koenig W, Ridker PM, Stroes ESG, Nurmohamed NS Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy. Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1595-1597. doi: 10.1161/ATVBAHA.123.319272. Epub 2023 Jun 15.
  • Derry K, Rehman TA, Sharkey A, Laham RJ, Katsiampoura A, Yunus RA, Sohail M, Mahmood F, Mahboobi SK, Bose RR Comprehensive Training Model for Procedural Guidance of Transcatheter Mitral Valve Edge-to-Edge Repair: Divide and Conquer Approach. J Cardiothorac Vasc Anesth. 2023 Nov;37(11):2194-2203. doi: 10.1053/j.jvca.2023.05.018. Epub 2023 May 16.
  • Simsek B, Rempakos A, Kostantinis S, Karacsonyi J, Rangan BV, Mastrodemos OC, Kirtane AJ, Bortnick AE, Jneid H, Azzalini L, Milkas A, Alaswad K, Linzer M, Egred M, Allana SS, Rao SV, Sandoval Y, Brilakis ES International Psychological Well-Being Survey of Interventional Cardiologists. JACC Cardiovasc Interv. 2023 Jun 12;16(11):1401-1407. doi: 10.1016/j.jcin.2023.03.033.
  • Galea R, Aminian A, Meneveau N, De Marco F, Heg D, Anselme F, Grani C, Huber AT, Teiger E, Iriart X, Franzone A, Vranckx P, Fischer U, Pedrazzini G, Bedogni F, Valgimigli M, Raber L Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success: A Swiss-Apero Trial Subanalysis. JACC Cardiovasc Interv. 2023 Jun 12;16(11):1332-1343. doi: 10.1016/j.jcin.2023.02.027. Epub 2023 May 3.
  • Zhang J, Van Spall HG, Li L, Khan MS, Pandey A, Thabane L, Bai X, Wang Y, Lip GY, Li G Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2023 Jul;17(7):102804. doi: 10.1016/j.dsx.2023.102804. Epub 2023 Jun 2.
  • Omboni S, Khan NA, Kunadian V, Olszanecka A, Schutte AE, Mihailidou AS Sex Differences in Ambulatory Blood Pressure Levels and Subtypes in a Large Italian Community Cohort. Hypertension. 2023 Jul;80(7):1417-1426. doi: 10.1161/HYPERTENSIONAHA.122.20589. Epub 2023 May 12.
  • Ortega-Paz L, Giordano S, Capodanno D, Mehran R, Gibson CM, Angiolillo DJ Correction to: Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clin Pharmacokinet. 2023 Jul;62(7):1043. doi: 10.1007/s40262-023-01277-9.
  • Michos ED, Bakris GL, Rodbard HW, Tuttle KR Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection. Am J Prev Cardiol. 2023 May 24;14:100502. doi: 10.1016/j.ajpc.2023.100502. eCollection 2023 Jun.
  • Scotti A, Coisne A, Granada JF, Driggin E, Madhavan MV, Zhou Z, Redfors B, Kar S, Lim DS, Cohen DJ, Lindenfeld J, Abraham WT, Mack MJ, Asch FM, Stone GW Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. J Am Coll Cardiol. 2023 Jul 11;82(2):128-138. doi: 10.1016/j.jacc.2023.04.047. Epub 2023 Jun 9.
  • Guimaraes PO, Franken M, Tavares CAM, Silveira FS, Antunes MO, Bergo RR, Joaquim RM, Hirai JCS, Andrade PB, Pitta FG, Mariani J Jr, Nascimento BR, de Paula JET, Silveira MS, Costa TAO, Dall’Orto FTC, Serpa RG, Sampaio FBA, Ohe LN, Mangione FM, Furtado RHM, Sarmento-Leite R, Monfardini F, Assis SRL, Nicolau JC, Sposito AC, Lopes RD, Onuma Y, Valgimigli M, Angiolillo DJ, Serruys PW, Berwanger O, Bacal F, Lemos PA P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial. EuroIntervention. 2023 Jul 17;19(4):e323-e329. doi: 10.4244/EIJ-D-23-00125.
  • Gulati M Saving women’s hearts: Improving outcomes with prevention & policy. Am J Prev Cardiol. 2023 May 14;14:100504. doi: 10.1016/j.ajpc.2023.100504. eCollection 2023 Jun.
  • Gulati M ASPC president’s page the 2023 ASPC congress on CVD prevention. Am J Prev Cardiol. 2023 May 26;14:100507. doi: 10.1016/j.ajpc.2023.100507. eCollection 2023 Jun.
  • Manla Y, Badarin FA, Bader N, Lee-St John T, Mehra MR, Bader F Worldwide and Country-Specific Impact of the COVID-19 Pandemic on Heart Transplantation Volumes: A Longitudinal Analysis of 2020 and 2021. Curr Probl Cardiol. 2023 Nov;48(11):101870. doi: 10.1016/j.cpcardiol.2023.101870. Epub 2023 Jun 10.
  • Bikdeli B, Khairani CD, Krishnathasan D, Bejjani A, Armero A, Tristani A, Davies J, Porio N, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Achanta A, Jesudasen SJ, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma A, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll BJ, Lan Z, Goldhaber SZ, Piazza G, CORONA-VTE-Network Investigators Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study. Thromb Res. 2023 Aug;228:94-104. doi: 10.1016/j.thromres.2023.05.019. Epub 2023 May 29.
  • Marchina S, Lee KH, Lioutas VA, Carvalho F, Incontri D, Heistand EC, Lin D, Selim M An updated systematic review and meta-analysis investigating perihematomal edema and clinical outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2023 Aug;32(8):107204. doi: 10.1016/j.jstrokecerebrovasdis.2023.107204. Epub 2023 Jun 9.
  • Rymer JA, Wegermann ZK, Kaltenbach LA, Webb LE, Peterson ED, Wang TY Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial. J Am Heart Assoc. 2023 Jun 20;12(12):e029063. doi: 10.1161/JAHA.122.029063. Epub 2023 Jun 10.
  • Visoiu IS, Rimbas RC, Nicula AI, Mihaila-Baldea S, Magda SL, Mihalcea DJ, Hayat M, Luchian ML, Chitroceanu AM, Vinereanu D Multimodality Imaging and Biomarker Approach to Characterize the Pathophysiology of Heart Failure in Left Ventricular Non-Compaction with Preserved Ejection Fraction. J Clin Med. 2023 May 23;12(11):3632. doi: 10.3390/jcm12113632.
  • Shaik A, Chobufo MD, Gonuguntla K, Patel N, Sattar Y, Thyagaturu H, Ludhwani D, Gulati M Association Between Social Vulnerability Index and Mortality Following Acute Myocardial Infarction in the US Counties. Curr Probl Cardiol. 2023 Oct;48(10):101854. doi: 10.1016/j.cpcardiol.2023.101854. Epub 2023 Jun 7.
  • Akhtar KH, Maqsood MH, Ansari SA, Siddiqi TJ, Arshad MS, Greene SJ, Butler J, Khan MS An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure. Am J Cardiol. 2023 Aug 1;200:32-39. doi: 10.1016/j.amjcard.2023.04.043. Epub 2023 Jun 7.
  • Kosiborod MN, Abildstrom SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, Moller DV, Shah SJ, Treppendahl MB, Verma S, Petrie MC Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype. JACC Heart Fail. 2023 Aug;11(8 Pt 1):1000-1010. doi: 10.1016/j.jchf.2023.05.010. Epub 2023 May 21.
  • Peikert A, Goyal P, Vaduganathan M, Claggett BL, Kulac IJ, Miao ZM, Vardeny O, Kosiborod MN, Desai AS, Jhund PS, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status. JACC Heart Fail. 2023 Oct;11(10):1380-1393. doi: 10.1016/j.jchf.2023.05.014. Epub 2023 May 21.
  • Wong GX, Kar S, Smith TW, Spangler T, Bolling SF, Rogers JH Transcatheter Left Atrial Appendage Exclusion: Preclinical and Early Clinical Results With the Laminar Device. JACC Cardiovasc Interv. 2023 Jun 12;16(11):1347-1357. doi: 10.1016/j.jcin.2023.04.028. Epub 2023 Jun 7.
  • Camm AJ, Steffel J, Virdone S, Bassand JP, Fox KAA, Goldhaber SZ, Goto S, Haas S, Turpie AGG, Verheugt FWA, Misselwitz F, Herreros RC, Kayani G, Pieper KS, Kakkar AK, GARFIELD-AF Investigators Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF. Eur Heart J Open. 2023 May 19;3(3):oead051. doi: 10.1093/ehjopen/oead051. eCollection 2023 May.
  • Rajkumar C, Simader F, Al-Lamee RK Typical angina and coronary artery disease: is the common ground smaller than we think? Heart. 2023 Sep 13;109(19):1422-1423. doi: 10.1136/heartjnl-2023-322681.
  • Mehrotra R, Davison SN, Farrington K, Flythe JE, Foo M, Madero M, Morton RL, Tsukamoto Y, Unruh ML, Cheung M, Jadoul M, Winkelmayer WC, Brown EA, Conference Participants Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 Sep;104(3):441-454. doi: 10.1016/j.kint.2023.05.019. Epub 2023 Jun 7.
  • Soerensen SJC, Montez-Rath ME, Cheng I, Gomez SL, Oh DL, Jackson C, Li J, Rehkopf D, Chertow GM, Langston ME, Ganesan C, Pao AC, Chung BI, Leppert JT Groundwater constituents and the incidence of kidney cancer. Cancer. 2023 Oct 15;129(20):3309-3317. doi: 10.1002/cncr.34898. Epub 2023 Jun 7.
  • Desai AS, Maisel A, Mehra MR, Zile MR, Ducharme A, Paul S, Sears SF, Smart F, Bhatt K, Krim S, Henderson J, Johnson N, Adamson PB, Costanzo MR, Lindenfeld J, GUIDE-HF Investigators Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides. JACC Heart Fail. 2023 Jun;11(6):691-698. doi: 10.1016/j.jchf.2023.01.007. Epub 2023 Apr 12.
  • Mohebi R, Wang D, Lau ES, Parekh JK, Allen N, Psaty BM, Benjamin EJ, Levy D, Wang TJ, Shah SJ, Gottdiener JS, Januzzi JL Jr, Ho JE Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort. J Am Coll Cardiol. 2023 Jun 13;81(23):2231-2242. doi: 10.1016/j.jacc.2023.04.007.
  • Schroder JN, Patel CB, DeVore AD, Bryner BS, Casalinova S, Shah A, Smith JW, Fiedler AG, Daneshmand M, Silvestry S, Geirsson A, Pretorius V, Joyce DL, Um JY, Esmailian F, Takeda K, Mudy K, Shudo Y, Salerno CT, Pham SM, Goldstein DJ, Philpott J, Dunning J, Lozonschi L, Couper GS, Mallidi HR, Givertz MM, Pham DT, Shaffer AW, Kai M, Quader MA, Absi T, Attia TS, Shukrallah B, Sun BC, Farr M, Mehra MR, Madsen JC, Milano CA, D’Alessandro DA Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023 Jun 8;388(23):2121-2131. doi: 10.1056/NEJMoa2212438.
  • Ray KK, Wright RS Plain language summary of results from ORION-10 and ORION-11: two studies to learn how well inclisiran works in people with high cholesterol. Future Cardiol. 2023 Mar;19(4):175-184. doi: 10.2217/fca-2022-0133. Epub 2023 Jun 6.
  • Kar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Am Heart J. 2023 Oct;264:123-132. doi: 10.1016/j.ahj.2023.05.022. Epub 2023 Jun 4.
  • Bujak K, Vidal-Cales P, Gabani R, Rinaldi R, Gomez-Lara J, Ortega-Paz L, Jimenez-Diaz V, Jimenez-Kockar M, Jimenez-Quevedo P, Diletti R, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, De Miguel-Castro A, Iniguez A, Nombela-Franco L, Ielasi A, Tespili M, Lenzen M, Biscaglia S, Al-Shaibani S, Romaguera R, Gomez-Hospital JA, Gasior M, Serruys PW, Sabate M, Brugaletta S Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study. Am Heart J. 2023 Oct;264:72-82. doi: 10.1016/j.ahj.2023.05.021. Epub 2023 Jun 4.
  • Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, Walker TA, Selvaggi CA, Shinnick DJ, Schulte CCM, Atchley-Challenner R, Alba GA, Alicic R, Altman N, Anglin K, Argueta U, Ashktorab H, Baslet G, Bassett IV, Bateman L, Bedi B, Bhattacharyya S, Bind MA, Blomkalns AL, Bonilla H, Brim H, Bush PA, Castro M, Chan J, Charney AW, Chen P, Chibnik LB, Chu HY, Clifton RG, Costantine MM, Cribbs SK, Davila Nieves SI, Deeks SG, Duven A, Emery IF, Erdmann N, Erlandson KM, Ernst KC, Farah-Abraham R, Farner CE, Feuerriegel EM, Fleurimont J, Fonseca V, Franko N, Gainer V, Gander JC, Gardner EM, Geng LN, Gibson KS, Go M, Goldman JD, Grebe H, Greenway FL, Habli M, Hafner J, Han JE, Hanson KA, Heath J, Hernandez C, Hess R, Hodder SL, Hoffman MK, Hoover SE, Huang B, Hughes BL, Jagannathan P, John J, Jordan MR, Katz SD, Kaufman ES, Kelly JD, Kelly SW, Kemp MM, Kirwan JP, Klein JD, Knox KS, Krishnan JA, Kumar A, Laiyemo AO, Lambert AA, Lanca M, Lee-Iannotti JK, Logarbo BP, Longo MT, Luciano CA, Lutrick K, Maley JH, Mallett G, Marathe JG, Marconi V, Marshall GD, Martin CF, Matusov Y, Mehari A, Mendez-Figueroa H, Mermelstein R, Metz TD, Morse R, Mosier J, Mouchati C, Mullington J, Murphy SN, Neuman RB, Nikolich JZ, Ofotokun I, Ojemakinde E, Palatnik A, Palomares K, Parimon T, Parry S, Patterson JE, Patterson TF, Patzer RE, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Quigley JG, Reddy U, Reece R, Reeder H, Reeves WB, Reiman EM, Rischard F, Rosand J, Rouse DJ, Ruff A, Saade G, Sandoval GJ, Santana JL, Schlater SM, Sciurba FC, Shepherd F, Sherif ZA, Simhan H, Singer NG, Skupski DW, Sowles A, Sparks JA, Sukhera FI, Taylor BS, Teunis L, Thomas RJ, Thorp JM, Thuluvath P, Ticotsky A, Tita AT, Tuttle KR, Urdaneta AE, Valdivieso D, VanWagoner TM, Vasey A, Verduzco-Gutierrez M, Wallace ZS, Ward HD, Warren DE, Weiner SJ, Welch S, Whiteheart SW, Wiley Z, Wisnivesky JP, Yee LM, Zisis S, Horwitz LI, Foulkes AS, RECOVER Consortium Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 Jun 13;329(22):1934-1946. doi: 10.1001/jama.2023.8823.
  • Bohm M, Butler J, Krawczyk M, Mahfoud F, Haring B, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Ofstad AP, Schuler E, Wanner C, Verma S, Packer M, Anker SD, EMPEROR-Preserved Trial Committees and Investigators Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial. Eur J Heart Fail. 2023 Aug;25(8):1375-1383. doi: 10.1002/ejhf.2922. Epub 2023 Jun 27.
  • Michos ED, Lopez-Jimenez F, Gulati M Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity. J Am Heart Assoc. 2023 Jun 6;12(11):e029282. doi: 10.1161/JAHA.122.029282.
  • Ballantyne CM, Ditmarsch M, Kastelein JJ, Nelson AJ, Kling D, Hsieh A, Curcio DL, Maki KC, Davidson MH, Nicholls SJ Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial. J Clin Lipidol. 2023 Jul-Aug;17(4):491-503. doi: 10.1016/j.jacl.2023.05.098. Epub 2023 Jun 3.
  • Wang H, Akanbi O, MacArthur JW, Sharma RP Strategies for Transcatheter Aortic Valve Replacement in Patients With a Right Aortic Arch. Struct Heart. 2022 Nov 1;7(2):100099. doi: 10.1016/j.shj.2022.100099. eCollection 2023 Mar.
  • Ahmad Y, Madhavan MV, Baron SJ, Forrest JK, Borger MA, Leipsic JA, Cavalcante JL, Wang DD, McCarthy P, Szerlip M, Kapadia S, Makkar R, Mack MJ, Leon MB, Cohen DJ Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future. Struct Heart. 2022 Nov 1;7(1):100102. doi: 10.1016/j.shj.2022.100102. eCollection 2023 Jan.
  • Baron SJ, Berry N Editorial: Extending the Minimalist Approach to the Pre-Transcatheter Aortic Valve Replacement Coronary Evaluation. Struct Heart. 2022 Dec 13;7(1):100131. doi: 10.1016/j.shj.2022.100131. eCollection 2023 Jan.
  • Ibrahim H, Lowenstern A, Goldsweig AM, Rao SV Integrating Structural Heart Disease Trainees within the Dynamics of the Heart Team: The Case for Multimodality Training. Struct Heart. 2023 Apr 18;7(3):100167. doi: 10.1016/j.shj.2023.100167. eCollection 2023 May.
  • Sabouret P, Manzo-Silberman S, Alasnag M, Fysekidis M, Gulati M, Galati G, Spadafora L, Banach M, Biondi-Zoccai G, Bhatt DL New approaches to reduce recurrent PCI: to angioplasty and beyond! Eur Heart J Open. 2023 May 17;3(3):oead049. doi: 10.1093/ehjopen/oead049. eCollection 2023 May.
  • Demirci D, Ersan Demirci D, Chi G, Gibson CM The Relationship Between the Age of First Acute Coronary Syndrome Episode and Internal Migration. Turk Kardiyol Dern Ars. 2023 Jun;51(4):250-255. doi: 10.5543/tkda.2023.44373.
  • Ishisaka Y, Watanabe A, Fujisaki T, Iwagami M, So M, Steiger D, Aoi S, Secemsky EA, Wiley J, Kuno T Comparison of interventions for intermediate to high-risk pulmonary embolism: A network meta-analysis. Catheter Cardiovasc Interv. 2023 Aug;102(2):249-265. doi: 10.1002/ccd.30745. Epub 2023 Jun 3.
  • Heerspink HJL, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, Wiese RJ, Wilson JM, Hemmingway A, Cherney DZI, Tuttle KR Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis. Diabetes Care. 2023 Aug 1;46(8):1501-1506. doi: 10.2337/dc23-0261.
  • Schrag D, Uno H, Rosovsky R, Rutherford C, Sanfilippo K, Villano JL, Drescher M, Jayaram N, Holmes C, Feldman L, Zattra O, Farrar-Muir H, Cronin C, Basch E, Weiss A, Connors JM, CANVAS Investigators Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial. JAMA. 2023 Jun 13;329(22):1924-1933. doi: 10.1001/jama.2023.7843.
  • Sunderraj A, Wong M, Gutierrez OM, Wolf M, Akhabue E, Carnethon MR, Yancy CW, Isakova T Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort. Kidney360. 2023 Sep 1;4(9):e1236-e1244. doi: 10.34067/KID.0000000000000172. Epub 2023 Jun 2.
  • Tokgozoglu L, Morrow DA, Nicholls SJ Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers. Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275.
  • Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, Lam CSP, Chioncel O, Diaz R, Filippatos G, Ponikowski P, Sliwa K, Voors AA, Kimmoun A, Novosadova M, Takagi K, Barros M, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G, Mebazaa A, Davison B Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction. J Am Coll Cardiol. 2023 Jun 6;81(22):2131-2144. doi: 10.1016/j.jacc.2023.03.426.
  • Hakim D, Pinilla-Echeverri N, Coskun AU, Pu Z, Kajander OA, Rupert D, Maynard C, Cefalo N, Siasos G, Papafaklis MI, Kostas S, Michalis LK, Jolly S, Mehta SR, Sheth T, Croce K, Stone PH The role of endothelial shear stress, shear stress gradient, and plaque topography in plaque erosion. Atherosclerosis. 2023 Jul;376:11-18. doi: 10.1016/j.atherosclerosis.2023.05.013. Epub 2023 May 18.
  • Ioannidou E, Shabnam S, Abner S, Kaur N, Zaccardi F, Ray KK, Seidu S, Davies MJ, Khunti K, Gillies CL Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023 Jun;17(6):102782. doi: 10.1016/j.dsx.2023.102782. Epub 2023 May 22.
  • Abramov D, Kobo O, Davies S, Mathew RO, Van Spall HGC, Mamas MA Cardiovascular mortality trends in patients with chronic kidney disease compared to the general population. J Nephrol. 2023 Jun;36(5):1489-1491. doi: 10.1007/s40620-023-01654-4. Epub 2023 May 31.
  • Lam CSP, Harding E, Bains M, Chin A, Kanumilli N, Petrie MC, Pohja-Hutchison P, Yang J, Butler J Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global survey. BMC Public Health. 2023 May 30;23(1):1023. doi: 10.1186/s12889-023-15405-4.
  • Potere N, Garrad E, Kanthi Y, Di Nisio M, Kaplanski G, Bonaventura A, Connors JM, De Caterina R, Abbate A NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. Cardiovasc Res. 2023 Sep 5;119(11):2046-2060. doi: 10.1093/cvr/cvad084.
  • Koenig W, Ray KK, Landmesser U, Leiter LA, Schwartz GG, Wright RS, Conde LG, Han J, Raal FJ Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11. Am J Prev Cardiol. 2023 May 14;14:100503. doi: 10.1016/j.ajpc.2023.100503. eCollection 2023 Jun.
  • Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavik V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA Sex-Based Differences in Severe Outcomes, Including Cardiovascular Hospitalization, in Adults With COVID-19 in Ontario, Canada. JACC Adv. 2023 May;2(3):100307. doi: 10.1016/j.jacadv.2023.100307. Epub 2023 May 10.
  • Fanikos J, Tawfik Y, Almheiri D, Sylvester K, Buckley LF, Dew C, Dell’Orfano H, Armero A, Bejjani A, Bikdeli B, Campia U, Davies J, Fiumara K, Hogan H, Khairani CD, Krishnathasan D, Lou J, Makawi A, Morrison RH, Porio N, Tristani A, Connors JM, Goldhaber SZ, Piazza G Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods. Am J Med. 2023 Sep;136(9):927-936.e3. doi: 10.1016/j.amjmed.2023.05.013. Epub 2023 May 27.
  • Heijman MWJ, Fiolet ATL, Mosterd A, Tijssen JGP, van den Bemt BJF, Schut A, Eikelboom JW, Thompson PL, van den Ende CHM, Nidorf SM, Popa CD, Cornel JH Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial. Ann Intern Med. 2023 Jun;176(6):737-742. doi: 10.7326/M23-0289. Epub 2023 May 30.
  • Arrigo M, Biegus J, Asakage A, Mebazaa A, Davison B, Edwards C, Adamo M, Barros M, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors AA, Cotter G, Cohen-Solal A Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial. Eur J Heart Fail. 2023 Jul;25(7):1145-1155. doi: 10.1002/ejhf.2920. Epub 2023 Jun 7.
  • Kim H, Shahbal H, Parpia S, Averbuch T, Van Spall HGC, Thabane L, Ma J Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies. J Clin Epidemiol. 2023 Aug;160:1-13. doi: 10.1016/j.jclinepi.2023.05.015. Epub 2023 May 27.
  • Eckardt KU, Delgado C, Heerspink HJL, Pecoits-Filho R, Ricardo AC, Stengel B, Tonelli M, Cheung M, Jadoul M, Winkelmayer WC, Kramer H, Conference Participants Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 Nov;104(5):888-903. doi: 10.1016/j.kint.2023.05.013. Epub 2023 May 26.
  • Aliyev N, Almani MU, Qudrat-Ullah M, Butler J, Khan MS, Greene SJ Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure. J Card Fail. 2023 Oct;29(10):1358-1366. doi: 10.1016/j.cardfail.2023.05.010. Epub 2023 May 25.
  • Darabont R, Mihalcea D, Vinereanu D Current Insights into the Significance of the Renal Resistive Index in Kidney and Cardiovascular Disease. Diagnostics (Basel). 2023 May 10;13(10):1687. doi: 10.3390/diagnostics13101687.
  • Blanco Echevarria A, Garcia Diaz JD, Caixas A, Plana Gil N, Rico Corral MA, Bridges I, Dhalwani N, Gatell Menchen S, Ray KK Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study. Clin Investig Arterioscler. 2023 Nov-Dec;35(6):263-271. doi: 10.1016/j.arteri.2023.04.004. Epub 2023 May 24.
  • Ku E, Del Vecchio L, Eckardt KU, Haase VH, Johansen KL, Nangaku M, Tangri N, Waikar SS, Wiecek A, Cheung M, Jadoul M, Winkelmayer WC, Wheeler DC, for Conference Participants Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 Oct;104(4):655-680. doi: 10.1016/j.kint.2023.05.009. Epub 2023 May 24.
  • Josephson MA, Becker Y, Budde K, Kasiske BL, Kiberd BA, Loupy A, Malyszko J, Mannon RB, Tonshoff B, Cheung M, Jadoul M, Winkelmayer WC, Zeier M, for Conference Participants Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 Dec;104(6):1076-1091. doi: 10.1016/j.kint.2023.05.010. Epub 2023 May 24.
  • Shetty NS, Parcha V, Abdelmessih P, Patel N, Hasnie AA, Kalra R, Pandey A, Breathett K, Morris AA, Arora G, Arora P Sex-Associated Differences in the Clinical Outcomes of Left Ventricular Assist Device Recipients: Insights From Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail. 2023 Jun;16(6):e010189. doi: 10.1161/CIRCHEARTFAILURE.122.010189. Epub 2023 May 26.
  • Kanagaratnam P, Francis DP, Chamie D, Coyle C, Marynina A, Katritsis G, Paiva P, Szigeti M, Cole G, de Andrade Nunes D, Howard J, Esper R, Khan M, More R, Barreto G, Meneguz-Moreno R, Arnold A, Nowbar A, Kaura A, Mariveles M, March K, Shah J, Nijjer S, Lip GYH, Mills N, Camm AJ, Cooke GS, Corbett SJ, Llewelyn MJ, Ghanima W, Toshner M, Peters N, Petraco R, Al-Lamee R, Boshoff ASM, Durkina M, Malik I, Ruparelia N, Cornelius V, Shun-Shin M A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial. J Thromb Haemost. 2023 Aug;21(8):2213-2222. doi: 10.1016/j.jtha.2023.04.045. Epub 2023 May 23.
  • Balagny P, Vidal-Petiot E, Renuy A, Matta J, Frija-Masson J, Steg PG, Goldberg M, Zins M, d’Ortho MP, Wiernik E Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort. ERJ Open Res. 2023 May 15;9(3):00053-2023. doi: 10.1183/23120541.00053-2023. eCollection 2023 May.
  • Verso M, Munoz A, Connors JM Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive. Intern Emerg Med. 2023 Sep;18(6):1619-1634. doi: 10.1007/s11739-023-03306-8. Epub 2023 May 25.
  • Khan MS, Segar MW, Usman MS, Patel KV, Van Spall HGC, DeVore AD, Vaduganathan M, Lam CSP, Zannad F, Verma S, Butler J, Tang WHW, Pandey A Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. JACC Heart Fail. 2023 Jul;11(7):825-835. doi: 10.1016/j.jchf.2023.03.025. Epub 2023 May 24.
  • Myadam R, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Jasti S, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J, Cardiac Sarcoidosis Consortium Risk of Adverse Outcomes Associated With Cardiac Sarcoidosis Diagnostic Schemes. JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 3):1719-1729. doi: 10.1016/j.jacep.2023.04.010. Epub 2023 May 24.
  • Wang R, Gerstein HC, Van Spall HGC, Lip GYH, Olier I, Ortega-Martorell S, Thabane L, Ye Z, Li G Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):537-545. doi: 10.1093/ehjqcco/qcad030.
  • Ostrominski JW, Thierer J, Claggett BL, Miao ZM, Desai AS, Jhund PS, Kosiborod MN, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JACC Heart Fail. 2023 Nov;11(11):1491-1503. doi: 10.1016/j.jchf.2023.05.015. Epub 2023 May 24.
  • Mehra MR, Nayak A, Desai AS Life-Prolonging Benefits of LVAD Therapy in Advanced Heart Failure: A Clinician’s Action and Communication Aid. JACC Heart Fail. 2023 Aug;11(8 Pt 1):1011-1017. doi: 10.1016/j.jchf.2023.05.013. Epub 2023 May 24.
  • Inciardi RM, Abanda M, Shah AM, Cikes M, Claggett B, Skali H, Vaduganathan M, Prasad N, Litwin S, Merkely B, Kosztin A, Nagy KV, Shah SJ, Mullens W, Zile MR, Lam CSP, Pfeffer MA, McMurray JJV, Solomon SD, PARAGON-HF Investigators Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2023 Aug 8;82(6):489-499. doi: 10.1016/j.jacc.2023.05.010. Epub 2023 May 22.
  • Butler J, Usman MS, Filippatos G, Ferreira JP, Bohm M, Brueckmann M, Januzzi JL, Kaul S, Pina IL, Ponikowski P, Senni M, Sumin M, Verma S, Zaremba-Pechmann L, Pocock SJ, Packer M, Anker S Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial. JAMA Cardiol. 2023 Jul 1;8(7):640-649. doi: 10.1001/jamacardio.2023.1090.
  • Okamura M, Konishi M, Butler J, Kalantar-Zadeh K, von Haehling S, Anker SD Kidney function in cachexia and sarcopenia: Facts and numbers. J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1589-1595. doi: 10.1002/jcsm.13260. Epub 2023 May 24.
  • Anker MS, Lena A, Roeland EJ, Porthun J, Schmitz S, Hadzibegovic S, Sikorski P, Wilkenshoff U, Frohlich AK, Ramer LV, Rose M, Eucker J, Rassaf T, Totzeck M, Lehmann LH, von Haehling S, Coats AJS, Friede T, Butler J, Anker SD, Riess H, Landmesser U, Bullinger L, Keller U, Ahn J Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer. J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1670-1681. doi: 10.1002/jcsm.13247. Epub 2023 May 24.
  • Iba T, Helms J, Connors JM, Levy JH The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care. 2023 May 23;11(1):24. doi: 10.1186/s40560-023-00672-5.
  • Ventura HO, Lavie CJ, Mehra MR Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: You Win Some, You Lose Some. J Am Coll Cardiol. 2023 Jul 4;82(1):13-15. doi: 10.1016/j.jacc.2023.05.002. Epub 2023 May 21.
  • Ostrominski JW, Claggett BL, Packer M, Pfeffer MA, Lam CSP, Zile MR, Desai AS, Jhund PS, Lefkowitz M, McMurray JJV, Solomon SD, Vaduganathan M Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial. J Card Fail. 2023 Nov;29(11):1494-1503. doi: 10.1016/j.cardfail.2023.05.003. Epub 2023 May 21.
  • Bhatt AS, Lindholm D, Nilsson A, Zaozerska N, Claggett BL, Vaduganathan M, Kosiborod MN, Lam CSP, Hernandez AF, Martinez FA, Inzucchi SE, Shah SJ, de Boer RA, Desai A, Jhund PS, Langkilde AM, Petersson M, McMurray JJV, Solomon SD Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER. Am Heart J. 2023 Sep;263:133-140. doi: 10.1016/j.ahj.2023.05.013. Epub 2023 May 21.
  • Butt JH, Kondo T, Yang M, Jhund PS, Docherty KF, Vaduganathan M, Claggett BL, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Shah SJ, Zaozerska N, Wilderang U, Bengtsson O, Solomon SD, McMurray JJV Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. Eur Heart J. 2023 Jun 25;44(24):2170-2183. doi: 10.1093/eurheartj/ehad276.
  • Chatur S, Vaduganathan M, Claggett B, Vardeny O, Desai AS, Jhund PS, de Boer RA, Lam CSP, Kosiborod MN, Shah SJ, Martinez F, Inzucchi SE, Hernandez AF, Haddad T, Mitter SS, Miao ZM, Petersson M, Maria Langkilde A, McMurray JJV, Solomon SD Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. Eur Heart J. 2023 Aug 14;44(31):2930-2943. doi: 10.1093/eurheartj/ehad283.
  • Blaha V, Margoczy R, Petrov I, Postadzhiyan A, Raslova K, Rosolova H, Bridges I, Dhalwani NN, Zachlederova M, Ray KK Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231172847. doi: 10.1177/10742484231172847.
  • Perreault L, Suresh K, Rodriguez C, Dickinson LM, Willems E, Smith PC, Williams J Jr, Gritz RM, Holtrop JS Baseline Characteristics of PATHWEIGH: A Stepped-Wedge Cluster Randomized Study for Weight Management in Primary Care. Ann Fam Med. 2023 May-Jun;21(3):249-255. doi: 10.1370/afm.2966.
  • Ornello R, Sposato LA, Sacco S Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update. Neurology. 2023 May 23;100(21):1033. doi: 10.1212/WNL.0000000000207400.
  • Adamo M, Pagnesi M, Mebazaa A, Davison B, Edwards C, Tomasoni D, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Novosadova M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Voors A, Cotter G, Metra M NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial. Eur Heart J. 2023 Aug 14;44(31):2947-2962. doi: 10.1093/eurheartj/ehad335.
  • Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis. Ann Intern Med. 2023 Jun;176(6):788-797. doi: 10.7326/M22-3228. Epub 2023 May 23.
  • Pierce JB, Vaduganathan M, Fonarow GC, Ikeaba U, Chiswell K, Butler J, DeVore AD, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Linganathan KK, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Greene SJ Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 Jul 1;8(7):652-661. doi: 10.1001/jamacardio.2023.1266.
  • Chatur S, Cunningham JW, Vaduganathan M, Mc Causland FR, Claggett BL, Desai AS, Miao ZM, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial. Eur J Heart Fail. 2023 Jul;25(7):1170-1175. doi: 10.1002/ejhf.2915. Epub 2023 Jun 8.
  • Bhatt AS, Kosiborod MN, Vaduganathan M, Claggett BL, Miao ZM, Kulac IJ, Lam CSP, Hernandez AF, Martinez F, Inzucchi SE, Shah SJ, de Boer RA, Jhund PS, Desai AS, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials. Eur J Heart Fail. 2023 Jul;25(7):981-988. doi: 10.1002/ejhf.2909. Epub 2023 Jun 7.
  • Angelico-Goncalves A, Leite AR, Neves JS, Saraiva F, Brochado L, Oliveira AC, Butler J, Packer M, Zannad F, Vasques-Novoa F, Leite-Moreira A, Ferreira JP Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis. Int J Cardiol. 2023 Sep 1;386:65-73. doi: 10.1016/j.ijcard.2023.05.032. Epub 2023 May 19.
  • d’Entremont MA, Marquis-Gravel G, Paradis JM, Berube S, Seto AH, Nguyen P, Mehta SR, Couture EL, Jolly SS Strategies to Reduce Transfemoral Access Complications in Contemporary Interventional Cardiology. Can J Cardiol. 2023 Oct;39(10):1392-1396. doi: 10.1016/j.cjca.2023.04.017. Epub 2023 May 19.
  • Chatur S, Kondo T, Claggett BL, Docherty K, Miao ZM, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HF. Eur J Heart Fail. 2023 Aug;25(8):1364-1371. doi: 10.1002/ejhf.2912. Epub 2023 Jun 8.
  • Peikert A, Chandra A, Kosiborod MN, Claggett BL, Desai AS, Jhund PS, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Janssens SP, Belohlavek J, Borleffs CJW, Dobreanu D, Langkilde AM, Bengtsson O, Petersson M, McMurray JJV, Solomon SD, Vaduganathan M Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial. JAMA Cardiol. 2023 Jul 1;8(7):684-690. doi: 10.1001/jamacardio.2023.1342.
  • Metra M, Tomasoni D, Adamo M, Bayes-Genis A, Filippatos G, Abdelhamid M, Adamopoulos S, Anker SD, Antohi L, Bohm M, Braunschweig F, Gal TB, Butler J, Cleland JGF, Cohen-Solal A, Damman K, Gustafsson F, Hill L, Jankowska EA, Lainscak M, Lund LH, McDonagh T, Mebazaa A, Moura B, Mullens W, Piepoli M, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Seferovic P, Sharma R, Tocchetti CG, Yilmaz MB, Vitale C, Volterrani M, von Haehling S, Chioncel O, Coats AJS, Rosano G Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 Jun;25(6):776-791. doi: 10.1002/ejhf.2874. Epub 2023 May 19.
  • Stone GW, Kereiakes DJ, Gori T, Metzger DC, Stein B, Erickson M, Torzewski J, Kabour A, Piegari G, Cavendish J, Bertolet B, Stockelman KA, West NEJ, Ben-Yehuda O, Choi JW, Marx SO, Spertus JA, Ellis SG, ABSORB IV Investigators 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique. J Am Coll Cardiol. 2023 Jul 18;82(3):183-195. doi: 10.1016/j.jacc.2023.05.003. Epub 2023 May 17.
  • Khan S, Fawaz S, Simpson R, Robertson C, Kelly P, Mohdnazri S, Tang K, Cook CM, Gallagher S, O’Kane P, Spratt J, Brilakis ES, Karamasis GV, Al-Lamee R, Keeble TR, Davies JR The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol. Front Cardiovasc Med. 2023 May 3;10:1172763. doi: 10.3389/fcvm.2023.1172763. eCollection 2023.
  • Zhou XD, Targher G, Byrne CD, Somers V, Kim SU, Chahal CAA, Wong VW, Cai J, Shapiro MD, Eslam M, Steg PG, Sung KC, Misra A, Li JJ, Brotons C, Huang Y, Papatheodoridis GV, Sun A, Yilmaz Y, Chan WK, Huang H, Mendez-Sanchez N, Alqahtani SA, Cortez-Pinto H, Lip GYH, de Knegt RJ, Ocama P, Romero-Gomez M, Fudim M, Sebastiani G, Son JW, Ryan JD, Ikonomidis I, Treeprasertsuk S, Pastori D, Lupsor-Platon M, Tilg H, Ghazinyan H, Boursier J, Hamaguchi M, Nguyen MH, Fan JG, Goh GB, Al Mahtab M, Hamid S, Perera N, George J, Zheng MH An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol Int. 2023 Aug;17(4):773-791. doi: 10.1007/s12072-023-10543-8. Epub 2023 May 19.
  • White HD Does it Matter What the Cause of Death Is in Revascularization Trials? JACC Cardiovasc Interv. 2023 May 22;16(10):1157-1159. doi: 10.1016/j.jcin.2023.03.042.
  • Ferro EG, Kramer DB, Li S, Locke AH, Misra S, Schmaier AA, Carroll BJ, Song Y, D’Avila AA, Yeh RW, Zimetbaum PJ, Secemsky EA Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction. J Am Coll Cardiol. 2023 Jun 20;81(24):2328-2340. doi: 10.1016/j.jacc.2023.04.017. Epub 2023 May 18.
  • Hussain A, Ramsey D, Lee M, Mahtta D, Khan MS, Nambi V, Ballantyne CM, Petersen LA, Walker AD, Kayani WT, Butler J, Slipczuk L, Rogers JG, Bozkurt B, Navaneethan SD, Virani SS Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 Aug;11(8 Pt 1):933-942. doi: 10.1016/j.jchf.2023.03.024. Epub 2023 May 17.
  • Nassif ME, Windsor SL, Gosch K, Borlaug BA, Husain M, Inzucchi SE, Kitzman DW, McGuire DK, Pitt B, Scirica BM, Shah SJ, Umpierrez G, Austin BA, Lamba S, Khumri T, Sharma K, Kosiborod MN Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials. Circ Heart Fail. 2023 Jul;16(7):e009837. doi: 10.1161/CIRCHEARTFAILURE.122.009837. Epub 2023 May 19.
  • Atallah J, Chiha T, Chen C, Siller-Matula JM, McCarthy CP, Januzzi JL Jr, Wasfy JH Clinical outcomes associated with type II myocardial infarction caused by bleeding. Am Heart J. 2023 Sep;263:85-92. doi: 10.1016/j.ahj.2023.05.008. Epub 2023 May 16.
  • Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I Baseline modern medical management in the BEST-CLI trial. J Vasc Surg. 2023 Sep;78(3):711-718.e5. doi: 10.1016/j.jvs.2023.05.006. Epub 2023 May 17.
  • Angiolillo DJ, Erlinge D, Ferreiro JL, Gale CP, Huber K, Musumeci G, Collet JP European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey. Int J Cardiol. 2023 Sep 1;386:8-16. doi: 10.1016/j.ijcard.2023.05.025. Epub 2023 May 17.
  • Kanumilli N, Butler J, Makrilakis K, Ryden L, Vallis M, Wanner C, Zieroth S, Alhussein A, Cheng A Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes. Diabetes Ther. 2023 Jul;14(7):1093-1110. doi: 10.1007/s13300-023-01418-0. Epub 2023 May 18.
  • Verma S, Dhingra NK, Bonaca MP, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Iwata T, Nordaby M, Brueckmann M, Pocock SJ, Packer M, EMPEROR Trials Committees and Investigators Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled. Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1334-1337. doi: 10.1161/ATVBAHA.123.319156. Epub 2023 May 18.
  • Sukumar S, Wasfy JH, Januzzi JL, Peppercorn J, Chino F, Warraich HJ Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 May 23;81(20):2043-2055. doi: 10.1016/j.jacc.2023.03.402.
  • McCarthy CP, Vyas A, Januzzi JL Jr What Is a Normal Troponin, Anyway? J Am Coll Cardiol. 2023 May 23;81(20):2040-2042. doi: 10.1016/j.jacc.2023.03.404.
  • Shah NP, Peterson ED, Page C, Blanco R, Navar AM Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample. Am Heart J. 2023 Sep;263:64-72. doi: 10.1016/j.ahj.2023.05.009. Epub 2023 May 15.
  • Alicic RZ, Neumiller JJ, Tuttle KR Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease. Curr Opin Nephrol Hypertens. 2023 Jul 1;32(4):377-385. doi: 10.1097/MNH.0000000000000894. Epub 2023 May 4.
  • Ludwig S, Conradi L, Cohen DJ, Coisne A, Scotti A, Abraham WT, Ben Ali W, Zhou Z, Li Y, Kar S, Duncan A, Lim DS, Adamo M, Redfors B, Muller DWM, Webb JG, Petronio AS, Ruge H, Nickenig G, Sondergaard L, Adam M, Regazzoli D, Garatti A, Schmidt T, Andreas M, Dahle G, Walther T, Kempfert J, Tang GHL, Redwood S, Taramasso M, Praz F, Fam N, Dumonteil N, Obadia JF, von Bardeleben RS, Rudolph TK, Reardon MJ, Metra M, Denti P, Mack MJ, Hausleiter J, Asch FM, Latib A, Lindenfeld J, Modine T, Stone GW, Granada JF, CHOICE-MI and the COAPT Trial Investigators Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison. Circ Cardiovasc Interv. 2023 Jun;16(6):e013045. doi: 10.1161/CIRCINTERVENTIONS.123.013045. Epub 2023 May 16.
  • Khan N, Javed Z, Acquah I, Hagan K, Khan M, Valero-Elizondo J, Chang R, Javed U, Taha MB, Blaha MJ, Virani SS, Sharma G, Blankstein R, Gulati M, Mossialos E, Hyder AA, Achirica MC, Nasir K Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 2023 May 16;23(1):900. doi: 10.1186/s12889-023-15621-y.
  • Girerd N, Levy D, Duarte K, Ferreira JP, Ballantyne C, Collier T, Pizard A, Bjorkman J, Butler J, Clark A, Cleland JG, Delles C, Diez J, Gonzalez A, Hazebroek M, Ho J, Huby AC, Hwang SJ, Latini R, Mariottoni B, Mebazaa A, Pellicori P, Sattar N, Sever P, Staessen JA, Verdonschot J, Heymans S, Rossignol P, Zannad F Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circ Heart Fail. 2023 May;16(5):e009694. doi: 10.1161/CIRCHEARTFAILURE.122.009694. Epub 2023 May 16.
  • Caraballo C, Massey DS, Ndumele CD, Haywood T, Kaleem S, King T, Liu Y, Lu Y, Nunez-Smith M, Taylor HA, Watson KE, Herrin J, Yancy CW, Faust JS, Krumholz HM Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020. JAMA. 2023 May 16;329(19):1662-1670. doi: 10.1001/jama.2023.7022.
  • Cerlinskaite-Bajore K, Lam CSP, Sliwa K, Adamo M, Ter Maaten JM, Leopold V, Mebazaa A, Davison B, Edwards C, Arrigo M, Barros M, Biegus J, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Takagi K, Tomasoni D, Voors AA, Cotter G, Celutkiene J Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial. Eur J Heart Fail. 2023 Jul;25(7):1156-1165. doi: 10.1002/ejhf.2882. Epub 2023 Jun 1.
  • Khan MS, Grayburn PA, Butler J Cardiac reverse remodelling with vericiguat: Victory or no victory? Eur J Heart Fail. 2023 Jul;25(7):1022-1024. doi: 10.1002/ejhf.2883. Epub 2023 May 25.
  • Gupta K, Spertus JA, Birmingham M, Gosch KL, Husain M, Kitzman DW, Pitt B, Shah SJ, Januzzi JL, Lingvay I, Butler J, Kosiborod M, Lanfear DE Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation. 2023 Jul 18;148(3):220-228. doi: 10.1161/CIRCULATIONAHA.122.063263. Epub 2023 May 16.
  • Bledsoe J, Woller SC, Brooks M, Sciurba FC, Krishnan JA, Martin D, Hou P, Lin JY, Kindzelski A, Handberg E, Kirwan BA, Zaharris E, Castro L, Shapiro NL, Pepine CJ, Majercik S, Fu Z, Zhong Y, Venugopal V, Lai YH, Ridker PM, Connors JM Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial. BMC Infect Dis. 2023 May 15;23(1):325. doi: 10.1186/s12879-023-08295-9.
  • Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky ML, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgozoglu LS, Catapano AL Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023 Jun;374:107-120. doi: 10.1016/j.atherosclerosis.2023.04.012. Epub 2023 Apr 28.
  • Smith JD, Agrawal A, Wicklund C, Duquette D, Friedewald J, Rasmussen LV, Gacki-Smith J, Tandon SD, Muhammad LN, Yancy CW, Dong S, Cooper M, Gilbert A, Shetty A, Gordon EJ Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre-post trial design. BMJ Open. 2023 May 15;13(5):e067657. doi: 10.1136/bmjopen-2022-067657.
  • Stevens CA, Lyons AR, Dharmayat KI, Mahani A, Ray KK, Vallejo-Vaz AJ, Sharabiani MT Ensemble machine learning methods in screening electronic health records: A scoping review. Digit Health. 2023 May 9;9:20552076231173225. doi: 10.1177/20552076231173225. eCollection 2023 Jan-Dec.
  • Zarini S, Zemski Berry KA, Kahn DE, Garfield A, Perreault L, Kerege A, Bergman BC Deoxysphingolipids: Atypical Skeletal Muscle Lipids Related to Insulin Resistance in Humans That Decrease Insulin Sensitivity In Vitro. Diabetes. 2023 Jul 1;72(7):884-897. doi: 10.2337/db22-1018.
  • Copur S, Tanriover C, Yavuz F, Tuttle KR, Kanbay M Tirzepatide and potential use for metabolically healthy obesity. Eur J Intern Med. 2023 Jul;113:1-5. doi: 10.1016/j.ejim.2023.05.012. Epub 2023 May 12.
  • Piazza G, Hurwitz S, Campia U, Bikdeli B, Lou J, Khairani CD, Bejjani A, Snyder JE, Pfeferman M, Barns B, Rizzo S, Glezer A, Goldhaber SZ Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2). Thromb Res. 2023 Jul;227:1-7. doi: 10.1016/j.thromres.2023.05.006. Epub 2023 May 11.
  • Talha KM, Anker SD, Butler J SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. Int J Heart Fail. 2023 Mar 13;5(2):82-90. doi: 10.36628/ijhf.2022.0030. eCollection 2023 Apr.
  • Yeung AM, Huang J, Pandey A, Hashim IA, Kerr D, Pop-Busui R, Rhee CM, Shah VN, Bally L, Bayes-Genis A, Bee YM, Bergenstal R, Butler J, Fleming GA, Gilbert G, Greene SJ, Kosiborod MN, Leiter LA, Mankovsky B, Martens TW, Mathieu C, Mohan V, Patel KV, Peters A, Rhee EJ, Rosano GMC, Sacks DB, Sandoval Y, Seley JJ, Schnell O, Umpierrez G, Waki K, Wright EE Jr, Wu AHB, Klonoff DC Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society. Prog Cardiovasc Dis. 2023 Jul-Aug;79:65-79. doi: 10.1016/j.pcad.2023.05.002. Epub 2023 May 11.
  • Muhyieddeen A, Cheng S, Mamas MA, Beasley D, Weins GC, Gulati M Racial Disparities in Mortality Associated With Acute Myocardial Infarction and COVID-19 in the United States: A Nationwide Analysis. Curr Probl Cardiol. 2023 Sep;48(9):101798. doi: 10.1016/j.cpcardiol.2023.101798. Epub 2023 May 11.
  • Spargias K, Lim DS, Makkar R, Kar S, Kipperman RM, O Neill WW, Ng MKC, Smith RL, Fam NP, Rinaldi MJ, Raffel CO, Walters DL, Levisay J, Montorfano M, Latib A, Carroll JD, Nickenig G, Windecker S, Marcoff L, Cohen GN, Schafer U, Webb JG, Szerlip M Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. Catheter Cardiovasc Interv. 2023 Jul;102(1):145-154. doi: 10.1002/ccd.30686. Epub 2023 May 13.
  • Ito S, Laham R, Nkomo VT, Forrest JK, Reardon MJ, Little SH, Mumtaz M, Gada H, Bajwa T, Langholz D, Heiser J, Chawla A, Jenson B, Attizanni G, Markowitz AH, Huang J, Oh JK Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis. Open Heart. 2023 May;10(1):e002297. doi: 10.1136/openhrt-2023-002297.
  • Galli M, Angiolillo DJ The evaluation and management of coagulopathies in the intensive therapy units. Eur Heart J Acute Cardiovasc Care. 2023 Jun 2;12(6):399-407. doi: 10.1093/ehjacc/zuad051.
  • Wang TF, Khorana AA, Agnelli G, Bloomfield D, Bonaca MP, Buller HR, Connors JM, Goto S, Jing ZC, Kakkar AK, Khder Y, Raskob GE, Soff GA, Verhamme P, Weitz JI, Carrier M Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. Oncologist. 2023 Jul 5;28(7):555-564. doi: 10.1093/oncolo/oyad116.
  • Kaufmann MB, Tan JC, Chertow GM, Goldhaber-Fiebert JD Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits. Med Decis Making. 2023 Jul;43(5):576-586. doi: 10.1177/0272989X231172169. Epub 2023 May 12.
  • Galindo RJ, Inselman SA, Umpierrez GE, Moazzami B, Munoz Mendoza J, Ali MK, Tuttle KR, McCoy RG National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017. Diabetes Care. 2023 Jul 1;46(7):e130-e132. doi: 10.2337/dc23-0554.
  • Zannad F, Crea F, Keaney J, Spencer S, Hill JA, Pfeffer MA, Pocock S, Raderschadt E, Ross JS, Sacks CA, Van Spall HGC, Winslow R, Jessup M Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges. Eur Heart J. 2023 Oct 21;44(40):4220-4229. doi: 10.1093/eurheartj/ehad279.
  • Butler J, Packer M, Siddiqi TJ, Bohm M, Brueckmann M, Januzzi JL, Verma S, Gergei I, Iwata T, Wanner C, Ferreira JP, Pocock SJ, Filippatos G, Anker SD, Zannad F Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories. J Am Coll Cardiol. 2023 May 16;81(19):1902-1914. doi: 10.1016/j.jacc.2023.03.390.
  • Baugh CW, Freund Y, Steg PG, Body R, Maron DJ, Yiadom MYAB Strategies to mitigate emergency department crowding and its impact on cardiovascular patients. Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):633-643. doi: 10.1093/ehjacc/zuad049.
  • Pandey A, Keshvani N, Alonso W Skeletal Muscle Mitochondrial Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2023 Jun 1;8(6):584-585. doi: 10.1001/jamacardio.2023.0963.
  • Wilson M, Wang JY, Andreev A, Katsanos AH, Selim M, Lioutas VA Diagnostic Utility of Brain MRI in Spontaneous Intracerebral Hemorrhage: A Retrospective Cohort Study and Meta-Analysis. medRxiv [Preprint]. 2023 Apr 25:2023.04.19.23288843. doi: 10.1101/2023.04.19.23288843.
  • Miyawaki IA, Gomes C, Caporal S Moreira V, R Marques I, A F de Souza I, H A Silva C, Riceto Loyola Junior JE, Huh K, McDowell M, Padrao EMH, Tichauer MB, Gibson CM The Single-Syringe Versus the Double-Syringe Techniques of Adenosine Administration for Supraventricular Tachycardia: A Systematic Review and Meta-Analysis. Am J Cardiovasc Drugs. 2023 Jul;23(4):341-353. doi: 10.1007/s40256-023-00581-w. Epub 2023 May 10.
  • Kataoka Y, Nicholls SJ, Puri R, Kitahara S, Kiyoshige E, Nishimura K, Murai K, Iwai T, Sawada K, Matama H, Honda S, Takagi K, Fujino M, Yoneda S, Otsuka F, Nishihira K, Takamisawa I, Asaumi Y, Noguchi T Sex Differences in the Density of Lipidic Plaque Materials: Insights From the REASSURE-NIRS MultiCenter Registry. Circ Cardiovasc Imaging. 2023 May;16(5):e015107. doi: 10.1161/CIRCIMAGING.122.015107. Epub 2023 May 10.
  • Varghese MS, Song Y, Xu J, Dahabreh I, Beatty AL, Sperling LS, Fonarow GC, Keteyian SJ, Yeh RW, Wu WC, Kazi DS Availability and Use of In-Person and Virtual Cardiac Rehabilitation Among US Medicare Beneficiaries: A Post-Pandemic Update. J Cardiopulm Rehabil Prev. 2023 Jul 1;43(4):301-303. doi: 10.1097/HCR.0000000000000803. Epub 2023 May 9.
  • Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Binder G, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene SJ Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction. J Am Heart Assoc. 2023 May 16;12(10):e028820. doi: 10.1161/JAHA.122.028820. Epub 2023 May 9.
  • Raygor V, Ayers C, Segar MW, Agusala K, Khera A, Pandey A, Joshi PH Impact of Family History of Premature Coronary Artery Disease on Noninvasive Testing in Stable Chest Pain. J Am Heart Assoc. 2023 May 16;12(10):e029266. doi: 10.1161/JAHA.122.029266. Epub 2023 May 9.
  • Viana-Rojas JA, Argaiz E, Robles-Ledesma M, Arias-Mendoza A, Najera-Rojas NA, Alonso-Bringas AP, De Los Rios-Arce LF, Armenta-Rodriguez J, Gopar-Nieto R, Briseno-De la Cruz JL, Gonzalez-Pacheco H, Sierra-Lara Martinez D, Gonzalez-Salido J, Lopez-Gil S, Araiza-Garaygordobil D Venous excess ultrasound score and acute kidney injury in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):413-419. doi: 10.1093/ehjacc/zuad048.
  • Sattar N, McMurray J, Boren J, Rawshani A, Omerovic E, Berg N, Halminen J, Skoglund K, Eliasson B, Gerstein HC, McGuire DK, Bhatt D, Rawshani A Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study. Circulation. 2023 Jun 20;147(25):1872-1886. doi: 10.1161/CIRCULATIONAHA.122.063374. Epub 2023 May 8.
  • Desai AS, Lam CSP, McMurray JJV, Redfield MM How to Manage Heart Failure With Preserved Ejection Fraction: Practical Guidance for Clinicians. JACC Heart Fail. 2023 Jun;11(6):619-636. doi: 10.1016/j.jchf.2023.03.011. Epub 2023 May 3.
  • Michaelsson E, Lund LH, Hage C, Shah SJ, Voors AA, Saraste A, Redfors B, Grove EL, Barasa A, Richards AM, Svedlund S, Lagerstrom-Fermer M, Gabrielsen A, Garkaviy P, Gan LM, Lam CSP Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF. JACC Heart Fail. 2023 Jul;11(7):775-787. doi: 10.1016/j.jchf.2023.03.002. Epub 2023 May 3.
  • Toda K, Bernhardt AM, Mehra MR Mechanical circulatory support for adults in Japan: A 10-year perspective. Artif Organs. 2023 Jun;47(6):914-924. doi: 10.1111/aor.14536. Epub 2023 May 4.
  • Butler J, Zheng Y, Khan MS, Bonderman D, Lund LH, deFilippi CR, Blaustein RO, Ezekowitz JA, Freitas C, Hernandez AF, O’Connor CM, Voors AA, Westerhout CM, Lam CSP, Armstrong PW, VICTORIA Study Group Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA. JACC Heart Fail. 2023 May;11(5):583-592. doi: 10.1016/j.jchf.2022.12.014. Epub 2023 Apr 12.
  • Kittleson MM, Panjrath GS, Amancherla K, Davis LL, Deswal A, Dixon DL, Januzzi JL Jr, Yancy CW 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19.
  • Gulati M, Holtzman JN, Kaur G Increased Rehospitalization in Young Women With Acute Myocardial Infarction at 1 Year: Adding Insult to Infarct. J Am Coll Cardiol. 2023 May 9;81(18):1807-1809. doi: 10.1016/j.jacc.2023.03.394.
  • Gilliland TC, Liu Y, Mohebi R, Miksenas H, Haidermota S, Wong M, Hu X, Cristino JR, Browne A, Plutzky J, Tsimikas S, Januzzi JL Jr, Natarajan P Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes. J Am Coll Cardiol. 2023 May 9;81(18):1780-1792. doi: 10.1016/j.jacc.2023.02.050.
  • Beavers CJ, Ambrosy AP, Butler J, Davidson BT, Gale SE, Pina IL, Mastoris I, Reza N, Mentz RJ, Lewis GD Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America. J Card Fail. 2023 Jul;29(7):1059-1077. doi: 10.1016/j.cardfail.2023.03.025. Epub 2023 May 1.
  • Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Hudgins LC, Kayikcioglu M, Masana L, Parhofer KG, Roeters van Lennep JE, Santos RD, Stroes ESG, Watts GF, Wiegman A, Stock JK, Tokgozoglu LS, Catapano AL, Ray KK 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023 Jul 1;44(25):2277-2291. doi: 10.1093/eurheartj/ehad197.
  • Jering KS, Claggett BL, Pfeffer MA, Granger CB, Kober L, Lewis EF, Maggioni AP, Mann DL, McMurray JJV, Prescott MF, Rouleau JL, Solomon SD, Steg PG, von Lewinski D, Braunwald E Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circ Heart Fail. 2023 May;16(5):e010259. doi: 10.1161/CIRCHEARTFAILURE.122.010259. Epub 2023 May 1.
  • Nedkoff L, Briffa T, Murray K, Gaw J, Yates A, Sanfilippo FM, Nicholls SJ Risk of early recurrence and mortality in high-risk myocardial infarction patients: A population-based linked data study. Int J Cardiol Cardiovasc Risk Prev. 2023 Apr 6;17:200185. doi: 10.1016/j.ijcrp.2023.200185. eCollection 2023 Jun.
  • Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Juni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Voller H, Vranckx P, Windecker S, Fox KAA Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease. Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):462-496. doi: 10.1093/ehjcvp/pvad032.
  • Heerspink HJL, Jongs N, Neuen BL, Schloemer P, Vaduganathan M, Inker LA, Fletcher RA, Wheeler DC, Bakris G, Greene T, Chertow GM, Perkovic V Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials. Kidney Int. 2023 Jul;104(1):181-188. doi: 10.1016/j.kint.2023.03.037. Epub 2023 Apr 28.
  • Chertow GM, Correa-Rotter R, Vart P, Jongs N, McMurray JJV, Rossing P, Langkilde AM, Sjostrom CD, Toto RD, Wheeler DC, Heerspink HJL, DAPA-CKD Trial Committees and Investigators Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. J Am Heart Assoc. 2023 May 2;12(9):e028739. doi: 10.1161/JAHA.122.028739. Epub 2023 Apr 29.
  • Ortega-Paz L, Giordano S, Franchi F, Rollini F, Pollack CV Jr, Bhatt DL, Angiolillo DJ Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clin Pharmacokinet. 2023 May;62(5):673-692. doi: 10.1007/s40262-023-01245-3. Epub 2023 Apr 28.
  • Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, Chioncel O, Defilippi CR, Drazner MH, Felker GM, Filippatos G, Fiuzat M, Ide T, Januzzi JL Jr, Kinugawa K, Kuwahara K, Matsue Y, Mentz RJ, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic PM, Teerlink J, Yamamoto K, Yoshimura M Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. J Card Fail. 2023 May;29(5):787-804. doi: 10.1016/j.cardfail.2023.02.009. Epub 2023 Apr 17.
  • Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, Morais J, Pordy R, Scemama M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome. Can J Cardiol. 2023 Oct;39(10):1315-1324. doi: 10.1016/j.cjca.2023.04.018. Epub 2023 Apr 26.
  • Khan MS, Singh S, Segar MW, Usman MS, Keshvani N, Ambrosy AP, Fiuzat M, Van Spall HGC, Fonarow GC, Zannad F, Felker GM, Januzzi JL Jr, O’Connor C, Butler J, Pandey A Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial. JACC Heart Fail. 2023 Nov;11(11):1507-1517. doi: 10.1016/j.jchf.2023.03.007. Epub 2023 Apr 26.
  • Mohebi R, Liu Y, Myhre PL, Felker GM, Prescott MF, Pina IL, Butler J, Ward JH, Solomon SD, Januzzi JL Jr Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan. JACC Heart Fail. 2023 Jul;11(7):855-858. doi: 10.1016/j.jchf.2023.03.006. Epub 2023 Apr 26.
  • Haywood HB, Fonarow GC, Khan MS, Nassif ME, Butler J, Greene SJ Hospital at Home as a Novel Care Strategy for Worsening Heart Failure. JACC Heart Fail. 2023 Oct;11(10):1443-1448. doi: 10.1016/j.jchf.2023.02.013. Epub 2023 Apr 26.
  • Diab A, Dastmalchi LN, Gulati M, Michos ED A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? Vasc Health Risk Manag. 2023 Apr 21;19:237-253. doi: 10.2147/VHRM.S379874. eCollection 2023.
  • Sanchez-Amaya DJ, Lopez-Lizarraga MA, Gutierrez Castaneda M, Araiza-Garaygordobil D, Arias-Mendoza A Reverse Takotsubo Cardiomyopathy During Immediate Post-partum: A Case Report. Cureus. 2023 Mar 26;15(3):e36700. doi: 10.7759/cureus.36700. eCollection 2023 Mar.
  • Pun PH, Assimon MM, Wang L, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis. Kidney Med. 2023 Feb 15;5(5):100618. doi: 10.1016/j.xkme.2023.100618. eCollection 2023 May.
  • Rastogi A, Januzzi JL Jr Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824.
  • Omar W, Hendren NS, Carter S, Mathew C, Alvarez KS, Bhavan K, Joglar J, Das SR Home Inotrope Program for Self-Funded Patients in a Safety-Net Hospital System (A Pilot Experience). Am J Cardiol. 2023 Jun 15;197:1-2. doi: 10.1016/j.amjcard.2023.03.028. Epub 2023 Apr 25.
  • Vart P, Jongs N, Wheeler DC, Heerspink HJL, Langkilde AM, Chertow GM Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e2310877. doi: 10.1001/jamanetworkopen.2023.10877.
  • Adamo M, Tomasoni D, Stolz L, Stocker TJ, Pancaldi E, Koell B, Karam N, Besler C, Giannini C, Sampaio F, Praz F, Ruf T, Pechmajou L, Neuss M, Iliadis C, Baldus S, Butter C, Kalbacher D, Lurz P, Melica B, Petronio AS, von Bardeleben RS, Windecker S, Butler J, Fonarow GC, Hausleiter J, Metra M Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration. JACC Cardiovasc Interv. 2023 Apr 24;16(8):896-905. doi: 10.1016/j.jcin.2023.01.362. Epub 2023 Mar 22.
  • Maqsood MH, Talha KM, Minhas AMK, Fudim M, Khan SS, Butler J, Khan MS CDC-WONDER Database Analysis of COVID-19 and Cardiovascular Disease-Related Mortality. J Am Coll Cardiol. 2023 May 2;81(17):1743-1745. doi: 10.1016/j.jacc.2023.02.044.
  • Nguyen DD, Spertus JA, Alexander KP, Newman JD, Dodson JA, Jones PG, Stevens SR, O’Brien SM, Gamma R, Perna GP, Garg P, Vitola JV, Chow BJW, Vertes A, White HD, Smanio PEP, Senior R, Held C, Li J, Boden WE, Mark DB, Reynolds HR, Bangalore S, Chan PS, Stone GW, Arnold SV, Maron DJ, Hochman JS, ISCHEMIA Research Group Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. J Am Coll Cardiol. 2023 May 2;81(17):1697-1709. doi: 10.1016/j.jacc.2023.02.048.
  • Fonarow GC, Van Spall HGC, Januzzi JL Jr Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure. J Am Coll Cardiol. 2023 May 2;81(17):1694-1696. doi: 10.1016/j.jacc.2023.02.047.
  • Jhund PS, Claggett BL, Talebi A, Butt JH, Gasparyan SB, Wei LJ, McCaw ZR, Wilderang U, Bengtsson O, Desai AS, Petersson M, Langkilde AM, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Vaduganathan M, Solomon SD, McMurray JJV Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial. JAMA Cardiol. 2023 Jun 1;8(6):554-563. doi: 10.1001/jamacardio.2023.0711.
  • Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, Chioncel O, Defilippi CR, Drazner MH, Felker GM, Filippatos G, Fiuzat M, Ide T, Januzzi JL Jr, Kinugawa K, Kuwahara K, Matsue Y, Mentz RJ, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic PM, Teerlink J, Yamamoto K, Yoshimura M Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail. 2023 May;25(5):616-631. doi: 10.1002/ejhf.2848. Epub 2023 Apr 26.
  • Khan MS, Usman MS, Talha KM, Van Spall HGC, Greene SJ, Vaduganathan M, Khan SS, Mills NL, Ali ZA, Mentz RJ, Fonarow GC, Rao SV, Spertus JA, Roe MT, Anker SD, James SK, Butler J, McGuire DK Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. Eur Heart J. 2023 Jun 1;44(21):1890-1909. doi: 10.1093/eurheartj/ehad171.
  • Sarnak MJ, Agarwal R, Boudville N, Chowdhury PCP, Eckardt KU, Gonzalez CR, Kooienga LA, Koury MJ, Ntoso KA, Luo W, Parfrey PS, Vargo DL, Winkelmayer WC, Zhang Z, Chertow GM Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis. Nephrol Dial Transplant. 2023 Sep 29;38(10):2358-2367. doi: 10.1093/ndt/gfad074.
  • Zarini S, Zemski Berry KA, Kahn DE, Garfield A, Perreault L, Kerege A, Bergman BC Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro. Diabetes. 2023 Apr 24:db221018. doi: 10.2337/db221018.
  • Cannon CP, Kim JM, Lee JJ, Sutherland J, Bachireddy R, Valentine CM, Hearne S, Trebnick A, Jaffer S, Datta S, Semmel E, Thorpe F, Doros G, Cavender MA, Reynolds MR, Benchmarking an Oral Anticoagulant Treatment Rate in Patients with Nonvalvular, Atrial Fibrillation (BOAT-AF) Investigators and Research Coordinators Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant. JAMA Netw Open. 2023 Apr 3;6(4):e239638. doi: 10.1001/jamanetworkopen.2023.9638.
  • Bansal N, Artinian NT, Bakris G, Chang T, Cohen J, Flythe J, Lea J, Vongpatanasin W, Chertow GM, American Heart Association Council on the Kidney in Cardiovascular Disease;, Council on Cardiovascular and Stroke Nursing; and Council on Epidemiology and, Prevention Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association. Hypertension. 2023 Jun;80(6):e112-e122. doi: 10.1161/HYP.0000000000000230. Epub 2023 Apr 24.
  • Arias-Mendoza A, Gonzalez-Pacheco H, Alvarez-Sangabriel A, Gopar-Nieto R, Rodriguez-Chavez LL, Araiza-Garaygordobil D, Ramirez-Rangel P, Martinez DS, Del Carmen Lacy-Niebla M, Briseno-De la Cruz JL, Juarez-Tolen J, Mendoza-Garcia S, Altamirano-Castillo A Women with Acute Myocardial Infarction: Clinical Characteristics, Treatment, and In-Hospital Outcomes from a Latin American Country. Glob Heart. 2023 Apr 20;18(1):19. doi: 10.5334/gh.1196. eCollection 2023.
  • Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrieres J, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL, SANTORINI Study Investigators Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur. 2023 Apr 5;29:100624. doi: 10.1016/j.lanepe.2023.100624. eCollection 2023 Jun.
  • Lawless M, Appelman Y, Beltrame JF, Navarese EP, Ratcovich H, Wilkinson C, Kunadian V Sex differences in treatment and outcomes amongst myocardial infarction patients presenting with and without obstructive coronary arteries: a prospective multicentre study. Eur Heart J Open. 2023 Mar 27;3(2):oead033. doi: 10.1093/ehjopen/oead033. eCollection 2023 Mar.
  • Okwuosa IS, Anderson A, Petty M, Wu T, Andrei AC, Kao A, Spertus JA, Pham DT, Yancy CW, Dew MA, Hsich E, Cotts W, Hartupee J, Pamboukian S, Pagani F, Lampert B, Johnson M, Murray M, Tekeda K, Yuzefpolskaya M, Kirklin JK, Grady KL Caregiver burden before heart transplantation and long-term mechanical circulatory support: Findings from the sustaining quality of life of the aged: Transplant or mechanical support (SUSTAIN-IT) study. J Heart Lung Transplant. 2023 Sep;42(9):1197-1204. doi: 10.1016/j.healun.2023.01.015. Epub 2023 Apr 21.
  • Rikken SAOF, Bor WL, Selvarajah A, Zheng KL, Hack AP, Gibson CM, Granger CB, Bentur OS, Coller BS, van ‘t Hof AWJ, Ten Berg JM Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa study. Am Heart J. 2023 Aug;262:75-82. doi: 10.1016/j.ahj.2023.04.009. Epub 2023 Apr 22.
  • Ritchie ND, Sauder KA, Perreault L Glycemic Improvement and Health Equity in the National Diabetes Prevention Program. Diabetes Care. 2023 Jun 1;46(6):e128-e129. doi: 10.2337/dc23-0552.
  • Kochar A, Deo SV, Charest B, Peterman-Rocha F, Elgudin Y, Chu D, Yeh RW, Rao SV, Kim DH, Driver JA, Hall DE, Orkaby AR Preoperative frailty and adverse outcomes following coronary artery bypass grafting surgery in US veterans. J Am Geriatr Soc. 2023 Sep;71(9):2736-2747. doi: 10.1111/jgs.18390. Epub 2023 Apr 21.
  • Rabbat MG, Lakshmanan S, Benjamin MM, Doros G, Kinninger A, Budoff MJ, Bhatt DL Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT. Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):866-873. doi: 10.1093/ehjci/jead063.
  • Galli M, Gargiulo G, Benenati S, Mehran R, Angiolillo DJ Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):666-668. doi: 10.1093/ehjcvp/pvad029.
  • Spirito A, Valgimigli M, Cao D, Baber U, Mehta SR, Gibson CM, Steg GP, Sharma SK, Goel R, Huber K, Kunadian V, Escaned J, Franzone A, Yaling H, Collier T, Kaul U, Kornowski R, Krucoff M, Moliterno D, Sartori S, Owen R, Zhang Z, Dangas GD, Kastrati A, Angiolillo DJ, Cohen DJ, Vranckx P, Windecker S, Pocock S, Mehran R Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT. Int J Cardiol. 2023 Jul 15;383:24-32. doi: 10.1016/j.ijcard.2023.04.027. Epub 2023 Apr 18.
  • Zhao W, Yeatts SD, Broderick JP, Selim MH, Adeoye OM, Durkalski-Mauldin VL, Meinzer CN, Martin RH, Dillon CR, Cassarly CN, Pauls KH, Elm JJ Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. Stroke. 2023 Jul;54(7):1909-1919. doi: 10.1161/STROKEAHA.122.040743. Epub 2023 Apr 20.
  • Tan S, Spear E, Sane N, Nelson AJ, Nerlekar N, Segelov E, Nicholls SJ Blood pressure surveillance in cancer patients treated with immune checkpoint inhibitors. J Hum Hypertens. 2023 Nov;37(11):1043-1046. doi: 10.1038/s41371-023-00831-z. Epub 2023 Apr 19.
  • Lena A, Wilkenshoff U, Hadzibegovic S, Porthun J, Rosnick L, Frohlich AK, Zeller T, Karakas M, Keller U, Ahn J, Bullinger L, Riess H, Rosen SD, Lyon AR, Luscher TF, Totzeck M, Rassaf T, Burkhoff D, Mehra MR, Bax JJ, Butler J, Edelmann F, Haverkamp W, Anker SD, Packer M, Coats AJS, von Haehling S, Landmesser U, Anker MS Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer. J Am Coll Cardiol. 2023 Apr 25;81(16):1569-1586. doi: 10.1016/j.jacc.2023.02.039.
  • Stroes ESG, Bays HE, Banach M, Catapano AL, Duell PB, Laufs U, Mancini GBJ, Ray KK, Sasiela WJ, Zhang Y, Gotto AM Jr Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. Atherosclerosis. 2023 May;373:1-9. doi: 10.1016/j.atherosclerosis.2023.03.020. Epub 2023 Apr 3.
  • Diamond J, Ayodele I, Fonarow GC, Joynt-Maddox KE, Yeh RW, Hammond G, Allen LA, Greene SJ, Chiswell K, DeVore AD, Yancy C, Wadhera RK Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 Jun 1;8(6):545-553. doi: 10.1001/jamacardio.2023.0695.
  • Sayed A, Munir M, Manson JE, Al Rifai M, Gulati M, Lavie CJ, Virani SS Factors Associated With Sex Disparities in Leisure-Time Physical Activity: An Analysis of the Behavioral Risk Factor Surveillance System, 2011 to 2021. Mayo Clin Proc. 2023 Jul;98(7):997-1008. doi: 10.1016/j.mayocp.2023.01.018. Epub 2023 Apr 19.
  • Holtzman JN, Kaur G, Power JE, Barkhordarian M, Mares A, Goyal A, Gulati M Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials. J Womens Health (Larchmt). 2023 Jun;32(6):635-640. doi: 10.1089/jwh.2022.0536. Epub 2023 Apr 17.
  • Rymer JA, Secemsky EA Use of Intravascular Ultrasound to Optimize Peripheral Vascular Interventions: How Do We Optimize Outcomes and Improve Uptake? Circ Cardiovasc Interv. 2023 Apr;16(4):e013016. doi: 10.1161/CIRCINTERVENTIONS.123.013016. Epub 2023 Apr 18.
  • Ganesan C, Holmes M, Liu S, Montez-Rath M, Conti S, Chang TC, Lenihan CR, Cheng XS, Chertow GM, Leppert JT, Pao AC Kidney Stone Events after Kidney Transplant in the United States. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):777-784. doi: 10.2215/CJN.0000000000000176. Epub 2023 Apr 18.
  • Garcia Sanchez JJ, James G, Carrero JJ, Arnold M, Lam CSP, Pollock C, Chen HT, Nolan S, Wheeler DC, Pecoits-Filho R Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort. Kidney Int Rep. 2023 Feb 3;8(4):785-795. doi: 10.1016/j.ekir.2023.01.037. eCollection 2023 Apr.
  • Alicic RZ, Neumiller JJ, Galindo RJ, Tuttle KR Author Response to “Insulin Dosing Safety in CKD”. Kidney Int Rep. 2023 Feb 2;8(4):947-948. doi: 10.1016/j.ekir.2023.01.033. eCollection 2023 Apr.
  • Cherney DZI, Cosentino F, McGuire DK, Kolkailah AA, Dagogo-Jack S, Pratley RE, Frederich R, Maldonado M, Liu CC, Cannon CP, VERTIS CV Investigators Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial. Kidney Int Rep. 2023 Jan 20;8(4):746-753. doi: 10.1016/j.ekir.2023.01.011. eCollection 2023 Apr.
  • Ebrahimzadeh SA, Du E, Ivanovic V, Bhadelia RA, Hacein-Bey L, Selim M, Chang YM Comparing the benefit of ASPECTS on maximum intensity projection images of computed tomography angiography to source images and noncontract computed tomography in predicting infarct volume and collaterals extent. J Stroke Cerebrovasc Dis. 2023 Jun;32(6):107091. doi: 10.1016/j.jstrokecerebrovasdis.2023.107091. Epub 2023 Apr 15.
  • Butler J, Talha KM, Fonarow GC STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With Care. Circulation. 2023 Apr 18;147(16):1189-1191. doi: 10.1161/CIRCULATIONAHA.122.063811. Epub 2023 Apr 17.
  • Parwani P, Kang N, Safaeipour M, Mamas MA, Wei J, Gulati M, Naidu SS, Merz NB Contemporary Diagnosis and Management of Patients with MINOCA. Curr Cardiol Rep. 2023 Jun;25(6):561-570. doi: 10.1007/s11886-023-01874-x. Epub 2023 Apr 17.
  • Silver B, Demers-Peel M, Alexandrov AW, Selim MH, Bernhardt J Early Mobilization Post Acute Stroke Thrombolysis and/or Thrombectomy Survey. Neurohospitalist. 2023 Apr;13(2):159-163. doi: 10.1177/19418744221138890. Epub 2022 Dec 5.
  • Rizzo SM, Tavakol S, Bi WL, Li S, Secemsky EA, Campia U, Piazza G, Goldhaber SZ, Schmaier AA Meningioma resection and venous thromboembolism incidence, management, and outcomes. Res Pract Thromb Haemost. 2023 Mar 15;7(2):100121. doi: 10.1016/j.rpth.2023.100121. eCollection 2023 Feb.
  • Anker SD, Khan MS, Butler J, von Haehling S, Jankowska EA, Ponikowski P, Friede T Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis. Eur J Heart Fail. 2023 Jul;25(7):1080-1090. doi: 10.1002/ejhf.2860. Epub 2023 May 21.
  • Filippatos G, Farmakis D, Butler J, Zannad F, Ferreira JP, Ofstad AP, Iwata T, Brueckmann M, Pocock SJ, Packer M, Anker SD, EMPEROR-Preserved Trial Committees and Investigators Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation. Eur J Heart Fail. 2023 Jul;25(7):970-977. doi: 10.1002/ejhf.2861. Epub 2023 May 8.
  • Talha KM, Butler J, Greene SJ, Aggarwal R, Anker SD, Claggett BL, Docherty KF, Solomon SD, McMurray JJV, Januzzi JL Jr, Vaduganathan M, Fonarow GC Potential global impact of sodium-glucose cotransporter-2 inhibitors in heart failure. Eur J Heart Fail. 2023 Jul;25(7):999-1009. doi: 10.1002/ejhf.2864. Epub 2023 Apr 24.
  • Sharma A, Ferreira JP, Zannad F, Pocock SJ, Filippatos G, Pfarr E, Petrini M, Kraus BJ, Wanner C, Packer M, Butler J, Anker SD Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial. Eur J Heart Fail. 2023 Aug;25(8):1337-1348. doi: 10.1002/ejhf.2857. Epub 2023 May 4.
  • Zoni CR, Mukherjee D, Gulati M Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion. Catheter Cardiovasc Interv. 2023 Jun;101(7):1177-1181. doi: 10.1002/ccd.30667. Epub 2023 Apr 16.
  • Jalloh MB, Granger CB, Fonarow GC, Van Spall HGC Multi-level implementation strategies to improve uptake of evidence-based therapies in heart failure. Eur Heart J. 2023 Jun 20;44(23):2055-2058. doi: 10.1093/eurheartj/ehad150.
  • Galli M, Angiolillo DJ How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention? Expert Rev Clin Pharmacol. 2023 May;16(5):383-385. doi: 10.1080/17512433.2023.2203381. Epub 2023 Apr 17.
  • Cutlip DE High-Intensity Statins Before Percutaneous Coronary Intervention in Acute Coronary Syndrome-Should It Be Added to Treatment Algorithm? Am J Cardiol. 2023 Jun 1;196:104-105. doi: 10.1016/j.amjcard.2023.03.019. Epub 2023 Apr 12.
  • Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ, CVD-REAL Investigators and Study Group Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. Diabetes Obes Metab. 2023 Aug;25(8):2402-2409. doi: 10.1111/dom.15092. Epub 2023 May 8.
  • Brandts J, Ray KK Novel and future lipid-modulating therapies for the prevention of cardiovascular disease. Nat Rev Cardiol. 2023 Sep;20(9):600-616. doi: 10.1038/s41569-023-00860-8. Epub 2023 Apr 13.
  • Tuttle KR, Lam CSP Kidney-Heart Connection: Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure. JACC Heart Fail. 2023 May;11(5):538-540. doi: 10.1016/j.jchf.2023.02.008. Epub 2023 Apr 12.
  • Filippatos G, Ponikowski P, Farmakis D, Anker SD, Butler J, Fabien V, Kirwan BA, Macdougall IC, Metra M, Rosano G, Ruschitzka F, van der Meer P, Wachter S, Jankowska EA, AFFIRM-AHF Investigators Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis. Circulation. 2023 May 30;147(22):1640-1653. doi: 10.1161/CIRCULATIONAHA.122.060757. Epub 2023 Apr 13.
  • Butler J, Petrie MC, Bains M, Bawtinheimer T, Code J, Levitch T, Malvolti E, Monteleone P, Stevens P, Vafeiadou J, Lam CSP Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post-hospital discharge period. Res Involv Engagem. 2023 Apr 13;9(1):23. doi: 10.1186/s40900-023-00412-x.
  • Verma S, Bhatt DL, Dhingra NK, Steg PG, Szarek M, Davies M, Metra M, Lund LH, Pitt B, SOLOIST Investigators Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure. J Am Coll Cardiol. 2023 Apr 18;81(15):1546-1549. doi: 10.1016/j.jacc.2023.02.022.
  • Narasimmaraj PR, Oseran A, Tale A, Xu J, Essien UR, Kazi DS, Yeh RW, Wadhera RK Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act. J Am Coll Cardiol. 2023 Apr 18;81(15):1491-1501. doi: 10.1016/j.jacc.2023.02.002. Epub 2023 Feb 20.
  • Landi A, Heg D, Frigoli E, Vranckx P, Windecker S, Siegrist P, Cayla G, Wlodarczak A, Cook S, Gomez-Blazquez I, Feld Y, Seung-Jung P, Mates M, Lotan C, Gunasekaran S, Nanasato M, Das R, Kelbaek H, Teiger E, Escaned J, Ishibashi Y, Montalescot G, Matsuo H, Debeljacki D, Smits PC, Valgimigli M, MASTER DAPT Investigators Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial. JACC Cardiovasc Interv. 2023 Apr 10;16(7):798-812. doi: 10.1016/j.jcin.2023.01.366.
  • Essa M, Ross JS, Dhruva SS, Desai NR, Yeh RW, Faridi KF Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020. J Am Heart Assoc. 2023 Apr 18;12(8):e028869. doi: 10.1161/JAHA.122.028869. Epub 2023 Apr 12.
  • Mohebi R, Liu Y, Felker GM, Ward JH, Pina IL, Butler J, Solomon SD, Januzzi JL Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure. J Am Heart Assoc. 2023 Apr 18;12(8):e029229. doi: 10.1161/JAHA.122.029229. Epub 2023 Apr 12.
  • Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S Diagnosis and Management of Prediabetes: A Review. JAMA. 2023 Apr 11;329(14):1206-1216. doi: 10.1001/jama.2023.4063.
  • Osadnik K, Osadnik T, Gierlotka M, Windak A, Tomasik T, Mastej M, Kuras A, Jozwiak K, Penson PE, Lip GYH, Mikhailidis DP, Toth PP, Catapano AL, Ray KK, Howard G, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Banach M, Jozwiak J Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies. Eur J Prev Cardiol. 2023 Sep 6;30(12):1195-1204. doi: 10.1093/eurjpc/zwad101.
  • Butler J, Siddiqi TJ, Zannad F, Ferreira JP, Fillipatos G, Anker SD, Packer M Interaction of natriuretic peptide levels and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure. Eur J Heart Fail. 2023 May;25(5):767-769. doi: 10.1002/ejhf.2854. Epub 2023 May 3.
  • Leon-Blanchet MF, Araiza-Garaygordobil D, Reynier-Garza V, Gopar-Nieto R, Belderrain-Morales N, Sarabia-Chao V, Martinez-Amezcua P, Cabello-Lopez A, Sandoval-Aguilar TT, Arias-Mendoza A Prediction of adverse cardiac outcomes in high-risk Mexican patients with chest pain in the emergency department. Arch Cardiol Mex. 2023;93(2):183-188. doi: 10.24875/ACM.22000041.
  • Seib CD, Ganesan C, Furst A, Pao AC, Chertow GM, Leppert JT, Suh I, Montez-Rath ME, Harris AHS, Trickey AW, Kebebew E, Kurella Tamura M Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism. Ann Intern Med. 2023 May;176(5):624-631. doi: 10.7326/M22-2222. Epub 2023 Apr 11.
  • Mentias A, Peterson ED, Keshvani N, Kumbhani DJ, Yancy CW, Morris AA, Allen LA, Girotra S, Fonarow GC, Starling RC, Alvarez P, Desai MY, Cram P, Pandey A Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure. Circulation. 2023 Apr 11;147(15):1121-1133. doi: 10.1161/CIRCULATIONAHA.122.061995. Epub 2023 Apr 10.
  • Bradley CK, Kolkailah AA, Shah NP, Page CB, Peterson ED, Navar AM Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice. J Clin Lipidol. 2023 May-Jun;17(3):412-414. doi: 10.1016/j.jacl.2023.03.006. Epub 2023 Mar 22.
  • Rao SV, Kandzari DE Lifting the Regulatory Blanket Off of Covered Stents. Cardiovasc Revasc Med. 2023 Jul;52:37-38. doi: 10.1016/j.carrev.2023.04.005. Epub 2023 Apr 5.
  • Kelsey MD, Mulder H, Chiswell K, Lampron ZM, Nilles E, Kulinski JP, Joshi PH, Jones WS, Chamberlain AM, Leucker TM, Hwang W, Milks MW, Paranjape A, Obeid JS, Linton MF, Kent ST, Peterson ED, O’Brien EC, Pagidipati NJ Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes. Am J Prev Cardiol. 2023 Mar 1;14:100478. doi: 10.1016/j.ajpc.2023.100478. eCollection 2023 Jun.
  • Eder M, Griffin M, Moreno-Villagomez J, Bellumkonda L, Maulion C, Asher J, Wilson FP, Cox ZL, Ivey-Miranda JB, Rao VS, Butler J, Borlaug BA, McCallum W, Ramos-Mastache D, Testani JM The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial. Int J Cardiol. 2023 Jun 15;381:57-61. doi: 10.1016/j.ijcard.2023.04.002. Epub 2023 Apr 5.
  • O’Lone E, Apple FS, Burton JO, Caskey FJ, Craig JC, deFilippi CR, Forfang D, Hicks KA, Jha V, Mahaffey KW, Mark PB, Rossignol P, Scholes-Robertson N, Jaure A, Viecelli AK, Wang AY, Wheeler DC, White D, Winkelmayer WC, Herzog CA Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. Kidney Int. 2023 Jun;103(6):1028-1037. doi: 10.1016/j.kint.2023.02.033. Epub 2023 Apr 5.
  • Ostrominski JW, Machado SR, Mossialos E, Mehra MR, Vaduganathan M Donor Diabetes Mellitus Status and Contemporary Outcomes After Cardiac Transplantation. JACC Heart Fail. 2023 Apr;11(4):483-486. doi: 10.1016/j.jchf.2023.01.020.
  • Pandey A, Kitzman DW Role of a Novel Self-Reported Questionnaire for Frailty Assessment in HFpEF. JACC Heart Fail. 2023 Apr;11(4):404-406. doi: 10.1016/j.jchf.2023.01.026.
  • Boe NJ, Hald SM, Jensen MM, Kristensen LMB, Bojsen JA, Elhakim MT, Clausen A, Moller S, Hallas J, Garcia Rodriguez LA, Selim M, Goldstein LB, Al-Shahi Salman R, Gaist D Major Cardiovascular Events After Spontaneous Intracerebral Hemorrhage by Hematoma Location. JAMA Netw Open. 2023 Apr 3;6(4):e235882. doi: 10.1001/jamanetworkopen.2023.5882.
  • Nelson AJ, Wegermann ZK, Gallup D, O’Brien S, Kosinski AS, Thourani VH, Kumbhani DJ, Kirtane A, Allen J, Carroll JD, Shahian DM, Desai ND, Brindis RG, Peterson ED, Cohen DJ, Vemulapalli S Modeling the Association of Volume vs Composite Outcome Thresholds With Outcomes and Access to Transcatheter Aortic Valve Implantation in the US. JAMA Cardiol. 2023 May 1;8(5):492-502. doi: 10.1001/jamacardio.2023.0477.
  • Warisawa T, Cook CM, Kawase Y, Howard JP, Ahmad Y, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Tanigaki T, Omori H, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Akashi YJ, Escaned J, Matsuo H, Davies JE Physiology-guided PCI versus CABG for left main coronary artery disease: insights from the DEFINE-LM registry. Cardiovasc Interv Ther. 2023 Jul;38(3):287-298. doi: 10.1007/s12928-023-00932-z. Epub 2023 Apr 5.
  • Nargesi AA, Clark C, Aminorroaya A, Chen L, Liu M, Reddy A, Amodeo S, Oikonomou EK, Suchard MA, McGuire DK, Lin Z, Inzucchi S, Khera R Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States. Am J Cardiol. 2023 Jun 1;196:89-98. doi: 10.1016/j.amjcard.2023.03.002. Epub 2023 Apr 1.
  • Yan J, Winkelmayer WC, Walther CP Iron Sucrose and Blood Pressure Patterns During Hemodialysis. Am J Kidney Dis. 2023 Jun;81(6):629-631. doi: 10.1053/j.ajkd.2023.01.439. Epub 2023 Apr 1.
  • Zoungas S, Curtis A, Spark S, Wolfe R, McNeil JJ, Beilin L, Chong TT, Cloud G, Hopper I, Kost A, Nelson M, Nicholls SJ, Reid CM, Ryan J, Tonkin A, Ward SA, Wierzbicki A, STAREE investigator group Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial). BMJ Open. 2023 Apr 3;13(4):e069915. doi: 10.1136/bmjopen-2022-069915.
  • Thomas KL, Al-Khatib SM, Kosinski AS, Sears SF Jr, Allen LaPointe NM, Jackson LR 2nd, Matlock DD, Haithcock D, Colley BJ 3rd, Hirsh DS, Peterson ED Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial. Ann Intern Med. 2023 May;176(5):615-623. doi: 10.7326/M22-2934. Epub 2023 Apr 4.
  • Fujino M, Nicholls SJ Lipoprotein(a): cardiovascular risk and emerging therapies. Expert Rev Cardiovasc Ther. 2023 Apr;21(4):259-268. doi: 10.1080/14779072.2023.2197593. Epub 2023 Apr 3.
  • Reynolds MR Addition by Subtraction: Disease Progression and the Value of Atrial Fibrillation Ablation. Circ Arrhythm Electrophysiol. 2023 Apr;16(4):e011918. doi: 10.1161/CIRCEP.123.011918. Epub 2023 Apr 3.
  • Elkin PL, Brown SH, Resendez S, McCray W, Resnick M, Hall K, Franklin G, Connors JM, Cushman M COVID-19 vaccination and venous thromboembolism risk in older veterans. J Clin Transl Sci. 2023 Feb 1;7(1):e55. doi: 10.1017/cts.2022.527. eCollection 2023.
  • Tromp J, van der Meer P, Tay WT, Ling LH, Loh SY, Soon D, Chin C, Jaufeerally F, Bamadhaj S, Ng TP, Lee SSG, Sim D, Yeo PSD, Leong GKT, Ong HY, Tantoso E, Eisenhaber F, Richards AM, Lam CSP Diagnostic Accuracy of the Electrocardiogram for Heart Failure With Reduced or Preserved Ejection Fraction. J Card Fail. 2023 Jul;29(7):1104-1106. doi: 10.1016/j.cardfail.2023.03.014. Epub 2023 Mar 31.
  • Pratley RE, Cannon CP, Cherney DZI, Cosentino F, McGuire DK, Essex MN, Lawrence D, Jones PLS, Liu J, Adamsons I, Dagogo-Jack S Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial. Lancet Healthy Longev. 2023 Apr;4(4):e143-e154. doi: 10.1016/S2666-7568(23)00032-6.
  • Fielding-Singh V, Chertow GM Clinically Indicated, Equitable Care for Ischemic Heart Disease in CKD: A Call to Action. J Am Soc Nephrol. 2023 Apr 1;34(4):525-526. doi: 10.1681/ASN.0000000000000100.
  • Pagidipati NJ, Mulder H, Chiswell K, Lampron Z, Jones WS, Machineni S, Waitman LR, Mongraw-Chaffin M, Waterman F, Kumar N, Ramasamy A, Smolarz G, Peterson ED, O’Brien E Evaluation of weight change and cardiometabolic risk factors in a real-world population of US adults with overweight or obesity. Prev Med. 2023 May;170:107496. doi: 10.1016/j.ypmed.2023.107496. Epub 2023 Mar 29.
  • Didichenko SA, Velkoska E, Navdaev AV, Greene BH, Lorkowski SW, Duffy D, Mears SJ, Wright SD, Gibson CM, Smith JD, Kingwell BA CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):855-869. doi: 10.1161/ATVBAHA.122.318243. Epub 2023 Mar 30.
  • Pieske B, Pieske-Kraigher E, Lam CSP, Melenovsky V, Sliwa K, Lopatin Y, Arango JL, Bahit MC, O’Connor CM, Patel MJ, Roessig L, Morris DA, Kropf M, Westerhout CM, Zheng Y, Armstrong PW, VICTORIA Study Group Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy. Eur J Heart Fail. 2023 Jul;25(7):1012-1021. doi: 10.1002/ejhf.2836. Epub 2023 Apr 18.
  • Dhaduk N, Xia Y, Feit F, Mamas M, Alviar C, Keller N, Rao SV, Bangalore S In-hospital Outcomes of Patients With and Without Previous Coronary Artery Bypass Graft Surgery Who Present With a Non-ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2023 May 1;194:78-85. doi: 10.1016/j.amjcard.2023.02.013. Epub 2023 Mar 28.
  • Mehta SR, Pinilla-Echeverri N, Cairns JA More Attention Should Be Paid to Less Severe Nonculprit Lesions-Reply. JAMA Cardiol. 2023 May 1;8(5):514. doi: 10.1001/jamacardio.2023.0300.
  • Lam CSP, Ho JE Do we need dedicated heart failure with preserved ejection fraction clinics? Eur Heart J. 2023 May 1;44(17):1557-1559. doi: 10.1093/eurheartj/ehad172.
  • Nurmohamed NS, Kraaijenhof JM, Mayr M, Nicholls SJ, Koenig W, Catapano AL, Stroes ESG Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J. 2023 May 7;44(18):1594-1607. doi: 10.1093/eurheartj/ehad161.
  • Cao D, Amabile N, Chiarito M, Lee VT, Angiolillo DJ, Capodanno D, Bhatt DL, Mack MJ, Storey RF, Schmoeckel M, Gibson CM, Deliargyris EN, Mehran R Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding. Eur Heart J. 2023 May 21;44(20):1780-1794. doi: 10.1093/eurheartj/ehad119.
  • Komori Y, Taniguchi A, Shibata H, Goto S, Saito H Partial Miscibility and Concentration Distribution of Two-Phase Blends of Crosslinked NBR and PVC. Polymers (Basel). 2023 Mar 10;15(6):1383. doi: 10.3390/polym15061383.
  • Raines NH, Leone DA, O’Callaghan-Gordo C, Ramirez-Rubio O, Amador JJ, Lopez Pilarte D, Delgado IS, Leibler JH, Embade N, Gil-Redondo R, Bruzzone C, Bizkarguenaga M, Scammell MK, Parikh SM, Millet O, Brooks DR, Friedman DJ Metabolic Features of Increased Gut Permeability, Inflammation, and Altered Energy Metabolism Distinguish Agricultural Workers at Risk for Mesoamerican Nephropathy. Metabolites. 2023 Feb 22;13(3):325. doi: 10.3390/metabo13030325.
  • Bethel MA, Sourij H, Stevens SR, Hannan K, Lokhnygina Y, Adler AI, Peterson ED, Holman RR, Lopes RD Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2023 Mar 28;22(1):72. doi: 10.1186/s12933-023-01802-x.
  • Anand S, Montez-Rath M, Varkila M, Yu X, Block M, Brillhart S, Leppink A, Hunsader P, Owens DK, Chertow GM, Parsonnet J, Block GA Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study. Clin J Am Soc Nephrol. 2023 Jul 1;18(7):930-932. doi: 10.2215/CJN.0000000000000137. Epub 2023 Apr 24.
  • Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann CE, Bistola V, Dahlstrom U, Dickstein K, Ertl G, Ghadanfar M, Hassanein M, Obergfell A, Perrone SV, Polyzogopoulou E, Schweizer A, Boletis I, Cleland JGF, Collins SP, Lam CSP, Filippatos G Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. Eur J Heart Fail. 2023 Jun;25(6):818-828. doi: 10.1002/ejhf.2833. Epub 2023 Apr 12.
  • Siddiqi TJ, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Bohm M, Brueckmann M, Chopra VK, Iwata T, Januzzi J, Pina IL, Ponikowski P, Senni M, Vedin O, Verma S, Zhang Y, Zannad F, Packer M, Butler J Health status across major subgroups of patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2023 Sep;25(9):1623-1631. doi: 10.1002/ejhf.2831. Epub 2023 Apr 4.
  • Thachil J, Connors JM, Mahlangu J, Sholzberg M Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets. J Thromb Haemost. 2023 Jul;21(7):1737-1740. doi: 10.1016/j.jtha.2023.03.016. Epub 2023 Mar 25.
  • Connors JM Fine Tuning Venous Thromboembolism Risk Prediction in Patients With Cancer. J Clin Oncol. 2023 Jun 1;41(16):2881-2883. doi: 10.1200/JCO.23.00100. Epub 2023 Mar 27.
  • Mehta A, Dixon DL, Saeed A, Kelly MS, Gulati M, Shapiro MD, Sperling LS, Virani SS With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? Curr Cardiol Rep. 2023 May;25(5):423-430. doi: 10.1007/s11886-023-01861-2. Epub 2023 Mar 27.
  • Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M, Ballantyne CM The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology. Am J Prev Cardiol. 2023 Feb 27;13:100472. doi: 10.1016/j.ajpc.2023.100472. eCollection 2023 Mar.
  • Siddiqi TJ, Rashid AM, Javaid SS, Siddiqi AK, Usman MS, Hervir O, Kamimura D, Lavie CJ, Mentz RJ, Butler J, Hall ME High-Intensity Interval Training Versus Moderate Continuous Training in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-analysis. Curr Probl Cardiol. 2023 Aug;48(8):101720. doi: 10.1016/j.cpcardiol.2023.101720. Epub 2023 Mar 24.
  • Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M, Ballantyne CM The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2023 Mar-Apr;17(2):208-218. doi: 10.1016/j.jacl.2023.02.003. Epub 2023 Feb 27.
  • Simsek B, Khatri J, Young L, Kostantinis S, Karacsonyi J, Rempakos A, Alaswad K, Jaffer FA, Doshi D, Gorgulu S, Goktekin O, Kerrigan J, Haddad EV, Rinfret S, Jaber WA, Nicholson W, Krestyaninov O, Khelimskii D, Choi JW, Patel TN, Jefferson BK, Bradley SM, Rao SV, Rangan BV, Allana SS, Sandoval Y, Burke MN, Brilakis ES, Poommipanit PB, PROGRESS-CTO investigators Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2023 May;101(6):1028-1035. doi: 10.1002/ccd.30644. Epub 2023 Mar 24.
  • Krishna H, Desai K, Slostad B, Bhayani S, Arnold JH, Ouwerkerk W, Hummel Y, Lam CSP, Ezekowitz J, Frost M, Jiang Z, Equilbec C, Twing A, Pellikka PA, Frazin L, Kansal M Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by Echocardiography. J Am Soc Echocardiogr. 2023 Jul;36(7):769-777. doi: 10.1016/j.echo.2023.03.008. Epub 2023 Mar 22.
  • Schmaier AA, Anderson PF, Chen SM, El-Darzi E, Aivasovsky I, Kaushik MP, Sack KD, Hartzell HC, Parikh SM, Flaumenhaft R, Schulman S TMEM16E regulates endothelial cell procoagulant activity and thrombosis. J Clin Invest. 2023 Jun 1;133(11):e163808. doi: 10.1172/JCI163808.
  • Nicholls SJ, Fujino M HDL cholesterol and cardiovascular risk: teasing the answer from the complexity. Eur J Prev Cardiol. 2023 Jun 1;30(8):644-645. doi: 10.1093/eurjpc/zwad074.
  • Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, Hernandez I, Lloyd-Jones DM, King JB, Rao S, Herrick JS, Bress AP, Pandey A Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA Cardiol. 2023 May 1;8(5):443-452. doi: 10.1001/jamacardio.2023.0228.
  • Evans JK, Usoh CO, Simpson FR, Espinoza S, Hazuda H, Pandey A, Beckner T, Espeland MA Long-term Impact of a 10-Year Intensive Lifestyle Intervention on a Deficit Accumulation Frailty Index: Action for Health in Diabetes Trial. J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2119-2126. doi: 10.1093/gerona/glad088.
  • McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter N, Engelmann MDM, Hovingh GK, Ripa MS, Gislum M, Brown-Frandsen K, Buse JB Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial. Diabetes Obes Metab. 2023 Jul;25(7):1932-1941. doi: 10.1111/dom.15058. Epub 2023 Apr 11.
  • Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, Moghadam KG, Rezaian S, Dabbagh A, Sezavar SH, Farrokhpour M, Abedini A, Aliannejad R, Riahi T, Yadollahzadeh M, Lookzadeh S, Rezaeifar P, Matin S, Tahamtan O, Mohammadi K, Zoghi E, Rahmani H, Hosseini SH, Mousavian SM, Abri H, Sadeghipour P, Baghizadeh E, Rafiee F, Jamalkhani S, Amin A, Mohebbi B, Parhizgar SE, Soleimanzadeh M, Aghakouchakzadeh M, Eslami V, Payandemehr P, Khalili H, Talakoob H, Tojari T, Shafaghi S, Tabrizi S, Kakavand H, Kashefizadeh A, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Ansarin K, Maleki M, Sadeghian S, Barco S, Siegerink B, Spatz ES, Piazza G, Kirtane AJ, Tassell BWV, Lip GYH, Klok FA, Goldhaber SZ, Stone GW, Krumholz HM, Bikdeli B Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. Thromb Haemost. 2023 Jul;123(7):723-733. doi: 10.1055/a-2059-4844. Epub 2023 Mar 21.
  • Packer M, Siddiqi TJ, Butler J Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure? Eur Heart J. 2023 May 1;44(17):1522-1525. doi: 10.1093/eurheartj/ehad158.
  • Liang P, Cronenwett JL, Secemsky EA, Eldrup-Jorgensen J, Malas MB, Wang GJ, Nolan BW, Kashyap VS, Motaganahalli RL, Schermerhorn ML Risk of Stroke, Death, and Myocardial Infarction Following Transcarotid Artery Revascularization vs Carotid Endarterectomy in Patients With Standard Surgical Risk. JAMA Neurol. 2023 May 1;80(5):437-444. doi: 10.1001/jamaneurol.2023.0285.
  • Litwin SE, Komtebedde J, Hu M, Burkhoff D, Hasenfuss G, Borlaug BA, Solomon SD, Zile MR, Mohan RC, Khawash R, Sverdlov AL, Fail P, Chung ES, Kaye DM, Blair J, Eicher JC, Hummel SL, Zirlik A, Westenfeld R, Hayward C, Gorter TM, Demers C, Shetty R, Lewis G, Starling RC, Patel S, Gupta DK, Morsli H, Penicka M, Cikes M, Gustafsson F, Silvestry FE, Rowin EJ, Cutlip DE, Leon MB, Kitzman DW, Kleber FX, Shah SJ, REDUCE LAP-HF Investigators and Research Staff Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2023 Aug;11(8 Pt 2):1103-1117. doi: 10.1016/j.jchf.2023.01.030. Epub 2023 Mar 20.
  • Galli M, Costa F, Angiolillo DJ Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions. Front Cardiovasc Med. 2023 Mar 3;10:1162630. doi: 10.3389/fcvm.2023.1162630. eCollection 2023.
  • Tan S, Pol D, Splatt L, Abrahams T, Mydin M, Nelson AJ, Nicholls SJ, Brown AJ Diagnostic accuracy of reperfusion criteria following fibrinolysis for ST-elevation myocardial infarction. AsiaIntervention. 2023 Mar 15;9(1):49-51. doi: 10.4244/AIJ-D-22-00036. eCollection 2023 Mar.
  • Vardeny O, Fang JC, Desai AS, Jhund PS, Claggett B, Vaduganathan M, de Boer RA, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, Kosiborod MN, DeMets D, O’Meara E, Zieroth S, Comin-Colet J, Drozdz J, Chiang CE, Kitakaze M, Petersson M, Lindholm D, Langkilde AM, McMurray JJV, Solomon SD Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med. 2023 Dec;29(12):3269. doi: 10.1038/s41591-023-02302-x.
  • Lavallee PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Labreuche J, Molina C, Rothwell PM, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong LKS, Amarenco P, TIAregistry.org Investigators Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study. Lancet Neurol. 2023 Apr;22(4):320-329. doi: 10.1016/S1474-4422(23)00067-4.
  • Chow JK, Bagai A, Tan MK, Har BJ, Yip AMC, Paniagua M, Elbarouni B, Bainey KR, Paradis JM, Maranda R, Cantor WJ, Eisenberg MJ, Dery JP, Madan M, Cieza T, Matteau A, Roth S, Lavi S, Glanz A, Gao D, Tahiliani R, Welsh RC, Kim HH, Robinson SD, Daneault B, Chong AY, Le May MR, Ahooja V, Gregoire JC, Nadeau PL, Laksman Z, Heilbron B, Yung D, Minhas K, Bourgeois R, Overgaard CB, Bonakdar H, Logsetty G, Lavoie AJ, De LaRochelliere R, Mansour S, Spindler C, Yan AT, Goodman SG, CONNECT AF+PCI Investigators Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF‚ÄØ+‚ÄØPCI-II program. J Cardiol. 2023 Aug;82(2):153-161. doi: 10.1016/j.jjcc.2023.03.004. Epub 2023 Mar 16.
  • Choe JC, Lee SH, Ahn JH, Lee HW, Oh JH, Choi JH, Lee HC, Cha KS, Jeong MH, Angiolillo DJ, Park JS Adjusted mortality of extracorporeal membrane oxygenation for acute myocardial infarction patients in cardiogenic shock. Medicine (Baltimore). 2023 Mar 17;102(11):e33221. doi: 10.1097/MD.0000000000033221.
  • Ortega-Paz L, Giordano S, Capodanno D, Mehran R, Gibson CM, Angiolillo DJ Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clin Pharmacokinet. 2023 Apr;62(4):541-558. doi: 10.1007/s40262-023-01224-8. Epub 2023 Mar 16.
  • Beyer SE, Secemsky EA, Khabbaz K, Carroll BJ Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort. Heart. 2023 Jun 26;109(14):1080-1087. doi: 10.1136/heartjnl-2022-322033.
  • Cartlidge T, Kovacevic M, Navarese EP, Werner G, Kunadian V Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome. Heart. 2023 Sep 13;109(19):1429-1435. doi: 10.1136/heartjnl-2022-321870.
  • Sarafidis P, Agarwal R, Pitt B, Wanner C, Filippatos G, Boletis J, Tuttle KR, Ruilope LM, Rossing P, Toto R, Anker SD, Liu ZH, Joseph A, Ahlers C, Brinker M, Lawatscheck R, Bakris G, FIDELIO-DKD and FIGARO-DKD Investigators Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis. Clin J Am Soc Nephrol. 2023 May 1;18(5):602-612. doi: 10.2215/CJN.0000000000000149. Epub 2023 Apr 7.
  • Acquah I, Hagan K, Javed Z, Taha MB, Valero-Elizondo J, Nwana N, Yahya T, Sharma G, Gulati M, Hammoud A, Shapiro MD, Blankstein R, Blaha MJ, Cainzos-Achirica M, Nasir K Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events. J Am Heart Assoc. 2023 Mar 21;12(6):e025581. doi: 10.1161/JAHA.122.025581. Epub 2023 Mar 16.
  • Zannad F, Alikhaani J, Alikhaani S, Butler J, Gordon J, Jensen K, Khatib R, Mantovani L, Martinez R, Moore WF, Murakami M, Roessig L, Stockbridge N, Van Spall HGC, Yancy C, Spertus JA Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectives. Eur J Heart Fail. 2023 Apr;25(4):478-487. doi: 10.1002/ejhf.2828. Epub 2023 Mar 22.
  • Correale M, Antohi EL, Inciardi RM, Mazzeo P, Coiro S, Ishihara S, Petroni R, Monitillo F, Leone M, Triggiani M, Sarwar CMS, Dungen HD, Talha KM, Brunetti ND, Butler J, Nodari S, Master Program Group on Drug Development for Heart Failure Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study. ESC Heart Fail. 2023 Jun;10(3):2066-2073. doi: 10.1002/ehf2.14331. Epub 2023 Mar 15.
  • Kar S, von Bardeleben RS, Rottbauer W, Mahoney P, Price MJ, Grasso C, Williams M, Lurz P, Ahmed M, Hausleiter J, Chehab B, Zamorano JL, Asch FM, Maisano F Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND Study. JACC Cardiovasc Interv. 2023 Mar 13;16(5):589-602. doi: 10.1016/j.jcin.2023.01.010.
  • Kaur G, Oliveira-Gomes D, Rivera FB, Gulati M Chest Pain in Women: Considerations From the 2021 AHA/ACC Chest Pain Guideline. Curr Probl Cardiol. 2023 Jul;48(7):101697. doi: 10.1016/j.cpcardiol.2023.101697. Epub 2023 Mar 14.
  • Zhou Z, Zhang W, Burgner D, Tonkin A, Zhu C, Sun C, Magnussen CG, Ernst ME, Breslin M, Nicholls SJ, Nelson MR The Association Between PCSK9 Inhibitor Use and Sepsis: A Systematic Review and Meta-Analysis of 20 Double-Blind, Randomized, Placebo-Controlled Trials. Am J Med. 2023 Jun;136(6):558-567.e20. doi: 10.1016/j.amjmed.2023.02.025. Epub 2023 Mar 13.
  • Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, Friedman DJ, Bramham K, Campbell K, Knebelmann B, Barisoni L, Falk RJ, Gipson DS, Lipkowitz MS, Ojo A, Bunnage ME, Pollak MR, Altshuler D, Chertow GM, VX19-147-101 Study Group Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396.
  • Pandey AK, Dhingra NK, Pandey A, Puar P, Ahmed S, Verma R, Mazer CD, Butler J, Badiwala M, Yau TM, Yanagawa B, Bhatt DL, Verma S Efficacy of sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors for heart failure in black patients: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2023 Apr;25(4):591-593. doi: 10.1002/ejhf.2825. Epub 2023 Mar 15.
  • Berry C, Kramer CM, Kunadian V, Patel TR, Villines T, Kwong RY, Raharjo DE Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina. Eur Heart J. 2023 Jul 7;44(26):2366-2375. doi: 10.1093/eurheartj/ehac597.
  • Girerd N, Leclercq C, Hanon O, Bayes-Genis A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. Rev Esp Cardiol (Engl Ed). 2023 Oct;76(10):813-820. doi: 10.1016/j.rec.2023.03.005. Epub 2023 Mar 11.
  • Goto S, Goto S Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis? Thromb Haemost. 2023 Jun;123(6):573-575. doi: 10.1055/a-2052-9650. Epub 2023 Mar 13.
  • Sandner S, Misfeld M, Caliskan E, Boning A, Aramendi J, Salzberg SP, Choi YH, Perrault LP, Tekin I, Cuerpo GP, Lopez-Menendez J, Weltert LP, Bohm J, Krane M, Gonzalez-Santos JM, Tellez JC, Holubec T, Ferrari E, Doros G, Vitarello CJ, Emmert MY, Registry Investigators; European DuraGraft Registry investigators’ Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study. Int J Surg. 2023 Apr 1;109(4):707-715. doi: 10.1097/JS9.0000000000000259.
  • Harwood OE, Matschke LM, Moriarty RV, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Winchester LC, Fletcher CV, Friedrich TC, Keele BF, O’Connor DH, Lang JD, Reynolds MR, O’Connor SL CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques. bioRxiv [Preprint]. 2023 Mar 2:2023.03.01.530655. doi: 10.1101/2023.03.01.530655.
  • Taqueti VR, Shah AM, Everett BM, Pradhan AD, Piazza G, Bibbo C, Hainer J, Morgan V, Carolina do A H de Souza A, Skali H, Blankstein R, Dorbala S, Goldhaber SZ, Le May MR, Chow BJW, deKemp RA, Hage FG, Beanlands RS, Libby P, Glynn RJ, Solomon SD, Ridker PM, Di Carli MF Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial. JACC Basic Transl Sci. 2022 Dec 21;8(2):141-151. doi: 10.1016/j.jacbts.2022.08.009. eCollection 2023 Feb.
  • Mantovani LG, Cozzolino P, Ferrara P, Virdone S, Camm AJ, Verheugt FWA, Bassand JP, Turpie AGG, Hacke W, Kayani G, Goldhaber SZ, Goto S, Pieper KS, Gersh BJ, Fox KAA, Haas S, van Eickels M, Kakkar AK, On Behalf Of The Garfield-Af Investigators Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry. Healthcare (Basel). 2023 Feb 21;11(5):638. doi: 10.3390/healthcare11050638.
  • Vranckx P, van Diepen S BIOVASC trial in perspective: complete revascularization strategies in patients presenting with acute coronary syndromes and multi-vessel coronary disease. Eur Heart J Acute Cardiovasc Care. 2023 Apr 17;12(4):217-218. doi: 10.1093/ehjacc/zuad023.
  • Catapano AL, Tokgozoglu L, Banach M, Gazzotti M, Olmastroni E, Casula M, Ray KK, Lipid Clinics Network Group Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. Atherosclerosis. 2023 Apr;370:5-11. doi: 10.1016/j.atherosclerosis.2023.02.007. Epub 2023 Feb 23.
  • Murphy SP, Januzzi JL Reply: Increasing the Utilization of Sac/Val in Elderly HFrEF Patients Eligible for ARNI Treatment. JACC Heart Fail. 2023 Mar;11(3):372-373. doi: 10.1016/j.jchf.2023.01.003.
  • Dawson LP, Nehme E, Nehme Z, Davis E, Bloom J, Cox S, Nelson AJ, Okyere D, Anderson D, Stephenson M, Lefkovits J, Taylor AJ, Nicholls SJ, Cullen L, Kaye D, Smith K, Stub D Sex Differences in Epidemiology, Care, and Outcomes in Patients With Acute Chest Pain. J Am Coll Cardiol. 2023 Mar 14;81(10):933-945. doi: 10.1016/j.jacc.2022.12.025.
  • Vaduganathan M, Claggett BL, Jhund P, Miao ZM, de Boer RA, Lam CSP, Desai AS, Bengsston O, McMurray JJV, Solomon SD Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2023 Mar 14;81(10):1004-1006. doi: 10.1016/j.jacc.2022.12.026.
  • Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, Lim WH, Huang DQ, Quek J, Fu CE, Xiao J, Syn N, Foo R, Khoo CM, Wang JW, Dimitriadis GK, Young DY, Siddiqui MS, Lam CSP, Wang Y, Figtree GA, Chan MY, Cummings DE, Noureddin M, Wong VW, Ma RCW, Mantzoros CS, Sanyal A, Muthiah MD The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab. 2023 Mar 7;35(3):414-428.e3. doi: 10.1016/j.cmet.2023.02.003.
  • Stathogiannis KE, MacArthur JW, Lee JT, Sharma RP Percutaneous Bailout Technique for Trapping an Embolized Valve During Valve-in-Valve TAVR. J Invasive Cardiol. 2023 Mar;35(3):E160. doi: 10.25270/jic/22.00253.
  • Siddiqi AK, Greene SJ, Fudim M, Mentz RJ, Butler J, Khan MS Vericiguat for the treatment of heart failure with reduced ejection fraction. Expert Rev Cardiovasc Ther. 2023 Apr;21(4):245-257. doi: 10.1080/14779072.2023.2189101. Epub 2023 Mar 13.
  • Buchanan GL, Paradies V, Karam N, Holmvang L, Mamas MA, Mehilli J, Capodanno D, Capranzano P, Appelman Y, Manzo-Silberman S, Kunadian V, Mauri J, Shuepke S, Petronio AS, Kaluzna-Oleksy M, Gilard M, Morice MC, Barbato E, Dudek D, Chieffo A Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement. Eur Heart J. 2023 Apr 17;44(15):1301-1312. doi: 10.1093/eurheartj/ehad053.
  • Shemesh E, Chevli PA, Islam T, German CA, Otvos J, Yeboah J, Rodriguez F, deFilippi C, Lima JAC, Blaha M, Pandey A, Vaduganathan M, Shapiro MD Circulating ketone bodies and cardiovascular outcomes: the MESA study. Eur Heart J. 2023 May 7;44(18):1636-1646. doi: 10.1093/eurheartj/ehad087.
  • Stassen J, Ewe SH, Pio SM, Pibarot P, Redfors B, Leipsic J, Genereux P, Van Mieghem NM, Kuneman JH, Makkar R, Hahn RT, Playford D, Marsan NA, Delgado V, Ben-Yehuda O, Leon MB, Bax JJ Managing Patients With Moderate Aortic Stenosis. JACC Cardiovasc Imaging. 2023 Jun;16(6):837-855. doi: 10.1016/j.jcmg.2022.12.013. Epub 2023 Feb 8.
  • Carson P, Teerlink JR, Komajda M, Anand I, Anker SD, Butler J, Doehner W, Ferreira JP, Filippatos G, Haass M, Miller A, Pehrson S, Pocock SJ, Schnaidt S, Schnee JM, Zannad F, Packer M Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial. JACC Heart Fail. 2023 Apr;11(4):407-417. doi: 10.1016/j.jchf.2022.11.017. Epub 2023 Feb 1.
  • Butt JH, Docherty KF, Claggett BL, Desai AS, Fang JC, Petersson M, Langkilde AM, de Boer RA, Cabrera Honorio JW, Hernandez AF, Inzucchi SE, Kosiborod MN, Kober L, Lam CSP, Martinez FA, Ponikowski P, Sabatine MS, Vardeny O, O’Meara E, Saraiva JFK, Shah SJ, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum. JACC Heart Fail. 2023 Apr;11(4):375-388. doi: 10.1016/j.jchf.2022.11.014. Epub 2023 Feb 1.
  • Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Bohm M, Greene SJ, Felker GM, Vaduganathan M, Butler J Medication-Attributable Adverse Events in Heart Failure Trials. JACC Heart Fail. 2023 Apr;11(4):425-436. doi: 10.1016/j.jchf.2022.11.026. Epub 2023 Feb 1.
  • Kaul P, Rathwell S, Lam CSP, Westerhout CM, Spertus JA, Anstrom KJ, Blaustein RO, Ezekowitz JA, Pieske B, Roessig L, Butler J, Armstrong PW, VITALITY-HFpEF Study Group Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF. JACC Heart Fail. 2023 Apr;11(4):392-403. doi: 10.1016/j.jchf.2022.11.015. Epub 2023 Feb 1.
  • Hamid A, Yimer WK, Oshunbade AA, Kamimura D, Clark D 3rd, Fox ER, Min YI, Muntner P, Shimbo D, Pandey A, Shah AM, Mentz RJ, Jones DW, Bertoni AG, Hall JE, Correa A, Butler J, Hall ME Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study. J Am Heart Assoc. 2023 Mar 21;12(6):e026463. doi: 10.1161/JAHA.122.026463. Epub 2023 Mar 7.
  • Schwartz GG, Szarek M, Bhatt DL, Bittner VA, Bujas-Bobanovic M, Diaz R, Fazio S, Fras Z, Goodman SG, Harrington RA, Jukema JW, Manvelian G, Pordy R, Ray KK, Scemama M, White HD, Steg PG, ODYSSEY OUTCOMES Investigators Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial. Eur Heart J. 2023 Mar 5;44(16):1408-17. doi: 10.1093/eurheartj/ehad144.
  • Schechter M, Wiviott SD, Raz I, Goodrich EL, Rozenberg A, Yanuv I, Murphy SA, Zelniker TA, Fredriksson M, Johansson PA, Leiter LA, Bhatt DL, McGuire DK, Wilding JPH, Gause-Nilsson IAM, Cahn A, Langkilde AM, Sabatine MS, Mosenzon O Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial. Lancet Diabetes Endocrinol. 2023 Apr;11(4):233-241. doi: 10.1016/S2213-8587(23)00009-8. Epub 2023 Mar 3.
  • Pagidipati NJ, Nelson AJ, Kaltenbach LA, Leyva M, McGuire DK, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Al-Khalidi HR, Webb L, Gaynor T, Pak J, Senyucel C, Lopes RD, Green JB, Granger CB, COORDINATE-Diabetes Site Investigators Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2023 Apr 18;329(15):1261-1270. doi: 10.1001/jama.2023.2854.
  • d’Entremont MA, Alrashidi S, Alansari O, Brochu B, Heenan L, Skuriat E, Tyrwhitt J, Raco M, Tsang M, Valettas N, Velianou JL, Sheth TN, Sibbald M, Mehta SR, Pinilla-Echeverri N, Schwalm JD, Natarajan MK, Kelly A, Akl E, Tawadros S, Camargo M, Faidi W, Bauer J, Moxham R, Nkurunziza J, Dutra G, Winter J, Jolly SS Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial. EuroIntervention. 2023 May 15;19(1):73-79. doi: 10.4244/EIJ-D-22-01130.
  • Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, Mishell JM, Whisenant B, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Asch FM, Mack MJ, COAPT Investigators Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation. N Engl J Med. 2023 Jun 1;388(22):2037-2048. doi: 10.1056/NEJMoa2300213. Epub 2023 Mar 5.
  • Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, Price MJ, Singh G, Fam N, Kar S, Schwartz JG, Mehta S, Bae R, Sekaran N, Warner T, Makar M, Zorn G, Spinner EM, Trusty PM, Benza R, Jorde U, McCarthy P, Thourani V, Tang GHL, Hahn RT, Adams DH, TRILUMINATE Pivotal Investigators Transcatheter Repair for Patients with Tricuspid Regurgitation. N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
  • Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ, CLEAR Outcomes Investigators Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4.
  • Kondo T, Jering KS, Borleffs CJW, de Boer RA, Claggett BL, Desai AS, Dobreanu D, Inzucchi SE, Hernandez AF, Janssens SP, Jhund PS, Kosiborod MN, Lam CSP, Langkilde AM, Martinez FA, Petersson M, Vinh PN, Vaduganathan M, Solomon SD, McMurray JJV Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 2023 Apr 4;147(14):1067-1078. doi: 10.1161/CIRCULATIONAHA.122.062918. Epub 2023 Mar 6.
  • Ren QW, Katherine Teng TH, Tse YK, Tay WT, Li HL, Tromp J, Yu SY, Hung D, Wu MZ, Chen C, Yuk Yuen JK, Huang JY, Ouwerkerk W, Li XL, Teramoto K, Chandramouli C, Tse HF, Lam CSP, Yiu KH Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure: A Population-Based Cohort Study. JACC Asia. 2023 Jan 3;3(1):108-119. doi: 10.1016/j.jacasi.2022.09.016. eCollection 2023 Feb.
  • Ferreira JP, Zannad F, Butler J, Filippatos G, Pocock S, Iwata T, Sumin M, Zeller C, Januzzi JL, Anker SD, Packer M Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled Analysis. JACC Heart Fail. 2023 Jun;11(6):702-712. doi: 10.1016/j.jchf.2023.01.018. Epub 2023 Feb 20.
  • Kitzman DW, Upadhya B, Pandey A Rate-Adaptive Pacing for Heart Failure With Preserved Ejection Fraction. JAMA. 2023 Mar 14;329(10):797-799. doi: 10.1001/jama.2023.1053.
  • Aggarwal R, Yeh RW, Joynt Maddox KE, Wadhera RK Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020. JAMA. 2023 Mar 21;329(11):899-909. doi: 10.1001/jama.2023.2307.
  • Mohebi R, Liu Y, Murphy SP, Gaggin HK, Januzzi JL Jr Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database. Int J Cardiol. 2023 May 1;378:71-76. doi: 10.1016/j.ijcard.2023.01.092. Epub 2023 Mar 2.
  • Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Juni P, Kunadian V, Leonardi S, Mehran R, Montalescot G, Niebauer J, Price S, Storey RF, Voller H, Vranckx P, Windecker S, Valgimigli M Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC). Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):271-290. doi: 10.1093/ehjcvp/pvad016.
  • Hale S, Yancy CW Race-Based Analyses in Heart Failure Clinical Trials: What Makes Them Informative? JACC Heart Fail. 2023 May;11(5):580-582. doi: 10.1016/j.jchf.2023.01.014. Epub 2023 Mar 1.
  • Bikdeli B, Muriel A, Wang Y, Piazza G, Khairani CD, Rosovsky RP, Mehdipoor G, O’Donoghue ML, Madridano O, Lopez-Saez JB, Mellado M, Brasero AMD, Grandone E, Spagnolo PA, Lu Y, Bertoletti L, Lopez-Jimenez L, Nunez MJ, Blanco-Molina A, Gerhard-Herman M, Goldhaber SZ, Bates SM, Jimenez D, Krumholz HM, Monreal M, RIETE Investigators Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study. Semin Thromb Hemost. 2023 Oct;49(7):725-735. doi: 10.1055/s-0043-1764231. Epub 2023 Mar 3.
  • Secemsky EA, Song Y, Sun T, Johnson CG, Gatski M, Wang L, Farb A, Lee RE, Shaw A, Xu J, Yeh RW Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study. Circulation. 2023 Apr 25;147(17):1264-1276. doi: 10.1161/CIRCULATIONAHA.122.062123. Epub 2023 Mar 3.
  • Wilkinson MJ, Xu I, Vasudevan RS, You H, Xu R, Taub PR Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease. Am J Prev Cardiol. 2023 Feb 13;13:100473. doi: 10.1016/j.ajpc.2023.100473. eCollection 2023 Mar.
  • Levy JH, Connors JM Evaluation and management of oral anticoagulant bleeding: quid didicimus? (what have we learned?). J Thromb Haemost. 2023 Mar;21(3):460-462. doi: 10.1016/j.jtha.2022.11.030.
  • Reynolds MR, Ahmad J The NCDR AFib Ablation Registry: Better Late Than Never? J Am Coll Cardiol. 2023 Mar 7;81(9):879-881. doi: 10.1016/j.jacc.2022.12.017.
  • Zelniker TA, Wiviott SD, Mosenzon O, Goodrich EL, Jarolim P, Cahn A, Bhatt DL, Leiter LA, McGuire DK, Wilding J, Averkov O, Budaj A, Parkhomenko A, Ray KK, Gause-Nilsson I, Langkilde AM, Fredriksson M, Raz I, Sabatine MS, Morrow DA Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial. JAMA Cardiol. 2023 May 1;8(5):503-509. doi: 10.1001/jamacardio.2023.0019.
  • Schwarz N, Fernando S, Chen YC, Salagaras T, Rao SR, Liyanage S, Williamson AE, Toledo-Flores D, Dimasi C, Sargeant TJ, Manavis J, Eddy E, Kanellakis P, Thompson PL, Tan JTM, Snel MF, Bursill CA, Nicholls SJ, Peter K, Psaltis PJ Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. FASEB J. 2023 Apr;37(4):e22846. doi: 10.1096/fj.202201469R.
  • Tuttle KR Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors. J Clin Invest. 2023 Mar 1;133(5):e167700. doi: 10.1172/JCI167700.
  • Yancy CW, Fonarow GC, O’Gara PT Is There a Role for Renal Denervation in the Treatment of Hypertension? JAMA Cardiol. 2023 May 1;8(5):473-474. doi: 10.1001/jamacardio.2023.0372.
  • Gustafsson F, Damman K, Nalbantgil S, Van Laake LW, Tops LF, Thum T, Adamopoulos S, Bonios M, Coats AJ, Crespo-Leiro MG, Mehra MR, Filippatos G, Hill L, Metra M, Jankowska E, de Jonge N, Kaye D, Masetti M, Parissis J, Milicic D, Seferovic P, Rosano G, Ben Gal T Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 Apr;25(4):457-468. doi: 10.1002/ejhf.2814. Epub 2023 Mar 10.
  • Krishnan AM, Zhang G, Sharma T, Hirashima F, Dauerman HL, Lahoud RN Trends and Predictors of Short Length of Stay Following Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2023 Jul;52:1-7. doi: 10.1016/j.carrev.2023.02.007. Epub 2023 Feb 14.
  • Galli M, Laborante R, Ortega-Paz L, Franchi F, Rollini F, D’Amario D, Capodanno D, Tremoli E, Gibson CM, Mehran R, Angiolillo DJ Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis. Thromb Haemost. 2023 Jun;123(6):576-584. doi: 10.1055/a-2043-0346. Epub 2023 Feb 25.
  • Mihalcea D, Memis H, Mihaila S, Vinereanu D Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors. Life (Basel). 2023 Jan 29;13(2):366. doi: 10.3390/life13020366.
  • Miyazaki K, Fujii T, Mori K, Tamimoto R, Nagamatsu H, Murakami T, Cho Y, Goto S, Mori H Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination. J Clin Med. 2023 Feb 10;12(4):1421. doi: 10.3390/jcm12041421.
  • Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure. Curr Probl Cardiol. 2023 Jun;48(6):101667. doi: 10.1016/j.cpcardiol.2023.101667. Epub 2023 Feb 23.
  • Diez J, Rosano GMC, Butler J Time to reconsider the perception and management of hypertensive heart disease. Eur J Heart Fail. 2023 Apr;25(4):450-453. doi: 10.1002/ejhf.2811. Epub 2023 Mar 16.
  • Johansen KL, Chertow GM, Gilbertson DT, Ishani A, Israni A, Ku E, Li S, Li S, Liu J, Obrador GT, Schulman I, Chan K, Abbott KC, O’Hare AM, Powe NR, Roetker NS, Scherer JS, St Peter W, Snyder J, Winkelmayer WC, Wong SPY, Wetmore JB US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2023 Mar;81(3 Suppl1):A8-A11. doi: 10.1053/j.ajkd.2022.12.001.
  • Ortega-Hernandez J, Gonzalez-Pacheco H, Nieto RG, Araiza-Garaygordobil D, Lara-Martinez DS, De La Cruz JLB, Mendoza-Garcia S, Altamirano-Castillo A, Orozco AM, Herrera LAB, Hernandez-Montfort J, Aguilar-Montano KM, Uriona LAS, Lopez JAFM, Loria CAL, Arias-Mendoza A COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRY. Shock. 2023 Apr 1;59(4):576-582. doi: 10.1097/SHK.0000000000002091. Epub 2023 Feb 24.
  • Averbuch T, Mamas MA, Van Spall HGC Predicting Risk of Cardiotoxic Effects in Breast Cancer: Are We There Yet? JAMA Netw Open. 2023 Feb 1;6(2):e230577. doi: 10.1001/jamanetworkopen.2023.0577.
  • Khan S, Dani SS, Hermann J, Neilan TG, Lenihan DJ, Fradley M, Parikh R, Khan S, Deswal A, Liu J, Barac A, Labib S, Majithia A, Nohria A, Baron SJ, Ganatra S Safety and efficacy of transcatheter edge-to-edge repair (TEER) in patients with history of cancer. Int J Cardiol Heart Vasc. 2022 Dec 31;44:101165. doi: 10.1016/j.ijcha.2022.101165. eCollection 2023 Feb.
  • Teng AE, Hsue PY, Secemsky EA Response to correspondence to “Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population”. AIDS. 2023 Mar 15;37(4):706. doi: 10.1097/QAD.0000000000003470.
  • Hu A, Liu S, Montez-Rath ME, Khairallah P, Niu J, Turakhia MP, Chang TI, Winkelmayer WC Associations of Serum and Dialysate Potassium Concentrations With Incident Atrial Fibrillation in a Cohort Study of Older US Persons Initiating Hemodialysis for Kidney Failure. Kidney Int Rep. 2022 Nov 14;8(2):305-316. doi: 10.1016/j.ekir.2022.11.003. eCollection 2023 Feb.
  • Meraz-Munoz AY, Jeyakumar N, Luo B, Beaubien-Souligny W, Chanchlani R, Clark EG, Harel Z, Kitchlu A, Neyra JA, Zappitelli M, Chertow GM, Garg AX, Wald R, Silver SA Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction. Kidney Int Rep. 2022 Nov 2;8(2):294-304. doi: 10.1016/j.ekir.2022.10.027. eCollection 2023 Feb.
  • Kobo O, Abramov D, Davies S, Ahmed SB, Sun LY, Mieres JH, Parwani P, Siudak Z, Van Spall HGC, Mamas MA CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020. Kidney Med. 2022 Dec 28;5(3):100597. doi: 10.1016/j.xkme.2022.100597. eCollection 2023 Mar.
  • Ridker PM, Lei L, Ray KK, Ballantyne CM, Bradwin G, Rifai N Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial. J Clin Lipidol. 2023 Mar-Apr;17(2):297-302. doi: 10.1016/j.jacl.2023.02.002. Epub 2023 Feb 14.
  • Coylewright M, Januzzi JL, Szerlip M Options to Improve Quality of Life for Aortic Stenosis: “No Decision About Me, Without Me”. J Am Coll Cardiol. 2023 Feb 28;81(8):753-755. doi: 10.1016/j.jacc.2022.12.016.
  • Butt JH, Docherty KF, Claggett BL, Desai AS, Petersson M, Langkilde AM, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Kober L, Lam CSP, Martinez FA, Ponikowski P, Sabatine MS, Shah SJ, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER. JAMA Cardiol. 2023 Apr 1;8(4):386-393. doi: 10.1001/jamacardio.2022.5608.
  • Bikdeli B, Lo YC, Khairani CD, Bejjani A, Jimenez D, Barco S, Mahajan S, Caraballo C, Secemsky EA, Klok FA, Hunsaker AR, Aghayev A, Muriel A, Wang Y, Hussain MA, Appah-Sampong A, Lu Y, Lin Z, Aneja S, Khera R, Goldhaber SZ, Zhou L, Monreal M, Krumholz HM, Piazza G Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study. Thromb Haemost. 2023 Jun;123(6):649-662. doi: 10.1055/a-2039-3222. Epub 2023 Feb 21.
  • Johansen ND, Vaduganathan M, Zahir D, Fiuzat M, DeFilippis EM, Januzzi JL, Butler J, O’Connor CM, Abraham WT, Psotka MA, McMurray JJV, Dewan P, Claggett BL, Solomon SD, Modin D, Butt JH, Jensen JUS, Schou M, Torp-Pedersen C, Kober L, Gislason GH, Biering-Sorensen T A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study. Circ Heart Fail. 2023 Feb;16(2):e009729. doi: 10.1161/CIRCHEARTFAILURE.122.009729. Epub 2023 Jan 25.
  • Helms J, Iba T, Connors JM, Gando S, Levi M, Meziani F, Levy JH How to manage coagulopathies in critically ill patients. Intensive Care Med. 2023 Mar;49(3):273-290. doi: 10.1007/s00134-023-06980-6. Epub 2023 Feb 17.
  • Pierce JB, Ikeaba U, Peters AE, DeVore AD, Chiswell K, Allen LA, Albert NM, Yancy CW, Fonarow GC, Greene SJ Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 Apr 1;8(4):376-385. doi: 10.1001/jamacardio.2023.0241.
  • Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam C, O’Connor CM, Roessig L, Hernandez AF, Armstrong PW, VICTORIA Study Group Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study. Circulation. 2023 Feb 21;147(8):694-696. doi: 10.1161/CIRCULATIONAHA.122.062055. Epub 2023 Feb 20.
  • Milling TJ Jr, Middeldorp S, Xu L, Koch B, Demchuk A, Eikelboom JW, Verhamme P, Cohen AT, Beyer-Westendorf J, Gibson CM, Lopez-Sendon J, Crowther M, Shoamanesh A, Coppens M, Schmidt J, Albaladejo P, Connolly SJ, ANNEXA-4 Investigators Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors. Circulation. 2023 Mar 28;147(13):1026-1038. doi: 10.1161/CIRCULATIONAHA.121.057844. Epub 2023 Feb 20.
  • Olshansky B, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Kowey PR, Reiffel JA, Tardif JC, Ballantyne CM, Chung MK, REDUCE-IT Investigators Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. J Am Heart Assoc. 2023 Mar 7;12(5):e026756. doi: 10.1161/JAHA.121.026756. Epub 2023 Feb 21.
  • Maqsood MH, Pancholy S, Tuozzo KA, Moskowitz N, Rao SV, Bangalore S Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv. 2023 Feb;16(2):e012781. doi: 10.1161/CIRCINTERVENTIONS.122.012781. Epub 2023 Feb 21.
  • Gerstein HC, Li Z, Ramasundarahettige C, Baek S, Branch KRH, Del Prato S, Lam CSP, Lopes RD, Pratley R, Rosenstock J, Sattar N Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. Circulation. 2023 Mar 28;147(13):1004-1013. doi: 10.1161/CIRCULATIONAHA.122.063716. Epub 2023 Feb 20.
  • Varkila M, Montez-Rath M, Salomon J, Yu X, Block G, Owens DK, Chertow GM, Parsonnet J, Anand S Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022. medRxiv [Preprint]. 2023 Feb 8:2023.02.06.23285542. doi: 10.1101/2023.02.06.23285542.
  • Salisbury AC, Grantham JA, Brown WM, Ballard WL, Allen KB, Kirtane AJ, Argenziano M, Yeh RW, Khabbaz K, Lasala J, Kachroo P, Karmpaliotis D, Moses J, Lombardi WL, Nugent K, Ali Z, Gosch KL, Spertus JA, Kandzari DE, OPTIMUM Investigators Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery. JACC Cardiovasc Interv. 2023 Feb 13;16(3):261-273. doi: 10.1016/j.jcin.2023.01.003.
  • McCarthy CP, Natarajan P Systolic Blood Pressure and Cardiovascular Risk: Straightening the Evidence. Hypertension. 2023 Mar;80(3):577-579. doi: 10.1161/HYPERTENSIONAHA.123.20788. Epub 2023 Feb 15.
  • Lutter D, Sachs S, Walter M, Kerege A, Perreault L, Kahn DE, Wolide AD, Kleinert M, Bergman BC, Hofmann SM Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. Diabetologia. 2023 May;66(5):873-883. doi: 10.1007/s00125-023-05874-y. Epub 2023 Feb 15.
  • Doshi SK, Kar S, Sadhu A, Horton R, Osorio J, Ellis C, Stone J Jr, Shah M, Dukkipati SR, Adler S, Nair DG, Kim J, Wazni O, Price MJ, Holmes DR Jr, Shipley R, Christen T, Allocco DJ, Reddy VY, PINNACLE FLX investigators [Link] Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial. J Am Heart Assoc. 2023 Feb 21;12(4):e026295. doi: 10.1161/JAHA.122.026295. Epub 2023 Feb 15.
  • Parikh RV, Hebbe A, Baron AE, Grunwald GK, Plomondon ME, Gordin J, Yeh RW, Jneid H, Swaminathan RV, Waldo SW, Monto A, Secemsky E, Hsue PY Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2023 Feb 21;12(4):e028082. doi: 10.1161/JAHA.122.028082. Epub 2023 Feb 15.
  • Korjian S, Kazmi SHA, Chi G, Kalayci A, Lee JJ, Talib U, Wright SD, Duffy D, Kingwell BA, Mehran R, Ridker PM, Gibson CM Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):387-398. doi: 10.1093/ehjcvp/pvad014.
  • Lorenz EC, Zaniletti I, Johnson BK, Petterson TM, Kremers WK, Schinstock CA, Amer H, Cheville AL, LeBrasseur NK, Winkelmayer WC, Navaneethan SD, Baez-Suarez A, Attia ZI, Lopez-Jimenez F, Friedman PA, Kennedy CC, Rule AD Physiological Age by Artificial Intelligence-Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates. Transplantation. 2023 Jun 1;107(6):1365-1372. doi: 10.1097/TP.0000000000004504. Epub 2023 Feb 13.
  • Bahit MC, Salvati A Sex Disparities in Cardiology: How Are We Doing in Latin America? Circulation. 2023 Feb 14;147(7):521-522. doi: 10.1161/CIRCULATIONAHA.122.063611. Epub 2023 Feb 13.
  • Coughlan JJ, Raber L, Brugaletta S, Kufner S, Maeng M, Jensen LO, Ortega-Paz L, Bar S, Laugwitz KL, Madsen M, Heg D, Aytekin A, Windecker S, Olesen KKW, Sabate M, Kastrati A, Cassese S Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation. Circulation. 2023 Feb 14;147(7):575-585. doi: 10.1161/CIRCULATIONAHA.122.062049. Epub 2023 Feb 13.
  • Krawisz AK, Pribish AM, Kennedy K, Secemsky EA Variation in the Use of Orbital Atherectomy During Coronary Artery Intervention in the United States. J Soc Cardiovasc Angiogr Interv. 2023 Jan-Feb;2(1):100529. doi: 10.1016/j.jscai.2022.100529. Epub 2022 Nov 26.
  • Vedovati MC, Giustozzi M, Munoz A, Bertoletti L, Cohen AT, Klok FA, Connors JM, Bauersachs R, Brenner B, Campanini M, Becattini C, Agnelli G Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. Eur J Intern Med. 2023 Jun;112:29-36. doi: 10.1016/j.ejim.2023.02.003. Epub 2023 Feb 9.
  • Michelhaugh SA, Januzzi JL Jr Using Artificial Intelligence to Better Predict and Develop Biomarkers. Clin Lab Med. 2023 Mar;43(1):99-114. doi: 10.1016/j.cll.2022.09.021.
  • Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M, International Lipid Expert Panel (ILEP) Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacol Res. 2023 Mar;189:106679. doi: 10.1016/j.phrs.2023.106679. Epub 2023 Feb 8.
  • Wang L, Smith-Salzberg B, Meyers KE, Glenn DA, Tuttle KR, Derebail VK, Brady TM, Gibson K, Smith AR, O’Shaughnessy MM, Srivastava T, Hall G, Zee J, Bitzer M, Sethna CB Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrol. 2023 Feb 9;24(1):30. doi: 10.1186/s12882-023-03073-w.
  • Gopar-Nieto R, Gonzalez-Pacheco H, Arias-Mendoza A, Briseno-De-la-Cruz JL, Araiza-Garaygordobil D, Sierra-Lara-Martinez D, Mendoza-Garcia S, Altamirano-Castillo A, Dattoli-Garcia CA, Manzur-Sandoval D, Raymundo-Martinez G Non-reperfused ST-elevation myocardial infarction: notions from a low-to-middle-income country. Arch Cardiol Mex. 2023;93(1):4-12. doi: 10.24875/ACM.21000312.
  • Khan MS, Xu H, Fonarow GC, Lautsch D, Hilkert R, Allen LA, DeVore AD, Alhanti B, Yancy CW, Albert NM, Butler J, Greene SJ Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States. JACC Heart Fail. 2023 Feb;11(2):211-223. doi: 10.1016/j.jchf.2022.11.007.
  • Parwani P, Yancy CW Sociodemographic Disparities in the GDMT Usage. JACC Heart Fail. 2023 Feb;11(2):173-175. doi: 10.1016/j.jchf.2022.11.020.
  • Gragnano F, Mehran R, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Calabro P, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Valgimigli M, Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. J Am Coll Cardiol. 2023 Feb 14;81(6):537-552. doi: 10.1016/j.jacc.2022.11.041.
  • Tuttle KR, Wilson JM, Lin Y, Qian HR, Genovese F, Karsdal MA, Duffin KL, Botros FT Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide. Am J Nephrol. 2023;54(1-2):74-82. doi: 10.1159/000529374. Epub 2023 Feb 8.
  • Khan MS, Van Spall HGC Effectiveness of Telemedicine Services After Hospitalization for Heart Failure: A Matter of Outcome? JACC Heart Fail. 2023 Feb;11(2):207-210. doi: 10.1016/j.jchf.2022.10.015. Epub 2023 Jan 11.
  • Zile MR, Kahwash R, Sarkar S, Koehler J, Butler J Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure. JACC Heart Fail. 2023 Feb;11(2):143-156. doi: 10.1016/j.jchf.2022.10.014. Epub 2023 Jan 11.
  • McCarthy PM, Whisenant B, Asgar AW, Ailawadi G, Hermiller J, Williams M, Morse A, Rinaldi M, Grayburn P, Thomas JD, Martin R, Asch FM, Shu Y, Sundareswaran K, Moat N, Kar S Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial. J Am Heart Assoc. 2023 Feb 21;12(4):e027504. doi: 10.1161/JAHA.122.027504. Epub 2023 Feb 8.
  • Shahim B, Cohen DJ, Ben-Yehuda O, Redfors B, Kar S, Lim DS, Arnold SV, Li Y, Lindenfeld J, Abraham WT, Mack MJ, Stone GW Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial. J Am Heart Assoc. 2023 Feb 21;12(4):e028444. doi: 10.1161/JAHA.122.028444. Epub 2023 Feb 8.
  • Cheng K, Lin A, Stecher X, Bernstein T, Zuniga P, Mazzon E, Brunser A, Diaz V, Martinez G, Cameron W, Nicholls SJ, Patel S, Dey D, Wong DT, Munoz Venturelli P Association between spontaneous internal carotid artery dissection and perivascular adipose tissue attenuation on computed tomography angiography. Int J Stroke. 2023 Aug;18(7):829-838. doi: 10.1177/17474930231158538. Epub 2023 Mar 2.
  • Carroll BJ, Larnard EA, Pinto DS, Giri J, Secemsky EA Percutaneous Management of High-Risk Pulmonary Embolism. Circ Cardiovasc Interv. 2023 Feb;16(2):e012166. doi: 10.1161/CIRCINTERVENTIONS.122.012166. Epub 2023 Feb 6.
  • Dowling C, Gooley R, McCormick L, Sharma RP, Yeung AC, Fearon WF, Dargan J, Khan F, Firoozi S, Brecker SJ Ongoing Experience With Patient-Specific Computer Simulation of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve. Cardiovasc Revasc Med. 2023 Jun;51:31-37. doi: 10.1016/j.carrev.2023.01.015. Epub 2023 Jan 24.
  • Krittanawong C, Rodriguez M, Lui M, Misra A, Tang WHW, Bozkurt B, Yancy CW Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction. Am J Med. 2023 May;136(5):422-431. doi: 10.1016/j.amjmed.2023.01.024. Epub 2023 Feb 3.
  • Nicholls SJ PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives. Kardiol Pol. 2023;81(2):115-122. doi: 10.33963/KP.a2023.0030. Epub 2023 Feb 5.
  • Tuttle KR, Bosch-Traberg H, Cherney DZI, Hadjadj S, Lawson J, Mosenzon O, Rasmussen S, Bain SC Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo. Kidney Int. 2023 Apr;103(4):772-781. doi: 10.1016/j.kint.2022.12.028. Epub 2023 Feb 2.
  • Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP, NSTEMI investigator group Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008.
  • Modrall JG, Zhu H, Prasad T, Moe O, Dworkin LD, Cutlip DE, Murphy TP, Cooper CJ, Toto R Retrieval of renal function after renal artery stenting improves event-free survival in a subgroup analysis of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions trial. J Vasc Surg. 2023 Jun;77(6):1685-1692.e2. doi: 10.1016/j.jvs.2022.12.067. Epub 2023 Feb 2.
  • Sivaraj K, Arora S, Hendrickson M, Slehria T, Chang PP, Weickert T, Vaduganathan M, Qamar A, Pandey A, Caughey MC, Cavender MA, Rosamond W, Vavalle JP Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study. Circ Heart Fail. 2023 Mar;16(3):e009653. doi: 10.1161/CIRCHEARTFAILURE.122.009653. Epub 2023 Feb 3.
  • Haeffele CL, Lui GK, Peng L, Chan F, Sharma RP First described mitral clip in an adult extracardiac Fontan patient: a case report. Eur Heart J Case Rep. 2022 Dec 16;7(1):ytac479. doi: 10.1093/ehjcr/ytac479. eCollection 2023 Jan.
  • Perl J, Brown EA, Chan CT, Couchoud C, Davies SJ, Kazancioglu R, Klarenbach S, Liew A, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC, Wilkie ME, for Conference Participants Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 May;103(5):842-858. doi: 10.1016/j.kint.2023.01.006. Epub 2023 Jan 31.
  • Sykes AV, Sonners C, Schmickl CN, Raphelson J, Swiatkiewicz I, Roberts E, Feldman E, Malhotra A, Taub PR The Impact of Underlying Obstructive Sleep Apnea Treatment on Exercise Capacity in Patients With Pulmonary Hypertension Undergoing a Cardiac Rehabilitation Program. J Cardiopulm Rehabil Prev. 2023 May 1;43(3):186-191. doi: 10.1097/HCR.0000000000000745. Epub 2022 Dec 14.
  • Marcucci R, Berteotti M, Gragnano F, Galli M, Cavallari I, Renda G, Capranzano P, Santilli F, Capodanno D, Angiolillo DJ, Cirillo P, Calabro P, Patti G, De Caterina R, Working Group of Thrombosis of the Italian Society of Cardiology Monitoring antiplatelet therapy: where are we now? J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e24-e35. doi: 10.2459/JCM.0000000000001406. Epub 2022 Dec 15.
  • Mead GE, Sposato LA, Sampaio Silva G, Yperzeele L, Wu S, Kutlubaev M, Cheyne J, Wahab K, Urrutia VC, Sharma VK, Sylaja PN, Hill K, Steiner T, Liebeskind DS, Rabinstein AA A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization. Int J Stroke. 2023 Jun;18(5):499-531. doi: 10.1177/17474930231156753. Epub 2023 Mar 1.
  • Boden WE, Marzilli M, Crea F, Mancini GBJ, Weintraub WS, Taqueti VR, Pepine CJ, Escaned J, Al-Lamee R, Gowdak LHW, Berry C, Kaski JC, Chronic Myocardial Ischemic Syndromes Task Force Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Feb 7;81(5):505-514. doi: 10.1016/j.jacc.2022.08.814.
  • Hausleiter J, Lim DS, Gillam LD, Zahr F, Chadderdon S, Rassi AN, Makkar R, Goldman S, Rudolph V, Hermiller J, Kipperman RM, Dhoble A, Smalling R, Latib A, Kodali SK, Lazkani M, Choo J, Lurz P, O’Neill WW, Laham R, Rodes-Cabau J, Kar S, Schofer N, Whisenant B, Inglessis-Azuaje I, Baldus S, Kapadia S, Koulogiannis K, Marcoff L, Smith RL, PASCAL IID Registry Investigators Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation. J Am Coll Cardiol. 2023 Feb 7;81(5):431-442. doi: 10.1016/j.jacc.2022.11.034.
  • Teng TK, Tay WT, Ouwerkerk W, Tromp J, Richards AM, Gamble G, Greene SJ, Yiu KH, Poppe K, Ling LH, Lund M, Sim D, Devlin G, Loh SY, Troughton R, Ren QW, Jaufeerally F, Lee SGS, Tan RS, Soon DKN, Leong G, Ong HY, Yeo DPS, Lam CSP, Doughty RN Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand. ESC Heart Fail. 2023 Apr;10(2):1280-1293. doi: 10.1002/ehf2.14275. Epub 2023 Feb 1.
  • Parker WAE, Angiolillo DJ, Rollini F, Franchi F, Bonaca MP, Bhatt DL, Steg PG, Orme RC, Thomas MR, Judge HM, Sabatine MS, Storey RF Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes. Vascul Pharmacol. 2023 Apr;149:107145. doi: 10.1016/j.vph.2023.107145. Epub 2023 Jan 28.
  • Galindo RJ, de Boer IH, Neumiller JJ, Tuttle KR Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):130-145. doi: 10.2215/CJN.04510422. Epub 2022 Sep 22.
  • Mark E, Oswald M, Kundar P, Gulati M Patient-Centered Insights and Biases Regarding Cardiologists Via Online Review Platform Analysis. J Am Heart Assoc. 2023 Feb 7;12(3):e027405. doi: 10.1161/JAHA.122.027405. Epub 2023 Jan 31.
  • Di Giovanni G, Kataoka Y, Bubb K, Nelson AJ, Nicholls SJ Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall. Atherosclerosis. 2023 Feb;367:8-14. doi: 10.1016/j.atherosclerosis.2023.01.017. Epub 2023 Jan 20.
  • Vranckx P, Morrow D, Verbrugge F On the brink of the new year, on the brink of a new era: European Heart Journal Acute CardioVascular Care goes online only. Eur Heart J Acute Cardiovasc Care. 2023 Jan 27;12(1):1. doi: 10.1093/ehjacc/zuac094.
  • Ward NC, Watts GF, Bishop W, Colquhoun D, Hamilton-Craig C, Hare DL, Kangaharan N, Kostner KM, Kritharides L, O’Brien R, Mori TA, Nestel PJ, Nicholls SJ, Psaltis PJ, Raffoul N, White HD, Sullivan DR Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. Heart Lung Circ. 2023 Mar;32(3):287-296. doi: 10.1016/j.hlc.2022.11.015. Epub 2023 Jan 25.
  • Filbey L, Zhu JW, D’Angelo F, Thabane L, Khan MS, Lewis E, Patel MR, Powell-Wiley T, Miranda JJ, Zuhlke L, Butler J, Zannad F, Van Spall HGC Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum. Eur Heart J. 2023 Mar 14;44(11):921-930. doi: 10.1093/eurheartj/ehac810.
  • Helms J, Frere C, Thiele T, Tanaka KA, Neal MD, Steiner ME, Connors JM, Levy JH Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023 Feb;21(2):373-396. doi: 10.1016/j.jtha.2022.11.014. Epub 2022 Dec 22.
  • Rosenstock J, Kolkailah AA, McGuire DK, Espeland MA, Mattheus M, Pfarr E, Lund SS, Marx N, CAROLINA Investigators Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial. Diabetes Obes Metab. 2023 Jun;25(6):1453-1463. doi: 10.1111/dom.14991. Epub 2023 Feb 14.
  • Elkind MSV, Witte KK, Kasner SE, Sawyer LM, Grimsey Jones FW, Rinciog C, Tsintzos S, Rosemas SC, Lanctin D, Ziegler PD, Reynolds MR Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US. BMC Cardiovasc Disord. 2023 Jan 25;23(1):45. doi: 10.1186/s12872-023-03073-6.
  • Sposato LA, Donnan GA CYP2C19 Genotyping to Guide Antiplatelet Therapy for the Secondary Prevention of Lacunar Strokes. Neurology. 2023 Apr 18;100(16):741-743. doi: 10.1212/WNL.0000000000206898. Epub 2023 Jan 25.
  • Ferrante G, Rao SV, Valgimigli M Reply: Distal Transradial Access in Acute Coronary SyndromesShould We Give the First Try? JACC Cardiovasc Interv. 2023 Jan 23;16(2):239-240. doi: 10.1016/j.jcin.2022.12.011.
  • Landi A, Branca M, Leonardi S, Frigoli E, Vranckx P, Tebaldi M, Varbella F, Calabro P, Esposito G, Sardella G, Garducci S, Ando G, Limbruno U, Sganzerla P, Santarelli A, Briguori C, Colangelo S, Brugaletta S, Adamo M, Omerovic E, Heg D, Windecker S, Valgimigli M, MATRIX Investigators Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary Syndrome. JACC Cardiovasc Interv. 2023 Jan 23;16(2):193-205. doi: 10.1016/j.jcin.2022.10.009. Epub 2022 Dec 28.
  • Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, Ponikowski P, Voors AA, Zannad F, Zieroth S, Butler J Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Jan 31;81(4):413-424. doi: 10.1016/j.jacc.2022.11.023.
  • Ray KK, Bruckert E, Peronne-Filardi P, Ebenbichler C, Vogt A, Bridges I, Sibartie M, Dhalwani N Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study. Atherosclerosis. 2023 Feb;366:14-21. doi: 10.1016/j.atherosclerosis.2023.01.002. Epub 2023 Jan 13.
  • Swan D, Connors JM, Thachil J Dilemmas in hematology: consults in patients with arterial thrombosis. J Thromb Haemost. 2023 Mar;21(3):421-432. doi: 10.1016/j.jtha.2023.01.002. Epub 2023 Jan 10.
  • Greco A, Finocchiaro S, Angiolillo DJ, Capodanno D Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Expert Opin Pharmacother. 2023 Mar;24(4):453-471. doi: 10.1080/14656566.2023.2171788. Epub 2023 Feb 7.
  • Ijaz SH, Baron SJ, Shahnawaz A, Kulbak G, Levy M, Resnic F, Ganatra S, Dani SS Utilization Trends In Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor and Cost Among Medicare Beneficiaries. Curr Probl Cardiol. 2023 May;48(5):101608. doi: 10.1016/j.cpcardiol.2023.101608. Epub 2023 Jan 20.
  • Shazly T, Torres WM, Secemsky EA, Chitalia VC, Jaffer FA, Kolachalama VB Understudied factors in drug-coated balloon design and evaluation: A biophysical perspective. Bioeng Transl Med. 2022 Jul 7;8(1):e10370. doi: 10.1002/btm2.10370. eCollection 2023 Jan.
  • Rawshani A, McGuire DK, Omerovic E, Sattar N, McMurray JJV, Smith U, Redfors B, Bergfeldt L, Eliasson B, Boren J, Bhatt DL, Bergstrom G, Rawshani A Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes. Sci Rep. 2023 Jan 21;13(1):1192. doi: 10.1038/s41598-023-27941-5.
  • Rashid AM, Khan MS, Fudim M, DeWald TA, DeVore A, Butler J Management of Heart Failure With Reduced Ejection Fraction. Curr Probl Cardiol. 2023 May;48(5):101596. doi: 10.1016/j.cpcardiol.2023.101596. Epub 2023 Jan 18.
  • Tan S, Sivakumar S, Segelov E, Nicholls SJ, Nelson AJ Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review. Cancer Epidemiol. 2023 Apr;83:102334. doi: 10.1016/j.canep.2023.102334. Epub 2023 Jan 18.
  • Handelsman Y, Butler J, Bakris GL, DeFronzo RA, Fonarow GC, Green JB, Grunberger G, Januzzi JL Jr, Klein S, Kushner PR, McGuire DK, Michos ED, Morales J, Pratley RE, Weir MR, Wright E, Fonseca VA Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2023 Feb;37(2):108389. doi: 10.1016/j.jdiacomp.2022.108389. Epub 2023 Jan 3.
  • Beernink JM, Persson F, Jongs N, Laverman GD, Chertow GM, McMurray JJV, Langkilde AM, Correa-Rotter R, Rossing P, Sjostrom CD, Toto RD, Wheeler DC, Heerspink HJL Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study. Diabetes Care. 2023 Mar 1;46(3):602-607. doi: 10.2337/dc22-1514.
  • Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, Hernandez A, Morris AA, Shafi T, Weir MR, Zannad F, Bakris GL, Butler J Albuminuria and Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 Jan 24;81(3):270-282. doi: 10.1016/j.jacc.2022.10.028.
  • Gulati M, Berg DD High-Sensitivity Cardiac Troponin Assays in U.S. Hospitals: A Report Card. J Am Coll Cardiol. 2023 Jan 24;81(3):220-223. doi: 10.1016/j.jacc.2022.11.015.
  • O’Toole RV, Stein DM, O’Hara NN, Frey KP, Taylor TJ, Scharfstein DO, Carlini AR, Sudini K, Degani Y, Slobogean GP, Haut ER, Obremskey W, Firoozabadi R, Bosse MJ, Goldhaber SZ, Marvel D, Castillo RC, Major Extremity Trauma Research Consortium (METRC) Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. N Engl J Med. 2023 Jan 19;388(3):203-213. doi: 10.1056/NEJMoa2205973.
  • Spirito A, Kastrati A, Cao D, Baber U, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Dangas G, Dudek D, Escaned J, Gibson CM, Zhang Z, Huber K, Kaul U, Kornowski R, Kunadian V, Han YL, Mehta SR, Sardella G, Sharma S, Shlofmitz RA, Vogel B, Collier T, Pocock S, Mehran R Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):328-336. doi: 10.1093/ehjcvp/pvad006.
  • Cavanagh CE, Rosman L, Chui P, Minges K, Desai NR, Goodlin S, Fedson S, Spertus JA, Gluckman TJ, Song Y, Zheng L, Turchin A, Doros G, Lee JJ, Burg MM Advance Care Planning and End-of-Life Education in Heart Failure: Insights From the NCDR PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e008989. doi: 10.1161/CIRCOUTCOMES.122.008989. Epub 2023 Jan 17.
  • Gibson CM, Steinhubl S, Lakkireddy D, Turakhia MP, Passman R, Jones WS, Bunch TJ, Curtis AB, Peterson ED, Ruskin J, Saxon L, Tarino M, Tarakji KG, Marrouche N, Patel M, Harxhi A, Kaul S, Nikolovski J, Juan S, Wildenhaus K, Damaraju CV, Spertus JA, Heartline Steering Committee Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study. Am Heart J. 2023 May;259:30-41. doi: 10.1016/j.ahj.2023.01.004. Epub 2023 Jan 12.
  • Chopard R, Campia U, Jering KS, Almarzooq ZI, Snyder JE, Rizzo S, Waxman AB, Goldhaber SZ, Piazza G Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center. Thromb Res. 2023 Feb;222:113-116. doi: 10.1016/j.thromres.2022.12.018. Epub 2022 Dec 30.
  • Filippatos G, Anker SD, August P, Coats AJS, Januzzi JL, Mankovsky B, Rossing P, Ruilope LM, Pitt B, Sarafidis P, Teerlink JR, Kapelios CJ, Gebel M, Brinker M, Joseph A, Lage A, Bakris G, Agarwal R Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):183-191. doi: 10.1093/ehjcvp/pvad001.
  • Arias-Mendoza A, Gonzalez-Pacheco H, Gopar-Nieto R, Damas-de Los Santos F, Jimenez-Rodriguez GM, Meza-Lopez J, Montanez-Orozco A, Araiza-Garaygordobil D Simultaneous Presentation of Spontaneous Coronary Artery Dissection and Acute Type B Aortic Dissection in the Puerperium. Can J Cardiol. 2023 May;39(5):678-680. doi: 10.1016/j.cjca.2023.01.005. Epub 2023 Jan 11.
  • Mehta SR, McGrath BP Anatomy vs. physiology: how should we achieve complete revascularization in acute coronary syndromes? Eur Heart J. 2023 Feb 7;44(6):485-487. doi: 10.1093/eurheartj/ehac786.
  • Gulati M, Minhas A Time to counter rising cardiovascular disease during pregnancy. Eur Heart J. 2023 Mar 1;44(9):738-740. doi: 10.1093/eurheartj/ehac770.
  • Shetty NS, Parcha V, Patel N, Yadav I, Basetty C, Li C, Pandey A, Kalra R, Li P, Arora G, Arora P AHA Life’s essential 8 and ideal cardiovascular health among young adults. Am J Prev Cardiol. 2022 Dec 23;13:100452. doi: 10.1016/j.ajpc.2022.100452. eCollection 2023 Mar.
  • Defilippi CR, Alemayehu WG, Voors AA, Kaye D, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, Roessig L, Seliger S, Shah P, Westerhout CM, Armstrong PW, O’Connor CM, VICTORIA Study Group Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy. J Card Fail. 2023 Apr;29(4):448-458. doi: 10.1016/j.cardfail.2022.12.013. Epub 2023 Jan 9.
  • Kaneko H, Yano Y, Okada A, Itoh H, Suzuki Y, Yokota I, Morita K, Fujiu K, Michihata N, Jo T, Yamaguchi S, Takeda N, Morita H, Node K, Yamauchi T, Nangaku M, Kadowaki T, McEvoy JW, Lam CSP, Yasunaga H, Komuro I Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease. J Am Heart Assoc. 2023 Jan 17;12(2):e027684. doi: 10.1161/JAHA.122.027684. Epub 2023 Jan 11.
  • Nicolajsen CW, Nielsen PB, Jensen M, Eldrup N, Larsen TB, Lip GYH, Goldhaber SZ, Sogaard M Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation. Thromb Haemost. 2023 May;123(5):555-564. doi: 10.1055/a-2009-8954. Epub 2023 Jan 10.
  • Kramer DB, Yeh RW Quantitative Analyses of Regulatory Policies for Medical Devices: Matching the Methods to the Moment. JAMA. 2023 Feb 14;329(6):467-469. doi: 10.1001/jama.2022.23888.
  • Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Craig JC, Tunnicliffe DJ, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10.
  • Capodanno D, Angiolillo DJ Long-Term P2Y(12) Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation. 2023 Jan 10;147(2):118-121. doi: 10.1161/CIRCULATIONAHA.122.063004. Epub 2023 Jan 9.
  • Mitchell P, Lee SCM, Yoo PE, Morokoff A, Sharma RP, Williams DL, MacIsaac C, Howard ME, Irving L, Vrljic I, Williams C, Bush S, Balabanski AH, Drummond KJ, Desmond P, Weber D, Denison T, Mathers S, O’Brien TJ, Mocco J, Grayden DB, Liebeskind DS, Opie NL, Oxley TJ, Campbell BCV Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients: The Stentrode With Thought-Controlled Digital Switch (SWITCH) Study. JAMA Neurol. 2023 Mar 1;80(3):270-278. doi: 10.1001/jamaneurol.2022.4847.
  • Nicholls SJ ORION-3: delivering lipid lowering treatment for longer. Lancet Diabetes Endocrinol. 2023 Feb;11(2):67-68. doi: 10.1016/S2213-8587(22)00362-X. Epub 2023 Jan 5.
  • Ray KK, Troquay RPT, Visseren FLJ, Leiter LA, Scott Wright R, Vikarunnessa S, Talloczy Z, Zang X, Maheux P, Lesogor A, Landmesser U Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. Lancet Diabetes Endocrinol. 2023 Feb;11(2):109-119. doi: 10.1016/S2213-8587(22)00353-9. Epub 2023 Jan 5.
  • Gulati M President’s page: The re-emergence of prevention in the forefront of cardiology. Am J Prev Cardiol. 2023 Mar;13:100458. doi: 10.1016/j.ajpc.2022.100458. Epub 2023 Jan 2.
  • Vidal-Petiot E, Elbez Y, Mesnier J, Ducrocq G, Ford I, Tendera M, Ferrari R, Tardif JC, Fox KM, Steg PG Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. Eur J Prev Cardiol. 2023 Aug 1;30(10):935-947. doi: 10.1093/eurjpc/zwad004.
  • Ihdayhid AR, Lan NSR, Figtree GA, Patel S, Arnott C, Hamilton-Craig C, Psaltis PJ, Leipsic J, Fairbairn T, Wahi S, Hillis GS, Rankin JM, Dwivedi G, Nicholls SJ Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT. Heart Lung Circ. 2023 Mar;32(3):297-306. doi: 10.1016/j.hlc.2022.12.003. Epub 2023 Jan 5.
  • Tam DY, Fang J, Rocha RV, Rao SV, Dzavik V, Lawton J, Austin PC, Gaudino M, Fremes SE, Lee DS Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada. JACC Cardiovasc Interv. 2023 Feb 13;16(3):277-288. doi: 10.1016/j.jcin.2022.10.016. Epub 2023 Jan 4.
  • Haynes NA, Johnson M, Lewsey SC, Alexander KM, Anstey DE, Dillenburg T, Njoroge JN, Gordon D, Ofili EO, Yancy CW, Albert MA Nurturing Diverse Generations of the Medical Workforce for Success With Authenticity: An Association of Black Cardiologists’ Roundtable. Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009032. doi: 10.1161/CIRCOUTCOMES.122.009032. Epub 2023 Jan 5.
  • Franchi F, Ortega-Paz L, Rollini F, Been L, Rivas A, Maaliki N, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni M, Angiolillo DJ Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study. EuroIntervention. 2023 Mar 20;18(15):1254-1265. doi: 10.4244/EIJ-D-22-00719.
  • Capodanno D, Angiolillo DJ Timing, Selection, Modulation, and Duration of P2Y(12) Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI. JACC Cardiovasc Interv. 2023 Jan 9;16(1):1-18. doi: 10.1016/j.jcin.2022.10.023.
  • Nicholls SJ, Kataoka Y, Nissen SE, Prati F, Windecker S, Puri R, Hucko T, Aradi D, Herrman JR, Hermanides RS, Wang B, Wang H, Butters J, Giovanni GD, Jones S, Pompili G, Wolski K, Psaltis PJ Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. JACC Cardiovasc Imaging. 2023 Jan;16(1):130-132. doi: 10.1016/j.jcmg.2022.07.020. Epub 2022 Nov 16.
  • Selvaraj S, Vaduganathan M, Claggett BL, Miao ZM, Fang JC, Vardeny O, Desai AS, Shah SJ, Lam CSP, Martinez FA, Inzucchi SE, de Boer RA, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER. JACC Heart Fail. 2023 Jan;11(1):76-89. doi: 10.1016/j.jchf.2022.09.002. Epub 2022 Oct 2.
  • Mohebi R, Liu Y, Felker GM, Prescott MF, Pina IL, Butler J, Ward JH, Solomon SD, Januzzi JL Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan. JACC Heart Fail. 2023 Jan;11(1):44-54. doi: 10.1016/j.jchf.2022.09.009. Epub 2022 Nov 9.
  • Shuvy M, von Bardeleben RS, Grasso C, Raake P, Lurz P, Zamorano JL, Asch F, Kar S, Maisano F, EXPAND Investigators Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study. ESC Heart Fail. 2023 Apr;10(2):1122-1132. doi: 10.1002/ehf2.14273. Epub 2023 Jan 4.
  • Pandey A, Kitzman DW, Nelson MB, Pastva AM, Duncan P, Whellan DJ, Mentz RJ, Chen H, Upadhya B, Reeves GR Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2023 Feb 1;8(2):167-176. doi: 10.1001/jamacardio.2022.4903.
  • Orban M, Rottbauer W, Williams M, Mahoney P, von Bardeleben RS, Price MJ, Grasso C, Lurz P, Zamorano JL, Asch FM, Maisano F, Kar S, Hausleiter J Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients – results from the Global EXPAND Post-Market study. Eur J Heart Fail. 2023 Mar;25(3):411-421. doi: 10.1002/ejhf.2770. Epub 2023 Jan 16.
  • Patel L, Keshvani N, Pandey A Are post-influenza vaccine reactions truly ‘adverse’? Eur J Heart Fail. 2023 Feb;25(2):311-312. doi: 10.1002/ejhf.2765. Epub 2023 Jan 22.
  • von Haehling S, Sato R, Butler J, Anker SD Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure. Eur J Heart Fail. 2023 Feb;25(2):235-237. doi: 10.1002/ejhf.2766. Epub 2023 Jan 16.
  • Matetic A, Mohamed MO, Essien UR, Guha A, Elkaryoni A, Elbadawi A, Van Spall HGC, Mamas MA Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):749-757. doi: 10.1093/ehjqcco/qcac090.
  • Docherty KF, McMurray JJV, Claggett BL, Miao ZM, Adams KF, Arias-Mendoza A, Cleland JGF, Diaz R, Echeverria Correa LE, Felker GM, Fonseca C, Li J, Metra M, Sliwa-Hahnle K, Solomon SD, Vandekerckhove HJ, Vinereanu D, Voors AA, Heitner SB, Kupfer S, Malik FI, Meng L, Teerlink JR Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. Eur J Heart Fail. 2023 Feb;25(2):248-259. doi: 10.1002/ejhf.2763. Epub 2023 Jan 16.
  • van der Hoef CCS, Boorsma EM, Emmens JE, van Essen BJ, Metra M, Ng LL, Anker SD, Dickstein K, Mordi IR, Dihoum A, Lang CC, van Veldhuisen DJ, Lam CSP, Voors AA Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. Eur J Heart Fail. 2023 Feb;25(2):163-173. doi: 10.1002/ejhf.2760. Epub 2023 Jan 16.
  • Delewi R, Vogel RF, Wilschut JM, Lemmert ME, Diletti R, van Vliet R, van der Waarden NWPL, Nuis RJ, Paradies V, Alexopoulos D, Zijlstra F, Montalescot G, Angiolillo DJ, Krucoff MW, Doevendans PA, Van Mieghem NM, Smits PC, Vlachojannis GJ Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction. Am Heart J. 2023 Apr;258:17-26. doi: 10.1016/j.ahj.2022.12.013. Epub 2022 Dec 31.
  • Cheng XS, Liu S, Han J, Stedman MR, Baiocchi M, Tan JC, Chertow GM, Fearon WF Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes. JAMA Intern Med. 2023 Feb 1;183(2):134-141. doi: 10.1001/jamainternmed.2022.6069.
  • Kim JM, Bhatt DL, Dagogo-Jack S, Cherney DZI, Cosentino F, McGuire DK, Pratley RE, Liu CC, Cater NB, Frederich R, Mancuso JP, Cannon CP Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. Diabetes Obes Metab. 2023 May;25(5):1398-1402. doi: 10.1111/dom.14965. Epub 2023 Feb 14.
  • Rikken SAOF, Selvarajah A, Hermanides RS, Coller BS, Gibson CM, Granger CB, Lapostolle F, Postma S, van de Wetering H, van Vliet RCW, Montalescot G, Ten Berg JM, van ‘t Hof AWJ, CELEBRATE investigators Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial. Am Heart J. 2023 Apr;258:119-128. doi: 10.1016/j.ahj.2022.12.015. Epub 2022 Dec 31.
  • Jain V, Maqsood MH, Siddiqi TJ, Siddiqi AK, Baloch ZQ, Kittleson MM, Fudim M, Felker GM, Greene SJ, Butler J, Khan MS Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure. Curr Probl Cardiol. 2023 Apr;48(4):101579. doi: 10.1016/j.cpcardiol.2022.101579. Epub 2022 Dec 30.
  • Price S, Kaski JC, Al-Lamee R, Boden WE, Huber K, Katz JN, Krychtiuk K The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease. Eur Heart J. 2023 Feb 7;44(6):445-447. doi: 10.1093/eurheartj/ehac811.
  • Platz E, Morrow DA, Verbrugge FH, Vranckx P, Cullen L Acute cardiovascular care in the emergency department and beyond: a call for interdisciplinary collaboration in clinical research. Eur Heart J Acute Cardiovasc Care. 2023 Feb 9;12(2):77-79. doi: 10.1093/ehjacc/zuac170.
  • Sharma G, Rao SJ, Douglas PS, Rzeszut A, Itchhaporia D, Wood MJ, Nasir K, Blumenthal RS, Poppas A, Kuvin J, Miller AP, Mehran R, Valentine M, Summers RF, Mehta LS Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists. J Am Coll Cardiol. 2023 Feb 14;81(6):574-586. doi: 10.1016/j.jacc.2022.11.025. Epub 2022 Dec 28.
  • Thum T, Lam CSP Accelerating developments in heart failure. Cardiovasc Res. 2023 Feb 3;118(18):3401-3402. doi: 10.1093/cvr/cvac185.
  • Marquis-Gravel G, Boivin-Proulx LA, Huang Z, Zelenkofske SL, Lincoff AM, Mehran R, Steg PG, Bode C, Alexander JH, Povsic TJ Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention. J Am Heart Assoc. 2023 Jan 3;12(1):e025666. doi: 10.1161/JAHA.122.025666. Epub 2022 Dec 30.
  • Wei S, Miranda JJ, Mamas MA, Zuhlke LJ, Kontopantelis E, Thabane L, Van Spall HGC Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990-2019. Eur Heart J Qual Care Clin Outcomes. 2023 Nov 2;9(7):662-672. doi: 10.1093/ehjqcco/qcac088.
  • Sabouret P, Spadafora L, Fischman D, Ullah W, Zeitouni M, Gulati M, De Rosa S, Savage MP, Costabel JP, Banach M, Biondi-Zoccai G, Galli M De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? Eur J Intern Med. 2023 Apr;110:1-9. doi: 10.1016/j.ejim.2022.12.008. Epub 2022 Dec 25.
  • Chi G, Violi F, Pignatelli P, Vestri A, Spagnoli A, Loffredo L, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ, Gibson CM External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial. J Thromb Thrombolysis. 2023 Feb;55(2):211-221. doi: 10.1007/s11239-022-02757-8. Epub 2022 Dec 24.
  • Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK, GARFIELD-VTE investigators 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2023 Feb;222:31-39. doi: 10.1016/j.thromres.2022.11.016. Epub 2022 Nov 25.
  • Khan MS, Butler J, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Pina IL, Bohm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Zeller C, Zannad F, Packer M Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. J Am Heart Assoc. 2023 Jan 3;12(1):e027652. doi: 10.1161/JAHA.122.027652. Epub 2022 Dec 24.
  • Hjort M, Eggers KM, Lakic TG, Lindback J, Budaj A, Cornel JH, Giannitsis E, Katus HA, Siegbahn A, Storey RF, Becker RC, Wallentin L, Lindahl B, PLATO trial investigators* Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial. J Am Heart Assoc. 2023 Jan 3;12(1):e027466. doi: 10.1161/JAHA.122.027466. Epub 2022 Dec 24.
  • Shahim B, Redfors B, Stuckey TD, Liu M, Zhou Z, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Srdanovic I, Madhavan MV, Mazzaferri EL Jr, Mehran R, Ben-Yehuda O, Kirtane AJ, Stone GW On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES. J Am Heart Assoc. 2023 Jan 3;12(1):e026482. doi: 10.1161/JAHA.122.026482. Epub 2022 Dec 24.
  • Tardif JC, Rouleau J, Chertow GM, Al-Shurbaji A, Lisovskaja V, Gustavson S, Zhao Y, Bouabdallaoui N, Desai AS, Chernyavskiy A, Evsina M, Merkely B, McMurray JJV, Pfeffer MA Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Fail. 2023 Apr;10(2):1066-1076. doi: 10.1002/ehf2.14268. Epub 2022 Dec 23.
  • Arevalos V, Spione F, Gabani R, Ortega-Paz L, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jimenez-Quevedo P, Diletti R, Pineda J, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, Bastos-Fernandez G, Iniguez A, Serra A, Escaned J, Ielasi A, Tespili M, Lenzen M, Fernandez-Ortiz A, Bordes P, Tebaldi M, Biscaglia S, Al-Shaibani S, Romaguera R, Gomez-Hospital JA, Rodes-Cabau J, Serruys PW, Sabate M, Brugaletta S Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial). Am J Cardiol. 2023 Mar 1;190:32-40. doi: 10.1016/j.amjcard.2022.11.035. Epub 2022 Dec 20.
  • Bongiovanni D, Schreiner N, Gosetti R, Mayer K, Angiolillo DJ, Sibbing D, Holdenrieder S, Anetsberger A, von Scheidt M, Schunkert H, Laugwitz KL, Schupke S, Kastrati A, Fegers-Wustrow I, Bernlochner I Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):e83-e93. doi: 10.1161/ATVBAHA.122.318614. Epub 2022 Dec 22.
  • Reynolds MR, Bunch TJ, Steinberg BA, Ronk CJ, Kim H, Wieloch M, Lip GYH Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data. J Cardiovasc Electrophysiol. 2023 Apr;34(4):790-799. doi: 10.1111/jce.15784. Epub 2023 Jan 6.
  • Galli M, Angiolillo DJ Efficacy and safety of lidocaine vs. opioid analgesics in acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2023 Jan 27;12(1):12-13. doi: 10.1093/ehjacc/zuac157.
  • Khan MS, Shahid I, Greene SJ, Mentz RJ, DeVore AD, Butler J Mechanisms of current therapeutic strategies for heart failure: more questions than answers? Cardiovasc Res. 2023 Feb 3;118(18):3467-3481. doi: 10.1093/cvr/cvac187.
  • Erickson KF, Worsley M, Winkelmayer WC Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 Jan 17;329(3):205-206. doi: 10.1001/jama.2022.23873.
  • Wang A, Ferro EG, Xu J, Song Y, Sun T, Strom JB, Kim DH, Yeh RW, Ko D, Kramer DB Comparative performance of distinct frailty measures among patients undergoing percutaneous left atrial appendage closure. Pacing Clin Electrophysiol. 2023 Mar;46(3):242-250. doi: 10.1111/pace.14649. Epub 2023 Jan 10.
  • Joyce E, McIllvennan CK, Esquivel JH, Sauer AJ, Correa A, Blumer V, Youmans QR, Alvarez-Garcia J, Chang H, Overbey J, Deych E, Sinha SS, Morris A, Defilippis EM, Reza N, Code J, Hajduczok AG, Fudim M, Rollins B, Vader JM, Pina IL, Teuteberg J, Zieroth S, Starling RC, Gulati M, Mentz RJ, Lala A Participating in the Peer Review Process: The Journal of Cardiac Failure Construct. J Card Fail. 2023 Feb;29(2):181-192. doi: 10.1016/j.cardfail.2022.11.007. Epub 2022 Dec 16.
  • Opstal TSJ, Nidorf SM, Fiolet ATL, Eikelboom JW, Mosterd A, Bax WA, Budgeon CA, Ronner E, Prins FJ, Tijssen JGP, Schut A, Thompson PL, El Messaoudi S, Cornel JH Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial. Int J Cardiol. 2023 Feb 1;372:1-5. doi: 10.1016/j.ijcard.2022.12.026. Epub 2022 Dec 15.
  • Kosiborod MN, Bhatt AS, Claggett BL, Vaduganathan M, Kulac IJ, Lam CSP, Hernandez AF, Martinez FA, Inzucchi SE, Shah SJ, de Boer RA, Jhund PS, Desai AS, Fang JC, Han Y, Comin-Colet J, Vardeny O, Lindholm D, Wilderang U, Bengtsson O, McMurray JJV, Solomon SD Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction. J Am Coll Cardiol. 2023 Feb 7;81(5):460-473. doi: 10.1016/j.jacc.2022.11.006. Epub 2022 Dec 14.
  • Woolley AE, Gandhi AR, Jones ML, Kim JJ, Mallidi HR, Givertz MM, Baden LR, Mehra MR, Neilan AAM The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients. Transplantation. 2023 Apr 1;107(4):961-969. doi: 10.1097/TP.0000000000004378. Epub 2022 Oct 27.
  • Gyldenkerne C, Maeng M, Kjoller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Erik Botker H, Engstrom T, Matsumura M, Mintz GS, Frobert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie O, Omerovic E, Held C, James SK, Ali ZA, Rosen HC, Stone GW, Erlinge D Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II. Circulation. 2023 Feb 7;147(6):469-481. doi: 10.1161/CIRCULATIONAHA.122.061983. Epub 2022 Dec 16.
  • Sacco S, Harriott AM, Ayata C, Ornello R, Bagur R, Jimenez-Ruiz A, Sposato LA Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update. Neurology. 2023 Apr 11;100(15):716-726. doi: 10.1212/WNL.0000000000201699. Epub 2022 Dec 15.
  • Wilson GJ, Van K, O’Lone E, Tong A, Craig JC, Sautenet B, Budde K, Forfang D, Gill J, Herrington WG, Jafar TH, Johnson DW, Krane V, Levin A, Malyszko J, Rossignol P, Sawinski D, Scholes-Robertons N, Strippoli G, Wang A, Winkelmayer WC, Hawley CM, Viecelli AK Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review. Transplant Direct. 2022 Dec 7;9(1):e1398. doi: 10.1097/TXD.0000000000001398. eCollection 2023 Jan.
  • Gilstrap L, Solomon N, Chiswell K, James O’Malley A, Skinner JS, Fonarow GC, Bhatt DL, Yancy CW, Devore AD The Association Between Beta-blocker and Renin-Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients. J Card Fail. 2023 Apr;29(4):434-444. doi: 10.1016/j.cardfail.2022.11.010. Epub 2022 Dec 11.
  • Kolkailah AA, Lingvay I, Dobrecky-Mery I, Aharonovich A, David JP, Holse C, Rasmussen S, McGuire DK Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes Obes Metab. 2023 Apr;25(4):1117-1120. doi: 10.1111/dom.14941. Epub 2022 Dec 23.
  • Siddiqi TJ, Shahid I, Arshad MS, Greene SJ, Pandey A, Vaduganathan M, VAN Spall HGC, Mentz RJ, Fonarow GC, Khan MS Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials. J Card Fail. 2023 Apr;29(4):425-433. doi: 10.1016/j.cardfail.2022.11.008. Epub 2022 Dec 11.
  • Karacsonyi J, Deffenbacher K, Benzuly KH, Flaherty JD, Alaswad K, Basir M, Megaly MS, Jaffer F, Doshi D, Poommipanit P, Khatri J, Patel M, Riley R, Sheikh A, Wollmuth JR, Korngold E, Uretsky BF, Yeh RW, Chandwaney RH, Elguindy AM, Tammam K, AbiRafeh N, Schmidt CW, Okeson B, Kostantinis S, Simsek B, Rangan BV, Brilakis ES, Schimmel DR Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 Feb 15;189:76-85. doi: 10.1016/j.amjcard.2022.10.049. Epub 2022 Dec 10.
  • Damluji AA, Forman DE, Wang TY, Chikwe J, Kunadian V, Rich MW, Young BA, Page RL 2nd, DeVon HA, Alexander KP, American Heart Association Cardiovascular Disease in Older Populations Committee, of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke, Nursing; Council on Cardiovascular Radiology and Intervention; and Council on, Lifestyle and Cardiometabolic Health Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association. Circulation. 2023 Jan 17;147(3):e32-e62. doi: 10.1161/CIR.0000000000001112. Epub 2022 Dec 12.
  • Popovic B, Ducrocq G, Elbez Y, Bode C, Mehta SR, Pollack CV, Sabate M, Rao SV, Parkhomenko A, Feldman LJ, Sayah N, Sabatine MS, Steg PG, TAO investigators Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention. Am J Cardiol. 2023 Feb 1;188:95-101. doi: 10.1016/j.amjcard.2022.11.013. Epub 2022 Dec 6.
  • Teramoto K, Tay WT, Tromp J, Katherine Teng TH, Chandramouli C, Ouwerkerk W, Lawson CA, Huang W, Hung CL, Chopra V, Anand I, Mark Richards A, Lam CSP Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry. Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009134. doi: 10.1161/CIRCOUTCOMES.122.009134. Epub 2022 Dec 9.
  • Bhm M, Anker S, Mahfoud F, Lauder L, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Saloustros I, Schler E, Wanner C, Zannad F, Packer M, Butler J Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur Heart J. 2023 Feb 1;44(5):396-407. doi: 10.1093/eurheartj/ehac693.
  • Costa F, Montalto C, Branca M, Hong SJ, Watanabe H, Franzone A, Vranckx P, Hahn JY, Gwon HC, Feres F, Jang Y, De Luca G, Kedhi E, Cao D, Steg PG, Bhatt DL, Stone GW, Micari A, Windecker S, Kimura T, Hong MK, Mehran R, Valgimigli M Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. Eur Heart J. 2023 Mar 14;44(11):954-968. doi: 10.1093/eurheartj/ehac706.
  • Chow SL, Bozkurt B, Baker WL, Bleske BE, Breathett K, Fonarow GC, Greenberg B, Khazanie P, Leclerc J, Morris AA, Reza N, Yancy CW, American Heart Association Clinical Pharmacology Committee and Heart Failure and, Transplantation Committee of the Council on Clinical Cardiology; Council on, Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2023 Jan 10;147(2):e4-e30. doi: 10.1161/CIR.0000000000001110. Epub 2022 Dec 8.
  • Raja A, Wadhera RK, Choi E, Chen S, Shen C, Figueroa JF, Yeh RW, Secemsky EA Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States. Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009199. doi: 10.1161/CIRCOUTCOMES.122.009199. Epub 2022 Dec 6.
  • Schechter M, Jongs N, Chertow GM, Mosenzon O, McMurray JJV, Correa-Rotter R, Rossing P, Langkilde AM, Sjostrom CD, Toto RD, Wheeler DC, Heerspink HJL Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD. Ann Intern Med. 2023 Jan;176(1):59-66. doi: 10.7326/M22-2115. Epub 2022 Dec 6.
  • Suresh K, Willems E, Williams J, Gritz RM, Dickinson LM, Perreault L, Holtrop JS An Assessment of Weight Loss Management in Health System Primary Care Practices. J Am Board Fam Med. 2023 Feb 8;36(1):51-65. doi: 10.3122/jabfm.2022.220224R1. Epub 2022 Dec 2.
  • Selvaraj S, Greene SJ, Ayodele I, Alhanti B, Allen LA, Lewsey SC, Adusumalli S, Reza N, Hernandez AF, Yancy CW, Jena AB, Fonarow GC, Bhatt DL Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure. Circ Heart Fail. 2023 Feb;16(2):e010069. doi: 10.1161/CIRCHEARTFAILURE.122.010069. Epub 2022 Dec 2.
  • Galli M, Franchi F, Rollini F, Ortega-Paz L, D’Amario D, De Caterina R, Mehran R, Gibson CM, Angiolillo DJ Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications. Expert Rev Clin Pharmacol. 2023 Jan;16(1):27-38. doi: 10.1080/17512433.2023.2154651. Epub 2022 Dec 12.
  • Adamstein NH, Cornel JH, Davidson M, Libby P, de Remigis A, Jensen C, Ekstrom K, Ridker PM Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial. JAMA Cardiol. 2023 Feb 1;8(2):177-181. doi: 10.1001/jamacardio.2022.4277.
  • Peters AE, Tromp J, Shah SJ, Lam CSP, Lewis GD, Borlaug BA, Sharma K, Pandey A, Sweitzer NK, Kitzman DW, Mentz RJ Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions. Cardiovasc Res. 2023 Feb 3;118(18):3403-3415. doi: 10.1093/cvr/cvac179.
  • Koch T, Lahu S, Coughlan JJ, Cassese S, Voll F, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, Bernlochner I, Joner M, Xhepa E, Mayer K, Kessler T, Laugwitz KL, Richardt G, Schunkert H, Angiolillo DJ, Sibbing D, Kastrati A, Kufner S Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. Thromb Haemost. 2023 Apr;123(4):464-477. doi: 10.1055/a-1988-5047. Epub 2022 Nov 28.
  • Mariani LH, Eddy S, AlAkwaa FM, McCown PJ, Harder JL, Nair V, Eichinger F, Martini S, Ademola AD, Boima V, Reich HN, El Saghir J, Godfrey B, Ju W, Tanner EC, Vega-Warner V, Wys NL, Adler SG, Appel GB, Athavale A, Atkinson MA, Bagnasco SM, Barisoni L, Brown E, Cattran DC, Coppock GM, Dell KM, Derebail VK, Fervenza FC, Fornoni A, Gadegbeku CA, Gibson KL, Greenbaum LA, Hingorani SR, Hladunewich MA, Hodgin JB, Hogan MC, Holzman LB, Jefferson JA, Kaskel FJ, Kopp JB, Lafayette RA, Lemley KV, Lieske JC, Lin JJ, Menon R, Meyers KE, Nachman PH, Nast CC, O’Shaughnessy MM, Otto EA, Reidy KJ, Sambandam KK, Sedor JR, Sethna CB, Singer P, Srivastava T, Tran CL, Tuttle KR, Vento SM, Wang CS, Ojo AO, Adu D, Gipson DS, Trachtman H, Kretzler M Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney Int. 2023 Mar;103(3):565-579. doi: 10.1016/j.kint.2022.10.023. Epub 2022 Nov 25.
  • Aktas MK, Zareba W, Butler J, Younis A, McNitt S, Brown MW, Rao N, Rao N, Steinberg J, Chen L, Alexis JD, Vidula H, Goldenberg I Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high-risk heart failure patients (Confirm-AF trial). Ann Noninvasive Electrocardiol. 2023 Jan;28(1):e13021. doi: 10.1111/anec.13021. Epub 2022 Nov 27.
  • Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023 Mar;16(3):269-278. doi: 10.1016/j.jcmg.2022.10.010. Epub 2022 Nov 16.
  • Aytekin A, Coughlan JJ, Ndrepepa G, Cassese S, Lahu S, Kufner S, Mayer K, Xhepa E, Gewalt S, Joner M, Hapfelmeier A, Angiolillo DJ, Menichelli M, Richardt G, Neumann FJ, Schunkert H, Kastrati A The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):231-239. doi: 10.1093/ehjcvp/pvac067.
  • Montalto C, Costa F, Leonardi S, Micari A, Oreglia JA, Vranckx P, Capodanno D, Ten Berg J, Lopes RD, Valgimigli M Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):220-230. doi: 10.1093/ehjcvp/pvac065.
  • Gay HC, Yu J, Persell SD, Linder JA, Srivastava A, Isakova T, Huffman MD, Khan SS, Mutharasan RK, Petito LC, Feinstein MJ, Shah SJ, Yancy CW, Kho AN, Ahmad FS Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease. Am J Cardiol. 2023 Feb 15;189:121-130. doi: 10.1016/j.amjcard.2022.10.041. Epub 2022 Nov 22.
  • Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hebert PC, MINT Investigators Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 Mar;257:120-129. doi: 10.1016/j.ahj.2022.11.015. Epub 2022 Nov 20.
  • Campos-Franco DR, Luna-Hernandez AM, Castillo-Castellon F, Gonzalez-Pacheco H, Arias-Mendoza A Porcelain aorto-coronary complex. Eur Heart J Cardiovasc Imaging. 2023 Jan 23;24(2):e29. doi: 10.1093/ehjci/jeac232.
  • Uriel N, Milano C, Agarwal R, Lee S, Cleveland J, Goldstein D, Wang A, Crandall D, Mehra MR Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis. Eur J Heart Fail. 2023 Feb;25(2):286-294. doi: 10.1002/ejhf.2746. Epub 2022 Nov 29.
  • Pollack R, Raz I, Wiviott SD, Goodrich EL, Murphy SA, Yanuv I, Rozenberg A, Mosenzon O, Langkilde AM, Gause-Nilsson IAM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS, Cahn A Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58. Diabetes Care. 2023 Jan 1;46(1):156-164. doi: 10.2337/dc22-1318.
  • Rashid HN, Rajani R, Leipsic J, Maurovitch-Horvat P, Patterson T, Redwood S, Lee J, Hurrell H, Nicholls SJ, Nasis A, Seneviratne S, Cameron JD, Prendergast B, Gooley RP Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2023 Jan-Feb;17(1):2-10. doi: 10.1016/j.jcct.2022.11.001. Epub 2022 Nov 8.
  • Mohebi R, Liu Y, van Kimmenade R, Gaggin HK, Murphy SP, Januzzi JL Jr Inflammation across universal definition of heart failure stages: the CASABLANCA study. Eur J Heart Fail. 2023 Feb;25(2):152-160. doi: 10.1002/ejhf.2742. Epub 2022 Nov 29.
  • Steg PG, Kikoine J Do We Need Ischemia Testing to Monitor Asymptomatic Patients With Chronic Coronary Syndromes? Circulation. 2023 Jan 3;147(1):5-7. doi: 10.1161/CIRCULATIONAHA.122.053565. Epub 2022 Nov 16.
  • Krawisz AK, Raja A, Jones WS, Schneider P, Shen C, Schermerhorn M, Secemsky EA Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions. EuroIntervention. 2023 Apr 3;18(16):e1378-e1387. doi: 10.4244/EIJ-D-22-00609.
  • Antaya TC, Le BN, Richard L, Qureshi A, Shariff SZ, Sposato LA, Burneo JG Epilepsy Surgery in Adult Stroke Survivors with New-Onset Drug-Resistant Epilepsy. Can J Neurol Sci. 2023 Sep;50(5):673-678. doi: 10.1017/cjn.2022.300. Epub 2022 Nov 14.
  • Joseph T, Foley M, Al-Lamee R Physiology and Intravascular Imaging Coregistration-Best of all Worlds? Interv Cardiol Clin. 2023 Jan;12(1):71-82. doi: 10.1016/j.iccl.2022.09.007.
  • Januzzi JL Jr, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Lewis GD, Marwick TH, Rosenstock J, Tang WHW, Zannad F, Lawson F, Perfetti R, Urbinati A Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy. Am Heart J. 2023 Feb;256:25-36. doi: 10.1016/j.ahj.2022.11.003. Epub 2022 Nov 11.
  • Chiou TT, Tomasi K, Taub PR, Wilkinson MJ Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic. J Clin Lipidol. 2023 Jan-Feb;17(1):73-77. doi: 10.1016/j.jacl.2022.10.009. Epub 2022 Nov 1.
  • Aliyev N, Almani MU, Qudrat-Ullah M, Harrington J, Fonarow GC, Butler J, Pandey A, Khan MS, Greene SJ Neighborhood Household Income and Trends in 30-Day Readmission for Patients With Heart Failure. JACC Heart Fail. 2023 Jan;11(1):121-123. doi: 10.1016/j.jchf.2022.10.003. Epub 2022 Oct 31.
  • Pierce JB, Maqsood MH, Khan MS, Minhas AMK, Butler J, Felker GM, Greene SJ, Durham, North Carolina; New York, New York;Hattiesburg and Jackson, Mississippi;, and Dallas, Texas Duration of Heart Failure, In-hospital Clinical Trajectory, and Postdischarge Outcomes in Patients Hospitalized for Heart Failure. J Card Fail. 2023 Feb;29(2):225-228. doi: 10.1016/j.cardfail.2022.10.427. Epub 2022 Nov 6.
  • Pagidipati NJ, Peterson ED Can System Solutions Be Scaled to Control High Blood Pressure and Lipids? JAMA Cardiol. 2023 Jan 1;8(1):21-22. doi: 10.1001/jamacardio.2022.4015.
  • Wu MZ, Teng TK, Tay WT, Ren QW, Tromp J, Ouwerkerk W, Chandramouli C, Huang JY, Chan YH, Teramoto K, Yu SY, Lawson C, Li HL, Tse YK, Li XL, Hung D, Tse HF, Lam CSP, Yiu KH Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2023 Mar;25(3):707-715. doi: 10.1111/dom.14916. Epub 2022 Nov 29.
  • Rao S, Essien UR, Powell-Wiley TM, Maddineni B, Das SR, Halm EA, Pandey A, Sumarsono A Association of US County-Level Eviction Rates and All-Cause Mortality. J Gen Intern Med. 2023 Apr;38(5):1207-1213. doi: 10.1007/s11606-022-07892-9. Epub 2022 Nov 7.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Gopar-Nieto R, Briseno-De-La-Cruz JL, Sierra-Lara D, Araiza-Garaygordobil D, Eid-Lidt G, Mendoza-Garcia S, Manzur-Sandoval D, Altamirano-Castillo A, Ontiveros-Mercado H, Aguilar-Montano KM, Rosas-Martinez M, Hernandez-Montfort J, Arias-Mendoza A Dynamic Invasive Hemodynamic Congestion Profile Impacts Acute Myocardial Infarction Complicated by Cardiogenic Shock Outcomes: A Real-World Single-Center Study. J Card Fail. 2023 May;29(5):745-756. doi: 10.1016/j.cardfail.2022.10.425. Epub 2022 Nov 5.
  • Patel RB, Greene SJ, Xu H, Alhanti B, Peterson P, Yancy CW, Piccini J, Fonarow GC, Vaduganathan M Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry. Eur J Heart Fail. 2023 Jan;25(1):63-73. doi: 10.1002/ejhf.2729. Epub 2022 Nov 20.
  • Verma S, Dhingra NK, Butler J, Anker SD, Pedro Ferreira J, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Pfarr E, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, EMPEROR-Pooled Trial Committees and Investigators Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled. Circulation. 2023 Jan 3;147(1):101-104. doi: 10.1161/CIRCULATIONAHA.122.062644. Epub 2022 Nov 7.
  • Wang X, Vaduganathan M, Claggett BL, Hegde SM, Pabon M, Kulac IJ, Vardeny O, O’Meara E, Zieroth S, Katova T, McGrath MM, Pouleur AC, Jhund PS, Desai AS, Inzucchi SE, Kosiborod MN, de Boer RA, Kober L, Sabatine MS, Martinez FA, Ponikowski P, Shah SJ, Hernandez AF, Langkilde AM, McMurray JJV, Solomon SD, Lam CSP Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER. Circulation. 2023 Feb 21;147(8):624-634. doi: 10.1161/CIRCULATIONAHA.122.062832. Epub 2022 Nov 7.
  • Kramer AD, Korsholm K, Jensen JM, Norgaard BL, Peelukhana S, Herbst T, Horton R, Kar S, Saw J, Alkhouli M, Nielsen-Kudsk JE Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing? Eur Heart J Cardiovasc Imaging. 2023 Jan 23;24(2):250-259. doi: 10.1093/ehjci/jeac222.
  • Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O’Brien SM, Mavromichalis S, Chang M, Contreras A, Rosenberg Y, Kirby R, Bhargava B, Senior R, Banfield A, Goodman SG, Lopes RD, Pracon R, Lopez-Sendon J, Maggioni AP, Newman JD, Berger JS, Sidhu MS, White HD, Troxel AB, Harrington RA, Boden WE, Stone GW, Mark DB, Spertus JA, Maron DJ, ISCHEMIA-EXTEND Research Group Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. 2023 Jan 3;147(1):8-19. doi: 10.1161/CIRCULATIONAHA.122.062714. Epub 2022 Nov 6.
  • Connelly KA, Mazer CD, Puar P, Teoh H, Wang CH, Mason T, Akhavein F, Chang CW, Liu MH, Yang NI, Chen WS, Juan YH, Opingari E, Salyani Y, Barbour W, Pasricha A, Ahmed S, Kosmopoulos A, Verma R, Moroney M, Bakbak E, Krishnaraj A, Bhatt DL, Butler J, Kosiborod MN, Lam CSP, Hess DA, Rizzi Coelho-Filho O, Lafreniere-Roula M, Thorpe KE, Quan A, Leiter LA, Yan AT, Verma S Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Circulation. 2023 Jan 24;147(4):284-295. doi: 10.1161/CIRCULATIONAHA.122.062769. Epub 2022 Nov 6.
  • Weissler EH, Osazuwa-Peters OL, Greiner MA, Hardy NC, Kougias P, O’Brien SM, Mark DB, Jones WS, Secemsky EA, Vekstein AM, Shalhub S, Mussa FF, Patel MR, Vemulapalli S Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection. JAMA Cardiol. 2023 Jan 1;8(1):44-53. doi: 10.1001/jamacardio.2022.4187.
  • Talha KM, Butler J, Greene SJ, Aggarwal R, Anker SD, Claggett BL, Solomon SD, McMurray JJV, Vaduganathan M, Fonarow GC Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US. JAMA Cardiol. 2023 Jan 1;8(1):66-73. doi: 10.1001/jamacardio.2022.4348.
  • Khan MS, Anker SD, Friede T, Jankowska EA, Metra M, Pina IL, Coats AJ, Rosano G, Roubert B, Goehring UM, Dorigotti F, Comin-Colet J, Vanveldhuisen DJ, Filippatos GS, Ponikowski P, Butler J Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency. J Card Fail. 2023 May;29(5):760-770. doi: 10.1016/j.cardfail.2022.10.423. Epub 2022 Nov 2.
  • Ray KK, Raal FJ, Kallend DG, Jaros MJ, Koenig W, Leiter LA, Landmesser U, Schwartz GG, Lawrence D, Friedman A, Garcia Conde L, Wright RS, ORION Phase III investigators Inclisiran and cardiovascular events: a patient-level analysis of phase III trials. Eur Heart J. 2023 Jan 7;44(2):129-138. doi: 10.1093/eurheartj/ehac594.
  • Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R, The EMPA-KIDNEY Collaborative Group Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
  • Mihalcea D, Memis H, Balinisteanu A, Vladareanu AM, Mihaila S, Vinereanu D Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients. J Clin Ultrasound. 2023 Mar;51(3):377-384. doi: 10.1002/jcu.23388. Epub 2022 Nov 4.
  • Sedhom R, Cortese B, Khedr M, Bharadwaj A, Brilakis ES, Pershad A, Basir MB, Alaswad K, Yeh RW, Megaly M Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 Jan 1;186:209-215. doi: 10.1016/j.amjcard.2022.09.033. Epub 2022 Nov 1.
  • McCarthy C, Li S, Wang TY, Raber I, Sandoval Y, Smilowitz NR, Wasfy JH, Pandey A, de Lemos JA, Kontos MC, Apple FS, Daniels LB, Newby LK, Jaffe AS, Januzzi JL Jr Implementation of High-Sensitivity Cardiac Troponin Assays in the United States. J Am Coll Cardiol. 2023 Jan 24;81(3):207-219. doi: 10.1016/j.jacc.2022.10.017. Epub 2022 Oct 31.
  • Khairani CD, Bejjani A, Piazza G, Jimenez D, Monreal M, Chatterjee S, Pengo V, Woller SC, Cortes-Hernandez J, Connors JM, Kanthi Y, Krumholz HM, Middeldorp S, Falanga A, Cushman M, Goldhaber SZ, Garcia DA, Bikdeli B Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials. J Am Coll Cardiol. 2023 Jan 3;81(1):16-30. doi: 10.1016/j.jacc.2022.10.008. Epub 2022 Oct 31.
  • Mc Causland FR, Claggett BL, Vaduganathan M, Desai AS, Jhund P, de Boer RA, Docherty K, Fang J, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Saraiva JFK, McGrath MM, Shah SJ, Verma S, Langkilde AM, Petersson M, McMurray JJV, Solomon SD Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial. JAMA Cardiol. 2023 Jan 1;8(1):56-65. doi: 10.1001/jamacardio.2022.4210.
  • Anker SD, Khan MS, Butler J, Ofstad AP, Peil B, Pfarr E, Doehner W, Sattar N, Coats AJS, Filippatos G, Ferreira JP, Zannad F, Pocock S, Packer M Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. Eur J Heart Fail. 2023 Jan;25(1):117-127. doi: 10.1002/ejhf.2728. Epub 2022 Nov 24.
  • Nanna MG, Kolkailah AA, Page C, Peterson ED, Navar AM Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice. JAMA Cardiol. 2023 Jan 1;8(1):89-95. doi: 10.1001/jamacardio.2022.3839.
  • Franchi F, Ortega-Paz L, Rollini F, Galli M, Been L, Ghanem G, Shalhoub A, Ossi T, Rivas A, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Reiter B, Jilma B, Angiolillo DJ Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study. JACC Cardiovasc Interv. 2023 Jan 9;16(1):36-46. doi: 10.1016/j.jcin.2022.10.034. Epub 2022 Oct 31.
  • McQueen RB, Baum SJ, Louie MJ, Sasiela WJ, Bilitou A, Shah H, Nash B, Gillard KK, Ray KK Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins. Am J Cardiovasc Drugs. 2023 Jan;23(1):67-76. doi: 10.1007/s40256-022-00552-7. Epub 2022 Oct 31.
  • Brucato A, Wheeler A, Luis SA, Abbate A, Cremer PC, Zou L, Insalaco A, Lewinter M, Lewis BS, Lin D, Nicholls S, Pancrazi M, Klein AL, Imazio M, Paolini JF Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis. Heart. 2023 Jan 27;109(4):297-304. doi: 10.1136/heartjnl-2022-321328.
  • Cosiano MF, Vista A, Sun JL, Alhanti B, Harrington J, Butler J, Starling RC, Mentz RJ, Greene SJ Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail. 2023 Jan;16(1):e010107. doi: 10.1161/CIRCHEARTFAILURE.122.010107. Epub 2022 Oct 31.
  • Chung M, Butala NM, Faridi KF, Almarzooq ZI, Liu D, Xu J, Song Y, Baron SJ, Shen C, Kazi DS, Yeh RW Days at home after transcatheter or surgical aortic valve replacement in high-risk patients. Am Heart J. 2023 Jan;255:125-136. doi: 10.1016/j.ahj.2022.10.080. Epub 2022 Oct 27.
  • Cavallari LH, Limdi NA, Beitelshees AL, Lee JC, Duarte JD, Franchi F, Tuteja S, Giri J, Empey PE, Kreutz RP, Skaar TC, Allen JM, Coons JC, Gong Y, McDonough CW, Stevenson JM, Thomas CD, Johnson JA, Stouffer GA, Angiolillo DJ, Lee CR, IGNITE Network Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y(12) Inhibitor Prescribing After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2023 Mar;113(3):615-623. doi: 10.1002/cpt.2776. Epub 2022 Nov 19.
  • Ortega-Paz L, Cristobal H, Ortiz-Perez JT, Garcia de Frutos P, Mendieta G, Sandoval E, Rodriguez JJ, Ortega E, Garcia-Alvarez A, Brugaletta S, Sabate M, Dantas AP Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction. ESC Heart Fail. 2023 Feb;10(1):453-464. doi: 10.1002/ehf2.14186. Epub 2022 Oct 27.
  • Galli M, Ortega-Paz L, Angiolillo DJ Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot. Eur Heart J. 2023 Jan 14;44(3):236. doi: 10.1093/eurheartj/ehac601.
  • McEwan P, Boyce R, Sanchez JJG, Sjostrom CD, Stefansson B, Nolan S, Correa-Rotter R, Rossing P, Chertow GM, McMurray JJV, Wheeler DC, Heerspink HJL Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrol Dial Transplant. 2023 May 4;38(5):1260-1270. doi: 10.1093/ndt/gfac280.
  • Qureshi N, Antoniou S, Cornel JH, Schiele F, Perrone-Filardi P, Brachmann J, Sidelnikov E, Villa G, Ferguson S, Rowlands C, Gonzalez-Juanatey JR European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction. Adv Ther. 2023 Jan;40(1):233-251. doi: 10.1007/s12325-022-02344-6. Epub 2022 Oct 26.
  • Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD Iron deficiency and cardiovascular disease. Eur Heart J. 2023 Jan 1;44(1):14-27. doi: 10.1093/eurheartj/ehac569.
  • Nelson AJ, Pagidipati NJ, Kelsey MD, Ardissino M, Aroda VR, Cavender MA, Lopes RD, Al-Khalidi HR, Braceras R, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O’Brien EC, Pak J, Pop-Busui R, Richardson CR, Levya M, Senyucel C, Webb L, McGuire DK, Green JB, Granger CB Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) – Diabetes: rationale and design. Am Heart J. 2023 Feb;256:2-12. doi: 10.1016/j.ahj.2022.10.079. Epub 2022 Oct 21.
  • Nakayama M, Goto S, Sakano T, Goto S Detection of the Relationship between the Multi-Dimensional Data Sets of Serially Measured Blood Pressure and the Future Risk of Death in Healthy Elderly Japanese Population. J Atheroscler Thromb. 2023 Aug 1;30(8):1002-1009. doi: 10.5551/jat.63798. Epub 2022 Oct 21.
  • Field TS, Sposato LA, Hill MD, Healey JS, Andrade JG, Zhou LW Embolic Stroke of Undetermined Source: Current Perspectives on Diagnosis, Investigations, and Management. Can J Cardiol. 2023 Feb;39(2):172-186. doi: 10.1016/j.cjca.2022.10.017. Epub 2022 Oct 20.
  • Abtan J, Bhatt DL, Elbez Y, Ducrocq G, Goto S, Smith SC Jr, Ohman EM, Eagle KA, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Petrov I, Sinnaeve PR, Pais P, Lev E, Bueno H, Wilson P, Steg PG, REACH Registry Investigators External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. Int J Cardiol. 2023 Jan 1;370:51-57. doi: 10.1016/j.ijcard.2022.10.132. Epub 2022 Oct 19.
  • Gada H, Vora AN, Tang GHL, Mumtaz M, Forrest JK, Laham RJ, Yakubov SJ, Deeb GM, Rammohan C, Huang J, Reardon MJ Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk Trial. Cardiovasc Revasc Med. 2023 Feb;47:48-54. doi: 10.1016/j.carrev.2022.10.004. Epub 2022 Oct 14.
  • Galli M, Benenati S, Zito A, Capodanno D, Zoccai GB, Ortega-Paz L, Iaconelli A, D’Amario D, Porto I, Burzotta F, Trani C, De Caterina R, Gaudino M, Escaned J, Angiolillo DJ, Crea F Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis. Int J Cardiol. 2023 Jan 1;370:58-64. doi: 10.1016/j.ijcard.2022.10.023. Epub 2022 Oct 18.
  • Lu H, Ashiqueali R, Lin CI, Walchale A, Clendaniel V, Matheson R, Fisher M, Lo EH, Selim M, Shehadah A Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier After Stroke. Mol Neurobiol. 2023 Jan;60(1):235-246. doi: 10.1007/s12035-022-03083-z. Epub 2022 Oct 18.
  • Hale S, Yancy CW New Biomarkers in Heart Failure: The Bar is High. J Card Fail. 2023 Feb;29(2):168-170. doi: 10.1016/j.cardfail.2022.09.010. Epub 2022 Oct 13.
  • Khan MS, Ahmed A, Greene SJ, Fiuzat M, Kittleson MM, Butler J, Bakris GL, Fonarow GC Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review. J Card Fail. 2023 Jan;29(1):87-107. doi: 10.1016/j.cardfail.2022.09.013. Epub 2022 Oct 13.
  • Bernier TD, Stern G, Buckley LF, Vieira JL, Siddiqi HK, Mehra MR Intravenous Iron Repletion in Patients With Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2023 Mar 1;69(3):e115-e117. doi: 10.1097/MAT.0000000000001800. Epub 2022 Oct 12.
  • Zhang Y, Gao C, Greene SJ, Greenberg BH, Butler J, Yu J, Zheng Z, Ma G, Wang L, Yang P, Ji X, Xu D, Wang J, Zhang Y, Liu Y, Zhao Y, Qi H, Zhai M, Feng J, Huang Y, Zhou Q, Zhang J Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry study. ESC Heart Fail. 2023 Feb;10(1):342-352. doi: 10.1002/ehf2.14184. Epub 2022 Oct 12.
  • Ortega-Paz L, Talasaz AH, Sadeghipour P, Potpara TS, Aronow HD, Jara-Palomares L, Sholzberg M, Angiolillo DJ, Lip GYH, Bikdeli B COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. Semin Thromb Hemost. 2023 Nov;49(8):816-832. doi: 10.1055/s-0042-1757634. Epub 2022 Oct 12.
  • Nelson AJ, Inohara T, Rao SV, Kaltenbach LA, Wojdyla D, Wang TY Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry. Am Heart J. 2023 Jan;255:117-124. doi: 10.1016/j.ahj.2022.10.002. Epub 2022 Oct 9.
  • Zon RL, Merz LE, Fields KG, Grandoni J, Stuart JC, Occhiogrosso RH, Li L, Baron RM, Fredenburgh LE, Woolley AE, Connors JM, Frendl G Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non-COVID-19 Intensive Care Unit Patients. Anesth Analg. 2023 Jan 1;136(1):70-78. doi: 10.1213/ANE.0000000000006214. Epub 2022 Oct 11.
  • Mohebi R, van Kimmenade R, McCarthy CP, Magaret CA, Barnes G, Rhyne RF, Gaggin HK, Januzzi JL Jr Performance of a multi-biomarker panel for prediction of cardiovascular event in patients with chronic kidney disease. Int J Cardiol. 2023 Jan 15;371:402-405. doi: 10.1016/j.ijcard.2022.09.074. Epub 2022 Oct 4.
  • Ouwerkerk W, Tromp J, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Filippatos G, Collins SP, Lam CSP Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail. 2023 Jan;25(1):43-51. doi: 10.1002/ejhf.2708. Epub 2022 Nov 23.
  • Hansen B, Holtzman JN, Juszczynski C, Khan N, Kaur G, Varma B, Gulati M Ischemia with No Obstructive Arteries (INOCA): A Review of the Prevalence, Diagnosis and Management. Curr Probl Cardiol. 2023 Jan;48(1):101420. doi: 10.1016/j.cpcardiol.2022.101420. Epub 2022 Sep 30.
  • Stone KH, Reynolds K, Davis S, Van Tassell BW, Gibson CM Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery. Gen Thorac Cardiovasc Surg. 2023 May;71(5):299-305. doi: 10.1007/s11748-022-01877-5. Epub 2022 Sep 30.
  • Nilsson E, Stenvinkel P, Liu S, Stedman MR, Chertow GM, Floege J Serum testosterone concentrations and outcomes in hemodialysis patients enrolled in the EVOLVE trial. Nephrol Dial Transplant. 2023 May 31;38(6):1519-1527. doi: 10.1093/ndt/gfac278.
  • Lee K, Ellison B, Selim M, Long NH, Filippidis A, Thomas AJ, Spincemaille P, Wang Y, Soman S Quantitative susceptibility mapping improves cerebral microbleed detection relative to susceptibility-weighted images. J Neuroimaging. 2023 Jan;33(1):138-146. doi: 10.1111/jon.13054. Epub 2022 Sep 28.
  • Mai AS, Matetic A, Elgendy IY, Lopez-Mattei J, Kotronias RA, Sun LY, Yong JH, Bagur R, Van Spall HGC, Mamas MA The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism. Int J Cardiol. 2023 Jan 15;371:354-362. doi: 10.1016/j.ijcard.2022.09.049. Epub 2022 Sep 24.
  • Wang AX, Liu S, Montez-Rath ME, Chertow GM, Lenihan CR Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients. Am J Kidney Dis. 2023 Mar;81(3):270-280.e1. doi: 10.1053/j.ajkd.2022.07.015. Epub 2022 Sep 24.
  • Gulati M, Khan N, George M, Berry C, Chieffo A, Camici PG, Crea F, Kaski JC, Marzilli M, Merz CNB Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international. Int J Cardiol. 2023 Jan 15;371:28-39. doi: 10.1016/j.ijcard.2022.09.047. Epub 2022 Sep 23.
  • Farmakis IT, Barco S, Hobohm L, Braekkan SK, Connors JM, Giannakoulas G, Hunt BJ, Keller K, Mavromanoli AC, Trinchero A, Konstantinides SV, Valerio L Maternal mortality related to pulmonary embolism in the United States, 2003-2020. Am J Obstet Gynecol MFM. 2023 Jan;5(1):100754. doi: 10.1016/j.ajogmf.2022.100754. Epub 2022 Sep 23.
  • Siddiqi HK, Defilippis EM, Biery DW, Singh A, Wu WY, Divakaran S, Berman AN, Rizk T, Januzzi JL, Bohula E, Stewart G, Carli MD, Bhatt DL, Blankstein R Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock After Acute Myocardial Infarction. J Card Fail. 2023 Jan;29(1):18-29. doi: 10.1016/j.cardfail.2022.08.012. Epub 2022 Sep 18.
  • Morton JI, Liew D, Nicholls SJ, Ademi Z Should we continue to subsidise therapeutics with uncertain efficacy? Health economic implications for icosapent ethyl. Eur J Prev Cardiol. 2023 Nov 30;30(17):1935-1938. doi: 10.1093/eurjpc/zwac212.
  • Balasubramanian RN, Mills GB, Wilkinson C, Mehran R, Kunadian V Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes. Heart. 2023 Mar 10;109(7):504-510. doi: 10.1136/heartjnl-2022-321470.
  • Diez J, Butler J Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action. Hypertension. 2023 Jan;80(1):13-21. doi: 10.1161/HYPERTENSIONAHA.122.19373. Epub 2022 Sep 9.
  • Du EH, Tenenbaum MN, Bhadelia RA, Sotman TE, Edlow JA, Selim MH, Chang YM Major radiological outcomes of CTA head and neck performed for dizziness in a major academic Emergency Department. Neuroradiol J. 2023 Jun;36(3):259-266. doi: 10.1177/19714009221124304. Epub 2022 Aug 31.
  • Belhassen M, Hanon O, Steg PG, Mahe I, Nee M, Jacoud F, Dalon F, Cotte FE, Guitard-Dehoux D, Marant-Micallef C, Van Ganse E, Danchin N Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France. Eur J Health Econ. 2023 Aug;24(6):867-875. doi: 10.1007/s10198-022-01513-2. Epub 2022 Aug 28.
  • Hassan MZO, Awadalla M, Tan TC, Scherrer-Crosbie M, Bakar RB, Drobni ZD, Zarif A, Gilman HK, Supraja S, Nikolaidou S, Zhang L, Zlotoff DA, Hickey SB, Patel SA, Januzzi JL, Keane F, Passeri JJ, Neilan TG, MacDonald SM, Jimenez RB Serial Measurement of Global Longitudinal Strain Among Women With Breast Cancer Treated With Proton Radiation Therapy: A Prospective Trial for 70 Patients. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):398-406. doi: 10.1016/j.ijrobp.2022.08.036. Epub 2022 Aug 24.
  • Lamy A, Eikelboom J, Tong W, Yuan F, Bangdiwala SI, Bosch J, Connolly S, Lonn E, Dagenais GR, Branch KRH, Wang WJ, Bhatt DL, Probstfield J, Ertl G, Stork S, Steg PG, Aboyans V, Durand-Zaleski I, Ryden L, Yusuf S The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial. Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):502-510. doi: 10.1093/ehjqcco/qcac054.
  • Wild J, Kaizer A, Willems E, Kramer ES, Perreault L Prelude to PATHWEIGH: pragmatic weight management in primary care. Fam Pract. 2023 Mar 28;40(2):322-329. doi: 10.1093/fampra/cmac092.
  • Copur S, Yildiz A, Basile C, Tuttle KR, Kanbay M Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury? J Nephrol. 2023 Jan;36(1):31-43. doi: 10.1007/s40620-022-01422-w. Epub 2022 Aug 13.
  • Miller M, Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Ballantyne CM, Budoff M, Mason RP Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):129-137. doi: 10.1093/ehjcvp/pvac045.
  • Kamimura D, Yimer WK, Shah AM, Mentz RJ, Oshunbade A, Hamid A, Suzuki T, Clark D 3rd, Waller J, Fox ER, Correa A, Butler J, Hall ME Vitamin D Levels in Black Americans and the Association With Left Ventricular Remodeling and Incident Heart Failure With Preserved Ejectin Fraction: The Jackson Heart Study. J Card Fail. 2023 Feb;29(2):150-157. doi: 10.1016/j.cardfail.2022.07.049. Epub 2022 Jul 26.
  • Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023 Feb 3;118(18):3434-3450. doi: 10.1093/cvr/cvac120.
  • Behnes M, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wohrle J, Bernlochner I, Gewalt S, Witzenbichler B, Hochholzer W, Sibbing D, Cassese S, Angiolillo DJ, Hemetsberger R, Valina C, Muller A, Kufner S, Hamm CW, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Fusaro M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schupke S, Kastrati A, Akin I Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial. Clin Res Cardiol. 2023 Apr;112(4):518-528. doi: 10.1007/s00392-022-02040-z. Epub 2022 Jul 5.
  • Offiah G, O’Connor C, Kennedy C, Gallagher J, O’Connor P, McAdam B, Ray KK, Schoonen M, Maher V The DA VINCI study: is Ireland achieving ESC/EAS guideline-directed LDL-C goals? Ir J Med Sci. 2023 Jun;192(3):1077-1084. doi: 10.1007/s11845-022-03050-6. Epub 2022 Jul 1.
  • Saha A, Patel KV, Ayers C, Ballantyne CM, Correa A, Defilippi C, Hall ME, Mentz RJ, Seliger SL, Yimer W, Butler J, Berry JD, De Lemos JA, Pandey A Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults. J Card Fail. 2023 Jan;29(1):6-15. doi: 10.1016/j.cardfail.2022.05.013. Epub 2022 Jun 8.
  • Secemsky EA, Barrette E, Bockstedt L, Yeh RW Assessment of the Social Security Administration Death Master File for Comparative Analysis Studies of Peripheral Vascular Devices. Value Health. 2023 Jan;26(1):55-59. doi: 10.1016/j.jval.2022.05.002. Epub 2022 Jun 6.
  • John R, Kanwar MK, Cleveland JC Jr, Uriel N, Naka Y, Salerno C, Horstmanshof D, Hall SA, Cowger JA, Heatley G, Somo SI, Mehra MR Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 Dec;166(6):1684-1694.e18. doi: 10.1016/j.jtcvs.2022.04.021. Epub 2022 Apr 25.
  • Chadow D, Audisio K, Perezgrovas-Olaria R, Cancelli G, Robinson NB, Rahouma M, Soletti G Jr, Angiolillo DJ, Metkus TS, Gaudino MFL Differences Among Clinical Trials and Registries on Surgical and Percutaneous Coronary Interventions. Ann Thorac Surg. 2023 Jan;115(1):79-86. doi: 10.1016/j.athoracsur.2022.05.015. Epub 2022 May 25.
  • Charles D, Sabouret P, Moll A, Plisson M, Nasir K, Biondi-Zoccai G, Gulati M, Bhatt DL, Fysekidis M The relationship between mortality and daily number of steps in type 2 diabetes. Panminerva Med. 2023 Sep;65(3):335-342. doi: 10.23736/S0031-0808.22.04732-2. Epub 2022 May 30.
  • Durand-Zaleski I, Ducrocq G, Mimouni M, Frenkiel J, Avendano-Sola C, Gonzalez-Juanatey JR, Ferrari E, Lemesle G, Puymirat E, Berard L, Cachanado M, Arnaiz JA, Martinez-Selles M, Silvain J, Ariza-Sole A, Calvo G, Danchin N, Paco S, Drouet E, Abergel H, Rousseau A, Simon T, Steg PG Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses. Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):194-202. doi: 10.1093/ehjqcco/qcac029.
  • Wojeck BS, Inzucchi SE, Neeland IJ, Mancuso JP, Frederich R, Masiukiewicz U, Cater NB, McGuire DK, Cannon CP, Yaggi HK Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial. Sleep Breath. 2023 May;27(2):669-672. doi: 10.1007/s11325-022-02594-2. Epub 2022 May 20.
  • Vallejo-Vaz AJ, Bray S, Villa G, Brandts J, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Kees Hovingh G, Jozwiak JJ, Jukema JW, Gabor Kiss R, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, Ray KK, DA VINCI Study Investigators Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI. Cardiovasc Drugs Ther. 2023 Oct;37(5):941-953. doi: 10.1007/s10557-022-07343-x. Epub 2022 May 14.
  • Ali M, Zhang X, Ascanio LC, Troiani Z, Smith C, Dangayach NS, Liang JW, Selim M, Mocco J, Kellner CP Long-term functional independence after minimally invasive endoscopic intracerebral hemorrhage evacuation. J Neurosurg. 2022 May 13;138(1):154-164. doi: 10.3171/2022.3.JNS22286. Print 2023 Jan 1.
  • Sarma AA, Hsu S, Januzzi JL, Goldfarb IT, Thadhani R, Wood MJ, Powe CE, Scott NS First Trimester Cardiac Biomarkers among Women with Peripartum Cardiomyopathy: Are There Early Clues to This Late-Pregnancy Phenomenon? Am J Perinatol. 2023 Jan;40(2):137-140. doi: 10.1055/s-0042-1748159. Epub 2022 May 6.
  • Zhang Y, Gutman T, Tong A, Craig JC, Sinha A, Dart A, Eddy AA, Gipson DS, Bockenhauer D, Yap HK, Groothoff J, Zappitelli M, J A Webb N, Alexander SI, Furth S, Samuel S, Blydt-Hansen TD, Dionne J, Michael M, Wenderfer SE, Winkelmayer WC, McTaggart S, Walker A, Zimmerman CT, Ralph AF, Ju A, James LJ, Hanson CS Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study. Pediatr Nephrol. 2023 Jan;38(1):249-260. doi: 10.1007/s00467-022-05551-z. Epub 2022 Apr 26.
  • Minhas AMK, Bhopalwala HM, Dewaswala N, Salah HM, Khan MS, Shahid I, Biegus J, Lopes RD, Pandey A, Fudim M Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction. Curr Probl Cardiol. 2023 Aug;48(8):101199. doi: 10.1016/j.cpcardiol.2022.101199. Epub 2022 Apr 9.
  • Bevan G, Pandey A, Griggs S, Dalton JE, Zidar D, Patel S, Khan SU, Nasir K, Rajagopalan S, Al-Kindi S Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease. Curr Probl Cardiol. 2023 Aug;48(8):101182. doi: 10.1016/j.cpcardiol.2022.101182. Epub 2022 Mar 27.
  • Gibson CM, Larson S, Behnen EM, Dugan SE, Moody AE, Wagner JL Feeding the Soul via Creation of a Suborganization to Promote a Sense of Community. Am J Pharm Educ. 2023 Jan;87(1):ajpe8927. doi: 10.5688/ajpe8927. Epub 2022 Mar 22.
  • Galli M, Franchi F, Rollini F, Angiolillo DJ Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention. Trends Cardiovasc Med. 2023 Apr;33(3):133-138. doi: 10.1016/j.tcm.2021.12.007. Epub 2021 Dec 20.
  • Romagnoli E, Paoletti G, Marco V, Gatto L, Calligaris G, Fabbiocchi F, Fineschi M, Boi A, Albertucci M, Nicholls SJ, Prati F Comparison between different approaches to evaluate fibrous cap thickness in sequential optical coherence tomography studies. Minerva Cardiol Angiol. 2023 Jun;71(3):275-283. doi: 10.23736/S2724-5683.20.05237-8. Epub 2020 Jul 10.